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Preface
The present report is based on data obtained primarily from the annual reports
questionnaires (ARQ) received by UNDCP up to February 1999.  Such reports hitherto presented
only the supply side data from the ARQ.  The present report now contains a statistical summary
of the demand side data obtained from the ARQ, and is meant to show one of the several ways
in which UNDCP is trying to put the “balanced approach” (putting demand on par with supply)
into practice.
While the supply side dimensions of the international drug problem have been recognized
for decades, the demand side has traditionally been considered a domestic issue, not conducive
to international assessment.  Thus, data on supply side indicators such as illicit drug cultivation,
production and seizures, has been systematically collected and published for most of this century.
Indicators to measure the demand for illicit drugs, such as the extent and incidence of abuse, or
the treatment and prevention of it, have not received commensurate attention at the international
level.
In adopting a Political Declaration,  as well as a Declaration on the Guiding Principles of
Drug Demand Reduction, the General Assembly at its twentieth special session not only reiterated
the importance of the “balanced approach” but also noted that effective demand reduction
activities could only develop on the basis of regular, objective and scientifically valid  assessments
of the drug problem.  (General Assembly resolution S-20/2 and S-20/3, annex).
The present report thus contains two parts, the first dealing with the supply side, and the
second dealing with the demand side of the drug problem.  Data, statistical summaries and some
analysis are provided, not only in the hope of making such a compilation internationally accessible,
but also of ensuring that States Members may benefit from, and continue to contribute to, the
information contained in the ARQ. 
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Explanatory note
The following abbreviations have been used in this report:
ARQ         annual reports questionnaire
ATS         amphetamine-type stimulants
CICAD       Inter-American Drug Abuse Control Commission
CIS        Commonwealth of Independent States
DEA         Drug Enforcement Administration
DMT N,N - dimethyltryptamine
DOB brolamfetamine
EMCDDA      European Monitoring Centre for Drugs and Drug Addiction
ESPAD European School Survey Project on Alcohol and other Drugs
IDU injecting drug use
INCB        International Narcotics Control Board
Interpol    International Criminal Police Organization
LSD         lysergic acid diethylamide
PCP         phencyclidine
UNDCP       United Nations International Drug Control Programme
UNAIDS      Joint and Co-sponsored United Nations Programme on Human  
Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
WHO         World Health Organization
The designations employed and the presentation of the material in this publication do not
imply the expression of any opinion whatsoever on the part of the Secretariat of the United
Nations concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries.
The names of territories and administrative areas are in italics.
This document has been reproduced without full formal editing.
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aThe term “supply refers to the production of drugs as well as their transportation/trafficking to
consumer areas.
Part one: supply
I. Executive summary
1. For many years trend analyses of the global supplya of illicit drugs have presented a
continuously rising picture, particularly for heroin and cocaine.  With some of these drugs having
reached apparent current saturation points, an interrelationship of the various drug types becomes
noticeable. Developments and emerging trends in the global supply of (and demand for) illicit
drugs differ significantly between drug types, suggesting that an increasing supply of one drug
may coincide with the decline/stabilization of another. Just as the interdependence of supply and
demand dynamics has received increased attention in recent years, leading to balanced approach
proposals to tackle the drug problem, an interrelationship of sometimes diverse supply trends
of different drug types has been acknowledged, which at times indicates that emerging/new
substances (not common in a certain region) are to a certain extent replacing traditional ones.
2. A second characteristic of the present drug market is the continued globalization of
illicit drug production, trafficking and consumption, as a result of which the old distinction
between so-called “producer” and “consumer” areas is becoming increasingly blurred.  Generated
by a spread of trafficking routes across the entire globe throughout recent years, and driven by
increased pressure upon traffickers to create new markets, the abuse of various drug types, most
of which were once  limited to certain regions, has became prevalent worldwide. At the same
time, production of plant-based drugs has arisen in countries and regions not traditionally known
as supply countries, though the main producer countries remain unchanged. The traditional drug
consumer regions remain mostly linked to the manufacture of synthetic drugs, but indoor and
small-scale outdoor cultivation of cannabis plant has also surfaced.
3. Production of both cocaine and heroin seems to have reached a peak globally, with  the
sharply rising trends of the 1980s and early 1990s having levelled out into a state of relative
stabilization (stabilization trends in respect of cocaine and heroin are reflected not only in
cultivation/production estimates but also in seizure statistics at the global level). However, while
the major cocaine and heroin consumer markets have reached saturation points for these particular
substances, drug consumption/demand on the whole is still growing in these regions. At the same
time, both drug types increasingly enter new markets outside of their major consumer zones.
4. The growing demand for illicit drugs per se in traditional cocaine and heroin consumer
regions - which seems to be being partly satisfied by amphetamine-type stimulants (ATS) - has
also led to (or followed) some displacement of cocaine trafficking to Western Europe and heroin
to North America.  Additionally,  abuse of cocaine and heroin (as well as ATS) is increasing in
other regions, including Eastern Europe, Asia and Africa. Rises in global consumption of cocaine
and heroin could spur renewed increases in their production. The potential for and risks of
renewed increases in coca and opium production are evident in many country situation reports
relating to traditional and new growing areas. This is briefly described in this paper. The risk of
increased cocaine and heroin production, coupled with an overall rise in global consumption, is
perhaps one of the most troubling features of the current illicit drug scene.
5. Whilst production of cocaine and heroin is currently stable, the illicit manufacture and
supply of psychotropic substances, particularly amphetamine-type stimulants, is rising fast and
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consumption is booming, deepening within traditional consumer regions and spreading to new
areas, such as Eastern Europe and East/South-East Asia (the increase in the supply of
amphetamine-type stimulants is mainly drawn from seizure statistics, while data on the volume
of manufacture are less comprehensive). Despite some fluctuations in seizure volumes, rising
trends are evident in respect of stimulants, hallucinogens and depressants (except methaqualone).
This may be the second troubling feature of the current illicit drug scene, with abuse of ATS
possibly substantially displacing consumption of traditional plant-based drugs in the future.
6. Statistics in respect of  cannabis, particularly with regard to production, are more difficult
to gather and data seem to fluctuate more than with other drugs. Nevertheless, the overall picture
currently presented of both cannabis resin and herbal cannabis more or less reflects a stable trend
at the global level but an increase in some areas where heroin or cocaine consumption has recently
seemed to decline or stabilize, e.g. cannabis resin in Western Europe (the trend in the supply of
cannabis is mainly drawn from seizure statistics, with data on cultivation and production lacking).
The increased abuse of cannabis products in some regions, as well as of stimulant tablets globally,
may have inflamed misperception of the apparent harmlessness of certain illegal substances and
re-initiated  discussion on the merits of their legalization, creating a third troubling situation.
Legalization of such substances could in fact pave the way to a substantial increase in illegal drug
consumption per se.
7. The globalization trend with regard to drug trafficking seems to have been further
strengthened by an intensified networking of trafficking groups and continued diversification
of transportation routes.  For example, well-established cocaine routes are increasingly being
used to smuggle heroin, and vice versa. According to Interpol, heroin from Colombia has for the
first time been seized in European countries which are traditional entry points for cocaine. All
indicators point to the fact that trafficking groups that previously confined themselves to cocaine
are now penetrating the European heroin market through their existing European cocaine
networks. Simultaneously, these groups are involved in smuggling heroin into North America.1
8. Trafficking groups as a whole tend no longer to confine their efforts to a single drug type.
In South-East Asia, for example, several recent reports have indicated a connection between
heroin and methamphetamine manufacture and trafficking. “Polydrug” trafficking, like “polydrug”
consumption, has become a common phenomenon.2
9. The diversification of trafficking routes can be witnessed throughout the globe. Virtually
the entire African continent may now be viewed as a transit region. The Balkan route is now more
complex, with an increasing number of countries being used as conduits.  The network of
trafficking routes in the Americas has also been expanded to ever-intensively involve the entire
continents (e.g. the increased use of Argentina in recent years). 
10. Finally, developments in prices of heroin and cocaine correspond to trends in production
of drugs. Cocaine and heroin prices were falling sharply in the main consumer regions, at the retail
as well as wholesale level, over the last decade. Since the initiation of a cutback in production in
recent years, prices of both drug types seemed to be nearing stabilization. However, latest
developments with regard to farmgate prices of opium, which were rising in recent years, revealed
a significant decrease in 1998, despite a severe decrease in production. Farmgate prices for coca
exist at various levels, i.e. coca leaf, coca paste (raw and washed) and cocaine base.
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Table 1. Overview of global supply indicators
(UNDCP estimates)
Cultivation
(in hectares)
Opium poppy Coca bush Cannabis Plant
1998: 237,873 ha
1997: 251,848 ha
1998: 180,000 ha
1997: 187,698 ha
average:
670,000-1,800,000 ha 
(as reported by Governments)
Production
(in metric tonnes)
Opium Coca Leaf Cannabis herb/resin
1998: 3,765 mt
1997: 4,823 mt
1998: 338,926 mt
1997: 359,185 mt
average:  500,000 mt
(as reported by Governments)
(more reasonable estimate: 
20,000-30,000 mt)
Farmgate prices
(in US$/kg)
Value of drugs
(at farmgate level)
(in US$)
average Asia:
1998: 180
US$/kg
1997: 289
US$/kg
average estimate:
1 US$/kg
total Asia:
1998: $ 528million 
1997: $ 679million
1998: $ 393million
1997: $ 411million
Potential 
manufacture
(in metric tonnes)
Heroin Cocaine Cannabis herb Cannabis resin Stimulants
1998: 376 mt
1997: 482 mt
1998: 785 mt
1997: 863 mt
Amphetamine:
mainly in Europe
Methamphetamine:
mainly in N-America
Seizures
(in metric tonnes)
1997: 28 mt
1996: 28 mt
1997: 322 mt
1996: 320 mt
1997: 2,914 mt
1996: 3,015 mt
1997: 747 mt
1996: 845 mt
1997: 10.8 mt
1996:   9.8 mt
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Figure 1. Opium production, 1986-1997 
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Figure 3. Coca leaf production, 1986-1997 
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Figure 4. Cocaine seized, 1986-1997 
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Figure 5. Cannabis resin seized, 1984-1997 
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Figure 6. Herbal cannabis seized, 1985-1997 
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Figure 7. Number of detected laboratories 
manufacturing ATS*, 1985-1997 
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Figure 8. Stimulants seized, 1984-1997 
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II.  Introduction
Data and information covered in this report
11. Part one of this report provides an overview of global and some regional trends in illicit
drug production and trafficking, with particular reference to opiates (opium, morphine and
heroin), cocaine, cannabis (herbal and resin) and psychotropic substances (stimulants,
hallucinogens and depressants). The focus is both on recent developments and emerging trends.
The chapters presented provide summary analyses and graphical presentations of issues such as
illicit cultivation, production and manufacture of drugs, as well as the patterns, routes,
methods and extent of trafficking and the prices of drugs. In the annex, detailed statistics are
presented on seizure volumes, manufacturing activities (detection of laboratories) and drug prices.
12. The data and analyses included in part one of this report mainly focus on 1997, with
reference to previous years for presentation of trends. Currently available data for 1998
concerning illicit cultivation and production of narcotic crops as well as farmgate prices
have also been included.
13. In view of the problems of ambiguous or incomplete reporting, the data presented in this
document cannot always be taken as representing comprehensive statistics but rather as indicators
of recent developments. All figures provided, particularly those of more recent years, are subject
to updating.  The boundaries shown in maps and graphical presentations do not imply any official
acceptance or endorsement by the United Nations.
Sources of information
14. The information on trafficking (and partly on manufacture), as presented in this report,
is mainly drawn from annual reports questionnaires (ARQ), relating mostly to 1997 and to
previous years for the purpose of trend analyses, which have been submitted by Governments to
UNDCP. Additional sources, such as other governmental reports, the International Criminal
Police Organization (Interpol), the World Customs Organization (WCO) and UNDCP’s field
offices, were used to supplement the information. In this context, the UNDCP/ICPO/WCO data
sharing initiative, which draws on reports of significant individual seizures of illicit drugs,
became operational in 1998 and will result in the availability of a more comprehensive worldwide
drug seizure data pool as of 1999. This will enable UNDCP to prepare more detailed analyses,
particularly on trafficking patterns and routes, provided that sufficient data are received. 
15. With information received from Governments and other sources, UNDCP has initiated the
establishment of a database on prices, which includes details by region, country and city, for
various drug types at different purity levels, in local currencies and converted into United States
dollars (US$). The database currently contains about 7,000-10,000 data, a brief summary of
which is annexed.
16. Data on cultivation of opium poppy and coca bush and production of opium and coca leaf,
which are presented in this report as UNDCP estimates, are drawn from various sources including
Governments, UNDCP field offices and the United States Department of State’s Bureau for
International Narcotics and Law Enforcement Affairs. The estimates were established by
considering all of the various sources available at the time of preparation of this report. These
estimates are subject to updating should more reliable data become available.
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Figure 9. Opium production and heroin seizures
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Limitations of data used
17. The main problems with regard to data relate to the irregularity and  incompleteness in
reporting affecting the quantity, quality and comparability of information received. First, the
irregular intervals at which some Governments report may result in absence of data in some years
but availability in others. Lack of regular data, for which UNDCP tries to compensate by
reference to other sources, could influence trend patterns.  Second, submitted questionnaires are
not always complete or sufficiently comprehensive. While data on seizures are provided by many
Governments in a very detailed manner, information on illicit cultivation and production of drugs,
clandestine laboratories and manufacturing activities, as well as on particulars of prices, is often
absent. Third, differences in  criteria of reporting between countries, or from single countries over
a period of time, may distort the trafficking picture and trend analyses. For example, some
countries include so-called “kitchen” laboratories in the total number of manufacturing sites
detected while others only count fully equipped clandestine laboratories. By the same token, a
country which in the past has included “kitchen” laboratories may them change its reporting
practice and omit such detections.  Also, the extent to which seizure statistics from some
countries constitute all reported national cases, regardless of the final destination of the illicit
drug, can vary and make it difficult to assess international trafficking.
18. The utilization of data which are available through the various sources is limited due to
two main shortcomings. First, some available information is not fully reliable due to the
complexity of the drug phenomenon and problems in assessing the specific nature of an illicit
activity. Analyses of illicit drug cultivation/production, for example, rely on estimates and cannot
be treated as hard data. Second, data (for example on seizures) reflect different factors, such as
changes in reporting modalities or variations in law enforcement practices. However, where such
factors do hold constant, changes in seizure statistics can indicate trends in trafficking, and some
inferences in the present report are drawn on this very basis.
Statistical evidence
19. The previous paragraphs emphasized that available, useful data on drugs are scarce and
indicators used to measure the drug problem entail a number of limitations and significant degree
of subjective evaluation due to the lack of objective data and direct, measurable indicators.
Nevertheless, comparisons, on a time-series basis, of different indicators with statistical
dependence show high correlations,
thus supporting their statistical
worth.
20. Figure 9, for example,
reflects a high congruency of global
trends in respect of opium
production and heroin seizure
quantities. Even with the exclusion
of the period prior to 1994 (which
is largely based on rough estimates
as regards the production trend,
while figures since 1994 are drawn
from UNDCP surveys), the trend
lines between 1994 and 1997
continue to overlap.   
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Figure  10. Heroin retail and wholesale prices 
per gramme in Western Europe , 1986-1996
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Figure 11. Coca leaf production and cocaine seizures
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Figure  12. Cocaine wholesale prices per gramme 
in Western Europe and the United States, 
1986-1996
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21. The reflection of the expected statistical dependence of heroin seizures on opium
production supports the objectivity of the data. On this basis, it can be conjectured that these
should be a close relationship between prices of heroin and the production (or seizure) trend.
Production and prices relate negatively in the sense that a rising trend in opium production should
result in a decline in heroin prices. Figure 10 shows that both retail and wholesale prices of heroin
in Western Europe (one of the main consumer markets) were falling over the last decade in line
with a rise in opium production (see figure 9). A comparison of both figures further reveals that
the trend towards stabilization in production since 1993/94 is also mirrored by a stable price trend
during the same period.
22. The correlation of data relating to production, seizures and prices, as explained in
paragraphs 20 and 21 in the case of opiates, is also reflected in figures 11 and 12 for coca.
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The value of drug seizure data as an analytical tool.
23. While a number of the drug-related data sets made available to UNDCP by Member States
have been used in the preparation of this report, the most comprehensive remains that in respect
of seizures, which provide the basis for a number of important conclusions and projections and
thereby  reaffirm the practical utility and strategic and analytical value of seizure data.
24. Article 1 (paragraph 1) of the 1988 United Nations Convention against Illicit Traffic in
Narcotic Drugs and Psychotropic Substances states that “‘Freezing’ or ‘seizure’ means
temporarily prohibiting the transfer, conversion, disposition or movement of property or
temporarily assuming custody or control of property on the basis of an order issued by a court or
competent authority”.  Article 5 of this Convention goes on to refer to parties adopting necessary
measures to enable their competent authorities to seize materials, which include narcotic drugs
and psychotropic substances, for the purpose of eventual confiscation.
25. In the context of UNDCP’s own data requirements, however, the term 'seizure' may be
interpreted in a broad sense. Thus, seizures may take the form of drugs being recovered by a
state’s national agencies within its own territory:
     
               i) when found in the physical or constructive possession of a person who is not
authorized under national law to be in possession or control of it;
     
               ii) as a consequence of action by enforcement bodies, even though this does not
result in the arrest of any individual (e.g., found during a search of a                 
                  commercial container, unattended premises or at a mail sorting depot); or
     
               iii) under any other circumstance (e.g., found abandoned, washed ashore or within
territorial waters).
26. A seizure may also be made outside a state’s territory, where enforcement action has been
taken in line with the provisions of the 1982 United Nations Convention on the Law of the Sea
and article 17 of the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and
Psychotropic Substances.  
27. Data on seizures are of particular value once ‘smoothed’, using various best-fit statistical
models (such as linear, logarithmic, or exponential regressions, or various polynomial functions,
or simple biennial or triennial moving averages)  to reduce the distorting effect of any figures that
may be  misleadingly high or low.  For example, the decision on whether a protracted enforcement
operation should culminate in December of one year or the January of the next will be  based
purely on tactical considerations but may result in data which appear to indicate that trafficking
activity is greater in one year than in the other.
28. By reflecting trafficking trends, seizure data also indirectly serve as an indicator of changes
in cultivation, production, manufacture and  consumption. In the case of consumption, the link
is particularly strong when larger geographic entities, such as Western Europe or North 
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America, are considered, since transit trade plays less of a role in these regions. While it is true
that a large proportion of the drugs trafficked and seized in individual European countries are
destined for neighbouring states, most drugs trafficked within Western Europe as a whole are for
consumption within that region.  
29. Detailed information on seizures may also be of crucial value in analyzing changing trends
in trafficking routes, diversion of narcotic drugs, psychotropic substances and precursor
chemicals, likely sites of clandestine drug laboratories, modes of transportation, methods of
concealment, emergence of local intermediary criminal organizations and potential local abuse,
as a result of the spill-over of transiting drugs onto local markets. 
30. Seizures provide the raw materials for scientific analysis and profiling and can also serve
as an indicator of the commitment, expertise and effectiveness of national and regional
enforcement bodies, even though in some cases increases or decreases in seizures can be
attributable to external factors. Often, sudden increases in seizures - particularly when coinciding
with falling drug prices -  may be viewed as reflecting an increase, rather than a decrease, in
trafficking activity. In the longer term, however, greater expertise and effectiveness on the part
of law enforcement agencies is a powerful factor in deterring traffickers.
31. When received, collated and analyzed, seizure data  are of invaluable assistance to
international organizations charged with responsibilities for combating drug trafficking, since they
help to achieve a more comprehensive and accurate picture of the nature, scale and dynamics of
the illicit drug trade and assist in the development of more effective countermeasures. 
32. Seizures may thus be viewed as a ready and highly effective diagnostic tool for the
formulation of multi-sectoral global, regional and sub-regional plans, since the analytical
‘mapping’ of  seizures drugs can provide a kind of ‘paper trail’ that is of strategic value to
agencies operating in every area of drug control.  They are rather like symptoms of a disease,
enabling an expert to  gauge more accurately the nature, scale and spread of an illness and
therefore make a diagnosis which ensures that the treatment administered is effective and
broadens overall understanding.
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A.  Opiates
Figure 13. Global trend in 
illicit cultivation of opium poppy and production of opium, 1986-1998
(in hectares and metric tonnes)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Estimated cultivation (ha)* 131,877 154,399 211,024 261,226 262,754 281,560 259,686 277,407 272,479 249,919 257,615 251,848 237,873 
Estimated production (mt) 1,821     2,617     2,794     3,395     3,760     4,274     4,143     4,610     5,621     4,452     4,356     4,823     3,765     
* Potentially harvestable, after eradication
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III. Global trends in illicit drug supply and trafficking
1. Global illicit cultivation of opium poppy and production of opium
33. A major development with regard to the global illicit production of opium, which saw
very large increases during the 1980s and early 1990s, has been a stabilizing trend in recent years.
The total world production in 1997 was estimated at roughly 4,800 tonnes, which was a minor
increase upon 1996 but consistent with the relatively stable level followed since 1993. In 1998,
however, the production level, estimated at  less than 3,800 tonnes, substantially decreased
compared to previous years. Largely as a result of extreme weather conditions in some major
producer countries in South-West and South-East Asia. Trends in global illicit cultivation of
opium poppy have levelled out since 1990, with estimates ranging between 240,000 and 280,000
hectares (see figure 13; for further details, see table 3).
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Figure 15. Global illicit cultivation of opium poppy and production of opium, 1998
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Figure 14. Global illicit production of opium, 1997-1998
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of opium amounted to 61 tonnes in 1998.
34. Together, Afghanistan and Myanmar continue to provide 90% of the illicit opium
produced worldwide (see figure 14). Even though the area under poppy cultivation in
Afghanistan increased only slightly in 1997 compared to the previous year, production rose by
25%, supplying 2,800 tonnes of opium. In 1998, in spite of an increase in cultivation, extreme
weather conditions led to the total opium production falling to its lowest figure since the early
1990s (details on the cultivation and production situation in Afghanistan, drawn from the UNDCP
opium poppy survey, are included in the box overleaf).  Cultivation and production estimates for
Myanmar, which remained relatively stable throughout the 1990s, suggest a minor decrease
during 1997, with the level of production at approximately 1,670 tonnes. In 1998, cultivation and
production decreased in Myanmar.
35. The total production of all other source countries in Asia, principally the Lao People’s
Democratic Republic, Pakistan, Thailand and Viet Nam, accounts for 4-5% (roughly 170
tonnes) of the global estimate. Most of these relatively small scale opium source countries have
significantly reduced cultivation and production during recent years, but estimates for 1998
reflected renewed increases in Pakistan and Thailand. 
36. An estimated 3-4% (120-160 tonnes) of the opium produced worldwide has originated
in Latin America in recent years.  Production in Mexico reflected a slight decrease during that
period but an increase in 1998. Estimates for Colombia indicate a rising trend.
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Afghanistan
A ground survey of cultivation of opium poppy and production of opium in Afghanistan
has been carried out by UNDCP annually since 1994. 
During the 1980s and early 1990s, cultivation and production in Afghanistan was
estimated to have risen sharply, resulting in an enormous peak of almost 3,500 tonnes of opium
produced in 1994. Although still lower than the 1994 level, cultivation has been increasing since
1995. The situations in 1997 and 1998 and possible emerging trends are described in the
following paragraphs.
In 1997, the area under cultivation increased marginally compared to 1996, reaching
over 58,000 hectares. This new increase was mainly attributable to provinces in the south of the
country, namely Qandahar and Helmand, while a small decrease in the area under cultivation
was reported from Nangarhar bordering Pakistan. Helmand and Nangarhar retained their
dominant positions as the largest cultivating and producing provinces of Afghanistan. While the
total cultivation increased only marginally, production rose by 25%, totalling 2,800 tonnes, due
to an increased yield in most provinces but most particularly in Helmand. This higher yield,
combined with the growth in cultivation area in Helmand, is the most important single factor
contributing to the 1997 rise in opium production in Afghanistan. In conclusion, the 1997
cultivation/production situation in Afghanistan showed no significantly changing trend, with the
main differing factor being an increased yield which was attributable to weather conditions and
did not necessarily reflect any changing pattern.
1998, however, reflected a higher increase in the extent of opium poppy cultivation in
Afghanistan,  which reached 63,700 hectares.   4 out of 13 producing provinces experienced
expansions in their areas of opium poppy cultivation, including Helmand and Nangarhar, the two
largest producing provinces.  Cultivation also spread to new districts in Afghanistan, all of which
are located in the north-eastern part of the country, whereas the sharpest decline in cultivation
was realized in Farah and Nimroz, provinces  bordering the Islamic Republic of Iran.
Production, in contrast, declined by approximately 25%, totalling 2,100 tonnes, due to adverse
weather conditions resulting in a reduced yield. In conclusion, the 1998 survey revealed two
developments which may indicate future trends in the opium production and trafficking situation
in that country. First, poppy cultivation is again rising in most provinces; second, the expansion
of cultivation areas was particularly evident in the north of the country, which may result in a
further preferred use of Central Asia as a transit zone for opium and heroin trafficking and a
possible reduction of trafficking through the Islamic Republic of Iran.
Source :UNDCP Afghanistan Programme Annual Opium Poppy Surveys.
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Table 2. Average opium yield per country and year
(estimates in kilogrammes per hectares)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
South-West Asia
Afghanistan 35  35  35  35  38  39  40  40  48  43  40  48  33  
Pakistan 22  22  20  20  20  20  19  22  22  22  27  28  28  
Average South-West Asia 28  28  27  27  29  30  30  31  35  33  34  38  30  
South-East Asia
Lao PDR 7    7    7    7    7    6    6    6    6    6    5    
Myanmar 11  11  11  11  11  11  11  11  11  11  11  11  10  
Thailand 11  8    6    10  11  6    5    17  7    10  14  13  11  
Viet Nam 5    5    5    5    5    5    5    5    5    5    5    5    5    
Average South-East Asia 9    8    7    8    8    7    7    10  7    8    9    9    8    
Latin America
Colombia* - 14  14  14  14  14  14  14  14  
Mexico 10  10  13  10  11  11  12  12  10  10  11  12  11  
Average Latin America 10  10  13  10  11  12  13  13  12  12  12  13  12  
* According to the Ministry of Foreign Affairs of Colombia, the yield is 10 kilogrammes per hectare.
37. The ratio of cultivation to production differs significantly between South-West Asia and
South-East Asia (see figure 15). This difference in yield (see table 2), is particularly evident when
comparing the largest producer countries. The average yield in Afghanistan throughout the 1990s
was 40 kilogrammes per hectare, ranging from a country-wide annual average of 33 kg/ha, which
was achieved in 1998, to a peak of 48 kg/ha reached in 1994 and 1997. The average yield in
Myanmar is estimated at 11 kg/ha. However, opium originating from Myanmar and other South-
East Asian countries, all of which have relatively low yields, is believed to be of higher quality
than that from Afghanistan or Pakistan.  
38. Throughout the last decade, the Lao People’s Democratic Republic remained the third
largest illicit cultivation and production country, though production of opium is much smaller than
in Afghanistan and Myanmar.  National surveys on the extent and geographic spread of poppy
cultivation and opium production were carried out  in 1992, 1996 and 1998.  Latest estimates
available to UNDCP revealed that the area under cultivation expanded during those years but
remained below the estimates of the 1980s.  Production reflected a decrease in 1998, due to a
reduced yield caused by unfavourable weather conditions (the average annual yield for the Lao
People’s Democratic Republic was estimated at 6-7 kilogrammes per hectare in recent years but
reduced to 4.6 kg/ha in 1998).  Levels of cultivation and production in Thailand and Viet Nam
remained relatively small and estimates for both countries have significantly reduced throughout
the 1990s.  While the levels of cultivation and production in Thailand were always below those
of Viet Nam, estimates since 1997 show higher figures than those in Viet Nam, where trends
declined to almost negligible amounts. Trends on cultivation and production in Pakistan showed
a significant decrease in recent years but reflected a slight increase in 1998.  Additionally, the
average country-wide yield in Pakistan, which was estimated at 20-22 kg/ha on average, has risen
to 27-28 kg/ha since 1996.
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Cultivation trends in Central Asia
In recent years, there has been growing concern that Central Asia may emerge as a
major producer and transit zone for illicit drugs, mainly opiates. The increasing involvement of
Central Asia  was perhaps unavoidable given its location as the natural transit zone between
Afghanistan, Pakistan and the Islamic Republic of Iran, on the one hand, and the Russian
Federation, other States members of the Commonwealth of Independent States and Turkey (all
with emerging consumer markets and/or access to Western Europe) on the other.
Many reports in recent years suggested that Central Asia could become a major drug
cultivation area, offering excellent climatic conditions for the cultivation of opium poppy and
cannabis plant.  A UNDCP survey, carried out in three Central Asian States (Kazakhstan,
Kyrgyzstan and Tajikistan), and other latest available information indicate that illicit cultivation
of opium poppy remained limited and largely confined to small individual plots (additionally,
cannabis and ephedra plants occur in extensive wild growth in the subregion). This potential
capacity for illicit cultivation continues to provide a dangerous opportunity that could be
exploited, for example, as a consequence of increased eradication measures in neighbouring
Afghanistan. 
Limited illicit cultivation of opium poppy currently takes place in Tajikistan where
opium poppy grows mainly in the Penjikent Valley (close to the Uzbekistan border). In
Turkmenistan,  small plots are scattered along the border with the Islamic Republic of Iran, in
the Akhal region (which includes Ashgabat) and in the eastern parts of Lebap and Mary regions.
Both countries, Tajikistan and Turkmenistan, have indicated rising trends in drug cultivation,
though this still remains very small. In Uzbekistan, moderate crops of opium poppy are
cultivated mainly in the Samarkand-Surkhandaria region, (in the eastern part of the country, on
the Tajikistan border region). These were, however, reportedly eradicated in the course of
Uzbekistan’s “Operation Black Poppy".  To a lesser extent, illicit opium poppy cultivation (and
wild growth) also takes place in Kyrgyzstan, which was once a key supplier of licit opium.  Due
to the large geographic area, Kazakhstan seems to be the biggest Central Asian source, though
cultivation is also limited to small-plot practices. The total area under illicit opium poppy
cultivation in Kazakhstan is currently estimated at around 2,000 hectares, capable of producing
about 30 tonnes of opium. Eradication programmes such as the “Black Poppy” campaign have
been initiated in all Central Asian States.
Availability of opium in the Central Asian States is decreasing with a parallel increase
of heroin trafficked from Afghanistan. Prices of opium are decreasing.
Sources: UNDCP Regional Office for Central Asia, Annual Report 1997/98
          UNDCP Survey on Central Asia, 1998. 
39. Despite widespread concern during the early 1990s that Central Asia would become a
future source of opium, illicit cultivation of opium poppy in that subregion has remained limited
and is largely confined to small individual plots (see box below). While the gloomiest of
predictions have not been fulfilled, the subregion continues to cause concern, since it offers
excellent climatic conditions for the cultivation of opium poppy as well as cannabis and ephedra.
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Table 3. Global illicit cultivation of opium poppy and production of opium, 1986-1998
(UNDCP estimates)
Year 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Region/subregion/country
Cultivation* in hectares
ASIA
South-West Asia
Afghanistan 10,000   25,000   32,000   34,300   41,300   50,800   49,300   58,300   71,470   53,759   56,824   58,416   63,612   
Pakistan 6,034     5,463     6,519     7,464     7,488     7,962     9,493     7,329     5,759     5,091     873        874        950        
Subtotal 16,034   30,463   38,519   41,764   48,788   58,762   58,793   65,629   77,229   58,850   57,697   59,290   64,562   
South-East Asia
Lao PDR -        -        40,400   42,130   30,580   29,625   19,190   26,040   18,520   19,650   21,601   24,082   26,837   
Myanmar 86,570   92,300   104,200 143,000 150,100 160,000 153,700 165,800 146,600 154,070 163,000 155,150 130,300 
Thailand 2,408     3,163     2,811     2,982     1,782     3,727     3,016     998        478        168        368        352        716        
Viet Nam 8,000     10,000   12,000   14,000   18,000   17,000   12,199   4,268     3,066     1,880     1,743     340        442        
Subtotal 96,978   105,463 159,411 202,112 200,462 210,352 188,105 197,106 168,664 175,768 186,712 179,924 158,295 
Other Asian countries
Combined 15,000   13,313   8,093     10,750   8,054     7,521     2,900     5,704     5,700     5,025     3,190     2,050     2,050     
Total
Asia 128,012 149,239 206,023 254,626 257,304 276,635 249,798 268,439 251,593 239,643 247,599 241,264 224,907 
LATIN AMERICA
Colombia -        -        -        -        -        1,160     6,578     5,008     15,091   5,226     4,916     6,584     7,466     **
Mexico 3,865     5,160     5,001     6,600     5,450     3,765     3,310     3,960     5,795     5,050     5,100     4,000     5,500     
Total Latin
America 3,865     5,160     5,001     6,600     5,450     4,925     9,888     8,968     20,886   10,276   10,016   10,584   12,966   
Global
total 131,877 154,399 211,024 261,226 262,754 281,560 259,686 277,407 272,479 249,919 257,615 251,848 237,873 
Production in tonnes
ASIA
South-West Asia
Afghanistan 350        875        1,120     1,200     1,570     1,980     1,970     2,330     3,416     2,335     2,248     2,804     2,102     
Pakistan 130        120        130        149        150        160        181        161        128        112        24          24          34          
Subtotal 480        995        1,250     1,349     1,720     2,140     2,151     2,491     3,544     2,447     2,272     2,828     2,136     
South-East Asia
Lao PDR -        198        267        278        202        196        127        169        120        128        140        147        124        
Myanmar 935        997        1,125     1,544     1,621     1,728     1,660     1,791     1,583     1,664     1,760     1,676     1,303     
Thailand 26          24          17          31          20          23          14          17          3            2            5            4            8            
Viet Nam 40          50          60          70          90          85          61          21          15          9            9            2            2            
Subtotal 1,001     1,269     1,469     1,923     1,933     2,032     1,861     1,998     1,722     1,803     1,915     1,829     1,437     
Other Asian countries
Combined 300        303        8            57          45          45          -        4            90          78          48          30          30          
Total 
Asia 1,781     2,567     2,727     3,329     3,698     4,217     4,012     4,493     5,356     4,328     4,235     4,687     3,603     
LATIN AMERICA
Colombia -        -        -        -        -        16          90          68          205        71          67          90          102        **
Mexico 40          50          67          66          62          41          40          49          60          53          54          46          60          
Total Latin
America 40          50          67          66          62          57          130        117        265        124        121        136        162        
Global
total 1,821     2,617     2,794     3,395     3,760     4,274     4,143     4,610     5,621     4,452     4,356     4,823     3,765     
*  Potentially harvestable, after eradication
** According to the Ministry of Foreign Affairs of Colombia, cultivation of opium poppy was 6,100 hectares and production of opium was 61 tonnes.
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Table 4. Eradication of opium poppy, 1986-1998
Breakdown by country and global trend
(in hectares)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Afghanistan -     -     -     -     -     -       -       -       -       -       -       -       -       
Pakistan -     1,300 1,708 610    185    440      977      856      463      1,309   5          -       259      
Lao PDR -     -     -     -     -     -       -       -       -       -       -       -       -       
Thailand 1,718 592    1,740 1,834 2,395 1,200   1,580   1,706   1,313   580      886      1,053   770      
Viet Nam -     -     -     -     -     -       3,243   10,051 672      477      1,142   1,143   -       
Myanmar -     -     -     86      116    873      4,228   160      1,041   3,310   1,938   3,093   3,172   
Mexico 2,135 2,200 2,737 3,000 4,650 6,545   11,222 13,015 10,959 15,389 14,671 17,732 17,449 
Colombia -     -     -     -     -     1,497   12,864 9,400   5,314   5,074   7,412   7,333   3,112   
Other countries -     -     -     -     -     576      470      426      150      86        -       -       -       
Global eradication 3,853 4,092 6,185 5,530 7,346 11,131 34,584 35,614 19,912 26,225 26,054 30,354 24,762 
Figure 16. Global trend in eradication of opium poppy
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1.1. Global eradication of opium poppy
40. A number of Governments of opium source countries have taken increased efforts in
recent years to eradicate opium poppy illicitly cultivated within their respective territories. These
efforts resulted in significant reductions in cultivation in some countries, as pointed out in the
previous chapter.  The following table 4 and figure 16 provide a breakdown of some details on
eradication of opium poppy, as reported to UNDCP.
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2. Illicit manufacture of heroin 
41. Global trends in illicit manufacture of heroin mirror the development in opium production,
with an average conversion rate of 1:10 estimated for all source countries.
(a)  South-West Asia
42. Relatively stable seizure trends in countries in the South-West Asian region imply that no
major changes occurred in 1997 with regard to the location of morphine and heroin laboratories,
which are active in southern Afghanistan, the Afghanistan-Pakistan border area and Turkey. While
seizures of opium, which is widely distributed and abused throughout the region, occur in many
countries in significant amounts, the volume of morphine and heroin seizures in certain countries
allows conclusions to be reached concerning relevant manufacturing sites and trafficking routes.
The Islamic Republic of Iran continues to account for 97% of the global morphine seizure volume,
the only other country featuring in this context being Turkey. This suggests that laboratories in
Afghanistan close to the border with the Islamic Republic of Iran remain directed towards the
manufacture of morphine base, and to a lesser extent heroin base, which is then trafficked across
the Islamic Republic of Iran into Turkey, where it is converted into heroin hydrochloride destined
for the European market. Whether the recent decrease of seizures in Turkey implies that morphine
base is also trafficked from the Islamic Republic of Iran to Central Asian States, and whether
heroin laboratories exist elsewhere in that region, cannot be determined from the information
currently available.  Pakistan, on the other hand, tends to record large volumes of heroin seizures,
indicating that laboratories located in the Afghanistan-Pakistan border area continue to
manufacture this drug.
43. Whether current developments with regard to possible increases of cultivation in the north
of Afghanistan indicate a changing trend in manufacturing sites and trafficking routes is yet to be
seen.
(b)  South-East Asia
44. According to Interpol, a total of 33 opiate refineries were destroyed in Myanmar in 1997,
mainly in Shan State. Additionally, 3 heroin laboratories were seized in northern Thailand during
the same year. In Malaysia, clandestine laboratories continued to process No. 3 heroin from
heroin base. 3 (South-East Asian heroin can be broken down into four types: “Heroin No. 1" is
crude morphine; heroin No. 2 is heroin base prior to its conversion to the hydrochloric salt; heroin
No. 3 is the smokable form of heroin, not as highly refined as the No. 4 form, containing 25-40%
of heroin hydrochloride and other substances; heroin No. 4 is the injectable form of heroin with
a purity up to 98% heroin hydrochloride4).
45. Another trend which has been highlighted with regard to illicit heroin manufacture in
South-East Asia is the increased connection of and networking in the production and subsequent
trafficking of heroin and methamphetamine.2
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3. Trafficking trends
3. 1. Destinations for opiates produced
(a) South-West Asian origin
46. Questions as to what happens to the drugs produced are crucial in identifying details of
drug trafficking. In the area of law enforcement, international trafficking is differentiated from the
local distribution of drugs, which mainly relates to domestic, traditional drug consumption
(though this has been changing). Table 5 summarizes some estimates available on the extent of
opiate distribution to various destinations, but the figures included cannot be assumed to be
accurate data.
47. Some estimates indicate that more than 50% of the opium produced in South-West Asia
is consumed within the region, mainly as opium but also as heroin.5  The bulk of the remaining
quantity (on average, approximately 100 - 150 tonnes in heroin equivalent) would be destined for
export and thus becomes relevant to international trafficking. However, prior to leaving the
region, an additional 15% of the total production (40-50 tonnes, in heroin equivalent) is seized
within South-West Asia in the form of opium, morphine or heroin (mainly in the Islamic Republic
of Iran and Pakistan). As a result and based on such estimates, it can be assumed that
approximately 1/3 of the total opium produced in South-West Asia (less than 100 tonnes in heroin
equivalent) would be exported from the region, destined mainly for European, and to a lesser
extent North American, markets  (table 5, part I).
48. The movement and final destinations of drugs after leaving the producer region seem even
more uncertain than the utilization/distribution of opiates within South-West Asia. Table 5, part
II, constitutes an attempt to calculate the potential volume of heroin (of South-West Asian origin)
consumed outside South-West Asia, predominantly in Western Europe. The volume of
interceptions of opiates (of South-West Asian origin) are subtracted from the total volume of
opium estimated to be transported outside the region.
49. The figures presented in table 5, however,  have to be treated with caution, particularly
those in part II, due to the following unknown variables: the extent of (traditional) opiate
consumption in South-West Asia (included as estimates) is uncertain and that of various
neighbouring countries (e.g Central Asian States and India) is not known at all; data on opiate
seizure quantities in the producer region, neighbouring states and other regions are not always
available; while the origin of drugs which have been seized in regions such as South-West Asia,
the Near and Middle East, Transcaucasia and Central Asia can safely be assumed to originate
from Afghanistan, less certainty exists in respect of seizures made in South Asia, Africa and
Europe (therefore, only half of the seizure quantity has been counted from these regions). No
estimates are possible of the volume of opiates lost, destroyed or stockpiled. 
50. If the calculation made in table 5 were to be taken as an indication of the distribution and
destinations of opiates, it could be concluded that approximately 60% of the opium produced in
South-West Asia is consumed as heroin (170 tonnes), roughly half that amount within the region
and the remainder outside of it.
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Table 5.  Destinations of opiates originating from South-West Asia
(Figures are based on 1997 estimates)
I. WITHIN SOUTH-WEST (SW) ASIA
Production of opium in SW-Asia
   A. Opium produced in Afghanistan and Pakistan
Consumption of opiates in SW-Asia
   B. Opium consumed in Pakistan, Afghanistan and the Isl.Rep.of
Iran
   C. Heroin consumed in Pakistan, Afghanistan and the Isl.Rep.of
Iran
Interceptions of opiates in SW-Asia
   D. Opium, heroin and morphine seized in theIsl.Rep.of Iran,
Pakistan
          (Seizures of other countries in the region, as reported, are minimal)
±  Amount remaining for potential export outside SW-Asia
     E: A - (B+C+D)
in  tonnes
(all figures
in 
opium
equivalent)
2,828 mt
580 mt
900 mt
435 mt
913 mt
in
percentage
of total
production
20%
32%
15%
32%
Final destinations
(in metric tonnes
opium equivalent
and % of production)
ESTIMATES
Total regional
consumption:
(B+C):     1,480 mt
                   52%
±  less than 1000 tonnes of opium (equal to 100 tonnes of heroin) 
(approx. 1/3 of the total production) are exported from SW-Asia.
II. OUTSIDE SOUTH-WEST ASIA
Interceptions of (SW-Asian) opiates outside SW-Asia
   F.a) Opium, morphine and heroin seized in Near/Middle East,
           Turkey, Transcaucasia, Central Asia and Europe
      (limited volumes, as included here, may originate from South-East Asia, but this
has been neglected in this calculation).
       b) Half of the opium, morphine and heroin seized in South            
 Asia and Africa 
(Due to the uncertainty of the origin of drugs seized in these regions, only half of
the total seizure volume has been calculated).
    Total (F)
±  Amount remaining for potential consumption (as heroin)     
outside SW-Asia (mainly in Western Europe)
    G: (E-F)
97 mt
816 mt
3%
29%
Total seizures of SW-Asian
opiates:
(D+F):       532 mt
                    18%
Potential (heroin)
consumption outside 
SW-Asia:
(G):     ~  800 mt (opium equiv.) 
            ~  30%
±   roughly 800 tonnes of opium (equal to 80 tonnes of heroin)
(approx. 30% of total production) are potentially consumed as  
heroin outside SW-Asia (mainly in Western Europe).
±  Total potential heroin consumption (C+G):
     1,700 mt (opium equiv.), 60%
Unknown variables:
Opium (and heroin) consumption in Central Asian States or other (neighbouring) countries;(“regional consumption”, see B and C)
                stockpiling
Unreported seizures
Losses of drugs
Origin of drugs seized (see calculation undertaken in F)
Sources: UNDCP Afghanistan Country Office, Afghanistan Opium Poppy Survey 1997.
UNDCP Annual Reports Questionnaires, supplemented by additional sources.
UNDCP Regional Office for South-West Asia
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(b)  South-East Asian origin
51. Similar to the situation in South-West Asia, a significant proportion of the opium
produced in South-East Asia is consumed in the source countries and their neighbours. While
opium is the main drug consumed domestically/regionally, the number of heroin addicts is
increasing throughout the region, including among the youth. Countries/territories in East/South-
East Asia and Oceania which have significant heroin markets include Australia, China, Hong Kong
Special Administrative Region (Hong Kong SAR) of China, Malaysia, Myanmar, New Zealand,
Singapore, Thailand and Viet Nam.6
52. A smaller but significant portion of the total heroin production in South-East Asia, mainly
originating from Myanmar, remains aimed at Canada and the United States.  However, several
recent reports indicate that the proportional share of South-East Asian heroin supply in the United
States markets has decreased, while heroin supply from Latin-American sources has increased.7
Should this be correct, establishing the current points of ultimate destination for and consumption
of South-East Asian heroin must be regarded as a priority issue.
53. Heroin of South-East Asian origin also reaches Europe, either directly by use of air or mail
services or via African countries. However, the European heroin market, which is dominated by
South-West Asian opiates, remains a minor point of destination for South-East Asian heroin.
54. Due to the lack of data on the volume of opiate consumption in South-East Asia, an
overview of the distribution and destinations of opiates (as presented in table 5 for South-West
Asia) could not be worked out for this region.
(c)  Latin American origin
55. Though the extent of opium production in Latin America seems very small compared to
the Asian standard, supply from that source is causing concern in the United States, the main
consumer country of heroin originating from that region. The United States Drug Enforcement
Administration (DEA) indicates that nearly all of the heroin produced in Mexico is destined for
distribution in the United States. The drug, known as “black tar”, is mainly sold in the Western
part of the country. It assumed that heroin originating from Mexico provides about 5% of the
illicit heroin market in the United States 8. Similarly, heroin produced in Colombia is aimed mainly
at the United States, where it is known for its high quality, with purity levels reportedly up to 90%
and above.9
56. High-purity heroin of Colombian origin also seems to have entered European markets, as
indicated by Interpol seizure reports1.  One possible explanation for this may be that users prefer
it due to its high purity, which allows them to ingest the heroin nasally and avoid the risks and
inconveniences of injections.
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3. 2. Trafficking routes
(a) Trafficking routes used for opiate trafficking out of South-West Asia
57. Afghanistan remains the principal source of opium in South-West Asia. The drug is mainly
manufactured into morphine/heroin base and heroin hydrochloride in Afghanistan, the
Afghanistan/Pakistan border area and Turkey, as described in the previous chapter. Consequently,
trafficking routes for transportation of opiates (heroin or morphine) outside the region follow
three main directions: First, one of the most frequently used routes continues to be the “western”
direction, bringing drugs across the Pakistan-Islamic Republic of Iran and Afghanistan-Islamic
Republic of Iran borders into the Islamic Republic of Iran and further on to Turkey, prior to being
picked up by the Balkan routes. In addition to opium, which is largely consumed within the
region, the main drug trafficked along this route is morphine base, which is destined for further
conversion into high grade heroin in Turkey and is seized in enormous quantities by Iranian law
enforcement units. To a lesser extent, heroin base is also smuggled along this route. While in the
past opiates transiting the Islamic Republic of Iran were almost exclusively flowing into Turkey,
significant quantities now also seem to leave Iranian territory through exit points in the north,
mainly to Turkmenistan, from where drugs are trafficked through Central Asia, Transcaucasia and
Eastern Europe. 
58. Seizure volumes of opiates in the Islamic Republic of Iran, which seemed to rise quickly
during the early 1990s but had more or less stabilized in more recent years, realized another
significant increase in 1997. At the same time, however, Turkey’s seizures of these drugs
decreased  by 31% (for heroin) and 23% (for morphine).  These trends seem to confirm some shift
in trafficking routes, presumably towards the north, as described in the previous paragraph.  The
predominant means of transportation of opiates via the “western” direction remains the land route,
although the Islamic Republic of Iran has recently reported an escalation of drug trafficking by
mail in their territory.
59. The Balkan route, which continues to originate in Turkey, has developed various off-
shoots as a result of conflict in the former Yugoslavia, on the one hand, and, on the other, the
opening up of new and independent countries in Eastern and Central Europe, increasingly
facilitating freer movement of people, goods, services and capital. 
60. The increased use of Central Asia as transit region has been highlighted in recent reports10.
This “northern” direction is supplied either directly from Afghanistan or via the Islamic Republic
of Iran, through Turkmenistan  (less data are available to measure trafficking trends in that
subregion).
61. In addition to the “western” and more recent “northern” directions, via the Islamic
Republic of Iran-Turkey and/or Central Asia, the “southern and eastern” directions across
Pakistan continue to be extensively used for drug trafficking activities, particularly by use of air
and sea routes.  In 1997, the volume of heroin seized in Pakistan rose slightly, while opium
seizures declined. Karachi remains the principal sea/airport for the smuggling of heroin originating
from the Afghanistan/Pakistan border area and mainly destined for Europe, whether directly or
via African seaports and airports. Some is also routed to India and its neighbouring countries,
including Bangladesh, Nepal and Sri Lanka, all of which serve as storage points and transit centres
for South-West Asian heroin bound for Western Europe or the United States. In addition, heroin
consumption is further spreading in South Asian countries, particularly among the youth.
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62. The development of new international airports in the States of the Persian Gulf, linked
with those States’ geographic proximity to and historical, political and cultural ties with countries
in South-West Asia, has fuelled the increased involvement of that region in drug trafficking in
recent years.
63. Africa’s increased involvement in heroin trafficking from Asia (mainly South-West Asia
via Pakistan and India) to Western Europe, and to a lesser extent North America, continues.
Though data are limited, total seizure volumes were consistently higher during the 1990s than in
the early/mid-1980s. Most of the seizures continue to be recorded in West and Central Africa,
followed by North Africa and East Africa. The North and East African subregions have recorded
similar volumes of heroin seizures in recent years.  East Africa seems to have followed a rising
trend but seizure volumes in countries in North Africa have slightly decreased.
Quantities involved in opiate trafficking on routes out of South-West Asia
64. While seizures clearly indicate that all of the routes previously described are actively used
for trafficking of opiates outside the region, it is difficult to estimate the extent to which each is
exploited. This question becomes particularly pertinent when considering the latest developments
as regards the opening up of the northern direction through Central Asia and its possible
implications for routes which have traditionally existed in the region. 
65. Figure 17 illustrates the rising trend in the illicit production of opium in Afghanistan over
the last ten years, compared with a similar, and in recent years even faster rising, trend in the
volume of heroin/morphine seized in the Islamic Republic of Iran and Turkey (opium seizures
have been eliminated due to their relative irrelevance with regard to international trafficking). This
indicates that trafficking along this route - which may have become more diversified (as described
earlier) - has increased along with the rise in production in Afghanistan. The southern/eastern
directions, on the other hand (portrayed in figure 18), whilst having remained as active as ever,
have not realized such an increase. The volume of heroin smuggled outside the region via Pakistan
seems to have remained at a stable level, without following the rising production trend in
Afghanistan. Less data are available for Central Asia but reports of recent years indicate a fast
rising trend of trafficking through this region.
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Figure 17. Opium production trend in Afghanistan 
compared to trafficking trends along the "western" route 
in South-West Asia, 1986-1997
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Figure 18. Opium production trend in Afghanistan compared to 
trafficking trends along the "southern/eastern" route 
in South-West Asia, 1986-1997
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Figure 19. Heroin seized in Germany at borders with 
neighbouring countries, 1996-1997
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66. While it is not possible to provide an exact breakdown of the extent to which each
direction is used for smuggling of drugs, figures 17 and 18 support the fact that the passage via
the Islamic Republic of Iran is still the predominant trafficking route.   It is assumed that the
northern route through Central Asian States, which is supplied directly from Afghanistan or via
the Islamic Republic of Iran, has now become equally important.  Trafficking across Pakistan has
become less dominant but remains important for transportations by sea and air.
67. Seizure statistics for Germany also partly affirm the continued extensive use of the Balkan
route, originating in Turkey and mainly supplied via trafficking of opiates through the Islamic
Republic of Iran. The ranking of countries in the following figure (19) provides an overview of
the extent of heroin seized at Germany’s borders with its neighbours. The volumes seized at the
border areas with Austria and the Czech Republic far exceed those at the entry points from
Poland. While the statistics do not reflect any details regarding the origins of the heroin or of the
trafficking routes used, it can be assumed that the Balkan route, which mainly flows into countries
in the centre of Europe, including Austria and the Czech Republic, remains the major supply route
for heroin. With its borders with the CIS, Poland is estimated to be a major transit country for
heroin trafficked through Central Asian States. Although Poland ranks relatively highly, the total
volume seized is less significant than that at the Austrian border area.  In this context, the German
Federal Police assess that 80% of the heroin available in Europe has been trafficked across the
Balkan route11.
-33-
68. While it seems that the Balkan route, supplied via the Islamic Republic of Iran and Turkey,
was the predominant channel of transportation used by drug traffickers until 1997, latest
developments in 1998 indicate a possible displacement effect. First, the opening up of access
to/through Central Asia and its increased use as transit region for several years may have led to
an increase in opium production in the north of Afghanistan in 1998. Second, reports from
Interpol indicate that the deployment of Iranian military units along the Islamic Republic of Iran-
Afghanistan border may have resulted in a recent reduction of opiate smuggling across this border
and an increasing use of Pakistan and  the Central Asian States as transit countries12.
69. Switching from the traditional trafficking routes out of Afghanistan to the northward route
through Central Asia may also have the added attraction to trafficking organizations of
significantly reducing their overheads in terms of paying off intermediaries and collaborators. This
could provide such organizations with the opportunity not only to substantially increase their
profits, but also to effect a reduction in the cost of their products within illicit markets.
Trafficking routes used for opiate trafficking within/out of South-East Asia
70. The most significant recent development in this region has been the decrease in the flow
of heroin across the Myanmar-Thailand border, resulting in a corresponding increase in heroin
trafficking from Myanmar to China. Use of the Myanmar-China border area as the main conduit
for large consignments of heroin and the simultaneous decrease in the flow of that drug across the
Myanmar-Thailand border were also highlighted in several reports received by UNDCP. Thailand
remains a significant transhipment country for South-East Asian heroin bound for international
markets, but much larger consignments now moved northwards across China.13
71. This shift in trafficking is also evident in seizure statistics. The volume of heroin seized in
the South-East Asian region increased by more than 25% in 1997 compared to the average level
of previous years. This increase was mainly due to China, which recorded a significant rise in the
volume of heroin seized. Quantities seized in Thailand have fallen in recent years.
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Volume seized
(in percentage, n = 13.5 tonnes)
by mail
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4%
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1%
by air
9%
unspecified
37%
by land
47%
*  including opium, morphine and heroin
Number of seizure cases
(in percentage, n = 1,727 cases)
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17%
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Figure  22. Trafficking of opiates by rail, 1997
Ranking of countries according to volumes seized
Other countries
Yugoslavia
Germany
Hungary
France
Uzbekistan
Myanmar
Russian Federation
Ukraine
Figure  21. Trafficking of opiates by land, 1997
Ranking of countries according to volumes seized
Other countries
China
Ukraine
Uzbekistan
Yugoslavia
Russian Federation
India
Bulgaria
Islamic Rep. of Iran
Pakistan
Germany
Myanmar
United Kingdom
Turkey
3.3. Methods of transportation14
72. The predominant method of transportation for opiates at the global level is the land route.
Air transport and, to a lesser extent, mail services and rail routes are also frequently used, but the
quantities trafficked are less significant (see figure 20). The figures below are mainly based on
seizures of heroin and morphine.
Figure 20. Methods of transportation for trafficking of opiates* 
Worldwide, 1997
73. Countries which recorded the biggest seizure volumes relating to trafficking by land in
1997 are listed in figure 21. Rail routes are predominantly used in Central Asia and Eastern
Europe, as observed from available seizure reports from the Russian Federation, Ukraine and
Uzbekistan (see figure 22). Myanmar was the only country outside of the South-West Asian,
Central Asian and European regions where big seizure quantities were reported in relation to land
and rail trafficking. 
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Figure 23. Trafficking of opiates by air, 1997
Ranking of countries according to volumes seized
Other countries
United Kingdom
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Pakistan
United States
Figure 24. Trafficking of opiates by mail, 1997
Ranking of countries according to volumes seized
Other countries
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Figure 25. Trafficking of opiates by sea, 1997
Ranking of countries according to volumes seized
Other countries
Singapore
Mauritius
Ukraine
Greece
Netherlands
Sri Lanka
Australia
United Kingdom
74. Trafficking by air involves much smaller quantities but has a wider geographic spread (see
figure 23). Countries and territories which
reported heroin seizures in connection with air
transport in 1997 have been grouped under
three categories, according to the extent of
seizures made. The United States and Pakistan
rank highest followed by a second category
group of countries including Australia, Canada,
Germany, the Netherlands, Saudi Arabia,
Spain, Sri Lanka and the United Kingdom. The
third category includes Argentina, China
(Hong Kong SAR), Colombia India, Italy,
Japan, Kuwait, the Russian Federation, Togo
and Puerto Rico. Finally, seizure reports
involving relatively small-scale opiate
trafficking via air routes are received from a
large number of other countries. In Africa these
include Benin, Egypt, Mauritius, Morocco,
Tunisia, Uganda and the United Republic of
Tanzania. 
75. Trafficking by mail was principally recorded by the United States, followed by Australia,
Pakistan and the United Kingdom (see figure 24). The sea route seems less prominent in heroin
trafficking but was recorded by Australia and the United Kingdom (see figure 25).
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Figure 26. Heroin seized, 1984-1997 
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Figure 27. Heroin seized in 
Western Europe, 1984-1997
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Figure 28. Heroin seized in the 
United States and Canada, 1984-1997
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3.4. Seizures statistics
76. Global seizures of heroin have more or less stabilized at a level of approximately 28
tonnes in recent years (see figure 26). This stabilization is consistent with the levelling off in global
production  of opium, as stated previously.
77. While seizures in Europe, one of the main consumer area for heroin, appear to mirror the
global stabilization trends (see figure 27), those in other regions, such as North America, though
remaining secondary in consumption of opiates, continue to reflect an increase (see figure 28).
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Figure 29. Production of opium in Colombia and 
heroin seized in the area, 1989-1997
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Figure 30. Production of opium and heroin seized 
in Mexico, 1984-1997
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78. Seizure statistics of opiates originating from Latin America also affirm available
information on trends in that region, though the extent of illicit poppy cultivation and heroin
trafficking remains limited compared to the Asian dimension. Subsequent to the emergence of
opium poppy cultivation in Colombia in 1991, regular seizures of heroin have been recorded by
that country and its neighbours Ecuador, Panama and Venezuela since 1992, with a rising trend
up to 1995. The seizure trends in those countries in turn mirror the cultivation situation in
Colombia, which has been rising during the early 1990s, with a peak in 1994 (see figure29).
79. Mexico, which has a much longer history of illicit poppy cultivation, has recorded heroin
seizures since the early 1980s. Both seizure statistics and estimates of opium production in
Mexico have reflected more or less stable trends in recent years.
80. Further details on seizure statistics of opiates are included in figures 31-33 and table 6.
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Seizures: Opium raw and prepared
Figure 31. Global trend, 1987-1997
Breakdown by subregion
(in metric tonnes)
Table 6. Countries ranked in order of volume of drug seized, 1987-1997
(in metric tonnes)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Iran (Islamic Rep. of) 36.8       39.4       26.2       20.3       23.0       38.3       63.9       117.1     126.6     149.6     162.4     
Pakistan 7.9        3.8        4.6        8.3        5.9        3.4        4.5        14.7       109.4     7.4        2.7        
India 2.9        3.3        4.9        2.1        2.1        1.9        2.9        2.3        1.3        2.9        3.2        
Myanmar 1.5        0.9        0.6        1.7        1.5        2.2        2.4        1.7        1.1        1.3        8.1        
Other countries of 
the world
7.9        14.2       5.7        4.2        9.0        7.0        11.5       8.8        7.3        13.0       10.0       
Total 56.9       61.6       41.9       36.6       41.5       52.8       85.3       144.5     245.7     174.2     186.4     
Figure 32. Trends of the three highest-ranking countries,  1987-1997
(in metric tonnes)
Figure 33.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
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Seizures: Heroin
Figure 34. Global trend, 1987-1997
Breakdown by subregion
(in metric tonnes)
Table 7. Countries ranked in order of volume of drug seized, 1987-1997
(in metric tonnes)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Pakistan 5.5        6.5        9.2        6.5        5.7        2.9        4.0        6.4        10.8       5.9        6.2        
China 0.1        0.2        0.6        1.7        2.0        4.5        4.5        4.1        2.4        4.3        5.4        
Turkey 1.3        1.0        1.2        1.0        1.4        1.1        2.3        2.2        3.5        4.4        1.4        
Iran (Islamic Rep. of) 1.4        1.7        1.4        1.8        1.8        4.1        2.0        0.9        2.1        0.8        2.0        
Other countries of 
the world
8.7        12.5       11.8       12.4       12.0       12.5       13.9       14.7       12.6       12.9       13.6       
Total 17.0       21.9       24.1       23.4       22.7       25.0       26.7       28.2       31.3       28.4       28.5       
Figure 35. Trends of the three highest-ranking countries,  1987-1997
(in metric tonnes)
Figure 36.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
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potential availability of heroin to illicit markets, 1988-1998
(in metric tonnes)
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
A - Total opium production 2,794     3,395     3,760     4,274     4,143     4,610     5,621     4,452     4,356     4,823     3,765     
B -  Potential* manufacture of heroin (A:10) 279        340        376        427        414        461        562        445        436        482        377        
C - Global seizure volume of heroin, morphine 29          29          32          36          40          64          56          69          58          66          66.4
       and opium (in heroin equivalent)
D - Interception rate (C:Bx100) (in %) 10% 9% 9% 8% 10% 14% 10% 15% 13% 14%
E - Potential* heroin availability ** (B-C) 250 310 344 391 375 397 506 377 378 416
*   This calculation refers to a potential manufacture and availability of heroin which differs from the actual figures to the extent that
     not all opium is converted into heroin.
** The total availability also includes quantities of drugs stored or lost, which could not be deducted due to lack of information.
Table 8.  Potential manufacture of heroin, global interception rate and 
Figure 37. Potential availability of heroin and global seizure volume of opiates, 1988-
1989
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4. Global interception rate and potential availability of heroin to the world market  
81. Opiate seizures represent some 8 to 15% of the estimated world production. In 1997, this
interception rate was about 14% (see table 8), with the South-West Asian and Near and Middle
East regions together accounting for 60% of global seizure volume of opium, morphine and
heroin, followed by Europe (16%) and East/South-East Asia (13%). 
82. The remaining 86% (amounting to more than 400 tonnes of heroin) of the 1997 world
production is assumed to have been potentially available to global illicit markets. In 1998, the
potential global availability of heroin would have been around 300 tonnes, on the assumption of
relatively stable seizures.  However, there are a number of unknown variables, such as storage,
losses, “cutting” (resulting in different levels of purities of drugs seized) and re-entry of seized
drugs onto illicit markets as a result of negligence or corrupt practice. Another point which needs
to be stressed in this context is that the potential availability of opiates, which is expressed in
heroin equivalent in table 8, will not reflect the actual quantity of heroin available to world
markets, since a large amount is consumed as opium in the producer regions.
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b Estimates on coca leaf production used in this document differ from those quoted in the UNDCP
Business Plans for Alternative Development in Bolivia, Colombia and Peru, due to the application of different
yield and/or conversion rates which are supported by further correlations between production figures and
interception rates. However, figures on cultivation, which are the main indicators of the various Business
Plans, concur with those used in this chapter.
B. Coca
Figure 38. Global trend in 
illicit cultivation of coca bush and production of coca leaf, 1986-1998
(in hectares and metric tonnes)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Cultivation* (ha) 200,440 218,800 260,900 283,300 288,400 234,700 190,600 203,900 189,600 194,000 178,300 187,698 180,800 
Production (mt) 240,133 265,085 317,472 345,272 361,138 386,400 377,524 366,615 333,738 341,668 339,690 359,185 338,926 
* Potentially harvestable, after eradication
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1. Global illicit cultivation of coca bush and production of coca leaf
83. Global illicit cultivation of coca bush in 1997 was estimated at 187,700 hectares, a minor
increase on 1996. Total estimated production of coca leaf also slightly increased in 1997, reaching
approximately 360,000 tonnes.  In 1998, figures for both cultivation and production reflected a
decrease (see figure 38).   The global levels of cultivation and production, which seem to have
reached a peak in the early 1990s, following sharp rises throughout the previous two decades,
have stabilized in recent years. However, trends differ between the three producer countries,
Bolivia, Colombia and Peru (see table 9).b
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Figure 39. Global illicit cultivation of coca bush, 1998 
Ranking of countries 
(in metric tonnes and percentage of global production)
101,800**
(56%)
51,000
(28%)
28,000
(16%)
Bolivia
Peru
Colombia
Figure 40. Global illicit production of coca leaf, 1998 
Ranking of countries 
(in metric tonnes and percentage of global production)
165,934
(49%)
95,600
(28%)
77,392
(23%)
Bolivia
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Colombia
Table 9. Global illicit cultivation of coca bush and production of cocal leaf, 1986-1998
(UNDCP estimates)
Country/year 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Cultivation* in hectares
Bolivia 25,800   29,300   36,900   40,900   38,300   35,900   33,500   35,200   36,100   36,600   36,100   36,000 28,000
Colombia 24,240   22,500   34,000   42,400   40,100   37,500   37,100   39,700   44,700   50,900   67,200   79,436 101,800
Peru 150,400 167,000 190,000 200,000 210,000 161,300 120,000 129,000 108,800 106,500 75,000   72,262 51,000
Global total 200,440 218,800 260,900 283,300 288,400 234,700 190,600 203,900 189,600 194,000 178,300 187,698 180,800 
Production in tonnes
Bolivia 71,311   80,985   101,992 113,048 105,861 99,228   92,594   97,293   99,780   101,162 99,780   99,504 77,392
Colombia 18,422   17,100   25,480   32,224   45,277   45,172   44,930   45,422   71,958   80,706   108,910 129,481 165,934
Peru 150,400 167,000 190,000 200,000 210,000 242,000 240,000 223,900 162,000 159,800 131,000 130,200 95,600
Global total 240,133 265,085 317,472 345,272 361,138 386,400 377,524 366,615 333,738 341,668 339,690 359,185 338,926 
* Potentially harvestable, after eradication
** According to the Ministry of Foreign Affairs of Colombia, the area under cultivation for coca leaf amounted to 78,200 hectares in March 1999.
84. Cultivation and production in Peru decreased significantly in recent years and continued
to decline in 1997 and 1998. Bolivia reflected a rather stable trend during the 1990s and a
decrease in 1997 and particularly in 1998. Estimates on Colombia, in contrast, reflect a
continuously rising trend since the 1980s and, in 1998, for the first time, significantly exceeded
the cultivation and production levels of both other countries (see table 9 and figures 39-40 below).
 It needs to be stressed, however, that the average yield applied by UNDCP differs, in some cases
significantly, from those of other sources. 
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Breakdown by country and global trend
(in hectares)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Bolivia -      1,109  1,341  1,553  7,919   5,211   4,935   2,241  932     5,475   7,512   7,026   11,621 
Colombia 870     572     230     641     760      459      944      846     4,904  25,402 23,025 44,123 69,209 
Peru 2,576  1,346  1,475  2,607  8,087   5,488   5,150   2,340  2,240  5,498   7,512   3,462   17,800 
Global eradication 3,446  3,027  3,046  4,801  16,766 11,158 11,029 5,427  8,076  36,375 38,049 54,611 98,630 
Figure 41. Global trend in eradication of coca bush
1986-1998
-
20,000
40,000
60,000
80,000
100,000
120,000
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
he
ct
ar
es
Global eradication Trend
1.1. Global eradication of coca bush
85. The Governments of Bolivia, Peru and Colombia have strengthened their eradication
efforts in recent years. In 1998, the total areas eradicated substantially increased in all three
countries (see table 10 and figure 41).
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Table 11.  Coca estimates 1998
Overview of the three producer countries and their global shares
Cultivation Average yield Production Conversion ratio Potential manufacture
Country of coca bush (production of coca leaf of coca leaf (coca leaf in tonnes required to of cocaine
(in hectare and %) in kilogramme, per hectare) (in tonnes and %) produce 1 tonne of cocaine) (in tonnes and %)
Bolivia   28,000      (16%) 2764     77,392    (23%) 353   219     (28%)
Colombia 101,800      (56%) 1630   165,934    (49%) 509   326     (41%)
Peru   51,000      (28%) 1875     95,600    (28%) 399   240     (31%)
Global total 180,800     (100%) Average: 2058  338,926    (100%) Average:     420   785    (100%)
2. Illicit manufacture of cocaine
86. As in the case of yield factors, precise information is lacking as regards the ratio for
conversion of coca leaf into cocaine, which appears to vary from country to country.
Consequently, the various sources drawn upon by UNDCP differ significantly and estimates
established may be adjusted as more information becomes available.
87. Currently available information suggests that an average of 420 tonnes of coca leaf is
required to produce 1 tonne of cocaine. This ratio seems to be lower in Bolivia and Peru than in
Colombia, to the effect that the lowest output of cocaine is achieved from coca leaf grown in
Colombia. The following table summarizes the estimated figures for 1998 in the three coca
producing countries and their global shares in terms of cultivation, production and manufacture.
A comparison between the three countries reveals that more than 40% of the world’s cocaine is
supplied from Colombia, about one third from Peru and slightly less than that from Bolivia.
88. Based on the estimates provided in table 11, global illicit manufacture of cocaine  reached
785 tonnes in 1998, which is a reduction from the average 850 tonnes of recent years (see figure
42).  It is important to note, however, that the calculation of cocaine manufacture refers to a
potential volume, which differs from the actual manufacture to the extent that not all coca leaf is
converted into cocaine. It further needs to be emphasized that the breakdown by country for
potential cocaine manufacture refers to the origin of coca leaf rather than the site of
manufacturing activity (refer to paragraph 89).
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Figure 42. Global trend in potential illicit manufacture of cocaine, 1986-1998
(in metric tonnes)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
potential manufacture (mt) 391 433 532 787 917 938 940 960 850 844 835 863 785
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Figure 42a. Comparision of trends of coca cultivation/production 
and potential cocaine manufacture, 1986-1998
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89. Little information is available as regards the sites of clandestine laboratories for the
manufacture of cocaine. However, recent information points to increased manufacturing activity
within the coca producer countries themselves, rather than the previous customary transportation
of coca paste to countries where most manufacture of cocaine hydrochloride would take place.
This trend seems to be particularly evident in Bolivia, where an increasing number of farmers are
clearly moving up the manufacturing scale, from producing only coca leaf and paste to also
manufacturing cocaine base and cocaine hydrochloride, which generate higher profit margins15.
Nevertheless, large quantities of coca paste and cocaine base continue to be transported from Peru
to Colombia for subsequent cocaine refinement.  Therefore, the much higher percentage for
Colombia’s potential cocaine manufacture, as indicated by some sources, relates to the
manufacturing activities taking place in the country.16  Table 11, however, only lists the estimated
potential of cocaine manufactured from coca leaf grown on the country’s territory. The following
figure (42a) provides an overview of global trends in illicit  coca cultivation and production in
comparison to potential cocaine manufacture.
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3. Trafficking trends
3.1. Destinations and routes
90. North America remains the principal destination for cocaine, though consumption is
currently declining. The drug mainly enters the United States at its south-western border with
Mexico. According to United States Drug Enforcement Administration information,
approximately 60% of the cocaine smuggled into the United States crosses the south-western
border. Colombian trafficking organizations control the worldwide supply of cocaine. These
organizations use sophisticated means to move cocaine by land, sea and air into the United States.
Over the past decade, the balance of criminal influence seems to have shifted a little with Mexico-
based trafficking organizations playing an ever increasing role in the US cocaine trade.17
91. The relentless evolution of the illicit cocaine threat directed primarily at North America
over the past 25 years has rendered the whole of the Americas a complex zone of illegal drug
trade, with virtually every nation now being affected by cocaine trafficking and consumption.
92. Europe remains the fastest growing market for cocaine, even though it is still considered
to be at a developmental stage. The current picture is one of widespread availability of cocaine
throughout the region, particularly in larger cities.  The drug is trafficked to Europe from South
America via three main exit points - Argentina, Brazil and Venezuela - with Argentina having
grown in strategic importance for cocaine trafficking only in recent years and Brazil remaining the
most significant player in terms of quantities trafficked.  The Caribbean, another major transit
area, continues to grow in importance for cocaine trafficking.  In addition, Africa, and in
particular West and Southern Africa, is increasingly used as a transit area for cocaine trafficking
from South America to Europe.  The southern cone of Africa has become one of the hottest spots
for cocaine smuggling in the world. Originating mainly from Brazil, cocaine is trafficked by ship
or air, either directly to South Africa or through Angola and other countries in West Africa, and
then transported through the southern part of the continent before leaving for Europe. 
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Figure 44. Trafficking of cocaine (base and paste) by sea, 1997
Ranking of countries/territories according to volumes seized
Other countries
Canada
Belize
Mexico
Belgium
Peru
Cuba
Bahamas
Panama
Colombia
Spain
Netherlands
Venezuela
United States
Puerto Rico
3.2  Methods of transportation14
93. The predominant methods of transportation for cocaine trafficking remain the sea and air
routes. Trafficking by sea is characterized by large bulk quantities. The land route is additionally
relevant in terms of quantities trafficked while mail services are the second most frequently used
method (see figure 43).
Figure 43 Methods of transportation for trafficking of cocaine
Worldwide, 1997
94. Trafficking by sea is primarily recorded by the United States (see figure 44).  Additional
countries in Latin America, the Caribbean and Europe are also ranking high. In this context, a shift
to smaller loads has been evident in recent years (especially in overseas trafficking to Europe),
which may be an attempt by trafficking organizations to minimize risk. Statistics reflect that the
number of seizures increased faster than the total quantities seized, with multi-tonne seizures
occurring less frequently18.
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Figure 45. Trafficking of cocaine (base and paste) by air, 1997
Ranking of countries/territories according to volumes seized
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Figure 46. Trafficking of cocaine (base and paste) by land, 1997
Ranking of countries according to volumes seized
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Figure 47. Trafficking of cocaine (base and paste) by mail, 1997
Ranking of countries/territories reporting volumes seized
Other countries
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95. The air route is by far the
most frequently used means of
transporting cocaine, but quantities
trafficked are naturally small.
Countries/terri tories which
recorded the largest seizures in
relation to air trafficking are
included in figure 45. In addition,
large quantities were also seized in
Argentina, Belize, Canada,
Colombia, Cuba, the Dominican
Republic, France, Germany, Italy,
Panama, Portugal, the United
Kingdom and the Netherlands
Antilles. 
96. Overland trafficking seems to be mainly relevant between Mexico and the United States,
which record the largest seizures in this context (see figure 46). Mail services account for
approximately 15% of reported cocaine seizure cases, occurring most frequently in the United
States, Germany and the Netherlands (see figure 47).
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Figure 48. Cocaine seized, 1986-1997 
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Figure 49. Cocaine seized in the 
United States and Canada, 1984-1997
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Figure 50. Cocaine seized in Western Europe
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3.3. Seizure statistics
97. Global seizures of cocaine (see figure 48) , which generally relate to interceptions made
in the Americas, were more or less stable in recent years and amounted to 312 tonnes in 1997,
a minor decrease compared to 1996. 
98. While seizure volumes continue to rise in a number of South and Central American
countries (except for Peru, which recorded a large decline coinciding with a reduction in coca
production there) North America recorded a recent decreasing trend (see figure 49). The
quantities of cocaine seized in Europe have steadily increased in recent years (see figure 50). The
region’s share in the global seizure volume climbed from an average 3% during the 1980s to 13%
in 1997, a rise which is reflected in both Eastern and Western Europe. 
99. Seizures in Africa increased from an annual average of 280 kilogrammes over the past
decade to more than 7 tonnes in 1997, of which, however, 5.8 tonnes can be attributed to cocaine
washed up at the Moroccan beaches after being jettisoned by a vessel bound for Spain or
Portugal19. Additionally, Angola recorded a large quantity of cocaine seized in 1997 and a number
of other African countries have reflected rising trends in recent years, though data are not
available on a consistent basis.
100. Further details on seizure statistics of cocaine are included in figures 51-53 and table 12.
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Seizures: Cocaine
Figure 51. Global trend, 1987-1997
Breakdown by subregion
(in metric tonnes)
Table 12. Countries ranked in order of volume of drug seized, 1987-1997
(in metric tonnes)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
United States 56.4       102.4     130.1     84.8       120.3     119.8     111.0     129.5     110.8     128.7     95.0       
Colombia 18.5       23.1       43.3       50.7       72.6       37.8       32.2       72.2       59.0       45.8       42.0       
Mexico 9.3        15.4       39.5       49.9       50.3       38.8       45.8       22.1       22.7       23.8       35.0       
Peru 40.2       36.7       9.6        34.3       7.8        7.7        8.9        10.6       22.7       19.7       8.8        
Other countries of 
the world
27.4       35.5       40.6       69.1       71.6       70.6       69.8       88.2       75.4       102.2     147.0     
Total 151.8     213.1     263.1     288.9     322.7     274.6     267.7     322.7     290.6     320.2     327.8     
Figure 52. Trends of the three highest-ranking countries,  1987-1997
(in metric tonnes)
Figure 53.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
4.7%
5.2%
5.7%
10.9%
13.1%
29.6%
- 0.05 0.10 0.15 0.20 0.25 0.30
United States
Colombia
Mexico
Spain
Venezuela
Panama
0
100
200
300
400
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
North America South America
Western Europe Central America
Other regions
0
20
40
60
80
100
120
140
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
United States
Colombia
Mexico
-51-
Table 13.  Potential manufacture of cocaine, global interception rate and 
potential availability of cocaine to illicit markets, 1988-1998
(in metric tonnes)
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
A - Coca leaf production
Bolivia 101,992 113,048 105,861 99,228   92,594   97,293   99,780   101,162 99,780   99,504 77,392
Colombia 25,480   32,224   45,277   45,172   44,930   45,422   71,958   80,706   108,910 129,481 165,934
Peru 190,000 200,000 210,000 242,000 240,000 223,900 162,000 159,800 131,000 130,200 95,600
Total production 317,472 345,272 361,138 386,400 377,524 366,615 333,738 341,668 339,690 359,185 338,926 
B - Estimated ratio to produce 1 tonne of cocaine
Bolivia 350       350       351       354       357       351       353       354       349       350       353       
Colombia 500       500       490       515       495       490       510       510       488       510       509       
Peru 1,000    500       402       425       407       380       380       400       402       401       399       
Average 617       450       414       431       420       407       414       421       413       420       420       
C - Potential* Cocaine  manufacture (A:B)
Bolivia 291       323       302       280       259       277       283       286       286       284       219       
Colombia 51         64         92         88         91         93         141       158       223       254       326       
Peru 190       400       523       570       590       590       426       400       326       325       240       
Total potential* cocaine 532       787       917       938       940       960       850       844       835       863       785       
D - Global seizure volume of cocaine 213       263       289       323       275       268       320       291       320       322       322       
E - Interception rate (D:Cx100) 40% 33% 32% 34% 29% 28% 38% 34% 38% 37%
F - Potential* cocaine availability **(C-D) 319      524      628      615      665      692      530      553      515      541      
*   This calculation refers to a potential manufacture and availability of cocaine which differs from the actual figures to the 
       extent that not all coca leaf is converted into cocaine.
** The total availability also includes quantities of drugs stored or lost, which could not be deducted due to lack of information.
Figure 54. Potential availability and global seizure 
volume of cocaine, 1988-1998
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4. Global interception rate and potential availability of cocaine to the world market
101. The assessed interception rate for cocaine has been between 28 and 40% over the last
decade (see table 13, figure 54). This appears to be high when compared with opiates, where an
average rate of 13% is assessed for recent years. In 1997, the cocaine interception rate was, with
37%, at a very high level. One explanation for the high interception rate of cocaine may be that
global production of coca leaf and its subsequent refining into cocaine may in fact exceed current
estimates.  Another is that cocaine tends to be trafficked in large bulk volumes, individual
interceptions of which may therefore indicate an apparent level of enforcement success greater
than those in respect of other substances, e.g. heroin.
102. The remaining approximate two-third of the global production is assumed to be potentially
available to the world’s illicit markets. However, as with opiates, there are a number of unknown
variables, such as storage, losses, “cutting”  (resulting in different levels of purities of drugs
seized) and  re-entry of seized drugs onto the illicit market as a result of negligence or corrupt
practice.  Another point which needs to be stressed in this context is that the potential availability
of cocaine is not equal to the actual quantity available at the world market, since a large amount
is used as coca leaf within the producer regions.
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C. Cannabis
Table 14. Cannabis source countries*
Africa: Benin, Cameroon, Congo, Côte d'Ivoire, Gambia, Ghana, Guinea, Kenya, Lesotho
Madagascar, Malawi, Mali, Morocco, Nigeria, South Africa, Swaziland, Togo,
Tunisia, Uganda, United Republic of Tanzania, Zaire, Zambia, Zimbabwe.
Central America and the Caribbean: Costa Rica, Cuba, Jamaica, St.Vincent and the Grenadines, Trinidad and Tobago.
North America: United States, Mexico.
South America: Argentina, Brazil, Chile, Colombia, Paraguay , Venezuela.
Europe: Albania, Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France,
Germany, Italy , Netherlands, Poland, Portugal, Romania, Russian Federation,
Slovakia, Spain, Sweden, Switzerland, the former Yugoslav Republic of Macedonia,
Turkey, United Kingdom.
Central Asia: Kazakhstan, Kyrgyzstan, Tajikistan, Uzbekistan.
Near/Middle East and South-West Afghanistan, India, Iran (Islamic Republic of), Jordan, Lebanon, Oman, Nepal,
Asia and South Asia: Pakistan, Syria, United Arab Emirates.
East/South-East Asia: Cambodia, China, Indonesia, Lao PDR, Myanmar, Philippines, Thailand.
*Primary source countries are in bold.
103. Estimates of the extent of illicit cannabis cultivation, production and trafficking are more
difficult to gauge than those relating to other plant-based drugs because of the significant amounts
of wild growth, the more dispersed nature of cultivation and the sheer magnitude of trafficking.
However, despite lack of accurate data, a brief summary of the information available on the
spread of illicit cannabis cultivation and the extent of and trends in trafficking is presented in this
chapter.
1. Global illicit cultivation of cannabis plant and production of cannabis herb and resin
104. Cannabis grows across the globe in a large number of countries and in almost all
geographic environments. The largest areas of wild growth seem to be in some of the States of
the Commonwealth of Independent States (CIS) notably the Russian Federation and Kazakhstan
and other Central Asian States. Large-scale illicit cultivation and production of cannabis takes
place in a number of Asian, African and Latin-American countries. The primary source countries
identified by Interpol20 include Afghanistan, Cambodia, Colombia, Jamaica, Morocco, Mexico,
Nigeria, Pakistan, South Africa and Thailand. In addition to a large number of secondary locations
spread over all continents (see table 14), a number of countries in South-East Asia, such as
Indonesia, the Lao People’s Democratic Republic and the Philippines, seem to have recently
emerged as significant cannabis sources. The main sources of cannabis resin continue to be
Morocco and countries in South-West Asia. The total global areas where cannabis plant is
cultivated and/or grows wild may range from 670,000 ha to 1,800,000 ha, and actual production
is roughly estimated at 20,000 to 30,000 tonnes a year21. 
105. Latest trends in indoor cultivation of high THC-content cannabis, by means of modern
hydroponic technologies, present an additionally worrying dimension of the cannabis production
situation. Although the production sites using indoor methods are naturally restricted, the output
is considerable because of the high THC content (reportedly up to 20% or even higher) and the
possibility of four full growth cycles per year. This development seems to be most marked in
Europe and North America.
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Figure 55. Herbal cannabis seized, 1985-1997 
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Figure 56. Cannabis resin seized, 1984-1997 
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2. Trafficking trends 
2.1. Seizure statistics
106. Trafficking of cannabis exceeds that of all other drugs in terms of geographic spread and
quantities smuggled. Almost all countries that provide data to UNDCP refer to cannabis seizures
and more than 50% of all seizure cases reported worldwide relate to some type of cannabis. The
largest quantities of herbal cannabis continue to be trafficked in North America, while trafficking
in cannabis resin remains largely focused on supplying European markets.
107. Global trends in trafficking of cannabis tend to fluctuate more than with other drugs.
However, seizure statistics, which seem to correlate closely with abuse patterns, as identified in
some national statistics22, provide the following picture. After a more of less stable trend during
the 1980s in the case of cannabis resin and a wide fluctuation with a decreasing tendency in the
case of herbal cannabis, seizure volumes of both drug types rose during the first half of the 1990s
but have more or less stabilized in recent years. The current global level of seizure quantities for
herbal cannabis is lower than the average level during the 1980s but is still higher than during the
early 1990s. In the case of cannabis resin, global seizure volumes have stabilized at their highest
level for decades and even seem to indicate a decrease since 1996. (See figures 55 and 56).
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108. Herbal cannabis is widely trafficked in all regions but particularly in North America,
which records by far the largest seizure quantities of that drug. Figures for North America have
been stable in very recent years, though remaining higher than during the early 1990s. The total
seizure volumes for Europe, Asia and South America are currently at similar levels, being roughly
20% of the North American totals, yet the trends in these regions differ. While South America
realized a recent decreasing trend and figures for Asia have been steady in recent years, Europe
has recorded an increase, which is reflected in both Western and Eastern Europe, though the latter
accounts for only a small portion. 
109. Other subregions also reflect differing trends, with seizure totals being on a smaller scale.
For example, annual seizure volumes in the Caribbean have been significantly lower during the
1990s than during the previous decade, while Central America has recorded an increase over the
last few years. Average figures for Africa, mainly relating to the Southern African subregion,
reflect more or less stable trends. In 1997, as in previous years, Mexico, the United States,
Colombia and South Africa recorded the world’s largest seizures of cannabis herb. Additionally,
India and the United Republic of Tanzania reported big seizure volumes during that year.
110. Details on seizure statistics of herbal cannabis are included in figures 57-59 and table 15.
111. A subregional breakdown of trafficking trends in the case of cannabis resin reflects an
equally widespread picture to that in respect of herbal cannabis, with  seizures being concentrated
in Western Europe, one of the biggest consumer areas, as well as in South-West Asia and North
Africa, which remain the main points of origin of that drug. Despite fluctuating trends, seizure
volumes in all three subregions were considerably higher during the 1990s compared to the
previous decade, but quantities intercepted in 1996 and 1997 seemed to stabilize globally, with
a falling trend in South-West Asia and a rise in Western Europe. 
112. Morocco and a number of Western European countries continue to seize large quantities,
but Pakistan’s seizures of cannabis resin, which used to rank highest worldwide, were reduced
by half in 1997 as against 1996. Whether this recent decline in Pakistan is a fluctuation or
indicates a reversing trend in cannabis trafficking remains to be seen.
113. Details on seizure statistics of cannabis resin are included in figures 60-62 and table 16.
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Seizures: Herbal cannabis
Figure 57. G lobal trend, 1987-1997
Breakdown by subregion
(in metric tonnes)
Table 15. Countries ranked in order of volume of drug seized, 1987-1997
(in metric tonnes)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Mexico 394.5     277.5     752.5     594.8     255.0     404.6     494.7     528.4     780.2     1,015.8   1,038.5  
Colombia 1,299.3  927.2     707.6     653.3     329.0     205.7     548.8     207.7     206.3     238.9      136.3     
United States 622.7     524.9     335.9     171.7     139.7     345.9     382.8     475.0     627.9     638.7      684.7     
South Africa 1,111.4  0.0        70.9       171.1     680.0     254.1     847.3     268.7     238.8     203.4      171.9     
Other countries of 
the world
784.3     502.7     1,977.7  830.6     396.6     1,119.7  1,076.2  843.8     1,363.8  918.0      883.4     
Total 4,212.2  2,232.4  3,844.7  2,421.6  1,800.3  2,330.0  3,349.9  2,323.5  3,217.0  3,014.8   2,914.8  
Figure 58. Trends of the three highest-ranking countries,  1987-1997
(in metric tonnes)
Figure 59.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
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Seizures: Cannabis resin
Figure 60. Global trend, 1987-1997
Breakdown by subregion
(in metric tonnes)
Table 16. Countries ranked in order of volume of drug seized, 1987-1997
(in metric tonnes)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Pakistan 159.5     146.1     140.4     240.6     236.9     188.1     189.0     189.3     357.7     192.8     107.0     
Spain 59.2       90.9       64.2       70.1       104.8     121.4     160.2     219.2     197.0     247.7     315.3     
Morocco 7.9        9.7        29.6       42.6       41.5       65.5       106.3     97.0       110.2     64.8       71.9       
Netherlands 31.9       46.2       14.1       90.0       74.0       75.3       28.2       43.3       80.0       11.4       31.5       
Other countries 
of the world
194.7     184.2     205.6     197.6     432.7     211.8     364.8     357.1     316.3     329.1     221.6     
Total 453.2     477.2     453.8     640.9     889.8     662.2     848.4     905.9     1,061.3  845.8     747.4     
Figure 61. Trends of the three highest-ranking countries,  1987-1997
(in metric tonnes)
Figure 62.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
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Figure 65. Trafficking of herbal cannabis by sea, 1997
Ranking of countries according to volumes seized
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Figure 64. Trafficking of herbal cannabis by land, 1997
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2.2.  Methods of transportation14
114. Cannabis (both herbal and resin) is predominantly transported by land or sea routes, the
latter being characterized by large consignments, which is reflected in the enormous volume seized
in relation to a relatively small number of seizure cases (see figure 63). 
Figure 63. Methods of transportation of cannabis (resin and herbal)
Worldwide, 1997
115. Seizure statistics received for 1997 reveal the following ranking of countries. The United
States accounted for by far the biggest quantities of herbal cannabis seizures in relation to
trafficking by land, followed by Mexico, India and South Africa (see figure 64). Herbal Cannabis
transported by sea route involved a large number of countries in all regions of the world; the
biggest seizure quantities were reported from Colombia, South Africa, the Netherlands, Peru,
Belgium, the United States, Jamaica, the United Kingdom, Viet Nam, Barbados, Australia and
others (see figure 65). 
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Figure 66. Trafficking of herbal cannabis by air, 1997
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Figure 67. Trafficking of cannabis resin by land, 1997
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Figure 68. Trafficking of cannabis resin by sea, 1997
Ranking of countries according to volumes seized
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Figure 69. Trafficking of cannabis resin by air, 1997
Ranking of countries according to volumes seized
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116. The use of air routes
to traffic herbal cannabis
mainly occurred in the
Netherlands, the United
Kingdom, France, Congo, the
United States, Canada and
Cuba  (see figure 66).
117. With regard to cannabis resin, the biggest quantities relating to trafficking by land were
seized in France, Spain, Pakistan and Morocco (see figure 67). The sea route was predominantly
recorded by Spain, the United Kingdom, Australia, Mozambique, Greece and Pakistan  (see
figures 68).
118. According  to
seizure reports received,
cannabis resin is trafficked
by air mainly to the
Netherlands, Canada,
Germany, the United
Kingdom and Spain  (see
figure 69).
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c A new format of the Annual Reports Questionnaire, which will split substance groups into single
drugs, is expected to be presented to the CND in 2000.
d The term “clandestine” laboratory”, although widely used, is not strictly defined and can be
somewhat misleading. Clandestine laboratories range from elaborate, purpose-built constructions to mere
“kitchen” operations (often literally set up in domestic kitchens). The fact that no neat cut-off points exist in
defining laboratories may have also distorted the picture presented in the statistics below, since reports on
detection of laboratories received from Governments vary to the extent that some countries include only
sophisticated stages of drug production or manufacture and other report any kind of operation which involve
illicit drug processing.
D. Psychotropic Substances
1.  Stimulants
119. Central nervous system stimulants, which comprise plant based drugs (cocaine) and
synthetic substances (amphetamine-type stimulants, anorectics), appear to be classified in various
ways in existing literature. This chapter principally refers to amphetamine-type stimulants
(ATS) including amphetamine, methamphetamine and Ecstasy-type substances.  However,
the annual reports questionnaires, which is the main source of information underlying this report,
requests data by substance group (stimulants, hallucinogens, depressants) rather than by individual
substance (except for LSD and methaqualone). The comparability of data is further complicated
by Ecstasy-type substances being partly reported in the hallucinogens group, rather than as
stimulants. Therefore, an effort has been made to extract Ecstasy-type substances as a separate
entry, and some details relating to the manufacture of that drug are summarized here (see section
1.1. below). On the other hand, seizure data of Ecstasy are included in the hallucinogen group
while seizure statistics referring to “stimulants” pertain to mainly amphetamine and
methamphetamine (see section 1.2. below). Additional sources have been used to describe
separately trends in respect of these drug types.c
120. In general, trends on the extent of production, trafficking and consumption of ATS
continued to rise in 1997. Methamphetamine continues to be mainly associated with North
America and East/South-East Asia, while amphetamine remains dominant in Europe. The
geographic range of Ecstasy-type substances has been further expanded and the rapid spread of
traffic in that substance around the world, which was one of the latest developments, has
continued in 1997, though at a somewhat slower pace than in 1996. Despite that spread of
Ecstasy-type substances, Europe remained the region most affected.23
1. 1.  Illicit manufacture of ATS   (including  amphetamine, methamphetamine and the
Ecstasy group)
121. The main indicator for estimating the extent and geographic distribution of illicit
manufacture is data on the detection of clandestine laboratoriesd. It needs to be noted, however,
that a rise or decline in the number of laboratories detected does not necessarily imply greater or
lesser manufacture, which could be affected, for example, by the establishment of fewer but larger
laboratories. 
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Figure 71. Number of amphetamine 
laboratories detected, 1985-1997
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122. The global trend in the number of detected laboratories manufacturing amphetamine,
methamphetamine or Ecstasy-type substances is reflected in figure 70. The rising trend during
the 1980s was followed by a decline during the early 1990s, but then an enormous increase in
more recent years. The decrease in the early 1990s was primarily on account of fewer detections
of amphetamine and methamphetamine laboratories in the United States, manufacture having
seemed to have shifted to Mexico24.
(a) Amphetamine
123. The decreasing trend in the number of ATS laboratories detected worldwide during the
early 1990s, as reflected in figure 70 above, is particularly relevant in the case of amphetamine
manufacture (see figure 71). As mentioned, the decline was mainly due to fewer detections made
by the United States, which reported the annual detection of an average 80 amphetamine
laboratories during the late 1980s but only two in recent years.  To a lesser extent, a decline was
also reflected in Australia, which has not reported any manufacturing activities since 1994. 
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Figure 73. Number of detected laboratories 
manufacturing amphetamine
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124. With the major decline in the number of amphetamine laboratories detected in North
America and slight decrease in Oceania, the share of Western Europe, where more or less similar
numbers of laboratories were seized throughout the last decade, doubled over that period (see
figure 72).  Additionally, Eastern Europe’s share rose from zero to 12%, which has contributed
to Europe having become the major centre of amphetamine production. This recent increase in
Europe’s manufacturing activities, particularly since 1996, is also reflected in the global trend (see
figure 71).
Figure 72. Global number of detected laboratories manufacturing amphetamine
Subregional breakdown
125. The main source countries for amphetamine in Europe, according to Interpol25,  appear
to be the Netherlands, followed by Belgium, Denmark, Germany, Spain and in recent years a
number of Eastern European countries, including Poland and Bulgaria. Amphetamine is also
illicitly manufactured in the United States, though production has been reduced, as mentioned
earlier. In reports received by UNDCP, the United Kingdom appears to be have become a major
source country for amphetamine, while the Netherlands and Australia did not provide data on
manufacture in recent years (see figure 73).
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Figure 74. Number of methamphetamine 
laboratories detected, 1985-1997
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Figure 75. Number of detected laboratories 
manufacturing methamphetamine
Annual average 1985-90/ 1991-97,  Ranking of countries
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(b) Methamphetamine
126. Global illicit manufacture of methamphetamine seems to have followed a similar trend to
amphetamine, with an increase during the 1980s and a decrease between 1990-95 (see figures 71
and 74).  As in the case of amphetamine, the decrease in methamphetamine was mainly due to less
manufacturing activity in the United States, which nevertheless accounted for more than 90% of
all methamphetamine laboratories detected worldwide. While both trends (amphetamine and
methamphetamine) have reflected a renewed increase since 1996, manufacture of
methamphetamine has been increasing much faster, exceeding previous levels of laboratory
detections.
127. Methamphetamine manufacture continues to be concentrated in the United States (see
figures 75 and 76). The only country in Europe manufacturing methamphetamine remained the
Czech Republic, though such activities now seem to be spreading to neighbouring countries, with
laboratories having been detected in Germany and Slovakia in 1997. Recent reports of increased
manufacture, trafficking and abuse of methamphetamine in East/South-East Asia are also to some
extent reflected in data received on laboratory detections but such data are not comprehensive.
The Republic of Korea continues to report on several laboratory seizures each year and statistics
from China reflected a big increase recently. Data on manufacture from other countries in that
region are currently not available.
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Figure 77. Number of  ecstasy-type 
laboratories detected, 1985-97
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Figure 76. Global number of detected laboratories manufacturing methamphetamine
Subregional breakdown
(c) Ecstasy-type substances
128. Global production trends of Ecstasy-type substances, though fluctuating, seem to have
followed a continuous rise during the last decade (see figure 77).
129. One of the most recent developments with regard to ATS is the ever-increasing popularity
of Ecstasy-type substances around the globe. Europe is still the main region for their production
and consumption but prevalence of that drug is spreading worldwide  (see figure 78). 
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Figure 79. Number of detected laboratories 
manufacturing ecstasy-type substances
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Figure 78. Global number of detected laboratories manufacturing Ecstasy-type substance
Subregional breakdown
130. Figure 79 lists countries which reported the detection of laboratories manufacturing
Ecstasy-type substances. A decade ago, manufacture seemed to be limited to the United Kingdom,
United States, the Netherlands, Germany, Canada and Belgium.  These countries continue to
report on manufacture of that drug, with mostly increasing trends in recent years, but additional
source countries seem to have emerged. The global peak of Ecstasy manufacture in 1996 (see
figure 77) was due to the United Kingdom. 
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Figure 81. Stimulant seizure cases, 1984-1997
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Figure 80. Stimulant seizure volume, 1984-1997
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Figure 82. Stimulant seizure volume, 1990-1997
Ranking of countries
(in percentage of global volume seized)
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2. Trafficking: seizure statistics (including mainly amphetamine and methamphetamine)
131. Seizures of mainly amphetamine and methamphetamine, as reported by Governments in
the annual reports questionnaires, are grouped under “stimulants”.  Trends as regards seizure
volumes and number of seizure cases of the stimulant group are presented in figures 80 and 81
as totals.  Seizures of Ecstasy-type substances are reported under the hallucinogen group (see
paras. 136-138) and cannot therefore be specified separately here.
132. International trafficking of
stimulants is gaining ground, with
large seizures being made in three
main regions, i.e. Europe, East
Asia/Oceania and North America. It
appears, however, that trafficking
from source to consumer countries
occurs mostly within these regions. A
ranking of countries, according to the
volume of stimulants reported seized
between 1990 and 1997, is presented
in figure 82. All countries listed there
are in the three regions described
above, except for Colombia, Egypt
and Nigeria.  Colombia recorded a
unique seizure level in 1993.  Egypt
seized large quantities during the
1980s, but these have decreased
steadily throughout the 1990s, falling
to a very modest level in 1997. Nigeria
has recorded increasing seizure
volumes in recent years, reaching a
particularly high level in 1997. 
133. Further seizure statistics of stimulants are included in figures 83-85 and table 17.
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Seizures: Stimulants
Figure 83. Global trend, 1987-1997
Breakdown by subregion
(in millions of doses *)
Table 17. Countries ranked in order of volume of drug seized, 1987-1997
(in millions of doses *)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
United States 26.0       109.5     176.2     45.5       26.1       32.1       57.5       191.8     99.8       146.9     155.1     
United Kingdom 1.8        12.0       10.9       30.4       42.1       60.2       96.6       130.5     81.3       262.3     271.8     
Thailand 107.7     93.9       53.0       32.2       105.5     56.9       129.0     81.2       56.1       44.2       216.7     
Egypt 288.1     183.9     146.8     132.6     53.6       30.0       17.5       6.5        4.1        0.4        0.1        
Other countries of 
the world
139.6     92.0       133.5     81.5       212.2     201.4     229.3     240.8     373.4     493.3     449.0     
Total 563.2     491.3     520.5     322.2     439.5     380.6     529.9     650.9     614.7     947.2     1,092.7  
Figure 84. Trends of the three highest-ranking countries,  1987-1997
(in millions of doses *)
Figure 85.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
* calculated on the basis of 1 dose equivalent to 10mg.
2.8%
6.4%
12.2%
14.2%
19.8%
24.9%
- 0.05 0.10 0.15 0.20 0.25
United Kingdom
Thailand
United States
China
Philippines
Nigeria
0
200
400
600
800
1,000
1,200
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Other regions
East and South-East Asia
Western Europe
Near and Middle East/South Asia
0
50
100
150
200
250
300
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
United States
United Kingdom
Thailand
-67-
e It should be noted that a clandestine laboratory in the case of LSD should be taken as meaning one
that is manufacturing LSD crystal and not merely perforating liquid LSD into material such as blotting paper
(often termed a “dipping” operation).
Figure 86. Number of  hallucinogen
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2. Hallucinogens
2.1. Illicit manufacture  (including LSD and other hallucinogens)
134. Data reported on the manufacture of
hallucinogens mainly refer to substances such as
LSD, PCP, DOB (brolamfetamine), mescaline
and DMT. The majority of laboratories detected
in this group, however, relates to PCP
(phencyclidine). The manufacture of
hallucinogens seems to have followed a
generally decreasing trend over the last decade
(see figure 86).
135. Most of the detected laboratories
manufacturing hallucinogens were reported
from the United States and, to a lesser extent, Canada. The only European countries reporting the
detection of hallucinogen laboratories included Germany (LSD, PCP, DOB, DMT, mescaline),
followed by the United Kingdom (mescaline and DMT) and the Netherlands (LSD).  Additionally,
Slovenia reported the detection of an LSD laboratory in 1996. (See figures 87 and 89). According
to Interpol26, however, the West Coast of the United States appears to be the main production
centre of LSD crystal and the Netherlands to be Europe’s main distribution point for LSD itself.e
Figure 87. Global number of detected laboratories manufacturing hallucinogens
Subregional breakdown
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Figure 89. Hallucinogen* seizure volume, 
1984-1997
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Figure 90. Hallucinogen* seizure cases, 
1984-1997
Global trend
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Figure 91. Hallucinogen* seizure volume, 1990-1997
Ranking of countries
(in percentage of global volume seized)
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2.2. Trafficking:  seizure statistics
(a) “Other” hallucinogens (excluding LSD) and Ecstasy-type substances
136. Seizures of hallucinogenic substances are reported by Governments in the annual reports
questionnaires as a total group, except for LSD which is reflected as a separate substance.
Additionally, as mentioned earlier, seizures of Ecstasy-type substances are reflected under the
hallucinogen group. The rising trends in figures 89 and 90 would appear mostly to relate to
Ecstasy-type substances (also see paras 128-130 for manufacture of Ecstasy).
137. The ranking of countries
with regard to seizure volumes of
hallucinogens, including Ecstasy-
type substances, reflects the
widespread prevalence of that drug
group (see figure 91). The United
States, which ranked high in the
manufacture of Ecstasy as well as
other hallucinogens, accounts for
almost 50% of the global
hallucinogen (including Ecstasy)
seizure volume. Additionally, a
number of European countries,
which seem to be mainly Ecstasy
source and consumer countries,
rank highly.
138. Further seizure statistics of hallucinogens are included in figures 94-96 and table 18.
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Seizures: Hallucinogens
(Excluding LSD but including Ecstasy)
Figure 94. Global trend, 1987-1997
Breakdown by subregion
(in thousand of doses *)
Table 18. Countries ranked in order of volume of drug seized, 1987-1997
(in thousand of doses *)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
United States 4,301.5  15,683.4  12,540.1  4,215.1  844.7     225.1       0.0        1,504.3    433.0     83,887.7  1,197.5    
Germany 0.0        3.7          115.8       18.8       5.7        31,012.1  111.1     269.2       380.9     692.4       694.3       
Netherlands 0.0        0.0          930.0       0.0        7.0        13,458.8  1,761.3  1,137.5    3,950.4  0.0          1,054.9    
United Kingdom 0.1        0.0          50.4        125.4     432.6     825.7       301.2     721.9       554.0     5,798.7    3,941.3    
Other countries of 
the world
2,611.2  1,155.9    238.9       910.9     1,618.7  949.4       4,024.1  8,145.0    3,414.6  1,610.3    10,751.3  
Total 6,912.9  16,843.0  13,875.2  5,270.2  2,908.7  46,471.1  6,197.6  11,777.8  8,732.8  91,989.1  17,639.3  
Figure 95. Trends of the three highest-ranking countries,  1987-1997
(in thousand of doses *)
Figure 96.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
* calculated on the basis of 1 dose equivalent to 100mg.
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Figure 92. LSD seizure volume, 1984-1997
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Figure 93. LSD seizure volume, 1990-1997
Ranking of countries
(in percentage of global volume seized)
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(b) LSD
139. In respect of LSD, seizure
volumes over the past decade ranged
between approximately 15 million and
over 30 million units, except for an
enormous record of over 130 million units
in 1987 (due to large seizures in Brazil,
Germany, Australia and Austria). Despite
the fact that seizures of LSD usually
fluctuate more than with other drugs and
trends are more difficult to conclude,
seizure volumes for the first half of the
1990s seemed to reflect a decrease while
those for 1996 and 1997 indicated a
renewed increase, reaching over 70
million units in 1997 (see figure 92).
140. Countries which record relatively large seizures of LSD more or less regularly include the
United States, Canada, Australia, Israel, Japan and a number of Western European countries
including, in the order of quantities seized, Norway, Italy, the United Kingdom, Ireland, the
Netherlands, France, Germany, Spain, Austria, Belgium and Switzerland. Fluctuating seizure
trends with LSD are partly due to unique seizure records made in various countries, such as
Zambia in 1997, Saudi Arabia in 1996 and Ethiopia in 1991. Even though seizures in these
countries are not reported on a regular basis, they reflect the world-wide trafficking and
widespread availability of this drug (see figure 93).
141. Further seizure statistics of LSD are included in figures 97-99 and table 19.
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Seizures: LSD
Figure 97. Global trend, 1987-1997
Breakdown by subregion
(in thousand of doses *)
Table 19. Countries ranked in order of volume of drug seized, 1987-1997
(in thousand of doses *)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Brazil 75,460.0    1.1          0.0        0.0          0.1          0.0          0.0        0.0          80.0       0.0          0.0          
Australia 15,760.0    10,020.8  1,161.0  200.0       13.1        13,827.3  46.5       22.6        761.4     12,946.2  0.0          
United States 3,662.4      1,008.2    731.1     77.4        120.5       2,920.0    0.0        165.2       180.0     2,054.4    38,879.1  
Canada 48.3          135.9       68.7       31.1        12,449.1  4,947.3    6,637.8  4,577.0    73.5       5,197.6    22.5        
Other countries 
of the world
39,102.5    20,532.9  1,055.0  19,388.7  14,726.5  617.4       1,230.3  7,644.0    2,935.4  8,013.6    31,713.8  
Total 134,033.3  31,698.8  3,015.8  19,697.3  27,309.2  22,312.0  7,914.6  12,408.9  4,030.3  28,211.8  70,615.4  
Figure 98. Trends of the three highest-ranking countries,  1987-1997
(in thousand of doses *)
Figure 99.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
* calculated on the basis of 1,000 doses equivalent to 50mg.
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3. Depressants
1. Trafficking: seizure statistics
142. Trafficking of depressants mainly relates to methaqualone and substances of the
benzodiazepine family. Africa seems to be the most important market for both drug types. 
(a) “Other depressants (excluding methaqualone)
143. Most seizures of depressant other than methaqualone seem to relate to diazepam,
flunitrazepam and temazepam27.  Depressants are seized in many regions around the world.
Trends are reflected in statistics in figures 102-104 and table 20.
144. Seizures in Africa are made mainly in the West and Central African subregions (mainly
Nigeria, followed by Côte d’Ivoire, Chad, Togo and Niger), but also in North Africa (mainly in
Egypt and Morocco). The enormous increases in 1996 and 1997 were mainly due to large
quantities seized in Nigeria.
145. In Asia, depressants (other than methaqualone) are mainly seized in the Near and Middle
East as well as in East/South-East Asia. Countries/territories which record relatively large seizures
more or less regularly include China (Hong Kong SAR), Indonesia, Japan, Lebanon (reported a
very large seizure in 1997) and Saudi Arabia. A number of other countries recorded large seizures
of depressants in some years, such as China in 1994 and 1995, Jordan in 1995, Malaysia in 1994
and the Republic of Korea in 1996 and 1997. Additionally, Australia records seizures of
depressants more or less regularly.
146. In Europe, this drug type is seized in various countries in both Western and Eastern
Europe. Countries that recorded large seizures over the last few years include, in the order of
volumes seized between 1990 and 1997, the Russian Federation, Greece, Ukraine, the United
Kingdom, Estonia, the Czech Republic, Spain, Sweden, Italy, Norway, Finland, Belgium, Latvia
and Denmark.
147. Seizures in the Americas are mainly recorded in the north and relate to the United States,
Canada and Mexico.
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Seizures: Depressants
Figure 102. Global trend, 1987-1997
Breakdown by subregion
(in thousand of doses *)
Table 20. Countries ranked in order of volume of drug seized, 1987-1997
(in thousand of doses *)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Nigeria 0.0             0.0             0.0                0.0             0.0             0.0                0.0             0.0                9,100.0         118,325.2       142,648.7       
India 0.0             0.0             72,000.0      0.0             0.0             118.0            0.0             0.0                0.0                0.0                   0.0                   
United States 27.5           503.5         342.4            120.9         390.8         1,376.6         0.0             25,427.8      307.4            475.6              799.0              
Russian Federation 0.0             0.0             0.0                0.0             0.0             0.0                0.0             3,278.7         1,680.0         9,100.0           1.0                   
Other countries of the 
world 3,125.0      6,187.0      6,505.5         5,942.9      6,749.7      13,782.3      2,820.3      2,123.8         6,878.5         8,868.8           11,244.7         
Total 3,152.5      6,690.5      78,847.9      6,063.8      7,140.5      15,277.0      2,820.3      30,830.3      17,965.9      136,769.6       154,693.3       
Figure 103. Trends of the three highest-ranking countries,  1987-1997
(in thousand of doses *)
Figure 104.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
* calculated on the basis of 1 dose equivalent to 10 mg.
0.3%
0.4%
0.4%
3.0%
34.8%
59.9%
- 0.10 0.20 0.30 0.40 0.50 0.60
Nigeria
Thailand
Côte d'Ivoire
Greece
Estonia
United States
0
50,000
100,000
150,000
200,000
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Other regions
Eastern Europe
North America
South Asia
West and Central Africa
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
Nigeria India United States
-74-
Figure 100. Methaqualone seizure volume, 1984-1997
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Figure 101. Methaqualone seizure volume, 1990-1997
Ranking of countries
(in percentage of global volume seized)
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(b) Methaqualone
148. Trafficking of methaqualone, also known as mandrax, received increased attention
throughout the last decade, particularly during the first half of the 1990s when global seizure
volumes were rising fast (see figure 100). Seizures of that drug were mainly reported by India,
South Africa and other countries in East/Southern Africa such as Zambia, Kenya, Zimbabwe,
United Republic of Tanzania, Swaziland and Malawi, in the order of volumes seized between
1990 and 1997 (see figure 101).
149. Efforts to combat clandestine methaqualone production in India in recent years seem to
have resulted in a reduction of trafficking of that drug from India to South Africa. India, which
recorded enormous seizure increases during the early 1990s, with a peak in 1994/95, reported a
significant decrease in 1996. However, quantities seized in 1997 were slightly up again. South
Africa’s seizure volume, on the other hand, remained more stable throughout the 1990s, indicating
that the illicit market there persists. The reduction of methaqualone production in the traditional
source country (India) may have
been compensated by local African
production, as was also indicated by
the detection of laboratories in some
East/Southern African countries
While some reported “laboratory”
activities, such as in Kenya, only
related to the tableting of the drug,
with the continued importation of
the powder from India, others seem
to involve the actual production of
methaqualone, though the origin of
the required precursors is
unknown28.  In 1997, the United
Arab Emirates reported a very large
seizure volume. According to Interpol, several large clandestine laboratories were dismantled in
that country29. 
150. Further seizure statistics of methaqualone are included in figures 105-107 and table 21.
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Seizures: Methaqualone
Figure 105. Global trend, 1987-1997
Breakdown by subregion
(in millions of doses *)
Table 21. Countries ranked in order of volume of drug seized, 1987-1997
(in millions of doses *)
Country 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997
India 6.0        6.6        3.5        8.6        17.7       29.9       58.9       181.3     81.9       8.8        13.9       
Zambia 0.0        0.3        0.4        1.5        1.0        1.7        0.1        0.0        78.2       0.0        0.0        
South Africa 14.9       1.3        0.7        1.2        2.0        3.8        3.5        2.7        1.0        0.6        1.8        
Philippines 0.0        0.0        0.0        0.0        0.0        0.0        0.0        28.0       0.0        0.0        0.0        
Other countries 
of the world 1.6        0.2        1.2        5.6        2.6        1.3        4.2        4.8        0.6        0.5        25.0       
Total 22.5       8.4        5.8        16.9       23.2       36.7       66.8       216.7     161.8     9.9        40.7       
Figure 106. Trends of the three highest-ranking countries,  1987-1997
(in millions of doses *)
Figure 107.  Countries ranked in order of volume of drug seized, 1997
(in proportion of total quantity seized worldwide)
* calculated on the basis of 1 dose equivalent to 250mg.
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Volume seized
(in percentage, n=13.8 tonnes + 7 million units)
by rail
4.5%
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3.1%
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0.5%
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10.4%
unspecified
37.5%
by land
44.1%
Number of seizure cases
(in percentage, n = 1,076 cases)
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14.4%
by mail
12.0%
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3.3%
by air
17.4%
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16.1%
by land
36.9%
4. Methods of transportation of psychotropic substances14
151. Currently available data provide only limited information with regard to methods of
transportation of psychotropic substances, since seizures are quoted by weight as well as differing
units  (ampoules, tablets, doses, etc.), making any comparison difficult. Analysis of trends and
identification of details on single drug types are further complicated because most data are
available per substance group only.  Despite these limitations, some graphics are presented below
which group together all seizures of psychotropic substances. 
152. The primary method of transportation is by road, presumably due to the generally shorter
distances between manufacturing and destination countries. Air, mail and rail transport also rank
highly with regard to numbers of seizures, but quantities trafficked are low. Transport by sea
seems insignificant.
Figure 108. Methods of transportation of psychotropic substances
Worldwide, 1997
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Figure 109. Trends of opium farmgate prices in Asia, 1986-1998
(in constant US$ - 1998)
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Afghanistan
Lao PDR
Myanmar
Average Asia
(in constant US$ - 1998, per kilogramme)
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
ASIA
Afghanistan 37 37 37 37 36 36 36 37 37 37 52 72 64
Pakistan 76 70 68 54 46 80 79 69 71 67 124 113 129
Lao PDR 161 161 161 120 110 144 131 92 147 250 273 162 65
Myanmar 220 249 260 243 249 170 120 123 178 277 214 279 222
Thailand 326 224 190 166 187 209 231 253 274 295 589 480 348
Viet Nam 248 248 248 248 248 189 232 239 283 350 652 681 250
Average Asia 178 165 161 145 146 138 138 136 165 213 317 298 180 (*)
LATIN AMERICA
Colombia 2334 1411 609 605 556 603 445 382
(*) Estimated for 1998
Table 22. Opium farmgate prices, 1986 - 1998
IV. Prices and value of drugs
153. Prices are among the most complex indicators of a market, including that of illicit drugs,
reflecting not only an interaction of supply and demand but also various other factors relating to
quality (purity), competition, risk, etc. Illicit drug prices are differentiated between farmgate and
wholesale/retail (street) prices. 
154. The value of drugs is the product of net production and farmgate prices and represents
the potential annual gross income made by farmers in a particular region/country though the
volume of drug produced.
A. Opium
1. Opium farmgate prices
155. The average farmgate price of opium in Asia, which was following a rather decreasing
trend throughout the last decade, reflected a rise during the mid-1990s reaching particularly high
levels in 1996 and 1997. In 1998, however, prices declined again. The greatest reductions were
observed in Viet Nam and the Lao People’s Democratic Republic.  The latest prices for Myanmar
and Thailand (final data are not available) are also estimated to have declined.  Prices in
Afghanistan in 1998 reflected a decrease, following consistent increases throughout recent years.
Pakistan was the only country where opium prices continued to rise in 1998.   (Table 22 and
figure 109).
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Figure 110. Opium farmgate prices, 1997
 Ranking of countries
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Figure 111. Trends of opium farmgate prices
 in Asia and Latin America, 1986-1998
(in constant US$ - 1998)
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156. In South-West Asia, opium prices are generally lower than in South-East Asia. This
contrasts with the situation in respect of yields, which are much higher in Afghanistan and
Pakistan than in producer countries in South-East Asia. It is generally believed that the opium
produced in South-West Asia, while having the highest yield, fetches the lowest price due to its
poorer quality (see figure 110; for comparison of yields, or refer to table 2).
157. Opium farmgate prices in Colombia are generally higher than the average level in Asia,
but prices continue to fall.  In 1998, opium prices in Colombia remained the highest worldwide,
despite a decrease of more than 10% (see figure 111).  (Prices for Mexico are not available).
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Figure 112. Correlation of opium production and price trends 
in  Asia, 1986-1998
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158. A correlation of opium production and price trends in Asia is presented in figure 112
below.  Prices were falling only modesty during the 1980s as compared to the fast increase in
production, which suggests that demand may have been rising as well. With the initiation of a
cutback in production in many countries in Asia during the mid-1990s, prices started to rise,
reaching peaks in 1996 and 1997.  In 1998, however, both production and prices were falling.
One possible explanation for the latest price reduction may be a decline in demand due to a shift
from heroin to other drugs among new consumers. Another might be that there is
hidden/unknown production of opium, which would bring production to a higher level than that
currently estimated.
2. Value of opium produced
159. During the last two years, the value of opium - calculated from estimated production and
average farmgate price per country in Asia (see table 23 and figure 113) - was highest in
Myanmar (US$ 360-460 million) followed by Afghanistan (US$ 150-200 million) and the Lao
People’s Democratic Republic (US$ 20 million).  The total value in Asia has decreased from US$
690 million in 1997 to $ 540 million  in 1998, with the latter being based on the 1997 farmgate
prices (due to the absence of 1998 data from Myanmar and Thailand).  With the application of
the farmgate prices for 1998 (as far as available), the total value per country will be even lower.
160. Since the number of families, farmers or persons involved in drug production is unknown
for most countries, the potential income can be calculated only per country, but not per individual
farmer. 
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A B C D = A x B E = A x C
1997 1997 1998 1997 1998
Country farmgate estimated estimated total value total value
prices production production of production of production
(in US$/kg) (in tonnes) (in tonnes) (in million US$) (in million US$)
(based on '97 farmgate price) (based on '97 farmgate price)
Viet Nam 670             2                   2                    1                                      1                                     
Pakistan 111             24                 34                  3                                      4                                     
Thailand 473             4                   17                  2                                      8                                     
Lao PDR 159             147               124                23                                    20                                   
Afghanistan 71               2,804            2,102             199                                  149                                 
Myanmar 275             1,676            1,303             461                                  358                                 
Total Asia 4,657            3,582             689                                  540                                 
Table 23. Estimated value of opium produced in Asia in 1997 and 1998
Figure 113. Estimated value of opium in Asia, 1997-1998
Ranking of countries
(in millions of US$)
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B. Coca
1. Coca farmgate prices (coca leaf/paste, cocaine base)
161. Farmgate prices of coca differ from those in the case of opium to the extent that coca is
sold at various levels, i.e. coca leaf, coca paste (sometimes in different forms, i.e. raw and washed
in Peru) and cocaine base (all of which tend to be produced at the “farmgate” level), and therefore
fetch different prices. The availability of price data at the various production stages differ from
country to country (perhaps reflecting different practices), thus making a comparison more
difficult. The following table 24 and figures 114-116 provide an overview of the data available
on various coca prices. Further details on the coca prices in Peru are included in tables 25-26 and
figures 117 and 118.
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Table 24. Coca prices, 1986-1998
(in constant US$-1998, per kilogramme)
Country 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998
Peru
leaf 1.77 0.95 1.74 2.86 2.22 2.73 1.27 0.68 0.8 1.39
paste raw 142 162 263 382 322 329 192 168 120 126
paste washed (or cocaine base) 832 486 736 831 705 739 317 327 261 345
Colombia
base 2,984    1,773    1,152    893       658       662       612       883       1,432    609       831       1,127    1,139    
Bolivia
leaf 2.97 2.87 1.38 1.31 1.25 1.2 1.16 1.13 1.1 1.47 1.2 1.61 1.5
base 2,067    1,454    750       542       525       853       795       942       601       682       
Figure 114. Price of coca leaf, 1986-1998 
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Figure 116. Price of cocaine base, 1986-1998
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Figure 115. Price of coca paste, 1989-1998
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Table 25 and figure 117. Price of coca leaf in Peru, Upper Huallaga
January 1990-December 1998
(in US$, per metric tonne)
Month/               
Year
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Average
1990 660      850      800      500      500      410      440      420      1,160    1,600    870      870      757        
1991 790      1,560    1,580    1,500    1,470    1,730    1,580    1,520    1,650    1,730    1,300    1,040    1,454     
1992 1,130    1,740    1,740    2,610    1,910    2,170    2,170    3,040    4,350    2,610    2,610    3,480    2,463     
1993 4,350    3,480    1,740    1,300    1,740    1,300    1,040    1,910    2,090    2,090    1,300    1,300    1,970     
1994 1,530    1,580    1,620    1,610    1,640    1,760    2,610    3,040    3,040    3,910    4,350    3,040    2,478     
1995 3,000    3,000    2,600    1,700    900      700      400      400      400      400      400      400      1,192     
1996 350      350      350      480      520      650      870      960      1,040    1,040    610      610      653        
1997 610      610      610      610      610      610      870      1,300    1,300    870      700      700      783        
1998 260      430      700      700      1,220    1,300    1,300    2,960    2,430    1,830    1,650    1,870    1,388     
Average 1,409    1,511    1,304    1,223    1,168    1,181    1,253    1,728    1,940    1,787    1,532    1,479    1,460     
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Note: Strong price declines (1993-1995) have been related to the dismantling of the Medellín and the Cali cartels,
going hand in hand with increased efforts by Peruvian authorities to prevent the landing of aircrafts transporting
consignments of cocaine.
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Coca paste raw
1992 1993 1994 1995 1996 1997 1998
Coca paste washed (or cocaine base)
1991
January 1991 - December 1998*
(in US$, per kilogramme)
 Year-
Month 
1991 1992 1993 1994 1995 1996 1997 1998 Year-
Month
1991 1992 1993 1994 1995 1996 1997 1998
Coca paste raw Coca paste washed (or cocaine base)
Jan 230    180    500    249    410    120    250    120    Jan 600    495      1,000    531    850    250    230    180    
Feb 250    280    400    251    410    120    80      130    Feb 700    600      900      528    800    250    190    200    
Mar 200    230    250    240    360    100    80      140    Mar 700    650      550      556    400    220    190    250    
Apr 175    260    200    248    210    160    80      120    Apr 650    680      450      537    340    340    190    250    
May 200    320    280    264    190    150    90      120    May 550    700      600      581    300    330    250    280    
Jun 250    370    250    283    150    180    97      Jun 600    730      550      656    200    350    250    340    
Jul 200    380    250    280    100    160    107    Jul 680    780      550      620    150    330    280    340    
Aug 200    400    280    280    80      150    118    Aug 680    450      500      650    120    320    350    700    
Sep 300    500    280    300    60      100    130    Sep 675    1,000    620      800    100    350    350    400    
Oct 280    280    280    350    60      200    150    Oct 680    700      620      850    100    360    300    400    
Nov 200    350    230    350    60      250    120    Nov 460    900      580      850    100    500    250    400    
Dec 150    400    230    500    60      250    110    Dec 400    900      580      900    100    180    250    400    
Average 220    329    286    300    179    162    118    126    Average 615    715      625      672    297    315    257    345    
Table 26 and figure 118. Price of coca paste raw and washed (cocaine base) in Peru, Upper Huallaga
* for coca paste raw, until May 1998.
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Figure 119. Estimated value of coca leaf, 1987-1998
Ranking of countries
(in millions of US$)
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B C D = A x B E = A x C
1997 1998 1997 1998
Country estimated estimated total value total value
production production of production of production
(in tonnes) (in tonnes) (in million US$) (in million US$)
(based on '97 farmgate price) (based on '97 farmgate price)
Bolivia 1.56       99,504     77,392     155                              121                              
Colombia 1.20       * 129,481   165,934   155                              199                              
Peru 0.77       130,200   95,600     100                              74                                
Total Latin America 359,185   338,926   411                              393                              
* estimated
Table 27. Estimated value of coca leaf produced in 1997 and 1998
1997
farmgate
prices
(in US$/kg)
A
2. Value of coca produced
162. The different levels of coca prices, as explained before, also provide an obstacle to
calculating the value of that drug, not least due to the unavailability of comparative data. In the
following graphic presentations, the value of coca is calculated on the basis of coca leaf (table 27
and figure 119) as well as cocaine base (table 28 and figure 120), to show a comparison. Some
of the prices included are estimates.
Coca leaf
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A B C D = A x B E = A x C
1998 * 1997 1998 1997 1998
Country cocaine base estimated estimated total value total value
prices production production of production of production
(in US$/kg) (in tonnes) (in tonnes) (in million US$) (in million US$)
(based on '98* cocaine base price) (based on '98* cocaine base price)
Bolivia 682              271          211          185                               144                               
Colombia 1,139           259          332          295                               378                               
Peru 345              543          398          187                               137                               
Total Latin America 1,073       941          667                               659                               
* except for Bolivia (1997 price)
Table 28. Estimated value of potential cocaine base produced in 1997 and 1998
Figure 120. Estimated value of potential cocaine base in Latin America, 1997-1998
Ranking of countries
(in millions of US$)
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f Prices of heroin and cocaine, as mentioned in this chapter, are presented on a comparative basis over
a time period and have, therefore, been inflation adjusted and weighted (by population). Thus, some prices
mentioned here slightly differ from those included in annex I, section A, which includes figures only for 1997
as received.
C. Heroin and cocainef
163. The prices that users will be prepared to pay for heroin and cocaine vary markedly and
may be affected by many factors, including their availability, perceived utility  (‘instrumental
use’), current popularity, reputation for quality and the image projected of them in terms of
potential harm. For example, a widespread change to what is seen as a safer means of
administration, such as from intravenous injection to inhalation,  may influence the nature and
dimension of the user base, affect purity levels and enhance profit potential, enabling prices to
hold steady or even fall. 
164. So-called ‘street prices’ will be linked to issues relating not only to the market
environment but to factors concerning those engaged at every level of  the
production/trafficking/distribution chain,  including perceived risk, competition, overhead costs
(e.g., for transportation or paying off intermediaries), access to viable threshold user populations
and the  purchasing powers of those populations.   At times when markets are saturated, suppliers
may stockpile commodities or even sell them off at a loss, in order to undercut competitors, pay
off debts or maintain their markets. 
165. Some generalizations may be made, such as that prices will tend to be considerably higher
in developed consumer countries than in developing countries in zones of production of the raw
materials for heroin and cocaine (i.e., opium and coca).  In 1997, the average street price of
heroin in Europe was $140 a gramme (ranging from $8.90 to $489), while that for cocaine was
about $110 (from $11 to $306). In the United States, the average price of heroin at that time, at
$ 214 (from $14 to $600), was significantly higher than that of cocaine, at US$ 66 ($7 to $200).
Far higher prices are fetched in Japan, where in 1996 cocaine was being sold at about $780 and
heroin at around US$ 1,000 a gramme. 
166. Painting a quite different picture, prices of heroin in 1997 were as low as $3 a gramme
in Thailand and $54 in Hong Kong SAR of China. Heroin fetched $2 a gramme in Pakistan in
1996, $15 in Iran (1994) and $35 in Turkey (1994). In Latin America in 1997, cocaine prices of
just $1 a  gramme were reported in Colombia and Bolivia and even less in Peru, where trafficking
organizations may have responded to increased law enforcement effectiveness and surpluses in
established consumer zones by ‘dumping’ stockpiles onto local communities.
167. Over the past decade, inflation-adjusted prices in Western Europe fell by 45% for cocaine
and 60% for heroin. Comparative falls in the United States were about 50% for cocaine and 70%
for heroin. Nevertheless, the overall decline of drug prices in industrialized countries has levelled
out in very recent years and given way to relative stabilization. While there was a massive decline
in prices of  “pure” heroin in the United States, drops in prices at street level were far less 
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pronounced,  rising levels of  supply having led to an increase in purity rather than any fall in
prices. US authorities reported  the mean purity level of heroin to be around 6% in 1987 but
about 37% by 1997, in which year levels were even reaching 60% in New York. 
168. In general, the market dynamics of illicit drugs are little different to those pertaining to
other ‘commodities’, their illicit nature notwithstanding. The ‘supply/demand’ equation generally
holds good, although equations between prices,  purity levels and availability of drugs are less
precise. The massive differentials in the price ranges quoted earlier illustrate that the first question
to be asked in response to issues of street prices is - which street?  To draw an analogy, a bottle
of wine may fetch one price in a local store but quite another in a smart restaurant or nightclub.
Despite the added factors of illicitness and attendant risk, the same is basically true for drugs, the
environment in which they are sold being inextricably linked to the prices that consumers are
prepared to pay for them.
   
169. A graphical overview of price trends are presented in figures 121-124, which include a
comparison of trends at the retail (street) and wholesale level of heroin and cocaine in Western
Europe as well as wholesale price trends in Europe compared to the United States.
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Figure 121. Heroin retail and wholesale prices
in Western Europe*, 1984-1997
(in constant 1997 US$ per gramme)
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* Weighted average (by population) of: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, 
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Figure 122. Heroin wholesale prices
in Western Europe* and the United States, 1984-1997
(in constant 1997 US$ per kilogramme)
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Figure 123. Cocaine retail and wholesale prices
in Western Europe*, 1984-1997
(in constant 1997 US$ per gramme)
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Figure 124. Cocaine wholesale prices
in Western Europe* and the United States , 1986-1997
(in constant 1997 US$ per kilogramme)
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g Net increase implies that there were more countries reporting increase than there were countries reporting decrease. 
Figure 125. Trend in net growth* in the number of countries 
reporting increase in the consumption of various drugs, 
1985-1996
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Part two: demand
V. Executive summary
170. Estimates presented in the World Drug Report30 show that cannabis is the most widely
abused drug in all parts of the world, with an estimated 141 million people consuming it. This
represents about 2.5% of the world population (annual prevalence). Prevalence data suggest that
the use of cannabis is particularly high in West Africa, Oceania, Central America, North America,
and in a number of European countries.  
171. In particular, large numbers of young people experiment with cannabis. The proportion
of school children and young adults who have used cannabis at least once in the last year is as high
as 37% in some countries, while the proportion for past-month use can be as high as 10-25%.
Such figures indicate that in certain parts of the world, cannabis use is becoming normalized and
is no longer confined to small marginal groups.
172. As far as trends in cannabis abuse are concerned, there has been a net increaseg during the
past ten years across all regions, especially marked in Europe but also in Africa and Asia and the
Americas. The upward trend accelerated during the 1990s. For example, in Germany the annual
prevalence among people 18-39 years old rose from 4% in 1990 to 7% in 1997. In  the United
Kingdom, the number of cannabis users in the age group 16-59 years rose from 5% in 1991 to 9%
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in 1996. Similarly large growth rates can be found in a number of other Western European
countries. (See figure 125)
173. Likewise, almost the whole American region seems to be characterized by a growing
cannabis problem in the 1990s with only a few countries reporting stabilization. In the main
cannabis market, the United States, where the number of cannabis consumers (annual prevalence)
had fallen strongly in the 1980s, from 30 million in 1982 to 16 million in 1992, cannabis use has
increased again. By 1997, nearly 20 million people consumed cannabis (almost a quarter more
than in 1992) annually.
174. As far as information from Africa is available, the overall trend is clearly upwards.  Only
a few countries have reported stabilization. The abuse of cannabis also seems to be on the rise in
South and South-East Asia (notably India, Myanmar, Lao People’s Democratic Republic,
Malaysia, Indonesia and the Philippines), while Pakistan reported a strong decline in 1997. This
seems to be in line with information from law enforcement agencies in several Western European
countries, which saw increases in recent years in seizures of cannabis originating from South-East
Asia and a decline in market share of cannabis coming from Afghanistan and Pakistan.
175. Clinical and epidemiological research using standardized diagnostic criteria has produced
evidence for a cannabis dependence syndrome that is characterized by impairment, or loss of
control over use of the substance, cognitive and motivational handicaps that interfere with
occupational performance and other related problems such as lowered self-esteem and depression,
particularly in long-term heavy users31. In this context it is worth noting that in the Americas and
in Europe, cannabis is the second largest problem drug in terms of demand for treatment (after
cocaine and heroin, respectively). Similarly, it is the second largest problem drug also in many
Asian countries (after opiates, which is the dominating drug of abuse in most treatment centers
except for centers in the Far East, where ATS dominate).   
176. What is the second most widely abused drug varies from region to region, and often also
from country to country. Globally, UNDCP estimates show that the abuse of synthetic drugs,
particularly of amphetamine-type stimulants (ATS), is widespread and increasing rapidly.
According to UNDCP estimates, published in the World Drug Report,  some 30 million people
abuse ATS (annual prevalence of 0.52%). 
177. Having spread relatively slowly in the 1980s, abuse of ATS increased rapidly in a large
number of countries in the 1990s. Over the period 1995-1997, the strongest increase was reported
from Europe, which is also an important producer region. Increasingly, synthetic drugs have
gained in significance, particularly among young people as their recreational drug of choice, often
in combination with cannabis. MDMA (Ecstasy) is popular in the industrialized world, especially
in Europe, and there are indications that recreational use of Ecstasy is spreading rapidly in South-
East Asia.  
178. In Australia and Europe, ATS are now the second most widely abused category of drugs
after cannabis. Although the situation is far from uniform in Asia, indicators such as arrest rates
for drug abuse and reports from treatment institutions and locally conducted ethnographic
research clearly point to the fact that methamphetamine is the main drug of concern in many
countries of the region. In fact, ATS are the main problem category of drugs in Seoul, Tokyo and
Manila in terms of demand for treatment and the second in Bangkok. In addition, there has been
an increase in the number of countries reporting injecting of ATS in Asia as well as in Europe. 
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179. In general, cocaine together with various other  “cocaine-type” substances is the second
most widely abused drug in the Americas after cannabis, and cocaine-type substances dominate
the demand for treatment. Abuse of cocaine still seems to be highest in the United States though
a large number of Latin American countries also show substantial levels of abuse of cocaine and
“bazuco” (coca paste). It could be estimated with reasonable accuracy that the annual prevalence
of cocaine-type substance abuse is around 2% in the United States among the population above
the age of eleven. The even higher prevalence figures reported by a number of Latin American
countries are, however, less robust. (See figure 126)
Figure 126. Average lifetime prevalence rates of drug abuse among youth, 1990-1997
180. According to UNDCP estimates, published in the World Drug Report,  some 13 million
people (annual prevalence of 0.23%) may abuse cocaine worldwide. While cocaine consumption
increased throughout the 1980s, the picture was more complex in the 1990s.  For example, trend
data suggest that the spread of cocaine abuse was strong in the Americas in the mid 1980s, lost
momentum in the early 1990s and started to rise again in the middle of the 1990s, notably in and
around coca leaf producing countries. The main trends over the period 1995 to 1997 have been
a stabilization of cocaine abuse in the main markets of North America - which still represent the
world’s largest markets for cocaine - and strong increases in the Andean countries as well as in
neighboring countries and along the trafficking routes to North America and Europe. 
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Figure 127. Annual prevalence of drug abuse among the general population in the 1990s
181. However, the strongest spread was observed in Europe even though the increase was less
significant than the increase in ATS abuse. Although cocaine abuse in Western Europe has risen
to substantial levels, it still falls short of the levels of cocaine abuse in the United States (about
one third of the levels of the United States). Even so, according to prevalence data, cocaine abuse
now seems to be about twice as widespread in Western Europe as heroin abuse.  
  
182. Compared to other drugs, the abuse of heroin and other opiate-type drugs is less
prevalent. According to UNDCP estimates, published in the World Drug Report,  around eight
million people (0.14% annual prevalence) abuse opiates, mostly in South-East and South-West
Asia. In general, consumption affects less than 2% of the population but can be more widespread
in some of the opium cultivating areas. For example, a UNDCP study in the Lao People’s
Democratic Republic in 1998 indicated a prevalence rate of 4 to 6% in the opium producing areas.
(See figure 127)
183. The use of opium, both by smoking and by oral ingestion, has a long history of medical
and social acceptance, particularly in some parts of Asia. Prevalence depends upon several factors,
of which the most important seem to be the degree of social acceptance of opium use, and the
price and availability. Prevalence rates as high as 10 to 12% have been reported previously from
opium producing areas in both the Lao People’s Democratic Republic and Thailand. In urban
areas, heroin is increasingly emerging as the main type of opiate of abuse. A worrying sign is that
injection of heroin has increased in Asia over the last five years. 
184. Despite the fact that Europe is the world’s largest market for illegal opiates in economic
terms, the prevalence rates are lower than those for ATS or cocaine abuse. In several European
countries the annual prevalence rates of opiate abuse (mostly heroin) range from 0.2% to 0.4 %
of the adult population. 
185. Heroin abuse is still a comparatively minor problem in the Americas, with the exception
of the United States, where following a recent increase, the abuse of heroin has now reached
levels close to the European average. The situation with regard to Africa is more difficult to
judge. As far as estimates are available, these suggest that heroin abuse has begun to appear in
a number of African countries but has not yet reached substantial proportions. 
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186. Even though opiate abuse may be less prevalent than the abuse of other drugs, it is by far
the most common cause for treatment in Europe and Asia. On average more than 70% of
treatment demand in Europe is linked to opiates, mostly heroin abuse. In Asia the corresponding
proportion is over 60%. 
187. By the end of 1997, there were more than 30 million people with HIV/AIDS, according
to UNAIDS estimates. Assuming that the proportion of HIV infection due to injecting drug use
were the same as the proportion of AIDS cases due to injecting drug use (11%), there could be
as many as 3.3 million people infected by HIV through drug injecting. 
188. Sharing injecting equipment, whether the injection method be intravenous, intramuscular
or beneath the skin,  carries a very high risk of transmission of HIV as well as other blood-borne
infectious diseases. Research has indicated that once HIV has been introduced into a local
community of injecting drug users, there is a possibility of extremely rapid spread of the virus.
Injecting drug use can now be found in all regions and almost all countries of the world. Over the
two-year period 1996 to 1998, the number of countries reporting injecting drug use increased by
9%. During the same period, however, the number of countries reporting HIV infection among
injecting drug users increased by 37%.  
189. While there has been a diversification of modes of intake of various drugs, injection has
not become less common, with the possible exception of cocaine. In Asia and Europe fewer
countries report injection of cocaine today than at the beginning of the decade, but in contrast
cocaine injection has not diminished in the Americas, where most of the world’s cocaine is
consumed. Furthermore, injection of ATS has increased in Asia and Europe while injection of
heroin has increased in Africa and Asia. Heroin injection has not become less common, even
though more countries report increases also in smoking, sniffing and inhalation.
190. Diversification seems to be the key word, both in terms of the spread of various drugs
across countries and regions and in terms of the spread of various modes of intake of the drugs.
The introduction of a “new” drug does not lead to a corresponding reduction in the use of “older”
drugs. Likewise, the introduction of new modes of intake, does not generally lead to drug abusers
abandoning customary modes of intake, such as injecting. New drugs are added to old ones, and
new modes of intake are added to old ones. 
Table 29. Overview of global drug demand indicators
Heroin Cocaine Cannabis      ATS
Annual Prevalence
(in millions of people, and in
% of global population)
in the 1990s:
8 million
0.14 %
in the 1990s:
13.3 million
0.23 %
in the 1990s:
141.2 million
2.45 %
in the 1990s:
30.2 million
0.52 %
Lifetime prevalence among
youth   (unweighted average)
1.0 % 1.9 % 13.5 % 2.6 %Ecstasy
Percentage of drug abusers
among prison population
 (unweighted average)
27.9 %
Percentage of AIDS cases
due to injecting drug use 11 %
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VI. Introduction
Data sources and limitations
191. UNDCP’s estimates of the drug abuse situation, globally and nationally, are to a large
extent based on information provided by governments. The information is gathered mainly
through the Annual Reports Questionnaire (ARQ), which is completed and submitted by
governments in response to the reporting obligations imposed by the three international drug
control conventions. Governments also sometimes supplement the data contained in the ARQ
with reports of the results of surveys and other studies.
192. The ARQ asks for information on types of drugs being abused; trends in drug abuse;
magnitude of the drug abuse problem; age and gender disaggregated data; ways drugs are taken;
health consequences of drug abuse; and also on steps being taken in dealing with drug abuse. 
193. The figure below illustrates the number of responses to some of the important demand-
related questions in the ARQ.
Figure 128.  Number of countries responding to demand related questions,
1995, 1996 and 1997
194. Trends in drug abuse and route of administration were the questions which received most
responses in 1995, 1996 and 1997.  Nevertheless, only around 70 of the 192 countries/territories
provided observations on trends: whether drug abuse increased, decreased or was stable during
the past year. The number of responses to the question as to how drugs are consumed (injecting,
snorting, smoking, etc.) in the country was almost equal to this.
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195. It should be noted that neither of these two questions requires quantitative responses.
When it comes to questions which actually require figures or numerical estimates, very few
countries respond. For example,  during the last three years only around 40 out of 192
countries/territories provided estimates of annual prevalence of drug abuse. Also when it comes
to drug abuse among children and young people only limited information is provided through the
ARQ. 
196. The Declaration on the Guiding Principles of Drug Demand Reduction emphasizes that
demand reduction programmes should be based on a regular assessment of the nature and
magnitude of drug abuse and drug-related problems. While in some mainly developed countries,
existing data and information may be adequate for the formulation of demand reduction policies
and strategies, in many developing countries, drug abuse data are very often inadequate or simply
unavailable. This is largely due to the fact that the drug problem is one among several of other
competing health and social development priorities in these countries.  Consequently, in many
instances insufficient resources are allocated to measures to effectively deal with drug abuse.
197. The ARQ asks if countries maintain a drug abuse registry and if they have conducted
surveys or other studies recently (Table below). Over the three year period 1995 to 1997, 116
countries responded to these questions. 
Table 30. Number of countries reporting existence of drug abuse registry, 
survey, or other studies on drug abuse
Registry Survey Other
Studies
Total
Number of countries reporting 65 63 51 116
Proportion of countries reporting 56% 54% 44%
Proportion of all countries 33% 32% 26% 192
198. It should be noted that the quality and usefulness of the various registries, surveys and
studies may vary considerably. For example, a registry may be a list of heroin abusers in official
treatment institutions, or files of persons arrested for drug offenses. Surveys, on the other hand,
can be a national survey of a representative sample of the general population, or a survey of a
small subgroup of the population. Studies can be even more varied in scope and quality.  
199. Incomplete or unreliable information on the drug abuse situation in individual countries
also limits UNDCP’s ability to provide the international community with a global overview of the
drug abuse phenomenon. A step to broaden UNDCP’s information base was taken in 1997, when
the Commission on Narcotic Drugs agreed to let UNDCP use alternative sources of information,
such as results of peer reviewed studies, to supplement the ARQ. 
200. This no doubt improves the situation with regard to countries that are already in a position
to provide drug abuse information. It does not, however, solve the problem of information
scarcity for the large number of countries that do not have the requisite capacity to carry out
epidemiological studies. For these, a totally different approach is called for. Through the UNDCP
Global Programme on Assessing the Magnitude of Drug Abuse, UNDCP will work directly, on
the ground, with individual countries and the epidemiology community to obtain data and to
simultaneously develop the capacity to sustain data collection. 
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201. In this way, UNDCP anticipates obtaining from 75% of countries in the world better
quality data on strategic key indicators over the period 1999-2003. The drug abuse indicator data
thus provided will be analysed together with other quantitative information compiled from various
sources such as community epidemiology networks, treatment providers, and enforcement
agencies, as well as qualitative information obtained from rapid situation assessments and
ethnographic research, with a view to arrive at more reliable estimates of the magnitude of the
global drug abuse problem and existing and emerging drug abuse patterns and trends.
202. It is evident that there are some important gaps in the data and information available to
UNDCP. This notwithstanding, an attempt is made in the following chapters to present an
overview of the drug abuse situation, globally as well as regionally. The information is based on
data provided by Member States, various international and regional organisations such as the
World Health Organization (WHO), the Inter-American Drug Abuse Control Commission
(CICAD) of the Organization of American States (OAS) and the European Monitoring Centre
for Drugs and Drug Addiction (EMCDDA), as well as research institutes and epidemiology
networks. In the following tables and figures, the sources noted above are not cited again. Only
specific sources other than the general ones mentioned previously are cited in the appropriate
tables and figures. 
203. Information about the extent of drug abuse among young people in the world is sporadic.
The most common information on drug abuse among young people often relates to specific
populations, namely, students. Such information, though valuable for the identification of trends
and attitudes, does not cover the extent of drug abuse among those who have left school or
among drop-outs and truants. Household surveys also have their limitations since youth may be
reluctant to admit using drugs in the presence of their families. Therefore, household surveys tend
to report a lower prevalence than school surveys, at least if the school surveys guarantee
anonymity.
204. In addition to the above, there are considerable problems with respect to the age groups
to be considered. The data presented in this report refer to the age range 15-24 years, but other
age ranges have also been taken into consideration. This is because the drug abuse problem in
many instances affects people younger than 15 and also because the information available from
studies and research carried out at the national level is presented in age ranges that are not always
comparable. Additionally, the gender factor is not always considered in the collection of data on
drug abuse among young people. 
205. A basic difficulty when presenting data from different countries is the limited
comparability. Different countries collect different data, carry out studies in different years, use
different sampling and data collection methods, and have different definitions of various drugs and
of what constitutes drug abuse. Cultural factors may also influence responses to survey questions,
resulting in under-reporting and in some cases even over-reporting of illicit drug consumption.
It is therefore very seldom possible - sometimes even misleading -  to compare data across
countries.
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h It may be noted that a similar approach is frequently taken in other areas of social and economic research, including by  economic
research institutes trying to obtain early indications of new economic trends in the business sector.  
VII. Global trends
A. Overview 
206. The identification of global drug abuse trends based on systematically undertaken
nationwide epidemiological surveys is, for the time being not possible. As noted in the
introduction, many countries do not have comprehensive monitoring systems in place. Existing
national monitoring system are not directly comparable as they are frequently based on different
indicators whose definition, in addition, may vary from country to country (e.g. definitions of drug
related deaths and  treatment cases, types of drug-use: annual, life-time, monthly drug use,
frequent drug use, problem drug use etc.), or results may be strongly influenced by particular
national decisions concerning provision of treatment places, or enforcement policy.  All of this
makes direct comparisons based on changes in quantitative indicators difficult and easily
misleading. 
207. In the ARQ, however, member states do report observed and/or perceived trends in drug
abuse. Countries report to UNDCP whether abuse of a specific drug has been characterized by
a “large increase”, “some increase”, a “stable” development, “some decline” or a “strong decline”.
On average about 70 countries have reported  drug abuse trends in recent years (1995-1997). This
information constitutes the basis for the subsequent discussion of global trends. In order to further
wider coverage, trends reported by other institutions such as the European Monitoring Center for
Drugs and Drug Addiction, the International Epidemiology Work Group, the Council of Europe
(Pompidou Group) and results provided by the United States  Department of State in its annual
International Narcotics Control Strategy Reports, have been used for the graphic presentations
of changes in drug abuse over the 1995-1997 period.
208. Reported trends are based on a multitude of indicators ranging from results of nationwide
or locally undertaken epidemiological research, data from various drug registries, including from
treatment services, emergency rooms, ambulance services, to morbidity, mortality and arrest data.
It goes without saying that in the process of combining results of various indicators, there is an
important element of subjectivity, requiring a fair amount of judgment. Nonetheless, as such
judgments are usually made by experts or agencies dealing with drug abuse, the results obtained
should - at least in the aggregate - be a reasonable reflection of reality.
209. In order to speak of what could be called “global trends”,  trends observed in one country
have to be noted in other countries as well.  One simple indicator for the determination of such
global trends is to calculate the “net-increase/decrease” of changes in drug abuse reported by
countries, i.e. to add up the number of countries reporting an increase and to deduct from that
figure the number of countries reporting declines in abuse of specific drugs.h The resulting “net-
increase” figure, if positive, suggests a (net-)spread of drug abuse across countries. A rise in the
“net increase” figure suggests a further acceleration of the drug abuse problem at the global level
over time. A decline in the “net-increase” figure indicates a deceleration of growth, but not yet
a decline. Only a negative figure (“net-decrease”) is an indication for an actual  reduction of drug
abuse at the global level. (See figure 129)   
210. On the basis of this indicator (“net increase”), the overall strongest increase of drug abuse
at the global level over the last few years concerned cannabis.  In 1996, thirty eight countries
reported an increase in cannabis consumption to UNDCP, 7 countries reported a decline and 17
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reported a stabilization, leaving a “net increase” of 31 countries. This was a significantly higher
number than the “net increase” of  8 countries in 1990. Data for 1997 show a further spread of
growing cannabis consumption at the global level. According to preliminary data for 1997, 44
countries reported an increase in cannabis consumption. There was a “net-increase” in  36
countries, signaling once again a far stronger spread of the increase in cannabis consumption than
for any other illegal substance.  
211. In 1996, the latest year for which a geographically balanced and relatively large data set
is available (68 countries reported on drug abuse trends), rise in cannabis consumption (“net
increase” in 31 countries) was followed by increases in amphetamine-type stimulants (“net
increase” in 26 countries), heroin (21 countries), cocaine (18 countries), hallucinogens (12
countries), inhalants (12 countries) and benzodiazepines (9 countries). In the case of opium, by
contrast, more countries reported declines than increases, reflecting a shift in a number of Asian
countries from traditional opium consumption to more “modern” heroin abuse. 
Figure 129. Number of countries reporting “increase”  less 
number of countries reporting “decrease” in drug abuse
212. While growth at the global level has been strongest in cannabis, the most dynamic increase
in the 1990s has been in amphetamine-type stimulants (ATS).  There were four times more
countries in 1996  reporting an increase in amphetamine-type stimulants abuse than in 1990. This
compares to a two-fold increase in the case of  cannabis, an increase by half in the case of heroin
and an almost unchanged  number of countries reporting an increase in the case of cocaine over
the same period.  In terms of calculated “net-increases”, the rise for ATS was six-fold over the
1990-96 period compared to a four-fold increase for cannabis, a tripling in the case of heroin and
an increase by a fifth in the case of cocaine. 
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213. Data thus suggest (i) that abuse of heroin and cocaine continued to grow in the 1990s,
mainly by shifting to countries that had not been affected hitherto, but (ii) that the spread of abuse
in these plant-based drugs was far less dynamic than for the amphetamine-type stimulants. 
214. Preliminary data for 1997 show a further increase in the spread of cannabis. 68% of all
countries reporting to UNDCP on cannabis in 1997 reported an increase, up from 61% of the
countries a year earlier. Growth in the abuse of other drugs, by contrast, seems to have lost
momentum as compared to 1996. Nonetheless, 66% of all the countries which provided UNDCP
with their views on trends in amphetamine-type stimulants, reported an increase in 1997, which
is still a  higher percentage than for heroin (59%) or cocaine (50%). (See figure 130)  
Figure 130. Drug abuse trends in 1996/97 
(countries reporting increases or decreases in % of all countries reporting) 
215. In terms of regional patterns, drug abuse seems to have increased particularly strongly in
Europe in recent years. For ATS, cannabis, opiates and cocaine, Europe consistently leads the list
of countries reporting increases. The relative “position” of the other regions is dependent upon
the specific drugs under investigation. 
216. In economic terms the largest markets are still North America and Western Europe. A
general pattern regarding heroin and cocaine abuse trends over the 1995-1997 period has been
a stagnation in those consumer markets that have had already high levels of abuse (cocaine in the
case of North America and heroin in the case of Western Europe), while abuse of the same
substances in the other  respective regions continued to spread (heroin in North America, cocaine
in Western Europe). Abuse of ATS and cannabis grew in both regions.    
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B. Cannabis
217. Cannabis, the most widely consumed illegal drug worldwide, has also shown the most
consistently rapid growth across all continents in recent years.   Following a deceleration in
growth over the 1987-1990 period after successful prevention campaigns and large-scale
eradications of the cannabis plant, notably in Latin America, use of cannabis started spreading
again in the 1990s.
218. Changing attitudes, particularly among the younger generations, the perception of low risk
and the growing use of cannabis along with synthetic drugs in rave parties and similar youth
events have contributed to the growing popularity of that drug.  The rapid growth in supply from
a number of traditional producer countries of Africa and Asia as well as increased supply of
domestically grown (high-tech) cannabis in many industrialized countries (mainly North America,
Europe and Australia) guaranteed sufficient supply to meet growing levels of demand.  
219. Preliminary figures for 1997 show that the upward trend continued. Assuming that trends
in  countries which reported on cannabis in 1996 but have not yet reported for the subsequent
year, continued, the overall upward trend of the 1990s could have accelerated even further in
1997.  
Figure 131. Number of countries reporting increase in cannabis abuse 
less number of countries reporting decrease
220. Compared to a decade ago, there has been a clear growth of cannabis use, particularly in
Europe but also in Africa and Asia.(See figure 131)
221. Consumption of cannabis increased across all regions, except Oceania (Australia) which
according to available prevalence data, however, already has high prevalence rates (13% of those
14 years and above in 1995).
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222. The strongest increase in cannabis abuse over the 1995-97 period was reported from
Europe, followed by countries in Africa, the Americas and in Asia. Nonetheless, cannabis
prevalence rates in Europe are still significantly lower than in the Americas and cannabis
prevalence rates in Western Europe are still far lower than in North America. Annual prevalence
rates of, on average 5.5% for those 15 years and older in the European Union (1994/1995)
compare with rates of 8.5% in 1995, and 9% in 1997 in the United States (12 years and above).
 
Figure 132. Cannabis trends (“net increase”)
223. In the Americas, the number of countries reporting increases has fallen slightly compared
to a decade ago, reflecting the large-scale eradications of the late 1980s and falling abuse levels
in the 1980s. However, there are no indications of a continuation of the downward trend in the
1990s. Compared to the early 1990s there are significantly more countries in the Americas which
report increases in cannabis. As reporting gaps the ARQ have been filled by additional information
from other sources (INCB, International Epidemiology Network, United States Department of
State and United States Drug Enforcement Agency), almost the whole of the Americas seem to
be characterized by a growing cannabis problem with only a few countries reporting a
stabilization. Growth in cannabis use seems to have been particularly pronounced in the Andean
countries, but also Brazil and in 1997 Argentina and Chile as well as a number of central
American countries reported rising levels of cannabis use.  In addition, in the main cannabis
market, the United States, where the number of cannabis consumers (annual prevalence) had
fallen strongly in the 1980s, from 30 million people in 1982 (15.9% of those 12 years and above)
to 16 million people in 1992 (7.9%), cannabis use has increased again in subsequent years. By
1997, almost 20 million people (9.0%) consumed cannabis, almost a quarter more than in
1992.(See figure 132) 
224. The rise in Western Europe has been even stronger. The number of 18-39 year olds in
Germany using cannabis (annual prevalence), for instance, rose by almost 75%, from 4.1% in
1990 to 7.2% by 1997, equivalent to a rate of 4.1% in the general population (18 to 59 year
olds)32.  In the United Kingdom, the number of cannabis users (annual prevalence) rose by almost
80%, from 5% in 1991 to 9% in 1996 of those 16 to 59 year olds according to data of the British
Crime Survey33; most of the increase, however, took place in the first half of the 1990s. Similarly
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 large growth rates can be also found in a number of other countries. By 1996/97, a number of
Western European countries, including the United Kingdom, Ireland, France, Switzerland, Spain
and Portugal, started reporting a stabilization of abuse while cannabis use continued to grow in
most other European countries. 
225. The main exceptions to the upward trend in Central and Eastern Europe were the Russian
Federation and Belarus. In both countries, authorities reported some decline in cannabis
consumption in 1996/1997,  apparently reflecting a shift from cannabis to synthetic drugs. But
within the Russian Federation, the situation differs strongly from region to region and the
apparent decline in the number of cannabis users has to be seen against the background of strong
growth experienced in previous years. In most Central Asian States, which have become
important suppliers of cannabis for other CIS countries, a strong upward trend in domestic
consumption continued while in neighboring China cannabis abuse is still rather small and seems
to have stabilized. 
226. Pakistan reported a strong decline in cannabis use in 1997.  This is basically in line with
reports of law enforcement agencies in several Western European countries which saw a loss in
market share of hashish from Afghanistan/Pakistan in recent years, possibly reflecting smaller
amounts produced in that region. The reported stabilization of cannabis use in the Islamic
Republic of Iran and States of the Arabian Peninsula would also fit this picture.
227. By contrast, cannabis use in South and South-East Asia (notably India, Myanmar, the Lao
People’s Democratic Republic, Malaysia, Indonesia and the Philippines) is apparently on the rise.
This is again in line with information provided by law enforcement agencies in Europe who have
reported on increases in cannabis originating in South-East Asia (notably Cambodia) in recent
years.    
228. As far as information from African countries is available, the overall trend of cannabis
consumption is clearly going upwards, including in Morocco in North Africa, South Africa in the
Southern African subregion, Kenya in East Africa, the Congo and the Democratic Republic of the
Congo in Central Africa as well as Ghana, Benin and Sierra Leone in West Africa. Most of the
cannabis is from domestic sources and/or from neighboring countries. Only a few countries
reported a stabilization and only one country in Africa, Nigeria, reported some decline in the level
of cannabis use in 1997 following a massive crackdown on the local drug scene over the last few
years after already having reached epidemic proportions.(See map 6)
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C.  Amphetamine-type stimulants
229. The most dynamic growth in abuse in recent years concerned the ATS.  Having spread
relatively slowly in the 1980s, use of ATS increased rapidly in a large number of countries in the
1990s. In many countries, notably in Europe but also in developing countries, the spread of ATS
was recreational, linked to youth culture, techno music and rave parties. In more recent years,
ATS use in a number of countries also spread to more traditional dance events and the club scene.
In contrast to heroin or crack cocaine, which are the preferred drug of marginalized groups, the
latest wave of ATS use seems to cover all social classes. In parallel, ATS use continued to be
“functional”, in a number of developing countries used by lorry drivers, fishermen or sex workers
to fight fatigue and/or improve communication skills.
230. According to preliminary figures for 1997, the massive upward trend of the 1991-1996
period, however, does not seem to have continued.  But, this deceleration of growth could be a
statistical artifact. A number of countries reporting rising levels of ATS in 1996 have not as yet
reported trend data for 1997.  Assuming that trends in those countries remained unchanged on
a year earlier, overall data would suggest a further acceleration in the spread of ATS abuse.
Nonetheless, the increase in the spread seems to be still less marked than over the 1993-1995
period. 
Figure 133. Number of countries reporting increase in abuse of amphetamine-type
stimulants less number of countries reporting decrease
231. The number of countries reporting increases in ATS was in all regions, except Africa,
larger over the 1995-1997 period compared to a decade ago or compared to the beginning of the
1990s. The largest “net increase” over the 1995-1997 period was reported from Europe, followed
by countries in Asia and the Americas.(See figure 133) 
232. By contrast, in Africa, the number of countries reporting increases in ATS declined over
the last decade. This is largely linked to progress made at the international level in preventing
diversions of ATS from licit sources. Diversion cases of ATS in other regions were also reduced
over the last decade. However, that progress was offset by increases in clandestine manufacture.
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233. Over the 1995-1997 period, the strongest increases in ATS abuse was reported from
Europe which is also an important production site for ATS. A large majority of countries in both
Western Europe, including France, Italy, Switzerland, Germany, Spain and the Nordic countries,
as well as a majority of countries in Eastern Europe, saw rising levels of ATS abuse. The rise was
for both amphetamine and Ecstasy.  Only Turkey, Greece and Latvia reported a decline in ATS
abuse.(See Figure 134)  
Figure 134. Amphetamine-type stimulants trends (“net increase”)
234.  In most European countries, the rise in ATS was more pronounced than the rise in other
substances, including cannabis. Thus ATS  emerged in Europe as the second most widely used
illicit drugs after cannabis, ahead of cocaine and heroin. In the Netherlands, for instance, monthly
prevalence of cannabis among those 12-18 year olds increased by 40% over the 1992-1996
period, while monthly prevalence of Ecstasy more than doubled over the same period (from 1.0%
to 2.2%)34. Available data for the western “Länder” of Germany (known as West-Germany prior
to reunification) show that while the number of  cannabis users (annual prevalence) rose by 60%
among the 18-39 year olds over the 1991-1997 period, the number of ATS users more than
doubled over the same period to a rate of 1.7% for Ecstasy and 0.9% for amphetamine in 1997
(18-39 year olds), representing in total a higher prevalence rate among the 18-39 year olds than
cocaine (1.2%) and heroin (0.3%) combined32.  The same is also true for the United Kingdom.
According to data of the 1996 British Crime survey33, use of cannabis rose by about 75% among
those 16-29 year olds over the 1991-1996 period while the prevalence of amphetamine use
doubled from 4% of the 16-29 year olds in 1991 to 8% in 1996 (in addition to a rise in Ecstasy
use to 4% by 1996); the level of cocaine use, by contrast, remained at about 1% over the same
period among the 16-29 year olds while the level of heroin abuse continued to remain  below the
0.5% benchmark.
235. In the Far-East/South-East Asia region, all countries/territories from which information
was obtained, saw an increase in ATS abuse including Thailand, China, Taiwan Province of
China, the Philippines, Malaysia, Indonesia, the Republic of Korea and Japan. In most countries
in that region, rising levels of ATS abuse refer to methamphetamine, though in a number of
countries of South-East Asia, Ecstasy consumption was reported rising as well. In a number of
countries/territories in the South-East Asia/Far-East region, including Japan, Republic of Korea,
China (Taiwan Province), the Philippines and, in recent years, Thailand, the number of abusers
of methamphetamine already exceeds the number of heroin abusers.  
236. Growth in ATS abuse was also reported from the United States and Mexico as well as from
a large number of countries in South America. While growth in North America was largely related
to methamphetamine, growing levels of ATS use in Latin America were mainly related to various
ATS  anorectics and - to a lesser degree - growth in Ecstasy.(See map 7) 
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D.  Cocaine
237. Cocaine consumption increased throughout the 1980s. The picture is, however, more
complex for the 1990s. Over the 1991-1995 period, growth in cocaine abuse decelerated before
accelerating again in 1996. Data for 1997 do not as yet give any clear picture. Preliminary figures
(“net-increase”) for 1997 show a deceleration in growth at the global level. However, if it is
assumed that the trends of countries that reported in 1996 but have not yet done so a year later
remained unchanged, there would be a significant acceleration in the spread of cocaine use in
1997.( See figure 135)     
Figure 135. Cocaine abuse trends (“net increase”)
Number of countries reporting “increase” less number of countries reporting “decrease” 
238. In terms of regional patterns, trend data suggest that the spread of cocaine was strong in
the Americas in the mid 1980s, lost momentum  in the early 1990s but has started to rise again as
of the mid 1990s, notably in the producer countries of coca leaf and in neighboring countries.
239. The strongest spread of cocaine abuse over the last decade, however, was to be observed
in Europe. Except for the Nordic countries where availability of and growth in amphetamine use
seems to have prevented it, a large majority of countries in Western and Eastern Europe, have
consistently reported minor increases in cocaine use. There are now more countries in Europe than
in the Americas reporting an increase in cocaine use. However, the reported increases in Europe
have been, in general, less significant than for the ATS, and cocaine use in Eastern Europe is still
comparatively small. 
240. There is also an ongoing spread of cocaine use in Africa and Asia though the abuse levels,
in most of these countries are still relatively modest. Government reports suggest that after a
strong boost up to the mid 1990s, the spread of cocaine use may have lost momentum in 1997 in
the larger countries of West Africa (Nigeria, Côte d’Ivoire) which were first exploited by
trafficking groups, shifting to smaller countries in the region instead (notably Togo and Benin but
also Ghana). In Southern Africa, notably South Africa (and to a lesser degree neighboring
countries), seem to be affected by rapidly growing levels of cocaine abuse. Shifts in trafficking
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routes from Latin America (notably Brazil) to countries in Southern Africa for further shipments
of cocaine to Europe, seem to have been at the origin of the spread of cocaine abuse in that region
which in the meantime has created a momentum of its own.(See figure 136) 
241. The main trends over the 1995-1997 period have been a stabilization of cocaine abuse in
the main markets of North America (United States, Canada) - which still represent the world’s
largest markets for cocaine - going hand in hand with strongly increased levels of cocaine abuse
in the Andean countries as well as in neighboring countries (Brazil, Paraguay and Venezuela) and
along the trafficking routes from the producer countries to the markets in North America, affecting
most of the countries of Central America, Mexico and some Caribbean countries.
242. There have been also a number of countries in Africa, mostly in Southern and in West
Africa, which have been exploited by drug trafficking organizations to become transhipment
destinations for cocaine from Latin America to Europe. Now, they also report rising levels of
cocaine abuse.  By contrast, authorities in Kenya, located in East Africa which is outside the main
trafficking routes of cocaine networks, have reported cocaine abuse to be falling.  
243. Most of the countries in Western Europe, including Spain, France, the United Kingdom and
Germany, reported increases in cocaine consumption over the 1995-1997 period, reflecting the
ongoing diversification of cocaine sales which are shifting to Europe where the cocaine market is
still far less developed than in North America. Annual prevalence rates of cocaine are, on average,
still less than half as high in Western Europe (0.7% of the population above 15 in 1995/1996) than
in the United States (1.9% of the population above the age of 12 in 1997), and cocaine is still far
less of a “problem drug” in Europe than in the United States. Over the 1982-1992 period, the
number of cocaine users (annual prevalence) in the United States fell from 10.5 million people to
4.3 million people and the number remained at that level up until 1997 (4.2 million people in 1997).
 
244. There were also some more recent cases of declining levels of cocaine use. In a number of
countries of East Asia, which in any case have very low levels of cocaine consumption, rising levels
of methamphetamine abuse have apparently led to a further decline in cocaine use. In Latin
America,  both Chile and Argentina saw a decline.(See map 8)  
Figure 136. Cocaine abuse trends ("net increase")
Number of countries reporting “increase” less number of countries reporting “decrease” 
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E. Opiates
245. The most critical “problem drugs” at the global level are still the opiates, notably heroin.
Data suggest that heroin consumption has gradually spread across the globe over the last decade.
Growth in heroin abuse was particularly strong in the late 1980s, in the early 1990s as well as over
the 1994-96 period. 
246. Preliminary figures (“net-increase”) for 1997, by contrast, show a deceleration in growth
at the global level.  Some of this deceleration may be due to purely statistical reasons as a number
of countries reporting increases in heroin abuse in 1996, have not yet reported trends in 1997. If
one assumes that the trends of all those countries remained unchanged, the downward trend
becomes less marked, suggesting that the previous acceleration of heroin abuse did not continue
in 1997. Nonetheless, there are still clearly more countries reporting increases than decreases. (See
figure 137)    
Figure 137. Heroin abuse trends (“net increase”)
Number of countries reporting “increase” less number of countries reporting “decrease” 
247. Compared to a decade ago, heroin consumption is now far more widespread (See figure
138). The strongest growth throughout the last decade was observed in Europe though heroin
abuse has been also growing in Asia and Africa. The most dynamic growth of heroin abuse in the
1990s was in the Americas, reflecting increased levels of domestic production in Latin America
which were not only produced for overseas exports but for consumption within the region as well.
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Figure 138. Heroin abuse trends ("net increase")
Number of countries reporting “increase” less number of countries reporting “decrease” 
248. While heroin consumption in Western Europe, which is estimated to affect about 1 million
people, stabilized over the 1995-1997 period (except for the United Kingdom, Ireland and the
Nordic countries), strong increases were reported from most of the CIS member States as well as
from the countries in Eastern Europe, particularly from countries located along the Balkan route.
249.  Increases in abuse were also reported from the  main immediate “transit countries” of the
opiates originating in Afghanistan, i.e. the Islamic Republic of Iran, Turkey and a number of
countries in Central Asia. While authorities in the Islamic Republic of Iran estimated the number
of opiate addicts in the early 1990s at around 500,000 people (of which 150,000 heroin addicts)
some estimates for 1998 see the number of opiate addicts to have risen to some 1.2 million people.
250. An even stronger growth in heroin addiction over the last decade was seen in  Pakistan
which for years was the main outlet of opiates produced in Afghanistan. The level of heroin abuse,
according to Government estimates in Pakistan rose from negligible levels in the early 1980s to
about 1.5 to 2 million people in the second half of the 1990s. However, for 1997, Pakistan
reported,  for the fist time in years, some decline in heroin abuse. The decline in 1997 may be a
reflection of first positive results of demand reduction measures that were initiated in the early
1990s, lower levels of domestic opium and heroin production as well as lower levels of transit
trafficking as trafficking groups from Afghanistan started to look for alternative outlets through
countries in Central Asia in order to circumvent the now better controlled border between Pakistan
and the Islamic Republic of Iran. Changes in transit trafficking patterns also seem to have had a
positive impact on India which - with an heroin addict population of around 1 million people in
addition to a few million opium consumers, ranging from one to five million according to unofficial
estimates35 - has been supplied with illegal heroin that mainly originated in South-West Asia. In line
with falling levels of abuse reported by neighboring Pakistan, authorities in India also saw, for the
first time in years, some decline in heroin abuse in 1997.  
  
251. China emerged in recent years as an important drug transit country for heroin originating
in the Golden Triangle, notably Myanmar, the world’s second largest source of opiates. Like many
other transit countries, China has experienced important spill-over effects and is increasingly
suffering from abuse problems as well. The number of registered drug users (mostly opiates) rose
from less than 150,000 in 1991 to 540,000 by 1998. In Viet Nam, where opium rather than heroin
-114-
is still the predominant substance of abuse (this is also the case in other countries of Indochina),
rising levels of abuse have been reported in recent years. Indonesia, another new market outlet of
heroin from the Golden Triangle, has also suffered from growing levels of abuse in recent years.
252. By contrast, a number of official reports suggest that opiate abuse in Thailand - affecting
some 300,000 people (of which some 75% are heroin abusers) - declined slightly over the 1995-
1997 period, reflecting a shift towards methamphetamine abuse, lower levels of domestic opium
production as well as a trend of trafficking groups to exploit other countries in the region for
transiting heroin to overseas markets. However, there are reasons to fear that the observed decline
may have been of only temporary nature. Preliminary reports obtained by UNDCP’s field office
in Thailand for 1998 suggest that the downward trend in the consumption of opiates has given way
to increased levels of abuse in 1998 as consumers reacted to falling heroin prices in line with
economic theory. This went hand in hand with reports that more stringent enforcement efforts by
authorities in China may have prompted some trafficking groups to again start using Thailand to
ship heroin to overseas markets.    
253. Shifts in trafficking patterns have also affected countries that are much further away from
the areas of production. Growing levels of heroin abuse were reported from countries in East
Africa which in recent years have been exploited by drug trafficking networks to ship Asian heroin
from Pakistan or Thailand via Africa to Europe.  
254. In the Americas, rising levels of abuse over the 1995-1997 period were reported from all
countries in North America (United States, Canada and Mexico) as well as from a number of South
American countries, including Colombia, Venezuela and Ecuador, reflecting the emergence of a
domestic production of opium in the region in the 1990s (notably in Colombia).
255. In line with increasing levels of heroin consumption in the United States - the number of
heroin abusers rose according to the United States national household survey (annual prevalence)
from 360,000 in 1991 to 600,000 people in 1997 - Canada, the United Kingdom, Ireland and
Australia also reported rising levels of heroin abuse over the 1995-1997 period.  
256. By contrast, in much of South-East, South and partly South-West Asia, countries reported
declining levels of abuse of opiates in 1997. This followed years of strongly growing heroin abuse
in much of the 1980s and 1990s. Shifts from heroin to methamphetamine abuse in South-East Asia
(notably Thailand) and falling levels of opium consumption, that have not been matched by
proportionately rising levels of heroin abuse, are part of the explanation. In addition, in Myanmar,
Thailand, Bangladesh and eastern India, the explanation may be also found in a reduced availability
of opiates due to bad opium harvests, rising price levels (up until 1996/1997) and changes in the
transit routes.(See map 9)
257. Lower levels of heroin abuse over the 1995-1997 period have been also reported from
some countries in West Africa, notably Nigeria and Côte d’Ivoire, reversing the upward trend of
the early 1990s. At the same time, however, countries such as Ghana, Benin, Togo or Sierra
Leone, which until recently have had less of a heroin problem,  are now reporting rising levels of
heroin abuse.  The authorities in South Africa, which reported significant growth in heroin abuse
in recent years up until 1996, saw the levels of heroin abuse stabilize in 1997. 
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VIII.  Extent of drug abuse
 
A.  Overview
258. The exact number of drug users worldwide is unknown. What does exist, however, are
basic orders of magnitude - which are subject to revision as new and better information is
generated. Estimates of illicit consumption for a significantly large number of countries have been
received by UNDCP over the years. On this basis - and taking various other epidemiological
studies, including ethnographic research and estimates of law enforcement agencies into account -
the World Drug Report estimated that the likely annual global prevalence rate of illicit drug use
was in the range of 3.3%-4.1% of the total world’s total population during the 1990s. This
indicates that regular drug use - at the global level - is still rather uncommon, in contrast to the
consumption of the main licit psychoactive substances such as alcohol and tobacco.
259. According the WHO estimates, there were about 1100 million tobacco smokers worldwide
in the early 1990s, representing about one-third of the population 15 years and above. Two-thirds
of them were men36 (daily prevalence of 47% as compared to 12 % among women). It is estimated
that smoking and other forms of tobacco use resulted in a loss of at least 3.5 million lives in 1998
and that the escalation in tobacco use is expected to cause at least ten million deaths a year by the
year 203037. 
260. While many countries collect information about the per capita consumption of alcohol, little
information is available on the number of people who consumed alcoholic beverages during the
past year (annual prevalence). From what is known, however, prevalence of alcohol use seems to
be comparatively high in several countries. For example, in Canada about 80% of the population
aged 15 years or older use alcohol to some extent.38 In Italy, lifetime prevalence has been estimated
at 81% and in Germany (west) at 91%. In the Nordic countries life time prevalence has been
reported to range from 82 to 96% as compared to 79 to 95% annual prevalence.39
261. The estimates presented in the 1997 World Drug Report showed that of the plant-based
drugs, the illicit consumption of cannabis products (mostly marijuana and hashish), was the most
widespread, with an estimated 141 million people consuming cannabis worldwide. This represented
about 2.5% of the world population (annual prevalence) during the 1990s. In particular, large
numbers of young people experimented with cannabis. 
262. Less prevalent, but with far more serious health effects in terms of substance abuse related
mortality, emergency room visits and treatment cases  is the abuse of cocaine and opiates.
Estimates suggest that some 13 million people (annual prevalence of 0.2%) may abuse cocaine
worldwide.  It is also estimated that about 8 million people (0.1% of the world population) may
be abusing heroin and other opiate-type drugs.
263. The abuse of synthetic drugs, particularly of amphetamine-type stimulants (ATS), has
increased rapidly in recent years with some 30 million people worldwide (annual prevalence of
0.5%) consuming ATS. Increasingly, synthetic drugs have gained in popularity, especially among
young people as their recreational drug of choice, often in combination with cannabis.
264.  It goes without saying that all of these figures have to be interpreted with caution. It is
very difficult, if not impossible, at this stage to put precise figures on the actual extent of illicit drug
abuse at the global level, mainly because there are still significant gaps in the data and because the
data provided by the contributing countries are often of unknown quality.
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Figure 139. Annual prevalence of drug abuse among the general population in the 1990s.
Source: UNDCP, World Drug Report 1997.
265. The most widely used indicator in this context at the global level is the “annual prevalence”
rate.  This looks at the number of people who have consumed an illicit drug at least once over the
last twelve months prior to the survey. This number is then frequently shown as a percentage of
those who are 15 years old and above, or those 12 years old and above, though a number of other
age groupings are used as well. The World Drug Report figures were presented as a percentage
of the total population (See figure 139). However, as most countries do not report prevalence as
a percentage of their total population, the following graphs - unless otherwise indicated - show the
prevalence figures as a percentage of the population above the age of 15.  In cases where studies
were based on significantly different age groups, the data were adjusted to take into account the
fact that drug abuse is usually significantly stronger among younger-age cohorts. In cases where
the authorities provided  UNDCP only with estimates on the total number of drug abusers, this
number has been expressed as a percentage of the population above the age of 15.
266. As “annual prevalence” is the most commonly used indicator to measure prevalence, it has
also been adopted by UNDCP as the key indicator for the extent of drug abuse. The use of “annual
prevalence” is a compromise between “life-time prevalence” data (drug use at least once in a life-
time) and data on current use. Life-time prevalence data are, in general, easier to generate but are
not very illustrative. (The fact that a 50-year-old person smoked marijuana at the age of 20 does
not  provide much insight into the current drug abuse problem). Data on current use (e.g. monthly
prevalence) are of  more value. But for most drugs, except a few major drug categories such as
cannabis, data on monthly prevalence need rather large samples to arrive at statistically relevant
results, requiring larger resources than most countries can afford.  
267. One key problem in currently available prevalence estimates is still the level of quality
which varies strongly from country to country. While a number of prevalence estimates are based
on sound epidemiological surveys, some are obviously the result of guesses. In other cases, the
estimates provided simply reflect the aggregate number of drug addicts found in some drug
registries which probably covers only a tiny fraction of the total drug abusing population in a
country. 
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268. Currently available results presented in the next few graphs  must be interpreted with a
large degree of caution. They can provide the reader with an idea of the likely magnitudes of drug
abuse in the different countries.  Nevertheless, results do not always accurately reflect reality. They
can only be an approximation of reality. The underlying methodological approaches used for
collecting data on an illicit activity vary a great deal from culture to culture and country to country.
In some cases, strongly differing results for one and the same country were obtained.  This required
a fair degree of judgment based on plausibility considerations of which results to select. Moreover,
in order to arrive at basically comparable results, it was necessary in a number of cases to
extrapolate from reported current use or life-time prevalence to annual prevalence rates and/or to
adjust results for differences in age groups. It goes without saying that all of these operations can
potentially lead to over-estimates or under-estimates. Nonetheless, the potential errors,  in general,
should be less than had unadjusted figures been used.
269. While some country results may be  questioned, the overall emerging picture is basically
in line with the pattern shown in the World Drug Report as well as other research (ethnographic,
rapid assessments, analysis of arrest data, analysis of treatment demand data, etc.) conducted in
this field.  
270. The data clearly show that cannabis is the most widely consumed illicit drug worldwide,
in the Americas, in Europe, in Africa and in Asia. The position of the second most widely
consumed substance, by contrast, differs from region to region, and partly from country to country.
Still, in most cases, the second position is held by one of the three types of substances: cocaine,
opiates or amphetamine-type stimulants. 
271. The data show that in general, cocaine together with various other “cocaine-type”
substances (crack-cocaine, basuco) is the second most widely abused substance in the Americas.
The abuse of cocaine type substance is significantly ahead of opiates which, except for North
America, are hardly mentioned in surveys.  In some Latin American countries, inhalants and
benzodiazepines also play an important role as substance of abuse. Abuse of cocaine still seems to
be the highest in the United States though a large number of Latin American countries now also
show substantial levels of abuse of cocaine and of bazuco.
272. In Australia and in Europe, notably in most Western European countries, amphetamine-
type stimulants are the second most widely abused category of drugs after cannabis.  The level of
cocaine use has been rising in both Eastern and Western Europe in recent years. The level of
cocaine abuse in Eastern Europe, however, is still very small by international standards. Though
cocaine use in Western Europe has risen to substantial levels, it still falls far short of the levels of
cocaine abuse experienced in the United States. On average, prevalence rates of cocaine in Western
Europe are only about a third of those in the United States.  According to available prevalence
data, however, cocaine use now seems to be about twice as widespread in Western Europe as
heroin. Nonetheless, the main problem drug in treatment clinics in Europe - as will be discussed
later - are still the opiates. ATS and cocaine abuse (though rising) still represent a small proportion
for which drug addicts require treatment.  
273. In much of Asia, the opiates, either in the form of opium and increasingly in the form of
morphine and heroin, are the main substances of abuse.  In some countries they seem to be even
more widely spread than cannabis. However, the situation in Asia is far from uniform. Though
epidemiological research in the East Asian region is still at its initial stage - and thus not many
reliable epidemiological data are available - other indicators such as the arrest rates for drug abuse
and reports from treatment institutions and locally conducted ethnographic research clearly point
to the fact that methamphetamine, far more than heroin, is the main drug of concern. One major
epidemiological study undertaken in Thailand (South-East Asia) in 1993 indicated that the abuse
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of methamphetamine in that country is already more widespread than abuse of heroin, though still
slightly less than that of all of the opiates combined (heroin and opium).  The importance of
cocaine, by contrast still appears to be of a negligible quantity in most of Asia.    
B. Cannabis
274. The large number of estimates made available to UNDCP underlines the global nature of
cannabis abuse, not only in the industrialized countries but also in most developing countries.  In
figure 140, the large number of countries which reported annual prevalence of less than 2% have
been omitted for reasons of brevity. 
275. Prevalence data/estimates suggest that the use of cannabis is particularly high in the
following regions: West Africa (e.g. Sierra Leone, Ghana, Nigeria); Oceania (Micronesia,
Australia, New Zealand, Papua New Guinea);  Central America/Caribbean (notably Jamaica);
North America (United States, Canada); and in a number of European countries such as the United
Kingdom, Spain, the Netherlands and Belgium. In general, cannabis use is higher in Western
Europe than in Eastern Europe. Even for a large number of developing countries, notably in Africa,
for which no or only very unreliable quantitative prevalence estimates are available, it is widely
acknowledged that cannabis is by far the most widely abused illegal substance. 
276. There are only a few countries in the world where cannabis ranks second or third. But even
in some of these cases it is not clear how far the results reflect reality. The fact that cannabis is not
found on the top list in a drug registry, in treatment centres or among people arrested, is no proof
that the spread of cannabis use among the general population is less than that of other drugs.  In
many countries where epidemiological research has been undertaken, it is shown that the cannabis
is the most widely consumed substance even though it does not show up prominently in various
drug registries.
277. In most countries, cannabis is consumed in the form of cannabis herb (known as marijuana
in the Americas).  However, in most of Europe, South-West Asia (notably Pakistan), North Africa
(notably Morocco) as well as in much of the Middle East (particularly Lebanon), there is a
preference for cannabis resin (hashish).
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  Figure 140. Annual prevalence of Cannabis abuse as a percentage of population aged 15 
and above (unless otherwise indicated)  
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C.  Amphetamine-type stimulants
278. Data/estimates for amphetamine-type stimulants (see figure 141) show high prevalence
rates for countries in Western Europe, notably for the United Kingdom, the Netherlands, Belgium
and Spain, for the Oceania region (notably Australia), as well as for a number of Latin American
countries. High prevalence rates for Ecstasy abuse are still restricted to the countries in Western
Europe and Australia. Abuse of Ecstasy in the United States is apparently less widespread.
279. Prevalence estimates obtained from a number of Central American countries vary strongly
with regard to the abuse of amphetamine-type stimulants. In the figure, the more conservative
estimates are presented. If other estimates had been used, several Central American countries
would have been significantly higher. 
280. The situation is similar in the Far-East Asian region. It is generally acknowledged, that
countries in that region have a severe problem of methamphetamine abuse. Nonetheless, estimates
for the extent of ATS abuse  are comparatively low.  This could be a statistical artifact.  Few
serious studies establishing the magnitude of ATS abuse have taken place in the region.  In some
cases available estimates vary strongly, by a factor of seven or more. Law enforcement agency
estimates are often substantially higher than estimates based on general population surveys. This
may be explained by the fact that there is a reluctance of those interviewed to openly admit to
drug-taking habits in societies where drug abuse constitutes a major crime.
D.  Cocaine
281. Available prevalence data shows that cocaine abuse is still very much concentrated in North
America, notably the United States, though a number of Latin American countries have also started
to report substantial levels of cocaine abuse in recent years. The same is true for a number of
Western European countries and Australia, even though cocaine still trails the amphetamine-type
stimulants in these regions.(See figure 142)  
282. Though cocaine abuse in the United States is significantly lower compared to a decade ago
(the number of annual cocaine users fell over the 1985-1997 period by almost 60%) data suggests
that the United States still has the highest level of cocaine abuse worldwide. According to the data
in  the United States Household survey40, 1.9% of the United States population above the age of
12  used cocaine while 0.6%  used crack-cocaine in the twelve months prior to the 1997 survey.
This means that when taking the overlap into consideration (as revealed in the United States
Monitoring the Future Study41), the total figure of those abusing cocaine is about 2.1% of the
population of the United States above the age of 12.
283. A number of Latin American countries reported even higher prevalence rates. Such high
estimates, however, resulted from one to one extrapolations from school surveys, surveys among
people in treatment, surveys among people in prisons or resulted from national surveys
investigating only the level of life-time prevalence. Using adjustment ratios, the estimates are below
the level of abuse in the United States.  The obtained results can, of course, only be considered as
rough approximations.
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Figure 141.  Annual prevalence of Amphetamine-type stimulant (ATS)
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Figure 142. Annual prevalence of Cocaine-type substance abuse as a percentage 
of population aged 15 and above (unless otherwise indicated)
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284. In contrast to the high levels of abuse in North America, Latin America and Western
Europe, the levels of cocaine abuse in much of the rest of the world seem to be small. This is
definitely the case for countries in Eastern Europe and in Asia where cocaine abuse is still restricted
to a few pockets in society. The same, however, is not necessarily the case in Africa. UNDCP has
received a number of reports suggesting the widespread abuse of cocaine in African countries,
notably in South Africa and Nigeria but also in some other West African countries. A few studies
among secondary school students, undertaken in Nigeria in the early 1990s suggest, that the abuse
of cocaine may have reached proportions that are far from negligible, and not much lower than
those found in Western countries. However, the extent to which such school surveys reflect the
situation in the general population is still subject to debate.
E. Opiates
285. Compared to other drugs, the prevalence data for opiates still seems to be relatively small.
Available data for the use of opiates suggest that abuse is  particularly strong in South-West and
in South-East Asia, often in countries neighboring major production centers which are exploited
for drug trafficking purposes. Pakistan, the Islamic Republic of Iran and the Lao People’s
Democratic Republic have the highest levels (see figure143). In general, consumption affects less
than 2% of the population. However, consumption is large in some of the opium producing areas.
A UNDCP study, undertaken in the Lao People’s Democratic Republic in 1998, showed that the
prevalence of regular opium use in the opium producing regions of the country ranged from 4%-
6%. Other countries in the region including Thailand, Myanmar, India, Maldives, also show rather
high levels of abuse. While heroin is increasingly emerging as the main type of opiate in the urban
centres, opium is still used in traditional opium poppy cultivation areas.
286. The next highest levels of abuse are reported from both Western and Eastern Europe. In
contrast to other drugs, prevalence data, however, do not indicate major differences between
countries. In several countries the abuse problem seems to be relatively similar, ranging from 0.2%-
0.4% of the population above the age of 15. Though Europe is, in economic terms, the world’s
largest market for illegal opiates, prevalence rates of opiates are, in general, lower than the
prevalence rates of  amphetamine-type stimulants or cocaine. 
287. Heroin abuse is still a comparatively minor problem in the Americas.  This is not the case
in the United States, which, following the recent increase in heroin abuse, has now reached levels
close to the European average.
288. The situation with regard to Africa is more difficult to judge. As far as estimates are
available, data suggests that heroin abuse has  begun to appear in a number of African countries,
although it has not yet reached epidemic proportions. 
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Figure 143.  Annual prevalence of Opiates abuse as a percentage of population 
aged 15 and above (unless otherwise indicated)
* UNDCP estimate based on local studies, special population group 
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i “Youth” is defined by the United Nations as reflecting the age group 15-24 years. The World Health
Organization (WHO) considers adolescence the period between 10 and 19 years and the term “young people”
refers to the composite age group 10-24 years. These definitions are based on a certain consensus about the
factors (biological, social and cultural) that define youth worldwide. However, it should be noted that the
notion of youth may vary considerably across countries in accordance to the socio-economic-cultural context.
The social and cultural entry into adult life may correspond to the economic autonomy of the person, the
establishment of a family or participation in a certain ritual.
IX. Drug abuse among youthi 
A. Overview
289. Drug abuse continues to emerge as a strategy among youth to cope with the problems of
unemployment, neglect, violence and sexual abuse. At the same time, there is considerable abuse
of drugs among socially integrated young people, in particular in the industrialized world. This may
be attributed in part to the fact that significant portions of the world’s youth population are
exposed to a culture that appears to be more tolerant towards the use of drugs.
290. The data available present a situation of concern in terms of the abuse of drugs among
young people in almost every region of the world. Lifetime prevalence of cannabis abuse is high
in many regions (the unweighted average is 13.5%) and its abuse is spreading. ATS abuse is
diffused and Ecstasy abuse, while stabilizing at a high level in some Western European countries,
is increasing in others and is also spreading to other regions. The unweighted average for Ecstasy
is 2.6%. There are high variations in cocaine prevalence, but it is reported to be increasing again
among youth in the United States. Injection of heroin is increasing among youth in Eastern Europe,
while there are signs of a rise in abuse of heroin by smoking (United States and Western Europe).
However, cocaine and heroin, with unweighted averages of 1.9% and 1.0%  respectively, are not
the main drugs of choice of youth. Inhalant abuse is common (unweighted average 7.8%) and
remains a serious problem for many young people.
291. The abuse of illicit drugs by youth seems to be part of a broader pattern of consumption
of various psychoactive substances which includes tobacco and alcohol that are most accessible
to everyone, including young people. Patterns of use of these substances are often established
during the adolescence. The 1995 European School Survey Project on Alcohol and Other Drugs
(ESPAD), covering 26 countries of Western and Eastern Europe, found that the majority of the
youth aged 15 to 16 years old had already tried tobacco once in their life: over 75% of the students
in most of these countries had tried tobacco and in no country was the proportion lower than 50%.
The prevalence of tobacco smoking is similar in other industrialized countries. In developing
countries tobacco use may be lower among youth but it is expected to rise rapidly as there is
evidence that the advertising strategies of major tobacco companies target young people in these
countries.
292. Although moderate use of alcohol by adults and older teenagers is socially acceptable in
many countries, use among younger people, and excessive use at any age is considered to be a
problem with serious health and social consequences. The use of alcohol is widespread among
youth. Prevalence rate of alcohol consumption are high in most countries. In 1996, about 80% of
young people aged 16 to 17 years old in the United States had tried alcohol once in their life. In
the United States, the most common substance related to the death of young people is alcohol.
There is evidence that alcohol misuse is a growing problem also in developing countries. Studies
of high school students in Ghana, Kenya and Zambia have shown that 70-80% of students use
alcohol, while 10-14% (mostly boys) could be classified as abusing it. 
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293. Data from various types of studies have been collected and are presented to give an idea
of the drug abuse situation among youth. In some countries, the reported prevalence may appear
high in comparison with other countries. In such cases, it is advisable to check the age range, since
one or two years of difference may influence the prevalence significantly. A low age range (14-17,
for example) is likely to register a lower prevalence rate as compared with a higher age range (20-
24, for example). In addition, household surveys tend to report a lower prevalence than school
surveys. School surveys usually promote anonymity and are thus more likely to produce more
reliable answers.
294. Given the limitations of the information provided through the ARQ, it has been necessary
to supplement the existing information with data from regional or national school surveys (such
as the European School Survey Project on Alcohol and Other Drugs and the Monitoring the Future
Study carried out in the United States), household or population surveys and other published
research available to UNDCP.
295. Throughout this chapter the reference is to lifetime prevalence of the abuse of the various
drugs. This choice is determined by the fact that lifetime prevalence data are available for a large
number of countries and that this indicator, while less significant when applied to the general
population, is more relevant when applied to youth. In fact, to know that a 65-year-old person has
tried cannabis once in his life is not valuable information, but it is for someone in his or her teens.
Data on the abuse of drugs in the previous year (annual prevalence) and in the previous month or
week (frequent use) were more sketchy and therefore have not been considered in the report.
296. The data reported are for the most recent year available. It is important to note that they
refer to different age ranges. In most cases the data presented have been collected through school
surveys and in other cases through surveys of the general population from which data referring to
youth have been extracted. Differences can also be found  between these two kinds of survey
because anonymous self-reporting questionnaires, which are usually used for school surveys, may
draw more information from young people than the questionnaires generally used for general
population surveys or household surveys (it is more difficult for a young person to admit to
abusing drugs in the context of a household interview). The data, though not comparable for the
reasons explained above, are presented together in the figures below  to give an idea of the
magnitude of the problem.
B. Cannabis
297. Figure 144 shows lifetime prevalence for cannabis for the 1990-1997 period in countries
with data available for youth. The proportion of school children and young adults who admit to
having used cannabis is as high as 37% in some countries, while the proportion for past-month use
can be as high as 10-25%. Such high figures indicate that in certain parts of the world cannabis use
is becoming normalized and is not confined to small marginal groups. 
298. The countries reporting the highest lifetime prevalence  rates (25% and above) of cannabis
abuse among young people are Australia, Canada, Denmark, Ireland, Spain, Switzerland, the
United Kingdom and the United States. In Western Europe cannabis abuse remains high, with most
of the countries above 10% and only a few (Austria, Finland, Portugal and Sweden) below that
threshold.
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299. In several countries of Central and Eastern Europe, the lifetime prevalence rates are lower
than for Western Europe, but cannabis abuse has been increasing constantly during the 1990s,
especially among youth.
300. While it is often difficult to obtain reliable prevalence data on youth from Africa, most
studies report that use of cannabis is increasing and that it is the most widely abused drug, apart
from inhalants, among young people in Africa. Lifetime prevalence rates are lower than in
industrialized countries, but there is anecdotal evidence of a gradual increase in recent years.
301. In Latin America and the Caribbean the highest lifetime prevalence is registered in Chile,
with 22.7% (age range 12-25). In Jamaica (age range 13-19) and the Bahamas (with a rather broad
age range 16-29), around 17% of youth indicated having tried cannabis once. Data from Brazil
indicate a 7.6% lifetime prevalence, but it must be pointed out that the school surveys here
included a population from 10 to 19 years of age. The other countries in the region all report a
lifetime prevalence of below 5%.
302. In Asia data on drug abuse among youth are available only for Hong Kong SAR of China
(1992), where the reported lifetime prevalence among students was 0.7%. However, anecdotal
information indicates that there are higher cannabis prevalence rates across the region.
C.  Ecstasy
303. In recent years, the most pronounced increase in drug abuse has been reported for synthetic
drugs, including ATS. In the World Drug Report it is estimated that some 30 million people (0.5%
of the global population) consume ATS worldwide. The most widespread ATS is
methamphetamine, with high levels reported from North America, as well as from a number of
countries in the Far East and the South-East Asian region. In many Asian countries,
methamphetamine is the most, or second most, abused substance after cannabis. 
304. Within the large group of ATS there has been a particular focus on the abuse of Ecstasy.
Though Ecstasy is a substance popular in the industrialized world (especially in Europe), there are
indications that its abuse is spreading to other regions (figure 145). In Western Europe lifetime
prevalence data  reported for Ecstasy range from 9% (Ireland) to 0.2% (Finland). However, in
several countries (Austria, Belgium, Germany, Italy, Netherlands, Spain and the United Kingdom)
lifetime prevalence among youth is above 3%.
305. The abuse of Ecstasy in the United States (3.1%) and Australia (3.6%) is below the levels
of a number of Western European countries. Some local studies and anecdotal evidence indicate
that Ecstasy abuse has also surfaced in Southern Africa (South Africa and Swaziland) and South-
East Asia (Indonesia, Singapore and Thailand). Central and Eastern Europe have registered an
increase in the abuse of Ecstasy during the 1990s as the dance scene associated with Ecstasy abuse
spread across the continent.
306. In Latin America natural plant-based stimulants are available in abundance. Nonetheless,
ATS have a significant share in illicit drug markets. Information on significant levels of Ecstasy
abuse among youth is not available, however.
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Figure 144. Lifetime prevalence rates of cannabis abuse among youth, 1990-1997*
Percentage of youth who have tried cannabis at least once in their life
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Figure 145. Lifetime prevalence rates of "ecstasy" abuse among youth, 1990-1997*
Percentage of youth who have tried "ecstasy" at least once in their life
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D. Cocaine
307. Cocaine abuse among youth varies from a lifetime prevalence of 6.3% in the Bahamas (it
should be noted that the wide age range considered is 16-29) to 0.2% in Finland (figure 146). The
group of countries with the highest lifetime prevalence is similar to that for cannabis with Australia,
the United States and some, but not all, Western European countries accounting for the highest
prevalence rates. Kenya (4.5%) and Chile (3.4%) also report high rates.
E. Heroin
308. Heroin, like cocaine, is not the main drug of abuse among young people. The average age
of heroin abusers is increasing in most countries of the world and injecting drug use, given the risk
of HIV/AIDS infection, is not popular among youth. Nevertheless, there are some signs that point
to the need for continuing the monitoring of heroin demand. 
309. The highest lifetime prevalence rates are registered in Europe (in Denmark, Greece, Ireland
and Italy the reported lifetime prevalence rate among 15 and 16 years old  is 2%) (figure 147).
There are some indications of an increase in heroin smoking in some countries of Western Europe.
Heroin injection has increased during the 1990s in Eastern Europe and this trend has also touched
youth. In particular, lifetime prevalence in Slovakia among 15  and 16 years old was reported to
be 1.9%, thus almost reaching the highest levels found in Western Europe. In the United States,
the rise in the abuse of heroin among youth, which began in the 1990s, was reported to have come
to a halt in 1998. There is an increase in heroin smoking among youth, however, who mistakenly
believe the practice to be less addictive than injecting.
F. Inhalants
310. Although volatile substances that can be abused by inhalation are not subject to
international control, their abuse is widespread among youth and is reported from every region of
the world. The abuse of volatile solvents is closely linked to the abuse of illicit drugs in many
ways. Given  their  easy  availability  and  low  price,  such substances are often the first drug of
choice for many young people who later move on to other drugs.
311. After cannabis, solvents are the most common substance abused by young people in several
countries, with lifetime prevalence rates over 10% in many of those countries (figure 148).
Australia reports the highest lifetime prevalence rate, 25.5%. Brazil, Croatia, Kenya, Lithuania,
Malta, Swaziland, the United Kingdom, the United States and Zimbabwe report rates of between
10% and 20%. No particular regional pattern seems to emerge. Only Asian countries do not
indicate prevalence of volatile substance abuse, but this may be due more to the lack of data for
the age range concerned rather than the absence of volatile solvent abuse in that region.
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Figure 146. Lifetime prevalence rates of cocaine abuse among youth, 1990-1997*
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Figure 147. Lifetime prevalence rates of heroin abuse among youth, 1990-1997*
Percentage of youth who have tried heroin at least once in their life
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Figure 148. Lifetime prevalence rates of inhalant abuse among youth, 1990-1997*
Percentage of youth who have tried inhalant at least once in their life
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X.  Drug abuse among prison populations
312. During the period 1992-1997, several Members States provided information on drug abuse
among prison populations. The way this information is obtained varies greatly from country to
country according to the different methods of recording data on people imprisoned. In some cases
it includes people imprisoned for drug offences. In other cases it refers to drug abusers identified
at entry into prisons or through random testing of body fluids. Analysis of this information gives
some idea of the magnitude of the problem and its trend. This knowledge, though limited and with
several gaps, could be of assistance in the identification of priority areas of intervention at national,
regional and international level.
A. Extent of drug abuse in prison
313. The ARQ (part II, section 3) asks what proportion of the prison population are drug
abusers. During the period under consideration (1992-1997), seventy-two countries provided such
information (figure 149). The extent of drug abuse varies considerably from 90% (Namibia, 1996)
to 1% (Belarus, 1996). However, the unweighted average of 27.9% shows that drug abusers
constitute a significant proportion of the prison population. No particular regional patterns seem
to emerge from the available data.
B. Gender distribution
314. The ARQ also asks what proportion of the drug abusers in the prison population are males
and what proportion females (figure 150 and 151). The gender distribution shows that the large
majority (87%) of the drug abusers are males. However, this information is biased by the fact that
in most countries the majority of the prison population is constituted by men. The data available
do not allow for establishing the proportion of drug abusers among the female prison population
or the male prison population separately. This  information would give a better idea of drug abuse
prevalence in the two different populations.    
Figure 149. Gender distribution of drug abusers in prison population, 1992-1997
(unweighted average)
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Figure 150. Percentage drug abusers among prison populations
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Figure 151. Proportion of females among drug abusers
 in prison populations, 1992-1997
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C. Trends
315. The information available during the period under consideration has several gaps (see annex
II/2). Nevertheless, an attempt has been made to present a global trend on the basis of the data
available for the various years. Gaps in the information have been filled by taking the two extremes
and assuming a regular trend over the years. For example, if one country reported 10% in 1994
and 20% in 1996, an assumption was made that in the year 1995 the value would have been 15%.
Also, when only one value was reported under the period considered, it was assumed that the value
would have remained constant. Though this extrapolation does not reflect the exact picture, it
indicates that the proportion of drug abusers in the prison population has been slowly growing
(from 27.1% to 28.1%) between 1992 and 1997 (See figure 152). 
Figure 152 . Percentage of drug abusers among prison population in the world,
1992-1997 (unweighted average)
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Figure 153. Variations in mode of intake of cannabis 
in the world, 1992-1994 and 1995-1997
0
20
40
60
80
100
Ingestion Inhalation Smoking Sniffing
Note: No. of countries reporting during 1992-1994 = 69
          No. of countries reporting during 1995-1997 = 88
N
o.
 o
f r
ep
or
ts
 re
ce
iv
ed
 fr
om
 
M
em
be
r S
ta
te
s 
on
 e
ac
h 
m
od
e 
of
 
in
ta
ke
1992-1994
1995-1997
Figure 154. Variations in mode of intake of cannabis 
in Africa, 1992-1994 and 1995-1997
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IX. Modes of intake
316. One of the questions in the ARQ refers to modes of intake for various drugs. Not  all
countries that submitted ARQ  responses over the periods 1992-1994 and 1995-1997, however,
provided information on modes of intake. Therefore, the data presented below on trends in modes
of intake of various drugs over the periods 1992-1994 and 1995-1997 may not necessarily be a
complete and accurate reflection of the situation, worldwide or regionally. It may however be
assumed that the available data do provide a broad indication of current and emerging trends in
regard to modes of intake of various drugs.
A. Cannabis
317. Over the period 1992-1997, smoking has remained the preferred mode of intake of
cannabis, worldwide and regionally (Figures 153 - 158). Ingestion of cannabis however appears
to have increased  in popularity during 1995-1997 in Africa (Figure 154), Asia (Figure 156),
Europe (Figure 157) and Oceania (Figure 158).
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Figure 155.  Variations in mode of intake of cannabis 
in the Americas, 1992-1994 and 1995-1997
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Figure 156. Variations in mode of intake of cannabis 
in Asia, 1992-1994 and 1995-1997
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Figure 157. Variations in mode of intake of cannabis
in Europe, 1992-1994 and 1995-1997
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Figure 158. Variations in mode of intake of cannabis 
in Oceania, 1992-1994 and 1995-1997
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Note:  No. of countries reporting during 1992-1994 = 5
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Figure 159. Variations in mode of intake of ATS 
in the world, 1992-1994 and 1995-1997
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Note: No. of countries reporting during 1992 - 1994 = 14
          No. of countries reporting during 1995 - 1997 = 22
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B. Amphetamine-type stimulants
318. During the period 1992-1994, the main modes of intake of ATS worldwide were reported
to be by injection and ingestion. This trend was reversed during the period 1995-1997 with
especially ingestion of ATS showing a marked increase as preferred mode of intake (Figure 159).
This emerging trend possibly reflects the popularity of ATS as recreational drugs.
319. Ingestion of ATS was also the preferred mode of intake in Africa and the Americas during
1995-1997 (Figures 160 and 161). While this trend was also evident in Asia and Europe (Figures
162 and 163), ATS injecting has been reported to be on the increase in Asia.  In Europe the wide
diversity reported in modes of intake other than by ingestion may be reflecting the growing
recreational use of ATS. 
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Figure 160. Variations in mode of intake of ATS 
in Africa, 1992-1994 and 1995-1997
0
1
2
3
4
5
6
Ingestion Inhalation
Note: No. of countries reporting during 1992 - 1994 = 0
         No. of countries reporting during 1995 - 1997 = 5
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Figure 161. Variations in mode of intake of ATS 
in the Americas, 1992-1994 and 1995-1997
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Note: No. of countries reporting during 1992 - 1994 = 3
         No. of countries reporting during 1995 - 1997 = 6
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Figure 162. Variations in mode of intake of ATS 
in Asia, 1992-1994 and 1995-1997
0
1
2
3
4
5
Ingestion Inhalation Injection Sniffing
Note: No. of countries reporting during 1992 - 1994 = 3
         No. of countries reporting during 1995 - 1997 = 5
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Figure 163. Variations in mode of intake of ATS 
in Europe, 1992-1994 and 1995-1997
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Note: No. of countries reporting during 1992 - 1994 =7
            No. of countries reporting during 1995 - 1997 = 13
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Figure 164. Variations in mode of intake of cocaine 
in the world, 1992-1994 and 1995-1997
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Note: No. of countries reporting during 1992 - 1994 = 44
         No. of countries reporting during 1995 - 1997 = 39
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320. Due to a lack of information in regard to modes of intake of ATS in Oceania, it is not
possible to provide any indication of current or emerging trends in this region.
C.  Cocaine
321. Worldwide, the preferred modes of intake of cocaine during the period 1992-1994 were
reported to be by sniffing, injection, smoking and inhalation (Figure 164). For the period 1995-
1997,  cocaine continued to be mainly sniffed although smoking of cocaine was reported to be
gaining in popularity.
322. During both 1992-1994 and 1995-1997, sniffing was also reported to be the preferred
mode of intake in Africa, the Americas, Asia and Europe (Figures 165- 168). However, smoking
of cocaine was reported to be gaining in popularity as a mode of intake  particularly in Africa, the
Americas and Europe during the period 1995-1997, as was also inhalation in the Americas. 
Inhalation and injection of cocaine appeared to be on the decline as preferred modes of intake in
Asia and Europe during the same period. It has not been possible to identify any trends for Oceania
due to insufficient data on modes of intake.
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Figure 165. Variations in mode of intake of cocaine 
in Africa, 1992-1994 and 1995-1997
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Note:  No. of countries reporting during 1992 - 1994 = 6
           No. of countries reporting during 1995 - 1997 = 10
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Figure 166. Variations in mode of intake of cocaine 
in the Americas, 1992-1994 and 1995-1997
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Note: No. of countries reporting during 1992 - 1994 = 9
            No. of countries reporting during 1995 - 1997 = 11
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Figure 167. Variations in mode of intake of cocaine 
in Asia, 1992-1994 and 1995-1997
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Figure 168. Variations in mode of intake of cocaine 
in Europe, 1992-1994 and 1995-1997
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Note: No. of countries reporting during 1992-1994 = 20
         No. of countries reporting during 1995-1997 = 12
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Figure 169. Variations in mode of intake of heroin 
in the world, 1992-1994 and 1995-1997
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Figure 170. Variations in mode of intake of heroin 
in Africa, 1992-1994 and 1995-1997
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           No. of countries reporting during 1995 - 1997 = 12
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D.Heroin
323. The injection of heroin has over the periods 1992-1994 and 1995-1997 remained the
preferred mode of intake worldwide and regionally (Figures 169 - 173) and is even reported to
have increased in popularity in some regions, such as Africa and Asia. In addition, smoking of
heroin in Africa and sniffing of heroin in Asia and Europe  have also surfaced as popular modes
of intake. It has not been possible to identify any trends for Oceania due to insufficient data on
modes of intake. 
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Figure 171. Variations in mode of intake of heroin 
in the Americas, 1992-1994 and 1995-1997
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Figure 172. Variations in mode of intake of heroin 
in Asia, 1992-1994 and 1995-1997
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Figure 173.  Variations in mode of intake of heroin 
in Europe, 1992-1994 and 1995-1997
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Figure 174. Primary drugs of abuse in treatment statistics as a percentage 
of drug treatment cases*, 1995-98
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* unweighted averages based on city/country reports.  
XII. Costs and consequences of drug abuse
A. Demand for treatment 
324. One of the main sources of drug abuse information can be found in treatment statistics. In
contrast to prevalence estimates, which usually contain a large element of uncertainty and
judgment, treatment data are readily available in many countries. Nonetheless, direct comparisons
of treatment data may be misleading as treatment systems tend to differ strongly from country to
country.  Moreover, the availability of treatment facilities may be as much a reflection of
government priorities as a consequence of the extent of the drug abuse problem in a country.  
325. However, if looked at in relative terms (proportion of people treated for a specific
substance) treatment data can provide interesting insights as to what the predominant problem
drugs are. The subsequent graphs, organized by regions, show the importance of different drugs
in various regions. Data are primarily based on research undertaken by the various regional
epidemiological networks which form a part of the International Epidemiology Work Group. In
some investigations alcohol was included but not in others; the data represented in the following
graphs were recalculated, excluding all treatment cases for alcohol abuse.
326. Data for cities in Europe, Asia and on countries in the Americas are shown in the next few
pages. Figure 174 provides an overview based on the unweighted averages of the proportions of
individual drugs in treatment statistics as reported by cities/countries. Though the situation differs
significantly from country to country, one can nonetheless identify clear regional patterns. While
cocaine-type substances dominate in the Americas, opiates are the main problem drugs in Europe
and in Asia.  In the Americas and in Europe cannabis is the second largest substance creating
treatment demand. In Asia, cannabis is the third largest problem drug after amphetamine-type
stimulants, notably methamphetamine, though this is still restricted to the Far-East Asian region.
327. The graph on European cities clearly shows that in most parts of Europe the main problem
drugs - despite comparatively low prevalence rates - are the opiates (of which an overwhelming
proportion is due to heroin abuse). On average more than 70% of treatment demand in Europe is
linked to opiates (unweighted average of results from 29 city studies); 9% is linked to cannabis,
7% to ATS (mostly amphetamine) and 3% to cocaine. (See figure 175)
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328.  If  the average is calculated on the basis of the total number of people treated in European
cities (“weighted average”), the share of opiates rises to more than 80%. Even higher proportions
for opiates have been reported from Madrid, Rome, as well as a number of Eastern European cities
such as Sofia, Bratislava, and St. Petersburg. Relatively low proportions for abuse of opiates are
found in Cyprus, where cannabis abuse constitutes the main drug problem.  In the Czech Republic,
the only European country which has a sizeable methamphetamine problem (more than 50% of all
treatment demand is located in Prague), the abuse of opiate is relatively low.  In other Eastern
European cities such as Budapest and Bucharest, benzodiazepines and barbiturates, rather than
opiates still cause significant problems.  In the Nordic countries (Finland, Sweden) amphetamine
abuse is widespread with 20% of treatment needs in Sweden and almost 40% of treatment needs
in Finland being related to amphetamine abuse in 1996. 
329. Relatively lower demand for treatment of opiates has also been recorded in Amsterdam
(less than 50%). This is due to high levels of treatment demand for cocaine abuse (more than
30%), the highest of any European city, and relatively high levels for cannabis (more than 15%).
Netherlands as a whole, however, shows results that are close to the European average.  66% of
treatment demand in 1997 was related to the abuse of opiates, 16% to the abuse of cocaine and
11% related to the abuse of cannabis. Nonetheless, the Netherlands is currently the country in
Europe with the highest need for treatment for cocaine abuse. The need for treatment  for
amphetamine-type stimulants are in line with the European average (5%).  This is in contrast to
neighboring Flanders (Belgium), where 24% of all patients in 1996 had to be treated for the abuse
of amphetamine-type stimulants. 
330. Similar to the situation in Europe, demand for treatment in the Asian region is still
dominated by opiates. The unweighted average for 15 Asian cities shows that almost two thirds
of treatment demand is related to the abuse of opiates, with heroin being responsible for more than
80% of all problems related to opiates. The relatively low share of opium in this context (on
average 4%) may be explained by the fact that the use of opium is traditionally widespread in the
countryside, while drug consumers in the cities increasingly turn to the more “modern” heroin.  
331. If the analysis is restricted to cities in South and South-East Asia, the share of opiates in
total treatment demand rises to 80%. Heroin alone would then be responsible for about 70% of
total treatment demand. Cannabis would be responsible for close to 15%. 
332. Thus, data reveals the fundamental differences between the Far-East Asian region and the
rest of Asia. In the Far-East Asian region, almost two thirds of treatment demand is already related
to the abuse of methamphetamine, while the abuse of opiates plays only a secondary role. 
333. For all 15 Asian cities together, the average share of methamphetamine in treatment
amounts to 17%, almost twice as high as cannabis (9%). These percentages may seem rather
arbitrary as far as methamphetamine is concerned. Abuse of methamphetamine is concentrated in
the Far-East Asian region and almost nonexistent in South Asia. But in recent years, it has started
spreading across South-East Asia. In Thailand it has already started to show up in treatment
statistics. In 1996, about 4% of all treatment cases were related to methamphetamine abuse, but
by 1997 the proportion had risen to 14% in Thailand.
334. In addition, there are a number of substances which pose problems to individual countries
(such as opium in Viet Nam, volatile substances in Lao People’s Democratic Republic, cough
syrups in the Philippines or buprenorphine in India). By contrast, it may be worth noting that
cocaine does not show up at all in treatment statistics in Asia. (See figure 176).
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Figure 175. Primary drug of abuse in treatment centres in European cities, 1996
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Figure 176. Primary drug of abuse in treatment centers in Asian cities 
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335. In contrast to Europe and Asia, the main problem drug in the Americas is cocaine.
Cocaine-type substances (cocaine, crack-cocaine and basuco) are predominant in all countries in
the Americas. On average, cocaine-type substances are responsible for close to 60% of all
treatment cases (unweighted average) in the Americas (19 countries). The next most widely quoted
substance in treatment facilities is cannabis (13%), followed by inhalants (5%). Heroin accounts
for less than 2%, and amphetamine-type stimulants for less than 1%. 
336. The relative importance of cocaine is less dominant in the larger countries (United States,
Mexico, Brazil - about 30%) which apparently have a “more diversified” drug problem as well as
distinct regional patterns within each country. Thus, 58% of all new treatment admissions in
Atlanta,  47% of all new treatment admissions in Miami and close to 40% of all new treatment
admissions in St. Louis, Detroit, Washington D.C., Texas, Illinois, New York City,  and
Philadelphia were related to cocaine abuse in 1997.  In other areas such as Los Angeles where
heroin abuse has become rampant in recent years (60% of all treatment admissions in 1997) or San
Diego where methamphetamine abuse is strong (43% of all treatment admissions), the share of
cocaine was relatively small (14%). The United States and Mexico are the only two countries in
the Americas reporting sizeable problems of heroin abuse (26% and 7%, respectively, of all
treatment cases). The United States is also the country with the largest problem of abuse of
amphetamine-type stimulants in the region (6% of all treatment cases of which a large proportion -
about two thirds - is related to methamphetamine abuse). Other countries with a problem of
amphetamine-type stimulants (though not methamphetamine) are Argentina (4%) and Colombia
(3%).(See figure 177) 
337. In general, cocaine-type substances, as compared to other drugs, play a stronger role in the
Andean countries (on average 64%) and in the smaller countries of Central America and the
Caribbean that are located along the main trafficking routes (on average 64%). In the coca-leaf-
producing countries, however, basuco (coca paste) rather than cocaine is the main problem.  In
Peru, for instance, 70% of all treatment demand (excluding alcohol) stems from basuco abuse.
Important proportions of treatment needs due to abuse of basuco have been also reported from
Bolivia, Chile, Ecuador, Colombia, Trinidad and Tobago, and in smaller proportions from Panama,
Costa Rica, Mexico and Argentina.  By contrast, in several of the smaller countries along the
trafficking routes to North America and Europe, crack-cocaine has been reported as the main
problem drug. Excluding alcohol, the ratio of crack-cocaine comes to 80% in Costa Rica, 68% in
the Dominican Republic, 67% in Barbados and 50% in Jamaica. Other important substances of
abuse, creating substantial treatment demand in some countries are inhalants (29% in Nicaragua,
24% in Bolivia, 11% in Guatemala) and tranquilizers (14% in Guatemala). 
338. Cannabis plays an important role all across the Americas. Particularly high ratios for
cannabis treatment demand have been reported from a number of Caribbean and Central American
countries (Jamaica 50%; Barbados 28%, Nicaragua 20%), but also from Chile (20%) and the
United States (19%). 
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Figure 177. Primary drug of abuse ("drug of impact") in 
treatment centers in the Americas
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j Injecting drug use practice is not limited to intravenous injecting but also includes intramuscular or
subcutaneous injecting. The generic term “injecting drug use” is therefore considered to reflect the actual
practice and behaviour more accurately.
Mother-to-child
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6%Injecting Drug 
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Homosexual
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Heterosexual
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B. HIV/AIDS and injecting drug usej
339. The first case of HIV infection among injecting drug users was diagnosed in New York late
in 1981. Since then, the cumulative number of HIV infection among injecting drug users could
have  risen to a figure as high as 3.3 million. This is an estimate based on the assumption that the
proportion of HIV infections due to injecting drug use (IDU) would be about the same as the
proportion of AIDS cases (11%) related to IDU. (See figure 178) 
 
Figure 178.  Modes of transmission of AIDS
(period of reporting, 1980-1997)
340. Since the start of the HIV/AIDS epidemic, 194,997 cases of AIDS related to IDU have
been reported. Map 10 shows the distribution of countries and areas that have reported IDU and
also indicates those countries or territories that have reported HIV infection among injecting drug
users. As shown by the map, IDU was reported by all regions and almost all countries in the world.
341. Based on information available to UNDCP in 1996 and 1998, respectively, the number of
countries reporting injecting drug use increased by 9% over the two years, while the number of
countries reporting HIV infection among injecting drug users increased by 36.6%. Research has
indicated that once HIV has been introduced into a local community of injecting drug users, there
is a possibility of extremely rapid spread of the virus. It is thus crucial not only to prevent the
spread of the virus among drug abusers but also to reduce the number of injecting drug users.
However, as indicated in Chapter IV, injection remains the preferred mode of intake of heroin
worldwide and is even reported to have increased in popularity in some regions, such as Africa and
Asia. Amphetamine-type stimulants (ATS) and cocaine are also  reported to be injected in several
countries across the world, with an increase in ATS injection reported in Asia.  
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342. In terms of spread of HIV among drug abusers, Western Europe and North America (with
the exception of Mexico), where the epidemic started,  are still the most affected regions with an
average proportion of 23% of AIDS cases related to IDU. In East and South-East Asia the share
of IDU in AIDS cases is 20%, in Eastern Europe 19%, in South America 11% and in the Near and
Middle East 6% (See figure 179). 
Figure 179. Proportion of AIDS cases due to IDU by Region, 1980-1997
343. While sustained prevention efforts to a large extent have been able to contain the
HIV/AIDS epidemic among injecting drug abusers in Western Europe and North America -
although in some cases at a high level -  the epidemic is now beginning to take a heavy toll on
injecting drug users in Latin America. In China the epidemic continues to spread among injecting
drug abusers in the south-west of the country. In Myanmar, two-thirds of the injecting drug
abusers are infected.
344. Among countries reporting AIDS related to injecting drug use, 18% of the number of cases
reported since the start of the epidemic are attributed to injecting drug use (unweighted average).
In Ukraine 64 % of the 25,000 cases of HIV infection reported so far are drug abusers. Likewise
China, Georgia, Italy, Malaysia, Poland, the Republic of Moldova,  Spain, Viet Nam, and
Yugoslavia report  injecting drug use as a major mode of transmission of HIV infection. In all these
countries, over 50% of the diagnosed cases of AIDS are related to drug injection. Argentina, Brazil
and Uruguay as well as the United States are also reporting a relatively high proportion, ranging
from 25 to 42%, of AIDS cases related to injecting drug abuse. (See figure 180)
- 175 -Figure 180. Percentage of  total number of AIDS cases reported from the start of the 
epidemic due to injecting drug use (IDU) (period of reporting 1980-1997)
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France
Tunisia
Uruguay
Austria
United States of America
Reunion
Switzerland
Argentina
Portugal
Ireland
Poland
Georgia
Yugoslavia
China
Ukraine
Republic of Moldova
Malaysia
Spain
Italy
Viet Nam
Unweighted average
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The following countries and territories reported injecting drug use, with those
reporting human immunodeficiency virus among injecting users drug in bold.
AFRICA
Angola
Algeria
Chad
Côte d'Ivoire
Egypt
Ethiopia
Gabon
Kenya
Mauritius
Mauritania
Morocco
Nigeria
Réunion
Senegal
South Africa
Sudan
Togo
Tunisia
Uganda
United Republic 
      of Tanzania
Zambia
AMERICAS
Argentina
Belize
Bahamas
Bermuda
Bolivia
Brazil
Canada
Chile
Colombia
Costa Rica
Dominican
    Republic
Ecuador
El Salvador
Guyana
Guatemala
Haiti
Honduras
Jamaica
Mexico
Nicaragua
Panama
Paraguay
Puerto Rico
Suriname
Uruguay
United States of
      America
Venezuela
ASIA
Bahrain
Bangladesh
China
Hong Kong SAR
    of China
Taiwan Province
    of China
India
Indonesia
Iran (Islamic     
      Republic of)
Iraq
Israel
Japan
Jordan
Kazakhstan
Kuwait
Kyrgyzstan
Lao People's      
  Democratic      
   Republic
Macao
Malaysia
Myanmar
Nepal
Oman
Pakistan
Philippines
Qatar
Republic of
    Korea
Saudi Arabia
Singapore
Sri Lanka
Syrian Arab 
     Republic
Tajikistan
Thailand
Turkmenistan
Viet Nam
United Arab  
     Emirates
Uzbekistan
EUROPE    
  
Albania
Austria
Azerbaijan
Belarus 
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Georgia
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Monaco
Netherlands
Norway
Poland
Portugal
Republic of
     Moldova
Romania
Russian 
    Federation
San Marino
Slovakia
Slovenia
Spain
Sweden
Switzerland
The former
    Yugoslav
    Republic of
    Macedonia
Turkey
Ukraine
United     
Kingdom
Uzbekistan
Yugoslavia
OCEANIA
Australia
Fiji
Guam
Micronesia
   (Fed. States   
     of)
New Caledonia
New Zealand
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A.  PRICES AND LEVELS OF PURITY
1. Retail and wholesale prices and purity levels:
breakdown by drug, region and country or territory
(prices expressed per gramme or dose in US$ or converted equivalent
and purity levels in percentage)
Heroin
RETAIL PRICE (per gramme)
Region / country or territory Range Average Purity Year Range Average Purity Year
Africa
East Africa
Kenya 30 - 35 32.5 75-90 1991 25,000 25,000 1994
Mauritius 113 - 169.5 141.2 1995
Uganda 17 - 25 21 80 1992 12,000 12,000 1992
United Republic of Tanzania 15 15 1997 10,000 10,000 1997
Average 52.4 24,000
North Africa
Egypt 59.3 59.3 1997 29,670-44,500 37,090 1997
Average 59.3 37,090
Southern Africa
South Africa 67 - 68 78 1997 44,700-55,900 50,300 1997
West and Central Africa
Burkina Faso 34.4 - 41.3 37.8 1993
Chad 10.4 10.4 1994 12,130 12,132 1994
Côte d'Ivoire 90 90 60 1991 28,850 28,850 1996
Ghana 20 20 18 1997 36,000 36,000 90 1997
Average 39.6 25,660
Americas
Central America
Guatemala 24.4 24.4 10 1996
Honduras 16,230 16,230 95 1996
North America
Canada 50.8 - 166 108.4 60-80 1997 65,220-11,5940 83,300 60-80 1997
Mexico 50.3 - 377.4 213.8 1994 126,000-180,000 153,000 1992
United States 70.5 - 450.0 214.1 1997 112,500 - 150,000 129,380 1997
Average 182.4 121,900
South America
Colombia 5.7 5.7 1997 7,560 7,560 1997
Venezuela 25,000-30,000 27,500 95 1994
Average 25,000-30,000 17,530
Caribbean
Bahamas 120,000 120,000 85 1994
ANNEX  I. Supply Statistics
WHOLESALE PRICE (per kilogramme)
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Heroin
RETAIL PRICE (per gramme)
Region / country or territory Range Average Purity Year Range Average Purity Year
WHOLESALE PRICE (per kilogramme)
Asia
Central Asia and Transcaucasia
Kyrgyzstan 8,000 - 20,000 14,000 1997
Uzbekistan 40,000 40,000 1996
Average 27,000
East and South-East Asia
Brunei Darussalam 30,000 - 60,000 45,000 1994
China (Hong Kong SAR) 48.6 - 59.9 54.3 44 1997 466,480 466,480 1998
Democratic People's Republic of Korea 600,000 600,000 1998
Indonesia 109.4 - 131.3 120.4 1996 109,400 - 131,300 120,350 1998
Japan 1,000 1,000 1996 100,000 100,000 1998
Lao People's Democratic Republic 4,000 - 5,000 4,500 100 1994
Macao 22.0 22.0 1996 22,405 22,405 1998
Malaysia 2,100 - 18,800 9,575 1998
Myanmar 114.3 114.3 1996 171 - 429 300 1998
Philippines 119.4 - 139.3 129.3 1994 100,000 100,000 90-95 1990
Republic of Korea 928.5 928.5 90 1997 432,000 432,000 1997
Singapore 70 - 100 85 1996
Thailand 0.35 - 5 3.1 1996 356 - 6700 3,108 1998
Viet Nam 13,000 - 16,000 14,500 1998
Average 253.3 183,900
Near and Middle East/ South-West Asia
Afghanistan 2.8 2.8 1996 2 ,730 2,730 1996
Bahrain 37.6 37.6 1995
Iran (Islamic Rep. of) 12.5 - 17.0 14.8 1994 5,480 5,480 1997
Israel 60 - 90 75 1996 34,300 - 45,000 39,650 1996
Jordan 28.9 - 72.4 50.7 1995 31,000 31,000 1997
Kuwait 333.3 - 500 416.7 1994 150,000 150,000 1994
Lebanon 20 20 40 1997 15,000 15,000 1997
Oman 117 117 1989
Pakistan 1.3 - 4 1.81 60-100 1996 1,330 - 4,000 2,665 1998
Qatar 137.0 - 164.0 150.6 1996 54,945 - 82420 68,680 1996
Saudi Arabia 226.7 226.7 80 1995 213,330 - 266,660 240,000 100 1995
Syrian Arab Republic 48.2 48.2 1997 34,640 34,640 1997
Average 96.8 53,370
South Asia
Bangladesh 8.2 8.2 1996 8,200 8,200 1998
India 4.5 4.5 1996 27,900-50,200 39,050 1998
Nepal 14.3 - 26.9 20.6 1996 7,170-17,900 12,550 1996
Sri Lanka 31.4 31.4 1997 10,500 10,500 1998
Average 16.1 17,575
Europe
Eastern Europe
Bulgaria 11.8 - 14.1 13 10 1997 10,000 10,000 40-60 1997
Croatia 58.8 58.8 6.-8. 1997 23,550 23,550 1997
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Heroin
RETAIL PRICE (per gramme)
Region / country or territory Range Average Purity Year Range Average Purity Year
WHOLESALE PRICE (per kilogramme)
Czech Rep. 14.7 - 29.5 22.1 1997 12,100 - 24,200 18,150 70 1997
Hungary 19.6 - 41.7 26.1 1.-60. 1996 98,000 98,000 60-65 1996
Romania 25 - 30 27.5 1993 10,000 - 20,000 15,000 1995
Slovakia 36.7 36.7 13-60 1994
The former Yug. Rep. of Macedonia 61.2 - 107.1 84.1 1995 33,660 - 38,250 359,550 1995
Average 38.3 87,400
Western Europe
Austria 75.6 - 117.7 117.7 1997 42,000 - 67,200 54,600 50-60 1997
Belgium 79.5 79.5 1995 17,241 - 20,115 18,678 70 1997
Cyprus 140 140 1995 40,000 40,000 90 1995
Denmark 50.9 - 290.9 140.8 1998 9,274 - 10,819 10,046 1997
Finland 156.6 - 489.2 308.2 1997 353,780 353,780 1995
France 43.6 - 209.0 126.3 1996 12,195 - 52,265 32,230 1997
Germany 8.8 - 129.4 51.5 1997 11,764 - 58,823 28,385 1997
Gibraltar 117,000 117,000 1997
Greece 65.7 - 73 73 10.- 20. 1997 14,600 - 36,500 25,547 15-40 1997
Iceland 372 372 1997
Ireland 228 228 15-20 1997 45,593 45,593 60-70 1997
Italy 90.9 - 99.4 95.1 1997 34,660 - 37,500 36,080 1997
Liechtenstein 35.5 - 63.8 49.7 1997 28,370 28,370 1997
Luxembourg 114.9 - 143.7 129.31 1997 57,470 - 86,200 71,840 39 1997
Malta 138.5 138.5 5.-10 1997 83,100 83,100 1997
Monaco 204.5 - 409 306.8 1995 87,100 87,100 65 1997
Netherlands 29.8 - 71.4 50.39 1996 21,200 - 26,500 23,850 42 1993
Norway 113 - 282.5 197.8 20-80 1997 53,670 - 84,750 69,209 20-80 1997
Portugal 44.6 - 174.0 109.4 1997 27,590 - 44,830 36,207 1995
Spain 87.6 - 89.2 88.4 27 1997 53,824 - 102,818 78,314 47-62 1997
Sweden 117 - 326 182.3 17 1997 39,000 - 104,000 68,250 1997
Switzerland 20.9 - 138.9 79.9 1997 17,361 - 56,738 36,846 1997
Turkey 30 - 40 35 7,194-10,791 8,992 1995
United Kingdom 111.5 - 199.7 114.1 1998 33,277 - 49,916 41,597 1998
Average 135.8 60,680
Oceania
Australia 107.9 - 143.8 125.8 1996
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Cocaine
RETAIL PRICE (per gramme)     WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Purity Year Range Average Purity Year
Africa
East Africa
Kenya 60 60 1994
Uganda 150 150 1996 150,000 150,000 1996
Average 105
North Africa
Egypt 118.7 - 148 133.4 1997 118,700 - 148,360 133,530 1997
Southern Africa
South Africa 44.7 - 55.9 50.3 1997 26,800 - 33,500 30,150 1997
West and Central Africa
Burkina Faso 20.7 - 24 22.3 1993
Chad 40 40 1992
Côte d'Ivoire 96,150 96,150 1996
Ghana 24 24 50 1997
Nigeria 11.9 11.9 1997
Average 24.6
Americas
Central America
Belize 16.7 16.7 38 1994 8,000 8,000 1994
Costa Rica 43.9 - 58.9 51.1 1996 3,480 - 3,980 3,730 1996
Guatemala 12.9 12.9 10 1996 8,120 8,120 1996
Honduras 15 - 50 35.3  30 - 45 1995 4,690 4,690 1997
Panama 3 3 100 1995 2,500 - 2,800 2,650 100 1995
Average 28.2 9,530
North America
Canada 43.5 - 145 94.3 75 1997 25,360 - 38,400 31,880 1997
Mexico 15.7 - 47.2 31.4 1994 10,000 - 15,000 12,500 1993
United States 22.1 - 120.6 68.6 1997 16,000 - 39,300 22,740 30 - 90 1997
Average 64.8 22,370
South America
Argentina 10 - 15 12.5 1997 5,000 1997
Bolivia 1 1 60 1997 500 1997
Brazil 4.9 4.9 1997 2,500 1996
Chile 2.4 2.4 1997 4,000 1995
Colombia 1 1 95 1997 59,460 1997
Ecuador 5.9 5.9 50 1995 4,800 89 1994
Guyana 6 - 10 8 1996 4,500 - 6,200 5,360 1996
Peru 0.7 0.7 1997 500 1997
Suriname 4,500 97-100 1996
Uruguay 10 - 12 11 70 1996 5,000 - 7,000 6,000 100 1996
Venezuela 10 10 15 - 20 1996 3,160 96 1996
Average 6.0 8,710
Caribbean
Antigua and Barbuda 14,000 1994
Bahamas 35 - 45 40 100 1994 5,000 - 10,000 7,500 100 1994
Barbados 10,000 1994
Bermuda 150 150 1997 70,550 - 141,100 105,825 70-99 1997
Cayman Islands 150 - 200 175 90 1996 12,000 - 15,000 13,500 90 1996
Cuba 100 100 1996 5,000 - 10,000 7,500 70-90 1996
Dominican Republic 150 150 55 1995 7,142 90-98 1997
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Cocaine
RETAIL PRICE (per gramme)     WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Purity Year Range Average Purity Year
Grenada 7,000 1990
Saint Lucia 10 10 1997 8,000 1997
Saint Vincent and the Grenadines 2,774 75 1990
Trinidad and Tobago 70 - 350 210 1994 25,000 - 30,000 27,500 1994
Turks and Caicos Islands 100 100 1997 11,000 70 1997
Average 95.3 17,915
Asia
East and South-East Asia
China (Hong Kong SAR) 90.6 - 161.7 126.2 1997 141,000 141,000 1998
Indonesia 208.5 1997 35,000 35,000 1998
Japan 778 778 1996 778,000 778,000 1998
Philippines 135 135.01 1996
Republic of Korea 928.5 928.5 1997 559,000 559,000 1997
Average 435.0 378,250
Near and Middle East/ South-West Asia
Israel 119.3 - 159.2 139.3 1996 42,000 - 51,000 46,500 1996
Lebanon 40 - 50 45 30 1997 100,000 100,000 70 1997
Syrian Arab Republic 80 - 120 100 1992 45,000 45,000 1991
Average 94.8 63,830
Europe
Eastern Europe
Bulgaria 53 - 64.7 58.9 1997 82,350 82,350 1997
Croatia 117.6 - 147 132.3 40 1997 35,300 - 47,100 41,180 97 1997
Czech Republic 47.3 - 94.6 71.7 80 1997 24,170 - 36,250 30,210 1997
Hungary 44 - 65.9 55 52.-91 1997
Lithuania 60,000 60,000 1997
Romania 35 - 40 37.5 1993 20,000-30,000 25,000 1995
Average 71.1 47,750
Western Europe
Austria 67.2 - 168.1 168.1 1997 29,410 - 84,000 56,705 1997
Belgium 97.1 97.1 1995 31,800 31,800 60-90 1997
Cyprus 129 - 193 161.2 1996 50,000 50,000
Denmark 87.3 - 145.5 110.9 1998 30,580 - 38640 34,610 80 1997
France 69.7 - 104.5 157.1 1997 34,840 - 52,260 43,550 1997
Germany 11.8 - 147.1 73.6 1997 17,650 - 88,230 44,230 30-90 1997
Gibraltar 117,000 117,000 90 1997
Greece 73.0 - 101.5 101.5 20 - 30 1997 36,500 - 51,100 43,800 70-80 1997
Iceland 238.1 238.1 1997
Italy 45.5 - 110.8 108.9 1998 44,890 - 52,270 48,580 1998
Liechtenstein 70.9 - 106.3 88.6 30-40 1997 35,460 - 49,650 42,550 70-80 1997
Luxembourg 86.2 - 143.7 114.9 30 1997 28,740 - 57,470 43,100 83-87 1997
Malta 157.9 1993 120,000 120,000 90 1995
Monaco 163.6 - 306.8 235.17 1995 174,200 174,200 1997
Netherlands 35.7 - 74.4 55.0 1996 26,500 26,500 76 1993
Norway 141.2 - 218.8 176.5 70 1997 49,430 - 70,620 60,030 70-90 1997
Portugal 115.5 1997 27,590 - 41,380 34,480 90 1995
Spain 67.6 - 68.4 68.1 44-47 1997 36,800 36,800 72 1997
Sweden 78 - 117 97.5 30-40 1997 39,000 - 52,000 45,500 70-90 1997
Switzerland 55.6 - 250 115.8 1997 24,300 - 80,000 40,500 1997
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Cocaine
RETAIL PRICE (per gramme)     WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Purity Year Range Average Purity Year
Turkey 56,000 56,000 1992
United Kingdom 28 - 291.2 140.1 1998 36,600 - 58,240 47,420 1998
Average 126.8 58,825
Oceania
Australia 129.4 - 172.6 151 1996
New Zealand 170 - 250 210 1996
Average 180.5
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Herbal cannabis
RETAIL PRICE (per gramme) WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Year Range Average Year
Africa
East Africa
Kenya 0.1 0.09 1996 54.2 - 85.6 59.9 1996
Mauritius 12,690 12,690 1996
North Africa
Egypt 5.1 5.07 1996 2,990 - 3,580 3,285 1996
Morocco 426 426 1997
Southern Africa
Namibia 0.3 0.29 1996 45 45 1997
South Africa 0.2 - 0.3 0.25 1997
West and Central Africa
Côte d'Ivoire 1.7 1.7 1997 190 190 1996
Ghana 0.01 1995
Nigeria 17.8 17.8 1997
Americas
Central America
Costa Rica 0.12 - 0.15 0.13 1995 200 - 220 210 1996
Guatemala 135.2 135.2 1996
Honduras 0.5 - 2 1.25 1995 39 39 1997
Panama 176 176 1995
North America
Canada 14.6 14.6 1996 3,196 - 4,793 3,994 1997
United States 1.7 - 18.5 7.3 1997 770 - 19,840 4,230 1997
Average 11.0 4,112
South America
Brazil 0.9 0.9 1997
Chile 1 1 1996
Colombia 14 - 15 14.5 1995
Guyana 0.16 0.16 1996 50 - 80 65 1996
Uruguay 1.5 - 2 1.75 1996 200 - 300 250 1996
Caribbean
Bermuda 4,410 - 11,000 7,705 1996
Cayman Islands 8 8 1996 2,000 2,000 1996
Turks and Caicos Islands 1,000 - 1,500 1,250 1997
Grenada 0.74 0.74 1995
Asia
Central Asia and Transcaucasia
Armenia 1,000 1,000 1996
Kyrgyzstan 1,000 - 1,500 1,250 1997
Tajikstan 20 - 100 60 1996
Uzbekistan 100 - 300 200 1996
East and South-East Asia
Brunei Darussalam 11.3 - 18.8 15.03 1995 7,530 - 9,370 8,450 1995
China  (Hong Kong SAR) 5.2 - 7.8 6.5 1997 6,090 6,090 1998
Indonesia 1 1 1997 875 875 1998
Japan 8.6 - 102 55.3 1997 56,000 56,000 1998
Malaysia 0.5 - 0.6 0.54 1997 308  - 717 513 1998
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Herbal cannabis
RETAIL PRICE (per gramme) WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Year Range Average Year
Myanmar 1 1 1996 1143 1143 1998
Philippines 45 - 91 68 1998
Republic of Korea 5 5 1997 3,200 3,200 1997
Singapore 4.6 4.6 1997 10,500 10,500 1998
Thailand 0.06 - 0.07 0.06 1996 59 - 70 64.5 1998
Near and Middle East/ South-West Asia
Israel 15 15 1996 450 - 600 525 1996
Lebanon 3 3 1996
South Asia
Bangladesh 0.04 0.04 1998 40 - 52 47 1998
India 0.1 0.05 1996 42 - 50 46 1998
Nepal 36 36 1996
Europe
Eastern Europe
Croatia 5,036 5,036 1995
Czech Republic 0.6 - 0.9 0.75 1996
Lithuania 7 7 1995 5,000 5,000 1995
Republic of Moldova 1,957 1,957 1997
Slovenia 1,176 - 2,941 2,058 1997
The former Yug.Rep.of Macedonia 3.4 - 5.1 4.3 1995 1,224 - 1,377 1,300 1995
Ukraine 1,000- 2,000 1,500 1997
Average 4.0 2,808
Western Europe
Austria 6.4 - 9.2 7.8 1996 3,670 - 5,500 4,585 1996
Belgium 2.9 - 5.8 4.35 1997 1,437 - 1,724 1,580 1997
Denmark 6.1 - 10.7 8.79 1997
France 1.7 - 8.7 5.2 1997 697 - 1,742 1,220 1997
Germany 4.0 - 10 6.78 1997 2,110 - 3,882 2,928 1997
Greece 2.2 - 3.6 2.9 1997
Italy 5.7 5.7 1998 2550 2,550 1998
Luxembourg 2.6 2.6 1997 1,724 - 2,299 2,011 1997
Norway 7 - 14.1 10.55 1997 4,944 - 6,356 5,650 1997
Spain 3 2.95 1997 1536 1,536 1997
Switzerland 2.8-7.1 4.95 1997 625 - 3,546 2,070 1997
United Kingdom 3.5 - 8.2 5.51 1998 4,159 - 5,990 5,074 1998
Average 5.7 2,921
Oceania
Australia 3 - 8.7 5.81 1996
New Zealand 5,600 5,600 1998
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Cannabis resin
RETAIL PRICE (per gramme) WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Year Range Average Year
Africa
North Africa
Egypt 7.1 7.1             1997 3,561 - 4,748 4,154.0             1997
Morocco 0.83 - 1.06 0.9             1995 295 - 413 354.0                1995
Tunisia 7.2 7.2             1995 2,400 2,400.0             1995
Average 5.1            2,303.0            
Southern Africa
South Africa 18.4 - 23 20.7           1996 9,220 - 13,820 11,520.0          1996
Average
Americas
North America
Canada 18.1 18.1           1997 5,070 - 7,246 6,158.0             1997
United States 3.5 - 42.3 22.9           1996 2,205 - 7,720 4,963.0             1996
Average 20.5          5,560.0            
Asia
Central Asia and Transcaucasia
Uzbekistan 500 - 800 650.0                1996
East and South-East Asia
Brunei Darussalam
China (Hong Kong SAR) 7.8 - 10.3 9.1             1997 7,692.3 7,692.3             1998
Japan 89 89.0           1996 89,000 89,000.0          1998
Philippines 0.5 0.5             1998
Republic of Korea 40,000 40,000.0          1996
Average 32.8          48,346.2          
Near and Middle East/ South-West Asia
Israel 3.75 - 7.5 5.7             1996 2,700 - 4,800 1,996.0             1996
Jordan 2.8 - 4.2 3.5             1996 706 706.0                1997
Lebanon 5 5.0             1997 3,000 3,000.0             1997
Pakistan 0.02 - 0.07 0.04           1996 20 - 67 44.0                  1998
Qatar 6.9 - 8.2 7.6             1996 5,995 - 6,870 6,433.0             1996
Syrian Arab Republic 1.2 1.2             1997 692 692.0                1997
Average 3.8            2,145.2            
South Asia
Bangladesh 0.03 0.03           1996 27.3 27.3                  1998
India 223  -  419 321.0                1998
Nepal 90 - 108 99.0                  1996
Sri Lanka 0.4 0.4             1997 280 280.0                1998
Average 0.2            181.8               
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Cannabis resin
RETAIL PRICE (per gramme) WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Year Range Average Year
Europe
Eastern Europe
Czech Republic 3.2-6.3 4.8             1997
Lithuania 15 15.0           1995 9,000 9,000.0             1995
Average 3.2-6.3 9.9            9,000.0            
Western Europe
Belgium 2.9 - 4 3.5             1997 2,012 - 2,300 2,160.0             1997
Cyprus 19.9 19.9           1997 3,976 3,976.0             1997
Denmark 3.6 - 8.7 6.3             1998 1,818 - 3,636 2,890.0             1998
Finland 9.8 - 17.6 13.7           1997 6,850 - 8,800 7,828.0             1997
France 5.2 5.2             1997 1,394 - 2,962 2,178.0             1997
Germany 4.1 - 20 6.8             1997 1.765 - 4,706 2,760.0             1997
Greece 5.5 5.5             1997 1,825 - 3,102 2,464.0             1997
Iceland 22.32 22.3           1998
Ireland 15.2 15.2           1997 3,039 3,039.0             1997
Italy 6.41 6.4             1996 1,920 - 3,210 2,565.0             1996
Liechtenstein 8.77 8.8             1995 3,947 3,947.0             1995
Luxembourg 4.8 4.8             1997 2,299 - 2,784 2,587.0             1997
Malta 2,000 2,000.0             1995
Monaco 20.44 20.4           1995 5807 5,807.0             1997
Norway 15.3 - 30.5 22.9           1996 7,630 - 9,160 8,395.0             1996
Portugal 2.6 2.6             1997 1,034 - 2,207 1,621.0             1995
Spain 3.7 - 4.1 4.0             1997 1684 1,684.0             1997
Sweden 10.4 10.4           1997 6510 6,510.0             1997
Switzerland 4.8 - 10.4 7.3             1997 2,128 - 4,965 3,547.0             1997
United Kingdom 15.6 15.6           1996 2,496. - 3993 3,245.0             1998
Average 10.5          3,709.8            
Oceania
Australia 5.8 - 9.7 7.7             1996 3,800 - 7,600 5,700.0             1998
New Zealand 2,260 2,260.0             1998
Average 3,980.0            
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Cannabis oil
RETAIL PRICE (per gramme) WHOLESALE PRICE (per kilogramme)
Region / country or territory Range Average Year Range Average Year
Americas
North America
Canada 18.1 18.1 1997 2,900 2,900 1997
United States 35 - 55 45 1996 3,510 - 8,820 6,165 1996
Average 31.6 4,530
Asia
East and South-East Asia
Philippines 1.77 1996 151 151 1998
Europe
Western Europe
Iceland 89.3 89.3 1998
Spain 9.7 9.7 1997 3,380 3,380 1997
Switzerland 20.8 - 31.9 26.3 1997
United Kingdom 25. - 33.3 27 1998
Average 38.1
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LSD
RETAIL PRICE (per dose) WHOLESALE PRICE (per thousand doses)
Region / country or territory Range Average Year Range Average Year
Africa
Southern Africa
South Africa 6.81 - 17.7 11.8 1995 5,593 - 8,949 7,271 1997
Americas
North America
Canada 3,600 - 7,250 5,425 1997
United States 1 - 10 5.5 1996 400 - 5,000 2,700 1996
Average 5.5        4,060
Asia
East and South-East Asia
Indonesia 26 - 35 30.5 1998 44,400 44,400 1998
Japan 44 44 1996
Average 26-35 37.3
Near and Middle East/ South-West Asia
Israel 15 - 21 18 1996
Europe
Eastern Europe
Czech Republic 4.7-9.5 7.1 1997
Hungary 6 6 1997
Western Europe
Austria 1.7 1.7 1997
Denmark 7.3 7.27 1998
France 9.6 - 19.2 14.4 1996
Germany 2.9 - 23.5 9.93 1997 882 - 4,706 2,574 1997
Greece 20.6 20.6 1996 12,350 12,350 1996
Iceland 17.9 17.9 1998
Italy 11.4 - 17.0 14.2 1998 2,840 - 4,545 3,690 1998
Luxembourg 14.4 1997
Netherlands 8.9 - 14.9 11.9 1996
Portugal 0.9 0.93 1997
Spain 6.9 - 8.28 7.6 1997
Switzerland 5.6 - 35.5 20.6 1997
United Kingdom 3.3 - 8.3 6.3 1998 1,248 - 1663 1,455 1998
Average 12.2 5,017
Oceania
Australia 19 19 1998
New Zealand 23 23 1998
Average 21
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Ecstasy
RETAIL PRICE (per dose) WHOLESALE PRICE (per thousand doses)
Region / country or territory Range Average Year Range Average Year
Africa
Southern Africa
South Africa 17.9 - 26.8 22.4           1997 5,592 - 8,948 7,270.0             1997
Asia
East and South-East Asia
Indonesia 43 - 109 76.0           1998 10,730.0                   10,730.0          1996
Malaysia 45 - 60 52.5           1998
Singapore 26.0          26.0           1998
Average 51.5          10,730.0                  10,730.0          
Near and Middle East/ South-West Asia
Israel 14.9 - 30 22.5           1996
Europe
Eastern Europe
Czech Republic 9.5 - 15.8 12.7           1997
Hungary 5.5 - 8.2 6.9             1997
Average 9.8            
Western Europe
Austria 12.6 - 33.6 23.1           1997 4,240.0                     4,240.0             1995
Belgium 17.7          17.7           1995
Denmark 10.18 - 29.09 21.0           1998
France 8.7 - 26 17.4           1997 1,840 - 10,220 6,030.0             1995
Germany 6.5 - 47.0 19.2           1997 1,470 - 8,823 3,914.0             1997
Greece 18.2 - 29.2 23.7           1997
Iceland 44.6          44.6           1998
Ireland 15.2          15.2           1997 3,000.0             1997
Italy 31.3 - 39.8 35.5           1998 8,523 - 10,227 9,375.0             1998
Luxembourg 14.4          14.4           1997
Netherlands 8.9 - 14.9 11.9           1996
Portugal 10.5          10.5           1997
Spain 15.9 - 16.9 16.4           1997
Switzerland 6.9 - 41.7 24.3           1997
United Kingdom 9.15 - 33.3 18.0           1998
Average 20.9          6,187.5            
Oceania
Australia 51.3          51.3           1998
New Zealand 23 - 40 31.5           1998
Average 41.4          
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Amphetamine
RETAIL PRICE (per gramme*) WHOLESALE PRICE (per kilogramme*)
Region / country or territory Range Average Year Range Average Year
Asia
East and South-East Asia
Philippines 8.3                 8.3             1996 6,371.0      1998
Viet Nam 2.5-3 2.8             1996 2,500 - 3,000 2,750.0      1998
Average 2.5-3 5.5            4,560.0      
Europe
Western Europe
Denmark 10.2 - 87.3 34.1           1998 6,926 - 17,793 11,870.0    1996
Finland 41.3 - 82.6 62.0           1995
France* 8.7 - 17.4 13.1           1997
Germany 3.5 - 41.2 19.6           1997 1,764 - 29,411 9,026.0      1997
Greece* 8.9                 8.9             1995 6,640.0                       6,640.0      1995
Iceland 59.5               59.5           1998
Italy* 22.7 - 28.4 25.6           1998 4,545-5,681 5,113.0      1998
Luxembourg 14.4               14.4           1997
Netherlands 4.8 - 14.9 9.8             1996
Spain* 2.4 - 3.6 3.1             1997
Sweden 20.8-48.6 34.7           1995 8,330 - 11,100 9,722.0      1995
United Kingdom 8.32-29.95 16.5           1998 1,660 - 4990 3,327.0      1998
Average (per gramme) 25.1          (per kilogramme) 6,525.0      
Oceania
Australia 17.97-25.16 21.6           1996
* per gramme except where otherwise indicated by (*), which are given in dose
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2. Retail price and wholesale prices and purity levels
 in the United States, 1997 
(in US$ per gramme or ounce)
Retail price
City Origin Purity
Price 
reported 
in
 Minimum  Maximum  Average 
Atlanta South Asia 60% oz 126.99       176.37       151.68     
Atlanta South Asia 60% gr. 180.00       200.00       190.00     
Atlanta Mexican brown 15% oz 211.65       282.20       246.93     
Atlanta South-East Asia 50% oz 211.65       317.47       264.56     
Chicago South-East Asia gr 175.00       175.00     
Denver Mexican black tar 32% oz 52.91        88.19         70.55       
Denver Mexican black tar 32% gr 120.00       140.00       130.00     
Hawaii (Hilo, Kona) Mexican black tar 67% oz 105.82       352.75       229.29     
Hawaii (Hilo, Kona) Mexican black tar 67% gr 200.00       500.00       350.00     
Minneapolis/St. Paul Mexican (black tar, brown), white powder oz 105.82       141.10       123.46     
Minneapolis/St. Paul Mexican (black tar, brown), white powder gr 350.00       500.00       425.00     
New Orleans South-East Asia, South Asia 14 to 27% oz 141.10       317.47       229.29     
New Orleans South-East Asia, South Asia 15 to 27% gr 300.00       600.00       450.00     
Phoenix Mexican (black tar, brown) oz 44.09        105.82       74.96       
Phoenix Mexican (black tar, brown) gr 100.00       120.00       110.00     
San Diego Mexican black tar oz 35.27        105.82       70.55       
San Diego Mexican black tar gr 50.00        200.00       125.00     
St. Louis Mexican gr 250.00       600.00       425.00     
Texas 30 - 90% oz 67.02        158.74       112.88     
Texas 30 - 90% gr 250.00       400.00       325.00     
Washington, DC Mexican, South-East Asia, South Asia 123.46       246.92       185.19     
Washington, DC Mexican, South-East Asia, South Asia 90.00        400.00       245.00     
Minimum 70.55       
Maximum 450.00     
Avererage 214.06     
Source: US Department of Health and Human Services
Wholesale price
Origin Minimum Maximum Average
Mexico kg 50.0          175.0         112.5       
South Asia kg 60.0          180.0         120.0       
South-East Asia kg 50.0          250.0         150.0       
South-West Asia kg 70.0          200.0         135.0       
Minimum 112.50     
Maximum 150.00     
Avererage 129.38     
Source: DEA
Heroin
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Cocaine
Retail price Wholesale price
CITY Price reported in minimum Maximum Average Minimum Maximum Average
Atlanta gram 90.0         100.0       95.0        22.0       28.0          25.0         
oz 31.8         42.3         37.0        
average 84.5        
Boston gram 80.0         100.0       90.0        22.0       30.0          26.0         
oz 28.2         38.8         33.5        
average 78.5        
Chicago gram 50.0         150.0       100.0      13.3       20.0          16.6         
oz 70.6         70.6        
average 120.6      
Denver gram 80.0         100.0       90.0        
oz 28.2         49.4         38.8        
average 83.8        
Honolulu gram 100.0       120.0       110.0      26.5       52.0          39.3         
oz 38.8         52.9         45.9        
average 100.9      
Miami gram 40.0         60.0         50.0        16.0       20.0          18.0         
oz 24.7         42.3         33.5        
average 58.5        
Minneapolies/ St. Paul gram 100.0       100.0      18.0       24.0          21.0         
oz 35.3         42.3         38.8        
average 88.8        
New Orleans gram 80.0         150.0       115.0      18.0       25.0          21.5         
oz 28.2         42.3         35.3        
average 92.8        
New York City gram 25.0         30.0         27.5        
Phoenix gram 80.0         100.0       90.0        14.0       21.0          17.5         
oz 17.6         26.5         22.1        
average 67.1        
San Diego gram 60.0         90.0         75.0        
oz 21.2         35.3         28.2        
average 65.7        
St. Louis gram 38.0         100.0       69.0        
Texas gram 20.0         100.0       60.0        10.0       22.0          16.0         
oz 14.1         42.3         28.2        
average 58.2        
Washington, DC gram 80.0         150.0       115.0      20.0       30.0          25.0         
oz 26.5         52.9         39.7        
average 97.2        
Minimum 22.1        16.0         
Maximum 120.6      39.3         
Average 68.6        22.6         
Source: US Department of Health and Human Services
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Herbal cannabis*
Quality City Minimum Maximum average
Commercial grade Boston 2.65           10.58         6.62           
Chicago 2.12           2.47           2.30           
San Francisco 1.41           3.53           2.47           
Washington 5.29           8.82           7.06           
Domestic (higher THC) Dallas 1.76           2.82           2.29           
Domestic sinsemilla Miami 8.82           21.16         14.99         
Seatle 7.05           12.35         9.70           
High quality Chicago 3.88           7.05           5.47           
Honolulu 12.35         24.69         18.52         
Home-grown/commercial Atlanta 3.53           4.41           3.97           
Imported commercial Miami 2.29           6.35           4.32           
Locally grown (elevated THC) Minneapolis/St. P 7.05           10.58         8.82           
Low quality Honolulu 8.82           17.64         13.23         
Mexican Dallas 1.76           2.82           2.29           
Poor quality Baltimore 3.35           3.35           1.68           
Premium grade Phoenix 2.65           3.53           3.09           
Sinsemilla Atlanta 7.05           8.82           7.94           
Boston 7.05           10.58         8.82           
San Diego 7.05           14.11         10.58         
San Francisco 7.05           21.16         14.11         
Washington 5.29           17.64         11.47         
Marihuana Denver 3.53           21.16         12.35         
New Orleans 4.41           5.64           5.03           
New York City 2.47           2.82           2.65           
San Diego 1.76           2.65           2.21           
Mininum 1.68           
Maximum 18.52         
Average 7.28           
Source: US Department of Health and Human Services
*  Prices originally reported in ounce have been converted into gramme
1. Statistics on drug seizure volumes
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B. SEIZURES
breakdown by drug, region and country or territory, 1995-1997
Cannabis (liquid)
 1995Region /country or territory  1996  1997
Narcotic drugs
AFRICA
North Africa
7.050 kgMorocco 4.300 kg 1.060 kg Govt
Sub-total North Africa 7.050 kg 4.300 kg 1.060 kg
Southern Africa
No reportZimbabwe 2.000 kg No report
Sub-total Southern Africa 2.000 kg
Total Africa 7.050 kg 6.300 kg 1.060 kg
ASIA
Central Asia  and Transcaucasia
No reportAzerbaijan 3.380 kg 1.790 kg ICPO
No reportGeorgia 0.000 kg No report
-Kyrgyzstan - 603.550 kg
Sub-total Central Asia  and
Transcaucasia 3.380 kg 605.350 kg
Near and Middle East /South-West Asia
-Jordan - 0.150 kg
-Lebanon 6.000 kg 58.000 kg
Sub-total Near and Middle East
/South-West Asia 6.000 kg 58.150 kg
South Asia
0.020 kgMaldives No report No report
2.000 kgNepal - 1,342.490 kg ICPO
Sub-total South Asia 2.020 kg 1,342.490 kg
East and South-East Asia
0.550 kgIndonesia 0.550 kg 4.020 kg
0.900 kgJapan 0.080 lt. 0.140 lt.
-Republic of Korea - 0.030 kg
No reportThailand 32.770 kg 45.170 kg ICPO
Sub-total East and South-East Asia 1.450 kg 33.310 kg
0.080 lt.
49.210 kg
0.140 lt.
Total Asia 3.460 kg 42.690 kg
0.080 lt.
2,055.200 kg
0.140 lt.
 1995Region /country or territory  1996  1997
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AMERICAS
North America
589.280 kgCanada 802.120 kg 824.000 kg
21.830 lt. 114.670 lt. -
779.530 kgUnited States 248.290 kg -
Sub-total North America 1,368.800 kg
21.830 lt.
1,050.400 kg
114.670 lt.
824.000 kg
Caribbean
No reportBahamas No report 0.020 kg ICPO
0.170 kgBarbados No report No report
No report - 46.040 kgCayman Islands
No report - 2 u .
No reportCuba 38.720 kg No report
No reportJamaica 263.420 kg 383.820 kg ICPO
No reportTrinidad Tobago No report 1,430.000 kg CICAD
Sub-total Caribbean 0.170 kg 302.140 kg 1,859.880 kg
2 u .
South America
30.210 lt.Colombia 199.250 lt. 8.000 lt.
-Paraguay - 17,218.110 kg
-Uruguay - 26.000 kg CICAD
-Venezuela - 8,003.000 kg CICAD
Sub-total South America
30.210 lt. 199.250 lt.
25,247.110 kg
8.000 lt.
Total Americas 1,368.970 kg
52.040 lt.
1,352.550 kg
313.920 lt.
27,930.980 kg
8.000 lt.
2 u .
EUROPE
Eastern Europe
0.300 kgBelarus - No report
36.180 kgRomania - No report
45.200 kgRussian Federation 42.200 kg -
0.020 kgUkraine - -
Sub-total Eastern Europe 81.700 kg 42.200 kg
Western Europe
0.170 kgAustria 0.230 kg 3.160 kg
0.200 kgDenmark 2.420 kg 0.120 kg
10.800 kgFrance 5.240 kg 5.440 kg
2.830 kgGermany 1.790 kg 3.510 kg
0.090 kgGreece - -
1.330 kgItaly 0.220 kg 6.260 kg
9 u . - 6 u .
-Monaco - 0.030 lt.
0.000 kgNorway 0.050 kg 0.310 kg
-Spain 962 u . 0.710 lt.
 1995Region /country or territory  1996  1997
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-Sweden 0.090 kg 0.020 kg
1.910 kgSwitzerland 1.710 kg 8.610 kg
292.000 kgTurkey - -
5.600 kgUnited Kingdom 17.780 kg 24.810 kg
- 28 u . -
Sub-total Western Europe 314.940 kg
9 u .
29.520 kg
990 u .
52.240 kg
0.730 lt.
6 u .
Total Europe 396.630 kg
9 u .
71.720 kg
990 u .
52.240 kg
0.730 lt.
6 u .
OCEANIA
0.890 kgAustralia 1.100 kg 4.950 kg
0.000 lt. 40 u . -
3.400 kgNew Zealand  Govt No report No report
Total Oceania 4.290 kg
0.000 lt.
1.100 kg
40 u .
4.950 kg
TOTAL  CANNABIS (LIQUID) 1,780.410 kg
52.040 lt.
9 u .
1,474.350 kg
314.000 lt.
1,030 u .
30,044.420 kg
8.880 lt.
8 u .
Cannabis herb
 1995Region /country or territory  1996  1997
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AFRICA
North Africa
1,475.250 kgAlgeria 0.040 kg No report
-Egypt 6,608.690 kg 10,185.540 kg
35,807.870 kgMorocco 38,521.140 kg 27,955.980 kg
No reportSudan 1,202.810 kg No report
3.870 kgTunisia 0.070 kg 18.160 kg ICPO
Sub-total North Africa 37,286.990 kg 46,332.740 kg 38,159.680 kg
West and Central Africa
42.700 kgBenin 312.830 kg 26.860 kg Govt  Govt
No reportBurkina Faso 140.000 kg 2,402.730 kg Govt  Govt
9.680 kgCameroon 581.870 kg No report
100.000 kgCentral African Republic  Govt No report No report
No reportChad 435.200 kg No report Govt
535.680 kgCôte d'Ivoire 1,482.550 kg 853.870 kg
1.500 kgEquatorial Guinea No report 3.500 kg INCB
90.840 kgGabon 160.190 kg 24.260 kg ICPO
286.590 kgGambia 11.160 kg 566.970 kg ICPO
209,506.860 kgGhana 902.650 kg 126.470 kg *
94.260 kgMali 80.000 kg 404.270 kg Govt  ICPO
No reportMauritania 6.750 kg No report Govt
690.930 kgNiger 777.380 kg 499.890 kg ICPO
15,258.000 kgNigeria  Govt 18,604.000 kg 15,904.720 kg
No report No report 3.010 kgSaint Helena
No reportSao Tome and Principe No report 0.200 kg
79,774.880 kgSenegal 212.160 kg No report
No report 118 u . No report
397.560 kgSierra Leone  Govt - No report
No reportTogo 156.850 kg 1,066.190 kg Govt
Sub-total West and Central Africa 306,789.480 kg 23,863.590 kg
118 u .
21,882.940 kg
East Africa
105.510 kgDjibouti No report No report
312.240 kgEthiopia 2.120 kg 135.350 kg
2,547.670 kgKenya 8,238.000 kg 11,250.000 kg
2,452.000 kgMadagascar 3,320.000 kg 510.460 kg INCB
4.090 kgMauritius 8.790 kg 18,435.000 kg ICPO
0.810 kgSeychelles 0.160 kg No report
No reportUganda 258.810 kg No report
4,011.650 kgUnited Republic of Tanzania No report 82,539.540 kg
Sub-total East Africa 9,433.970 kg 11,827.880 kg 112,870.340 kg
Southern Africa
2,223.230 kgAngola 63.850 kg 518.010 kg Govt  ICPO
1,349.000 kgBotswana 1,588.200 kg 1,446.150 kg ICPO
No reportDemocratic Republic of the Congo 1.070 kg No report Govt
No reportLesotho 15,390.090 kg 10,472.070 kg Govt  ICPO
39,911.250 kgMalawi 8,453.500 kg 10,320.110 kg
. (*)  Includes other cannabis
 1995Region /country or territory  1996  1997
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No reportMozambique No report 184.020 kg ICPO
-Namibia - 298.830 kg INCB
238,813.210 kgSouth Africa 203,353.950 kg 171,929.320 kg
No reportSwaziland 440.490 kg 11,302.510 kg ICPO
4,291.500 kgZambia 7,794.400 kg 11,176.310 kg ICPO
3,934.590 kgZimbabwe 2,428.650 kg 4,667.320 kg ICPO
Sub-total Southern Africa 290,522.780 kg 239,514.190 kg 222,314.650 kg
Total Africa 644,033.220 kg 321,538.400 kg
118 u .
395,227.610 kg
ASIA
Central Asia  and Transcaucasia
33.410 kgArmenia 90.250 kg -
203.210 kgAzerbaijan  Govt 10.950 kg 37.480 kg ICPO
No reportGeorgia 642.090 kg No report
-Kazakhstan 6,800.000 kg 11,800.000 kg Govt  Govt
-Kyrgyzstan 560.070 kg 110.190 kg
No reportTajikistan 88.000 kg No report *
862.630 kgUzbekistan 512.910 kg 374.500 kg
Sub-total Central Asia  and
Transcaucasia 1,099.250 kg 8,704.260 kg 12,322.160 kg
Near and Middle East /South-West Asia
0.680 kgBahrain 6.530 kg 7.380 kg
3,207.090 kgIsrael 1,075.180 kg 10,635.000 kg
-Jordan 1.040 kg 0.110 kg
0.400 kgKuwait 124.620 kg 28.580 kg ICPO
-Oman No report 1,979.000 kg INCB
0.040 kgQatar 0.030 kg No report
1,809.700 kgSaudi Arabia 3,531.230 kg 1,321.290 kg ICPO
1,662.880 kgSyrian Arab Republic - 1,714.640 kg
2,545.060 kgUnited Arab Emirates 1,377.590 kg 3,505.590 kg
No reportYemen No report 0.570 kg ICPO
Sub-total Near and Middle East
/South-West Asia 9,225.870 kg 6,116.220 kg 19,192.140 kg
South Asia
No reportBangladesh 121.940 kg No report
121,873.000 kgIndia 62,992.000 kg 80,866.000 kg Govt
5,521.150 kgNepal 2,271.920 kg 2,040.890 kg ICPO
7,997.900 kgSri Lanka 20,332.380 kg 63,338.730 kg
Sub-total South Asia 135,392.050 kg 85,718.250 kg 146,245.630 kg
East and South-East Asia
0.500 kgBrunei Darussalam 1.130 kg 0.140 kg
1,085.000 kgCambodia  Govt No report 53,751.000 kg ICPO
466.000 kgChina 4,876.000 kg 2,300.000 kg ICPO
1,052.400 kg  Govt 8,822.700 kg 1,002.100 kgChina (Hong Kong SAR)
443.860 kgIndonesia 443.860 kg 715.740 kg
208.050 kgJapan 172.660 kg 155.250 kg
. (*)  Includes other cannabis
 1995Region /country or territory  1996  1997
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5,197.000 kgLao People's Dem. Rep.  Govt 1,896.300 kg 7,026.000 kg Govt  Govt
0.920 kg 21.690 kg 5.520 kg ICPOMacao
15.990 kgMalaysia 1,425.730 kg 3,889.130 kg Govt
245.770 kgMyanmar 263.790 kg 288.030 kg
2,212.710 kgPhilippines 2,044.570 kg 2,226.890 kg ICPO
164.520 kgRepublic of Korea 44.430 kg 59.550 kg
54.220 kgSingapore  * 70.870 kg 4,363.450 kg
45,205.020 kgThailand 40,997.630 kg 28,862.620 kg ICPO
578.700 kgViet Nam 581.100 kg 7,986.000 kg ICPO
Sub-total East and South-East Asia 56,930.650 kg 61,662.450 kg 112,631.420 kg
Total Asia 202,647.810 kg 162,201.170 kg 290,391.350 kg
AMERICAS
North America
149,265.430 kgCanada 176,673.000 kg 50,624.000 kg
780,169.600 kgMexico 1,015,755.540 kg 1,038,470.040 kg
627,945.700 kgUnited States 638,661.300 kg 684,745.400 kg
Sub-total North America 1,557,380.730 kg 1,831,089.840 kg 1,773,839.440 kg
Central America
No reportBelize 184.000 kg 263.000 kg CICAD
63.120 kgCosta Rica 387.050 kg No report
263 u . - No report
133.000 kgEl Salvador 650.000 kg 971.250 kg ICPO
No reportGuatemala 16,388.290 kg 256.220 kg Govt
489.650 kgHonduras 472.000 kg 2.150 kg
459.480 kgNicaragua 853.960 kg 285.200 kg
316.910 kgPanama 18,125.550 kg 14,102.060 kg
Sub-total Central America 1,462.160 kg
263 u .
37,060.860 kg 15,879.870 kg
Caribbean
90.000 kg - 0.640 kgAnguilla
219.570 kgAntigua and Barbuda 1,210.000 kg No report
215.790 kg No report 12,850.000 kg INCBAruba
No reportBahamas No report 3,759.010 kg ICPO
73.480 kgBarbados 3,118.000 kg 1,132.030 kg INCB
No report 118 u . No report
79.480 kg 107.050 kg 91.800 kgBermuda
235.530 kg - No reportBritish Virgin Islands
No report 3,188.020 kg 3,422.070 kgCayman Islands
No report - 427 u .
4,482.140 kgCuba 3,931.680 kg 7,625.280 kg ICPO
No reportDominica 136.250 kg 407.550 kg ICPO
1,055.700 kgDominican Republic 245.900 kg 800.660 kg
1,167 u .Grenada - 123.200 kg INCB
54,697.830 kgJamaica 41,262.700 kg 24,728.730 kg ICPO
2.000 kg No report 3.290 kgMontserrat
No report No report 14,090 u .
. (*)  Includes other cannabis
 1995Region /country or territory  1996  1997
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No report No report 1,553.310 kg INCBNetherlands Antilles
3.190 kgSaint Kitts and Nevis 5.000 kg 61.700 kg INCB
102.330 kgSaint Lucia 326.050 kg 621.680 kg
No reportSaint Vincent and the Grenadines 1,227.000 kg 495.240 kg INCB
No reportTrinidad Tobago 11,408.530 kg No report
9.700 kg 25.000 kg 22.000 kgTurks and Caicos Islands
Sub-total Caribbean 61,266.740 kg
1,167 u .
66,191.170 kg
118 u .
57,698.200 kg
14,517 u .
South America
5,149.620 kgArgentina 8,893.190 kg 13,709.620 kg Govt
12.940 kgBolivia 175.000 kg -
11,730.800 kgBrazil 22,430.590 kg 31,828.430 kg
3,788.310 kgChile 912.630 kg 784.430 kg
206,260.000 kgColombia 238,943.000 kg 136,250.000 kg
13,946.000 kgEcuador 175.240 kg 224.210 kg
1,007.120 kgGuyana 196.230 kg 186.160 kg ICPO
97,566.280 kgParaguay 43,325.410 kg 1.780 kg
6,442.810 kgPeru - 20,910.330 kg
41.730 kgSuriname 42.920 kg -
97.010 kgUruguay 258.540 kg No report
13,684.610 kgVenezuela 2,983.940 kg No report
Sub-total South America 359,727.220 kg 318,336.680 kg 203,894.950 kg
Total Americas 1,979,836.850 kg
1,430 u .
2,252,678.560 kg
118 u .
2,051,312.460 kg
14,517 u .
EUROPE
Eastern Europe
112.000 kgBelarus 56.000 kg 90.800 kg INCB
93.900 kgBulgaria 5,475.650 kg 227.440 kg
35.010 kgCroatia 40.650 kg 135.870 kg
-Czech Republic - 5.400 kg
No reportEstonia 1.240 kg 3.440 kg
88.180 kgHungary 3.080 kg 2,140.000 kg Govt
11.000 kgLatvia 793.000 kg 22.000 kg
24,200 u . - -
1.440 kgLithuania 0.830 kg 8.060 kg
2,086.570 kgPoland 2,631.160 kg 62.480 kg
229.690 kgRepublic of Moldova 906.510 kg 435.500 kg
4.590 kgRomania 1,737.210 kg 40.190 kg ICPO
20,141.900 kgRussian Federation 18,967.800 kg 602.960 kg
10.400 kgSlovakia 24.000 kg 865.620 kg
29.910 kgSlovenia 34.600 kg 47.560 kg
10.110 kgThe former Yug.Rep of Macedonia 130.620 kg No report
3,141.000 kgUkraine 1,279.200 kg -
Sub-total Eastern Europe 25,995.700 kg
24,200 u .
32,081.540 kg 4,687.300 kg
Western Europe
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1.120 kgAndorra 2.000 kg 1.890 kg ICPO
458.780 kgAustria 270.660 kg 668.070 kg
38,103.510 kgBelgium 56,791.000 kg 39,072.000 kg
13.100 kgCyprus 5.920 kg 17.580 kg
-Finland 3.150 kg 12.150 kg
3,055.960 kgFrance 31,279.680 kg 3,452.210 kg
10,436.230 kgGermany 6,108.580 kg 4,167.280 kg
No report 0.030 kg - *Gibraltar
931.590 kgGreece 2,565.960 kg 12,409.780 kg
- 542 u . 482 u .
10.930 kgIceland 49.000 kg No report
77.500 kgIreland 2.400 kg 34.820 kg
473.250 kgItaly 5,722.200 kg 45,011.040 kg
999 u . - 2,675 u .
0.020 kgLiechtenstein 25.920 kg 1.530 kg
0.960 kgLuxembourg 16.460 kg 34.390 kg
0.220 kgMalta 7,217.050 kg 0.160 kg
0.010 kgMonaco 0.010 kg 0.030 kg
275,035.000 kgNetherlands 82,232.000 kg -
19,444.570 kgNorway 70.000 kg 44.100 kg
159.890 kgPortugal 35.970 kg 72.240 kg
16.720 kgSpain 13,267.760 kg 24,890.310 kg
26.110 kgSweden 148.420 kg 30.710 kg
221.820 kgSwitzerland 3,559.770 kg 6,634.840 kg
-Turkey - 5,186.740 kg
13,871.500 kgUnited Kingdom 34,382.520 kg 26,647.000 kg
- 45 u . -
Sub-total Western Europe 362,338.780 kg
999 u .
243,756.440 kg
587 u .
168,388.860 kg
3,157 u .
Total Europe 388,334.490 kg
25,199 u .
275,837.980 kg
587 u .
173,076.160 kg
3,157 u .
OCEANIA
1,393.270 kgAustralia 1,747.720 kg 4,398.990 kg *
117 u . 1,922 u . -
16.990 kgFiji 6.990 kg No report
No report 138.000 kg 133.610 kg INCBNew Caledonia
700.000 kgNew Zealand  Govt 455.000 kg No report
No reportTonga 150.000 kg 0.300 kg Govt  INCB
Total Oceania 2,110.260 kg
117 u .
2,497.710 kg
1,922 u .
4,817.910 kg
TOTAL  CANNABIS HERB 3,216,962.620 kg
26,746 u .
3,014,753.820 kg
2,745 u .
2,914,825.490 kg
17,674 u .
. (*)  Includes other cannabis
Cannabis plant
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AFRICA
North Africa
51,153,274 u .Egypt 231,482,728 u . 63,542,819 u .
51,153,274 u .Sub-total North Africa 231,482,728 u . 63,542,819 u .
West and Central Africa
36.740 kgCongo - 3,435.000 kg
-Côte d'Ivoire 502 u . -
37 u .Gabon No report No report
137.960 kgNigeria No report -
No report No report 18 u .Saint Helena
Sub-total West and Central Africa 174.700 kg
37 u . 502 u .
3,435.000 kg
18 u .
East Africa
40.760 kgEthiopia No report -
-Kenya - 5.570 kg
- - 2,226 u .
36,417 u .Mauritius 22,066 u . No report
No reportUganda 4,000 u . No report
Sub-total East Africa 40.760 kg
36,417 u . 26,066 u .
5.570 kg
2,226 u .
Southern Africa
200.000 kgAngola No report No report
2,000 u . No report No report
2,001 u .Lesotho 2,625 u . No report Govt
31,364.080 kgMalawi 22,959 u . 1,116.730 kg
731,580 u . - 8,313 u .
1,188,018.000 kgSouth Africa 69,450.970 kg 243,565.690 kg
4,195.610 kgSwaziland No report No report
26.470 kgZimbabwe No report No report
Sub-total Southern Africa 1,223,804.170 kg
735,581 u .
69,450.970 kg
25,584 u .
244,682.410 kg
8,313 u .
Total Africa 1,224,019.630 kg
51,925,309 u .
69,450.970 kg
231,534,880 u .
248,122.980 kg
63,553,376 u .
ASIA
Central Asia  and Transcaucasia
15,000.000 kgArmenia - -
255,000.000 kgAzerbaijan  Govt No report 507,380.000 kg ICPO
8,329.000 kgKazakhstan No report No report
525.720 kgKyrgyzstan - -
30 u .Uzbekistan - 18.930 kg
Sub-total Central Asia  and
Transcaucasia 278,854.720 kg
30 u .
507,398.930 kg
Near and Middle East /South-West Asia
1 u .Bahrain 0.160 kg -
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0.170 kgIraq 5.310 kg 34.810 kg
6 u .Kuwait No report No report
0.510 kgOman No report No report
35.960 kgQatar 220.900 kg No report
Sub-total Near and Middle East
/South-West Asia 36.640 kg
7 u .
226.370 kg 34.810 kg
South Asia
No reportBangladesh 25,307 u . No report
694,617.000 kgIndia No report -
51,451.000 kgSri Lanka 65,010.000 kg 49,900.000 kg
Sub-total South Asia 746,068.000 kg 65,010.000 kg
25,307 u .
49,900.000 kg
East and South-East Asia
-Brunei Darussalam - 1 u .
80,823 u .Indonesia 80,823 u . 200,000.000 kg
- - 132,748 u .
18.190 kgJapan 7.250 kg 36.920 kg
828 u . 3,301 u . 2,232 u .
86,424.000 kgLao People's Dem. Rep.  Govt 104,595.000 kg No report Govt
29,655,644 u .Philippines 12,161,117 u . No report
12,976 u .Republic of Korea 47,465 u . 31,501 u .
Sub-total East and South-East Asia 86,442.190 kg
29,750,271 u .
104,602.250 kg
12,292,706 u .
200,036.920 kg
166,482 u .
Total Asia 1,111,401.540 kg
29,750,308 u .
169,838.620 kg
12,318,013 u .
757,370.660 kg
166,482 u .
AMERICAS
North America
274,150 u .Canada - 776,288 u .
24,562.630 kgUnited States 676,866.400 kg - Govt
Sub-total North America 24,562.630 kg
274,150 u .
676,866.400 kg
776,288 u .
Central America
No reportBelize 87,546.000 kg 294,712.000 kg CICAD
389,222 u .Costa Rica 110,002 u . No report
No reportGuatemala 1,052,845 u . 587,096 u .  Govt
2,729,915 u .Honduras 2,309.000 kg 337,322 u .
No reportNicaragua 53,528.000 kg 24,239.000 kg
Sub-total Central America
3,119,137 u .
143,383.000 kg
1,162,847 u .
318,951.000 kg
924,418 u .
Caribbean
No report - 48 u .Anguilla
No report 53 u . 871 u .Bermuda
No reportCuba 3,517 u . No report
No reportDominica 176,713 u . No report
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29 u .Dominican Republic 110 u . 116 u .
1,804.150 kgGrenada - No report
No reportJamaica No report 6,858.300 kg ICPO
259,456 u .Saint Lucia 163,893 u . 26,037 u .
Sub-total Caribbean 1,804.150 kg
259,485 u . 344,286 u .
6,858.300 kg
27,072 u .
South America
-Argentina 2,152 u . 458 u . Govt
No reportBolivia No report 3,450.000 kg
2,532,461 u .Brazil 1,523.200 kg 2,884,811 u .
72,787 u .Chile 94,481 u . 34,263 u .
280,000 u .Colombia 37.000 kg -
-Ecuador 336 u . 1 u .
9,988.000 kgGuyana 52,181.000 kg 18,993.000 kg ICPO
2,106,125.000 kgParaguay 749,412.500 kg 167.550 kg
-Peru 150,481.230 kg 140,700.000 kg
35.000 kgSuriname 35.000 kg 65.840 kg
17 u .Uruguay 6 u . No report
94 u .Venezuela - No report
Sub-total South America 2,116,148.000 kg
2,885,359 u .
953,669.930 kg
96,975 u .
163,376.390 kg
2,919,533 u .
Total Americas 2,142,514.780 kg
6,538,131 u .
1,773,919.330 kg
1,604,108 u .
489,185.690 kg
4,647,311 u .
EUROPE
Eastern Europe
16.000 kgBelarus - No report
2,828 u .Bulgaria 50,000.000 kg 127,000.000 kg
6,902 u .Croatia 4,602 u . 31,710 u .
-Czech Republic 11,866.130 kg -
No reportEstonia No report 72 u .
500.000 kgHungary 140 u . No report
650 u . - No report
8,000.000 kgPoland 200.000 kg 12,105.080 kg
9 u .Romania - No report
No reportSlovenia 5,019 u . 44,944 u .
107 u .The former Yug.Rep of Macedonia No report No report
1,547 u .Ukraine 2,159.000 kg 6,091.000 kg
Sub-total Eastern Europe 8,516.000 kg
12,043 u .
64,225.130 kg
9,761 u .
145,196.080 kg
76,726 u .
Western Europe
2,784 u .Belgium - 653.000 kg
847 u .Cyprus 260 u . 787 u .
3,012.300 kgDenmark 2,177.600 kg 2,692.300 kg
2,054 u .Finland 2,065 u . 82.520 kg
- - 2,328 u .
21,888 u .France 38,341 u . 38,115 u .
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11,151 u .Germany 53,179 u . 5,000.000 kg
- - 67,065 u .
No report 1 u . -Gibraltar
30,499 u .Greece 15,192 u . 11,010 u .
221 u .Iceland No report No report
No reportIreland 542 u . 753 u .
411,432 u .Italy 491,390 u . 379,851 u .
24 u .Malta 100 u . 153 u .
No reportNetherlands No report 1,479,821 u .
11.610 kgNorway 7.300 kg 23.330 kg
145 u .Portugal 1,646 u . 7,982 u .
1,188.080 kgSpain 14,001.400 kg 1,734.000 kg
6.920 kgSweden 4.170 kg 2.430 kg
- - 269 u .
8,867 u .Switzerland 32,488 u . 313,258 u .
75.820 kgTurkey - 52,100,621 u .
1,989,215 u . - -
94,202 u .United Kingdom 126,191 u . -
Sub-total Western Europe 4,294.720 kg
2,573,329 u .
16,190.460 kg
761,395 u .
10,187.580 kg
54,402,013 u .
Total Europe 12,810.720 kg
2,585,372 u .
80,415.600 kg
771,156 u .
155,383.650 kg
54,478,739 u .
OCEANIA
367,709 u .Australia 2,745.060 kg 4,445.340 kg
- 187,837 u . -
No report 2 u . No reportCook Islands
2,239.000 kgFiji 5,388 u . No report
291,000 u .New Zealand  Govt No report No report
0.800 kgVanuatu No report No report
2 u .  . No report No report
Total Oceania 2,239.800 kg
658,711 u .
2,745.060 kg
193,227 u .
4,445.340 kg
266,867 u .
TOTAL  CANNABIS PLANT 4,492,986.480 kg
91,457,831 u .
2,096,369.570 kg
246,421,384 u .
1,654,508.310 kg
123,112,775 u .
Cannabis resin
 1995Region /country or territory  1996  1997
- 190-
AFRICA
North Africa
1,920.610 kgAlgeria 712.160 kg No report
1,026.860 kgEgypt  Govt - 441.590 kg
110,245.330 kgMorocco 64,769.100 kg 71,887.470 kg
170.200 kgTunisia 555.160 kg 201.070 kg ICPO
Sub-total North Africa 113,363.000 kg 66,036.420 kg 72,530.130 kg
West and Central Africa
No reportBurkina Faso No report 4,647.000 kg Govt
0.010 kgGambia No report 0.050 kg ICPO
No reportSao Tome and Principe No report 4.000 kg
No reportSierra Leone 987.000 kg No report
Sub-total West and Central Africa 0.010 kg 987.000 kg 4,651.050 kg
East Africa
5,707.000 kgKenya 19,633.000 kg 7.010 kg
4.450 kgSeychelles 6.600 kg No report
Sub-total East Africa 5,711.450 kg 19,639.600 kg 7.010 kg
Southern Africa
2,979.000 kgLesotho No report 3.940 kg ICPO
No reportMozambique No report 12,000.000 kg ICPO
7.860 kgSouth Africa 1.070 kg 2.150 kg
258.220 kgZambia 15.720 kg 40.270 kg ICPO
Sub-total Southern Africa 3,245.080 kg 16.790 kg 12,046.360 kg
Total Africa 122,319.540 kg 86,679.810 kg 89,234.550 kg
ASIA
Central Asia  and Transcaucasia
8.540 kgArmenia 0.520 kg -
No reportGeorgia 8.570 kg No report
1,555.000 kgKazakhstan 1,500.000 kg 4,100.000 kg Govt  Govt
86.430 kgKyrgyzstan - -
394.250 kgUzbekistan 144.500 kg 316.060 kg
Sub-total Central Asia  and
Transcaucasia 2,044.220 kg 1,653.590 kg 4,416.060 kg
Near and Middle East /South-West Asia
-Bahrain - 0.010 kg
15,854.000 kgIran ( Islamic Republic of) 13,063.000 kg 11,095.790 kg
206.120 kgIsrael 83.580 kg 133.000 kg
2,910.920 kgJordan - -
631.570 kgKuwait 3.670 kg 0.530 kg ICPO
3,760.150 kgLebanon 4,908.760 kg 1,876.280 kg
308.950 kgOman 1,500.000 kg No report
357,690.530 kgPakistan 192,837.460 kg 107,000.000 kg ICPO
-Qatar - 361.690 kg ICPO
-Syrian Arab Republic 1,569.290 kg -
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Sub-total Near and Middle East
/South-West Asia 381,362.240 kg 213,965.760 kg 120,467.300 kg
South Asia
No reportBangladesh 7.210 kg No report
3,629.000 kgIndia 6,520.000 kg 3,285.000 kg Govt
2,133.430 kgNepal 1,917.370 kg No report
1.400 kgSri Lanka 11,027.420 kg 17.760 kg
Sub-total South Asia 5,763.830 kg 19,472.000 kg 3,302.760 kg
East and South-East Asia
-China - 98.000 kg ICPO
20.100 kg  Govt 27.900 kg 38.900 kgChina (Hong Kong SAR)
0.550 kgIndonesia 2.050 kg -
130.670 kgJapan 145.140 kg 107.420 kg
No report 4.240 kg No reportMacao
965.030 kgMalaysia No report -
5.790 kgPhilippines 0.030 kg 0.280 kg ICPO
-Republic of Korea - 0.640 kg
Sub-total East and South-East Asia 1,122.130 kg 179.360 kg 245.240 kg
Total Asia 390,292.410 kg 235,270.700 kg 128,431.350 kg
AMERICAS
North America
40,369.470 kgCanada 24,655.000 kg 6,178.000 kg
13,477.190 kgMexico 8.800 kg 115.020 kg
14,636.800 kgUnited States 38,205.000 kg 1,072.600 kg
Sub-total North America 68,483.460 kg 62,868.800 kg 7,365.620 kg
Caribbean
1.850 kgAntigua and Barbuda 33.000 kg 1,944.900 kg ICPO
No report No report 0.000 kg INCBAruba
No reportBahamas No report 5.030 kg ICPO
992.250 kgBarbados No report No report
0.430 kg 0.980 kg 0.610 kgBermuda
No report 0.100 kg -Cayman Islands
No reportCuba 35.500 kg No report
0.040 kgDominican Republic 0.000 kg -
No reportJamaica 172.680 kg 67.590 kg ICPO
No report No report 0.350 kg INCBNetherlands Antilles
0.030 kgSaint Lucia - - *
Sub-total Caribbean 994.610 kg 242.270 kg 2,018.490 kg
South America
-Argentina 6.720 kg 0.060 kg Govt
6.340 kgBrazil 8.510 kg 12.160 kg
12,510.000 kgColombia - 7.000 kg
No report No report 0.120 kgFalkland Islands
0.000 kgGuyana - No report
0.480 kgParaguay 0.880 kg 2,009,500 u .
. (*)  Includes other cannabis
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Sub-total South America 12,516.820 kg 16.110 kg 19.340 kg
2,009,500 u .
Total Americas 81,994.880 kg 63,127.170 kg 9,403.450 kg
2,009,500 u .
EUROPE
Eastern Europe
0.290 kgBelarus 14.520 kg 5.380 kg INCB
-Bulgaria 8,995.840 kg 533.570 kg
3.280 kgCroatia 3.100 kg 3.260 kg
5.000 kgCzech Republic 2.810 kg 0.320 kg
No reportEstonia 4.460 kg 0.320 kg
0.620 kgHungary 816.220 kg 21.740 kg Govt
1.500 kgLatvia 1.500 kg 0.650 kg
1,500 u . - -
6.470 kgLithuania 0.250 kg 0.080 kg
10,001.340 kgPoland 5.250 kg 628.000 kg
0.830 kgRepublic of Moldova 0.210 kg -
36.460 kgRomania 4,851.530 kg 1,309.790 kg ICPO
458.100 kgRussian Federation 650.500 kg 104.090 kg
No reportSlovakia No report 0.040 kg
No reportSlovenia 5.440 kg 0.940 kg
-The former Yug.Rep of Macedonia 2.530 kg No report
51.010 kgUkraine 20.820 kg 9.500 kg
Sub-total Eastern Europe 10,564.900 kg
1,500 u .
15,374.970 kg 2,617.670 kg
Western Europe
2.080 kgAndorra No report No report
238.280 kgAustria 247.040 kg 243.910 kg
32,582.150 kgBelgium 49,899.000 kg -
33.200 kgCyprus 29.910 kg 3.410 kg
2,414.100 kgDenmark 1,772.400 kg 467.100 kg
147.510 kgFinland 99.440 kg 197.660 kg
39,203.450 kgFrance 35,575.820 kg 51,664.370 kg
3,809.260 kgGermany 3,246.540 kg 7,327.560 kg
No report 481.430 kg 655.880 kgGibraltar
287.730 kgGreece 830.320 kg 6,825.730 kg
0.310 kgIceland No report No report
15,529.000 kgIreland 1,933.000 kg 1,247.240 kg
14,921.710 kgItaly 5,939.920 kg 14,740.520 kg
1,376 u . - 1,954 u .
0.160 kgLiechtenstein 0.080 kg 0.010 kg
11.280 kgLuxembourg 14.420 kg 0.870 kg
0.940 kgMalta 1.070 kg 1.790 kg
0.080 kgMonaco 0.650 kg 0.170 kg
79,985.000 kgNetherlands 11,378.000 kg 31,513.200 kg
501.170 kgNorway 641.000 kg 904.060 kg
6,334.290 kgPortugal 5,324.090 kg 9,621.180 kg
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197,024.050 kgSpain 247,745.100 kg 315,328.000 kg ICPO
494.300 kgSweden 304.110 kg 627.990 kg
585.500 kgSwitzerland 676.740 kg 653.470 kg
17,359.650 kgTurkey 12,294.000 kg 0.010 kg
44,607.000 kgUnited Kingdom 66,941.160 kg 74,828.000 kg
- 493 u . -
Sub-total Western Europe 456,072.180 kg
1,376 u .
445,375.220 kg
493 u .
516,852.120 kg
1,954 u .
Total Europe 466,637.080 kg
2,876 u .
460,750.190 kg
493 u .
519,469.790 kg
1,954 u .
OCEANIA
17.280 kgAustralia 9.200 kg 537.290 kg
30 u . 246 u . -
No report No report 0.000 kg INCBNew Caledonia
0.710 kgNew Zealand  Govt No report 2.200 kg INCB
Total Oceania 17.990 kg
30 u .
9.200 kg
246 u .
539.490 kg
TOTAL  CANNABIS RESIN 1,061,261.890 kg
2,906 u .
845,837.070 kg
739 u .
747,078.630 kg
2,011,454 u .
Cannabis seed
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AFRICA
North Africa
-Egypt - 33.420 kg
0.100 kgTunisia No report No report
Sub-total North Africa 0.100 kg 33.420 kg
East Africa
0.050 kgMauritius 167 u . No report
No reportUganda 10.350 kg No report
Sub-total East Africa 0.050 kg 10.350 kg
167 u .
Southern Africa
0.700 kgMalawi - -
625.860 kgNamibia 278.300 kg No report
191.940 kgZambia 0.040 kg No report
Sub-total Southern Africa 818.500 kg 278.340 kg
Total Africa 818.640 kg 288.690 kg
167 u .
33.420 kg
ASIA
Near and Middle East /South-West Asia
0.000 kgIraq - -
0.000 kgJordan 26.320 kg 0.770 kg
-Lebanon - 20.000 kg
31 u .Qatar - No report
0.300 kgUnited Arab Emirates 4.880 kg -
Sub-total Near and Middle East
/South-West Asia 0.300 kg
31 u .
31.190 kg 20.770 kg
East and South-East Asia
-Brunei Darussalam 0.010 kg -
No report - 8.200 kgChina (Hong Kong SAR)
0.390 kgIndonesia 0.390 kg 1.220 kg
230.810 kgPhilippines 267.800 kg No report
-Republic of Korea 13.870 kg 58.790 kg
4.460 kgThailand 3.010 kg No report
Sub-total East and South-East Asia 235.660 kg 285.070 kg 68.210 kg
Total Asia 235.970 kg
31 u .
316.270 kg 88.980 kg
AMERICAS
North America
7,421.860 kgMexico 5,098.840 kg 3,968.040 kg
-United States 229,291.740 kg -
Sub-total North America 7,421.860 kg 234,390.580 kg 3,968.040 kg
Central America
No reportGuatemala 427.610 kg 1.840 kg Govt
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73.480 kgHonduras No report 3.400 kg
No reportNicaragua 5.180 kg 2.060 kg
Sub-total Central America 73.480 kg 432.790 kg 7.300 kg
Caribbean
No report 0.010 kg -Bermuda
No reportCuba 2,836 u . No report
No reportDominica 4.250 kg No report
134 u .Dominican Republic 200 u . 72 u .
Sub-total Caribbean
134 u .
4.260 kg
3,036 u . 72 u .
South America
6,045 u .Argentina 10.970 kg 39.440 kg Govt
56.830 kgBrazil 84.620 kg 68.310 kg
-Chile 0.600 kg -
177.500 kgColombia 49.000 kg -
-Guyana 6.770 kg No report
646.360 kgParaguay 207.550 kg -
36.180 kgPeru 1.920 kg 9.380 kg
7.000 kgSuriname 6.000 kg -
Sub-total South America 923.870 kg
6,045 u .
367.440 kg 117.130 kg
Total Americas 8,419.210 kg
6,179 u .
235,195.070 kg
3,036 u .
4,092.470 kg
72 u .
EUROPE
Eastern Europe
-Bulgaria 5.990 kg 1.250 kg
88,820 u .Croatia 13.060 kg 38,037 u .
200.000 kgPoland 150.000 kg 300.000 kg
-Russian Federation - 0.020 kg
Sub-total Eastern Europe 200.000 kg
88,820 u .
169.050 kg 301.270 kg
38,037 u .
Western Europe
0.470 kgBelgium - 75 u .
9 u .Finland 0.920 kg 0.360 kg
- 1,108 u . 369 u .
0.030 kgGreece - -
0.490 kgIceland No report No report
-Italy 45,227 u . 220.120 kg
- - 47,646 u .
129 u .Malta 4.010 kg 0.050 kg
6 u .Portugal 0.460 kg 53 u .
-Spain - 1.380 kg
9,462.070 kgTurkey - -
Sub-total Western Europe 9,463.070 kg
144 u .
5.390 kg
46,335 u .
221.910 kg
48,143 u .
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Total Europe 9,663.070 kg
88,964 u .
174.440 kg
46,335 u .
523.180 kg
86,180 u .
OCEANIA
237.260 kgAustralia 304.090 kg - *
1,558 u . 39,567 u . - *
1,545.390 kgNew Zealand No report No report
Total Oceania 1,782.650 kg
1,558 u .
304.090 kg
39,567 u .
TOTAL  CANNABIS SEED 20,919.540 kg
96,732 u .
236,278.560 kg
89,105 u .
4,738.050 kg
86,252 u .
. (*)  Includes other cannabis
Coca bush
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ASIA
East and South-East Asia
-Philippines 2 u . No report
Sub-total East and South-East Asia 2 u .
Total Asia 2 u .
AMERICAS
Caribbean
1,960 u . - No reportBritish Virgin Islands
1,960 u .Sub-total Caribbean
1,960 u .Total Americas
TOTAL   COCA BUSH 1,960 u . 2 u .
Coca leaf
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ASIA
Near and Middle East /South-West Asia
-Bahrain 0.010 kg -
Sub-total Near and Middle East
/South-West Asia 0.010 kg
Total Asia 0.010 kg
AMERICAS
North America
-Canada - 0.190 kg
Sub-total North America 0.190 kg
Central America
No reportGuatemala 28,903 u . -
60.570 kgPanama - -
Sub-total Central America 60.570 kg
28,903 u .
South America
54,749.930 kgArgentina 56,853.820 kg 49,754.100 kg Govt
76,710.000 kgBolivia No report -
0.030 kgBrazil - 0.040 kg
21.720 kgChile 4.870 kg -
394,216.000 kgColombia 686,018.000 kg 117,817.000 kg
40,092.950 kgPeru 99,104.240 kg 146,824.950 kg
Sub-total South America 565,790.630 kg 841,980.930 kg 314,396.090 kg
Total Americas 565,851.200 kg 841,980.930 kg
28,903 u .
314,396.280 kg
EUROPE
Western Europe
0.510 kgFrance 0.010 kg -
0.150 kgGreece - -
0.390 kgItaly 1.660 kg -
73 u . - -
-Portugal - 0.040 kg
0.270 kgSweden 1.050 kg -
Sub-total Western Europe 1.320 kg
73 u .
2.720 kg 0.040 kg
Total Europe 1.320 kg
73 u .
2.720 kg 0.040 kg
OCEANIA
0.050 kgAustralia 0.020 kg 0.590 kg
Total Oceania 0.050 kg 0.020 kg 0.590 kg
TOTAL  COCA LEAF 565,852.570 kg
73 u .
841,983.680 kg
28,903 u .
314,396.910 kg
Cocaine (base and salts)
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AFRICA
North Africa
0.000 kgAlgeria No report No report
0.220 kgEgypt 0.930 kg 0.910 kg
6.290 kgMorocco 91.200 kg 6,055.550 kg
-Tunisia 0.000 kg 0.050 kg ICPO
Sub-total North Africa 6.520 kg 92.130 kg 6,056.510 kg
West and Central Africa
6.960 kgBenin 40.370 kg 15.160 kg Govt  Govt
No reportBurkina Faso 4.830 kg 278.000 kg Govt  Govt
0.230 kgCameroon No report No report
0.010 kgCongo - -
2.860 kgCôte d'Ivoire 33.150 kg 22.030 kg
0.090 kgGabon 0.020 kg No report
0.070 kgGambia 0.880 kg 0.060 kg ICPO
18.450 kgGhana 0.790 kg 0.220 kg
No reportMali 4.300 kg No report Govt
No reportMauritania 0.330 kg No report Govt
No reportNiger 0.020 kg 28.870 kg ICPO
15.910 kgNigeria  Govt 6.160 kg 0.390 kg
No reportSao Tome and Principe No report 0.100 kg
2.160 kgSenegal 1.900 kg No report
4.000 kgSierra Leone  Govt 0.000 kg No report
No reportTogo 1.080 kg 13.870 kg Govt
Sub-total West and Central Africa 50.730 kg 93.830 kg 358.690 kg
East Africa
No reportBurundi 3.820 kg No report Govt
0.420 kgKenya 3.440 kg 0.410 kg
No reportUganda 4.000 kg No report
-United Republic of Tanzania No report 0.200 kg
Sub-total East Africa 0.420 kg 11.260 kg 0.610 kg
Southern Africa
8.900 kgAngola 64.360 kg 536.000 kg Govt  ICPO
0.410 kgBotswana 3.000 kg 0.980 kg ICPO
No reportDemocratic Republic of the Congo 1.100 kg No report Govt
No reportLesotho No report 2.350 kg ICPO
0.600 kgNamibia 5.950 kg 23.930 kg INCB
187.770 kgSouth Africa 106.630 kg 151.520 kg
2.770 kgSwaziland 6.750 kg 9.650 kg ICPO
1.760 kgZambia 4.440 kg 6.500 kg ICPO
0.090 kgZimbabwe 0.600 kg No report
Sub-total Southern Africa 202.280 kg 192.830 kg 730.930 kg
Total Africa 259.960 kg 390.050 kg 7,146.740 kg
ASIA
Central Asia  and Transcaucasia
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No reportArmenia 0.000 kg -
No reportGeorgia 0.000 kg No report
Sub-total Central Asia  and
Transcaucasia 0.010 kg
Near and Middle East /South-West Asia
-Iran ( Islamic Republic of) - 1.700 kg
14.090 kgIsrael 73.340 kg 43.700 kg
0.020 kgJordan 1.100 kg -
0.050 kgKuwait 0.020 kg 0.010 kg ICPO
12.740 kgLebanon 166.690 kg 4.800 kg
4.310 kgSaudi Arabia 11.810 kg 0.350 kg ICPO
5.140 kgSyrian Arab Republic 1.670 kg 0.240 kg
0.000 kgUnited Arab Emirates 40.010 kg -
Sub-total Near and Middle East
/South-West Asia 36.340 kg 294.640 kg 50.800 kg
South Asia
40.000 kgIndia 3.000 kg 24.000 kg Govt
-Nepal - 24.000 kg ICPO
-Sri Lanka 0.050 kg -
Sub-total South Asia 40.000 kg 3.050 kg 48.000 kg
East and South-East Asia
11.000 kgCambodia No report No report
1.800 kg  Govt 13.900 kg 31.300 kgChina (Hong Kong SAR)
0.110 kgIndonesia 0.390 kg 3.300 kg
36.620 kgJapan 37.110 kg 25.460 kg
1.420 kgPhilippines 1.590 kg 1.000 kg ICPO
-Republic of Korea 0.770 kg 11.220 kg
2.000 kgViet Nam No report No report
Sub-total East and South-East Asia 52.960 kg 53.760 kg 72.270 kg
Total Asia 129.300 kg 351.450 kg 171.080 kg
AMERICAS
North America
3,597.730 kgCanada 3,123.470 kg 2,090.000 kg
- - 312 u .
22,708.230 kgMexico 23,835.200 kg 34,952.070 kg
110,842.200 kgUnited States 128,725.100 kg 95,019.700 kg Govt
Sub-total North America 137,148.160 kg 155,683.770 kg 132,061.770 kg
312 u .
Central America
No reportBelize 720.000 kg 2,691.000 kg CICAD
1,170.240 kgCosta Rica 1,872.720 kg 7,857.000 kg ICPO
14,825 u . 11,391 u . No report
65.000 kgEl Salvador 99.000 kg 234.430 kg ICPO
No reportGuatemala 3,950.870 kg 5,098.470 kg Govt
No report - 17 u .  Govt
408.850 kgHonduras 3,275.000 kg 2,187.670 kg
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32 u . No report 209 u .
1,506.890 kgNicaragua 398.440 kg 2,790.200 kg
No report 3,531 u . 7,109 u .
7,168.560 kgPanama 8,617.620 kg 15,177.250 kg
Sub-total Central America 10,319.540 kg
14,857 u .
18,933.650 kg
14,922 u .
36,036.020 kg
7,335 u .
Caribbean
75.000 kg - 0.000 kgAnguilla
No report - 8 u .
115.310 kgAntigua and Barbuda 5.000 kg 156.600 kg ICPO
151.300 kg No report 408.310 kg INCBAruba
No reportBahamas No report 2,579.040 kg ICPO
247.000 kgBarbados 37.000 kg 88.050 kg INCB
40.190 kg 24.660 kg 4.520 kgBermuda
1,194.020 kg - No reportBritish Virgin Islands
No report 2,219.090 kg 1,054.000 kgCayman Islands
No report - 319 u .
371.500 kgCuba 7,923.370 kg 1,443.800 kg ICPO
No reportDominica 2.950 kg 101.490 kg ICPO
4,391.090 kgDominican Republic 1,341.300 kg 1,234.210 kg
3.530 kgGrenada - 7.000 kg INCB
611 u . - No report
570.010 kgJamaica 253.530 kg 414.680 kg ICPO
No report 2,321 u . 6,296 u .  ICPO
0.060 kg No report 0.130 kgMontserrat
No report No report 1 u .
No report No report 850.340 kg INCBNetherlands Antilles
5.810 kgSaint Kitts and Nevis No report 150.000 kg INCB
27.250 kgSaint Lucia 19.800 kg 7.780 kg
No reportSaint Vincent and the Grenadines 2.000 kg 0.350 kg INCB
No reportTrinidad Tobago 179.380 kg 71.000 kg CICAD
20.000 kg 400.000 kg 1.500 kgTurks and Caicos Islands
Sub-total Caribbean 7,212.060 kg
611 u .
12,408.080 kg
2,321 u .
8,572.790 kg
6,624 u .
South America
3,416.080 kgArgentina 2,451.250 kg 5,192.570 kg Govt
8,496.640 kgBolivia 8,305.000 kg 13,688.940 kg
5,814.860 kgBrazil 4,070.500 kg 4,309.380 kg
2,900.360 kgChile 2,962.100 kg 2,660.720 kg
59,030.000 kgColombia  Govt 45,779.000 kg 42,044.000 kg Govt
4,284.400 kgEcuador 9,533.970 kg 3,697.160 kg
51.120 kgGuyana 91.500 kg 66.010 kg ICPO
58.630 kgParaguay 47.490 kg 77.080 kg
22,660.850 kgPeru 19,694.670 kg 8,795.620 kg
63.620 kgSuriname 1,412.690 kg 116.100 kg
231.720 kgUruguay 84.790 kg 28.000 kg CICAD
6,650.190 kgVenezuela 5,906.450 kg 16,741.000 kg CICAD
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Sub-total South America 113,658.450 kg 100,339.420 kg 97,416.570 kg
Total Americas 268,338.210 kg
15,468 u .
287,364.920 kg
17,243 u .
274,087.150 kg
14,271 u .
EUROPE
Eastern Europe
-Belarus - 2.070 kg INCB
7.610 kgBulgaria 21.520 kg 2.010 kg
0.060 kgCroatia 1.530 kg 563.010 kg
51.720 kgCzech Republic 23.360 kg 66.830 kg
No reportEstonia No report 0.010 kg
18.680 kgHungary 4.990 kg 7.000 kg Govt
0.010 kgLatvia 0.010 kg 0.020 kg
- - 0.900 lt.
24 u . - -
1.720 kgLithuania 1.060 kg 2.050 kg
383.230 kgPoland 31.380 kg 15.500 kg
16.090 kgRomania 712.610 kg 69.560 kg ICPO
44.800 kgRussian Federation 73.800 kg 70.830 kg
25.710 kgSlovakia No report 9.580 kg ICPO
3.240 kgSlovenia 0.830 kg 3.570 kg
-The former Yug.Rep of Macedonia 13.740 kg No report
No reportUkraine - 625.010 kg
Sub-total Eastern Europe 552.870 kg
24 u .
884.810 kg 1,437.040 kg
0.900 lt.
Western Europe
0.030 kgAndorra No report 0.110 kg ICPO
55.260 kgAustria 72.790 kg 86.900 kg
576.180 kgBelgium 838.000 kg 3,329.000 kg
2.500 kgCyprus 0.000 kg 0.020 kg
110.100 kgDenmark 32.000 kg 58.000 kg
0.040 kgFinland 0.070 kg 0.120 kg
873.580 kgFrance 1,752.700 kg 860.600 kg
1,846.020 kgGermany 1,378.440 kg 1,721.190 kg
No report 0.040 kg 0.100 kgGibraltar
8.980 kgGreece 155.250 kg 16.730 kg
0.140 kgIceland No report No report
21.800 kgIreland 642.000 kg 11.040 kg
2,556.580 kgItaly 2,147.350 kg 1,639.540 kg
364 u . - 887 u .
0.500 kgLiechtenstein 0.010 kg 1.070 kg
0.530 kgLuxembourg 12.890 kg 8.980 kg
0.160 kgMalta 0.170 kg 0.300 kg
0.020 kgMonaco 0.000 kg 0.000 kg
4,896.000 kgNetherlands 8,067.000 kg 6,743.600 kg
3.800 kgNorway 24.140 kg 4.630 kg
2,115.840 kgPortugal 811.570 kg 3,162.640 kg
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6,897.020 kgSpain 13,742.900 kg 18,418.760 kg
4.040 kgSweden 28.700 kg 33.920 kg
262.090 kgSwitzerland 255.680 kg 349.440 kg
75.670 kgTurkey 13.000 kg -
672.100 kgUnited Kingdom 1,218.840 kg 2,135.000 kg
- 13 u . -
Sub-total Western Europe 20,978.970 kg
364 u .
31,193.540 kg
13 u .
38,581.700 kg
887 u .
Total Europe 21,531.830 kg
388 u .
32,078.360 kg
13 u .
40,018.740 kg
0.900 lt.
887 u .
OCEANIA
348.040 kgAustralia 1.760 kg 81.940 kg
- 24 u . -
0.080 kgNew Zealand  Govt No report 0.040 kg INCB
No reportTonga No report 0.000 kg INCB
Total Oceania 348.120 kg 1.760 kg
24 u .
81.980 kg
TOTAL  COCAINE (BASE AND SALTS) 290,607.410 kg
15,856 u .
320,186.540 kg
17,280 u .
321,505.680 kg
0.900 lt.
15,158 u .
Heroin
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AFRICA
North Africa
0.110 kgAlgeria 0.220 kg No report
48.200 kgEgypt 48.260 kg 51.220 kg
- - 224.500 lt.
7.150 kgMorocco 0.360 kg 0.320 kg Govt
- 6 u . -
5.000 kgTunisia 4.580 kg 0.310 kg ICPO
Sub-total North Africa 60.450 kg 53.420 kg
6 u .
51.850 kg
224.500 lt.
West and Central Africa
5.160 kgBenin 30.350 kg 142.820 kg Govt  Govt
No reportBurkina Faso 1.140 kg 222.000 kg Govt  Govt
No reportChad 0.500 kg No report Govt
-Congo - 0.070 kg
5.420 kgCôte d'Ivoire 4.530 kg 0.540 kg
No reportGabon 0.010 kg No report
No reportGambia 0.080 kg 0.090 kg ICPO
5.570 kgGhana 0.450 kg 0.010 kg
0.250 kgMali 2.710 kg No report Govt
No reportMauritania 0.170 kg No report Govt
0.030 kgNiger 0.100 kg 0.100 kg ICPO
30.270 kgNigeria  Govt 19.380 kg 10.490 kg
15.090 kgSenegal 0.250 kg No report
No report 18 u . No report
0.000 kgSierra Leone  Govt 0.000 kg No report
No reportTogo 0.030 kg 81.600 kg Govt
Sub-total West and Central Africa 61.790 kg 59.700 kg
18 u .
457.710 kg
East Africa
No reportBurundi 0.800 kg No report Govt
3.620 kgEthiopia 27.470 kg 36.110 kg
29.030 kgKenya 15.490 kg 7.790 kg
0.860 kgMadagascar No report No report
0.790 kgMauritius 5.240 kg 6.920 kg ICPO
No reportRwanda 2.520 kg No report Govt
1.520 kgUganda  Govt 2.720 kg No report
2.830 kgUnited Republic of Tanzania No report 4.850 kg
Sub-total East Africa 38.650 kg 54.240 kg 55.670 kg
Southern Africa
0.020 kgAngola No report 0.010 kg ICPO
0.470 kgBotswana No report 0.230 kg ICPO
No reportDemocratic Republic of the Congo 2.650 kg No report Govt
5.940 kgSouth Africa 0.810 kg 1.550 kg
0.450 kgSwaziland 0.000 kg 1.040 kg ICPO
152.620 kgZambia 0.940 kg No report
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0.290 kgZimbabwe 0.030 kg No report
Sub-total Southern Africa 159.790 kg 4.440 kg 2.830 kg
Total Africa 320.680 kg 171.790 kg
24 u .
568.060 kg
224.500 lt.
ASIA
Central Asia  and Transcaucasia
No reportArmenia 0.170 kg 0.430 kg
0.120 kgAzerbaijan  Govt 0.100 kg 0.170 kg ICPO
No reportGeorgia 0.310 kg No report
-Kazakhstan No report 40.000 kg Govt
0.200 kgKyrgyzstan 30.000 kg 4.400 kg Govt
No reportTajikistan 6.350 kg No report
10.060 kgUzbekistan 18.000 kg 70.270 kg Govt
Sub-total Central Asia  and
Transcaucasia 10.380 kg 54.930 kg 115.270 kg
Near and Middle East /South-West Asia
2.130 kgBahrain 12.700 kg 4.170 kg
2,075.000 kgIran ( Islamic Republic of) 804.500 kg 1,986.040 kg
94.450 kgIsrael 80.400 kg 75.100 kg
5.650 kgJordan 67.390 kg 82.450 kg
7.290 kgKuwait 47.530 kg 23.590 kg ICPO
20.720 kgLebanon 50.770 kg 2.360 kg
6.270 kgOman 8.000 kg 0.760 kg INCB
10,760.100 kgPakistan 5,872.110 kg 6,156.000 kg ICPO
0.190 kgQatar 0.340 kg No report
324.150 kgSaudi Arabia 483.420 kg 115.670 kg ICPO
16.560 kgSyrian Arab Republic 9.780 kg 12.260 kg
76.480 kgUnited Arab Emirates 21.640 kg 35.770 kg
Sub-total Near and Middle East
/South-West Asia 13,388.970 kg 7,458.570 kg 8,494.160 kg
South Asia
No reportBangladesh 16.800 kg No report
1,678.000 kgIndia 1,257.000 kg 1,332.000 kg Govt
0.020 kgMaldives No report No report
7.320 kgNepal 9.990 kg No report
40.330 kgSri Lanka 39.820 kg 55.020 kg
Sub-total South Asia 1,725.680 kg 1,323.600 kg 1,387.020 kg
East and South-East Asia
0.010 kgBrunei Darussalam 0.030 kg 0.000 kg
80.000 kgCambodia  Govt No report 16.000 kg ICPO
2,375.000 kgChina 4,347.000 kg 5,400.000 kg ICPO
411.000 kg  Govt 309.100 kg 202.200 kgChina (Hong Kong SAR)
1.710 kgIndonesia 1.710 kg 20.430 kg
20 u . 20 u . -
7.740 kgJapan 3.970 kg 5.990 kg
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49.650 kgLao People's Dem. Rep.  Govt 16.200 kg 72.300 kg Govt  Govt
0.370 kg 0.350 kg 0.230 kg ICPOMacao
119.260 kgMalaysia 240.730 kg 276.150 kg Govt
72.610 kgMyanmar 504.600 kg 1,401.080 kg
-Philippines 1.530 kg 3.010 kg ICPO
3.630 kgRepublic of Korea 1.790 kg 0.600 kg
50.230 kgSingapore 121.290 kg 82.610 kg
517.790 kgThailand  Govt 597.650 kg 385.690 kg ICPO
20.500 kgViet Nam 54.750 kg 24.300 kg ICPO
Sub-total East and South-East Asia 3,709.500 kg
20 u .
6,200.720 kg
20 u .
7,890.600 kg
Total Asia 18,834.530 kg
20 u .
15,037.820 kg
20 u .
17,887.050 kg
AMERICAS
North America
106.440 kgCanada 83.000 kg 95.000 kg
203.180 kgMexico 363.460 kg 114.090 kg
1,337.100 kgUnited States 1,366.300 kg 1,542.000 kg
Sub-total North America 1,646.720 kg 1,812.760 kg 1,751.090 kg
Central America
9.730 kgCosta Rica - No report
No reportEl Salvador No report 2.150 kg ICPO
No reportGuatemala 13.480 kg 17.420 kg Govt
1.000 kgNicaragua 1.000 kg 2.000 kg
29.610 kgPanama 10.050 kg 33.310 kg
Sub-total Central America 40.340 kg 24.530 kg 54.880 kg
Caribbean
4.590 kg No report 3.300 kg INCBAruba
0.110 kg 0.100 kg 0.400 kgBermuda
No reportCuba 1.630 kg 0.700 kg ICPO
2.910 kgDominican Republic 12.160 kg 11.330 kg
0.230 kgJamaica 0.600 kg No report
No reportTrinidad Tobago 0.720 kg No report
Sub-total Caribbean 7.840 kg 15.210 kg 15.720 kg
South America
-Argentina No report 38.580 kg
0.010 kgBrazil - -
145.020 kgColombia 80.770 kg 129.740 kg
34.950 kgEcuador 80.980 kg 53.100 kg
1.600 kgUruguay - No report
80.950 kgVenezuela 56.000 kg 16.090 kg CICAD
Sub-total South America 262.530 kg 217.750 kg 237.500 kg
Total Americas 1,957.430 kg 2,070.240 kg 2,059.190 kg
EUROPE
Eastern Europe
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1.700 kgBelarus - 0.640 kg INCB
199.380 kgBulgaria 248.270 kg 322.690 kg
38.290 kgCroatia 2.270 kg 3.040 kg
5.000 kgCzech Republic 20.130 kg 21.440 kg
568.080 kgHungary 319.210 kg 206.160 kg Govt
-Latvia - 0.010 kg
0.030 kgLithuania - 0.090 kg
66.350 kgPoland 43.190 kg 142.810 kg
0.010 kgRepublic of Moldova - 10.000 kg
54.480 kgRomania 103.350 kg 117.920 kg ICPO
6.500 kgRussian Federation 18.100 kg 24.030 kg
120.950 kgSlovakia 11.000 kg 90.450 kg
18.150 kgSlovenia 24.570 kg 29.830 kg
110.340 kgThe former Yug.Rep of Macedonia 29.340 kg No report
9.500 kgUkraine 4.030 kg 3.730 kg
No reportYugoslavia No report 15.430 kg ICPO
Sub-total Eastern Europe 1,198.760 kg 823.440 kg 988.260 kg
Western Europe
0.010 kgAndorra No report 0.010 kg ICPO
47.020 kgAustria 81.330 kg 102.140 kg
129.400 kgBelgium 133.000 kg 55.000 kg
-Cyprus 0.000 kg -
37.400 kgDenmark 61.400 kg 37.900 kg
16.120 kgFinland 6.450 kg 2.530 kg
498.630 kgFrance 617.240 kg 415.450 kg
933.380 kgGermany 898.190 kg 722.210 kg
No report 0.000 kg -Gibraltar
172.810 kgGreece 193.660 kg 146.310 kg
20 u . 38 u . 38 u .
6.400 kgIreland 10.800 kg 8.180 kg
939.520 kgItaly 1,251.430 kg 470.340 kg
6,144 u . - 5,360 u .
0.010 kgLiechtenstein 9.300 kg 18.680 kg
13.250 kgLuxembourg 2.930 kg 2.530 kg
2.130 kgMalta 2.660 kg 4.540 kg
0.000 kgMonaco 0.000 kg 0.010 kg
351.000 kgNetherlands 361.000 kg 190.400 kg
48.390 kgNorway 74.080 kg 55.510 kg
65.510 kgPortugal 46.700 kg 57.390 kg
546.010 kgSpain 537.220 kg 479.450 kg
31.880 kgSweden 39.620 kg 11.510 kg
0.000 lt. - -
212.690 kgSwitzerland 405.730 kg 209.260 kg
3,456.460 kgTurkey 4,422.000 kg 1,388.650 kg
1,394.600 kgUnited Kingdom 1,071.690 kg 2,077.000 kg
- 8,730 u . -
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Sub-total Western Europe 8,902.610 kg
0.000 lt.
6,164 u .
10,226.430 kg
8,768 u .
6,454.990 kg
5,398 u .
Total Europe 10,101.370 kg
0.000 lt.
6,164 u .
11,049.870 kg
8,768 u .
7,443.250 kg
5,398 u .
OCEANIA
49.430 kgAustralia 46.600 kg 365.370 kg
0.110 lt. 278 u . -
8 u . - -
0.080 kgNew Zealand  Govt 1.000 kg 0.170 kg INCB
Total Oceania 49.510 kg
0.110 lt.
8 u .
47.600 kg
278 u .
365.540 kg
TOTAL  HEROIN 31,263.510 kg
0.110 lt.
6,192 u .
28,377.330 kg
9,090 u .
28,323.080 kg
224.500 lt.
5,398 u .
Morphine
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AFRICA
North Africa
0.010 lt.Egypt 0.020 lt. 0.000 kg
-Morocco 0.110 kg 0.320 kg
Sub-total North Africa
0.010 lt.
0.110 kg
0.020 lt.
0.320 kg
West and Central Africa
No reportNigeria 0.020 kg 0.130 kg
Sub-total West and Central Africa 0.020 kg 0.130 kg
East Africa
0.010 lt.Ethiopia No report -
-United Republic of Tanzania No report 0.280 kg
Sub-total East Africa
0.010 lt.
0.280 kg
Southern Africa
0.000 kgSwaziland No report No report
0.500 kgZambia No report No report
Sub-total Southern Africa 0.500 kg
Total Africa 0.500 kg
0.020 lt.
0.130 kg
0.020 lt.
0.730 kg
ASIA
Central Asia  and Transcaucasia
1.180 kgArmenia 12 u . 3 u .
No reportGeorgia 0.020 kg No report
No report 0.060 lt. No report
No report 1,659 u . No report
7.840 kgKyrgyzstan 21 u . -
-Uzbekistan - 8 u .
Sub-total Central Asia  and
Transcaucasia 9.020 kg 0.020 kg
0.060 lt.
1,692 u . 11 u .
Near and Middle East /South-West Asia
11,046.000 kgIran ( Islamic Republic of) 10,430.000 kg 18,949.750 kg
0.040 kgIsrael 0.010 kg -
- 25 u . -
No reportKuwait 0.010 kg No report
317.080 kgLebanon - -
-Qatar - 0.130 kg ICPO
Sub-total Near and Middle East
/South-West Asia 11,363.120 kg 10,430.010 kg
25 u .
18,949.890 kg
South Asia
4.000 kgIndia 4.000 kg 76.000 kg Govt
-Nepal - 11.130 kg ICPO
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Sub-total South Asia 4.000 kg 4.000 kg 87.130 kg
East and South-East Asia
113.000 kgChina 178.000 kg No report
No report 17.300 kg -China (Hong Kong SAR)
0.000 kgIndonesia 0.000 kg 0.320 kg
-Japan 0.840 kg 0.010 kg
- - 1.110 lt.
- - 229 u .
0.270 kg No report No reportMacao
0.010 kgMalaysia No report -
-Myanmar - 45.730 kg
- - 200 u .
0.630 kgThailand  Govt No report 0.010 kg ICPO
3.000 kgViet Nam 12,937 u . No report
Sub-total East and South-East Asia 116.910 kg 196.140 kg
12,937 u .
46.070 kg
1.110 lt.
429 u .
Total Asia 11,493.050 kg 10,630.170 kg
0.060 lt.
14,654 u .
19,083.080 kg
1.110 lt.
440 u .
AMERICAS
North America
0.040 kgCanada 0.100 kg 1.080 kg
0.530 lt. 0.170 lt. 2,468 u .
- 329 u . -
3.020 kgMexico - 2.010 kg
0.120 kgUnited States 0.080 kg 0.010 lt.
- 482 u . -
- - 560 u .
Sub-total North America 3.190 kg
0.530 lt.
0.180 kg
0.170 lt.
811 u .
3.080 kg
0.010 lt.
3,028 u .
Central America
No reportGuatemala - 0.720 kg Govt
Sub-total Central America 0.720 kg
Caribbean
No reportCuba 23 u . No report
Sub-total Caribbean 23 u .
South America
80 u .Chile - -
290.240 kgColombia 94.120 kg 87.120 kg
0.000 kgPeru 0.000 kg -
Sub-total South America 290.240 kg
80 u .
94.120 kg 87.120 kg
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Total Americas 293.430 kg
0.530 lt.
80 u .
94.300 kg
0.170 lt.
834 u .
90.920 kg
0.010 lt.
3,028 u .
EUROPE
Eastern Europe
3.620 kgBelarus - 0.000 kg INCB
4.900 kgBulgaria - 4.000 kg
103 u .Croatia 17 u . -
No reportEstonia 0.510 lt. - *
6.400 kgHungary 0.210 kg 0.690 kg Govt
0.030 kgLatvia - -
30 u . - -
0.250 kgLithuania 0.370 lt. -
No reportRepublic of Moldova - 31 u .
51 u .Romania 74 u . 71 u .  ICPO
3.500 kgRussian Federation 45.140 kg 6.040 kg
- - 8 u .
Sub-total Eastern Europe 18.690 kg
184 u .
45.350 kg
0.870 lt.
91 u .
10.720 kg
110 u .
Western Europe
0.430 kgAustria 0.820 kg 0.330 kg
19.080 kgBelgium - 10.000 kg
1.060 kgDenmark 0.980 kg 1.560 lt.
0.000 kgFinland 0.070 kg 0.010 kg
- 2,422 u . -
0.100 kgFrance 0.080 kg 0.020 kg
0.010 kgGreece 0.000 kg -
979 u .Ireland 1,261 u . 0.000 kg
- - 528 u .
0.020 kgItaly 0.040 kg 0.100 kg
1 u . - 9 u .
0.260 kgNorway - 0.010 kg
1,149 u . - -
-Portugal 11 u . -
-Spain 74 u . 8 u .
0.010 kgSweden 0.170 kg 0.000 kg
0.330 lt. - 104 u .
0.100 kgSwitzerland 0.040 kg -
939.270 kgTurkey 1,157.000 kg 267.640 kg
2.000 kgUnited Kingdom 1.600 kg -
Sub-total Western Europe 962.330 kg
0.330 lt.
2,129 u .
1,160.800 kg
3,768 u .
278.110 kg
1.560 lt.
649 u .
. (*)  Includes other
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Total Europe 981.020 kg
0.330 lt.
2,313 u .
1,206.150 kg
0.870 lt.
3,859 u .
288.830 kg
1.560 lt.
759 u .
OCEANIA
0.010 kgAustralia 1.090 kg 2.050 kg
61 u . 56 u . -
0.000 kgNew Zealand No report 1.420 kg INCB
0.000 lt. No report No report
Total Oceania 0.020 kg
0.000 lt.
61 u .
1.090 kg
56 u .
3.470 kg
TOTAL  MORPHINE 12,768.010 kg
0.880 lt.
2,454 u .
11,931.840 kg
1.130 lt.
19,403 u .
19,467.040 kg
2.670 lt.
4,227 u .
Other opiates
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AFRICA
North Africa
30.900 lt.Egypt - - +
30.900 lt.Sub-total North Africa
East Africa
0.230 kgMauritius - 26 u .  ICPO
Sub-total East Africa 0.230 kg
26 u .
Total Africa 0.230 kg
30.900 lt.
26 u .
ASIA
Central Asia  and Transcaucasia
No reportArmenia 50 u . -
No reportGeorgia 30.150 kg No report
No report 3,980 u . No report
416.000 kgKazakhstan No report No report
1.640 kgKyrgyzstan 7.480 kg -
No reportTajikistan 66.000 kg No report
7.230 kgUzbekistan 0.170 kg 0.020 kg
Sub-total Central Asia  and
Transcaucasia 424.870 kg 103.800 kg
4,030 u .
0.020 kg
Near and Middle East /South-West Asia
-Iran ( Islamic Republic of) - 255.070 kg
-Jordan 1,349.460 kg 894.740 kg
0.050 kgKuwait No report No report
-Qatar 0.020 kg No report
- 42 u . No report
Sub-total Near and Middle East
/South-West Asia 0.050 kg 1,349.480 kg
42 u .
1,149.800 kg
South Asia
No reportBangladesh 85,903 u . No report
-Nepal - 4,971 u .  ICPO
Sub-total South Asia 85,903 u . 4,971 u .
East and South-East Asia
488.240 lt.Brunei Darussalam 309.270 lt. 85.170 kg
- - 554 u .
- 3,714 u . -
0.150 kg - -China (Hong Kong SAR)
138 u .Indonesia - -
0.030 kgJapan 0.000 kg 0.140 kg
177 u . 88 u . 1,809 u .
No report 159 u . 64 u .  ICPOMacao
    . (+ )  Small quantity
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-Myanmar - 194.380 kg
163 u .Singapore 525 u . 136 u .
No reportViet Nam 1.400 kg No report
Sub-total East and South-East Asia 0.180 kg
488.240 lt.
478 u .
1.400 kg
309.270 lt.
4,486 u .
279.690 kg
2,563 u .
Total Asia 425.100 kg
488.240 lt.
478 u .
1,454.690 kg
309.270 lt.
94,461 u .
1,429.510 kg
7,534 u .
AMERICAS
North America
0.140 kgCanada 1.360 kg 0.910 kg
- 2,524 u . 0.300 lt.
3,055 u . - 4,826 u .
0.070 kgUnited States 6.110 kg -
19,431 u . 72,075 u . -
Sub-total North America 0.210 kg
22,486 u .
7.470 kg
74,599 u .
0.910 kg
0.300 lt.
4,826 u .
Total Americas 0.210 kg
22,486 u .
7.470 kg
74,599 u .
0.910 kg
0.300 lt.
4,826 u .
EUROPE
Eastern Europe
4.330 kgBulgaria - -
No reportEstonia 73.530 lt. 23.330 lt.
-Latvia - 0.130 kg
-Lithuania 0.000 kg -
76.000 kgPoland 2,801.000 kg 1,004.000 lt.
No reportRepublic of Moldova - 1,000 u .
-Russian Federation 106.400 kg 4.930 kg
- - 11 u .
No reportUkraine 486.500 kg -
Sub-total Eastern Europe 80.330 kg 3,393.900 kg
73.530 lt.
5.060 kg
1,027.330 lt.
1,011 u .
Western Europe
2 u .Andorra No report No report
0.040 kgAustria 0.480 kg 0.080 kg
0.020 kgBelgium - -
1,092 u . - -
338 u .Denmark - -
0.040 kgGreece 0.280 kg 2.310 kg
4,672 u . 5,089 u . 15,322 u .
0.100 kgItaly 0.170 kg 0.000 kg
1 u . - 7 u .
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0.000 kgMonaco - -
6,454 u .Norway - -
-Portugal - 21 u .
-Spain 373 u . 1,159 u .
-Switzerland 4,305 u . 0.010 kg
50.700 kgUnited Kingdom - -
Sub-total Western Europe 50.890 kg
12,559 u .
0.930 kg
9,767 u .
2.400 kg
16,509 u .
Total Europe 131.220 kg
12,559 u .
3,394.830 kg
73.530 lt.
9,767 u .
7.460 kg
1,027.330 lt.
17,520 u .
OCEANIA
0.000 kgAustralia 0.120 kg - +
4 u . - -
207 u .New Zealand No report No report
Total Oceania 0.000 kg
211 u .
0.120 kg
TOTAL  OTHER OPIATES 556.760 kg
519.140 lt.
35,734 u .
4,857.100 kg
382.800 lt.
178,827 u .
1,437.890 kg
1,027.630 lt.
29,906 u .
    . (+ )  Small quantity
Opium (liquid)
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AFRICA
North Africa
1.020 lt.Egypt 0.020 lt. 0.010 lt.
1.020 lt. 0.020 lt. 0.010 lt.Sub-total North Africa
1.020 lt. 0.020 lt. 0.010 lt.Total              Africa
ASIA
Central Asia  and Transcaucasia
-Kyrgyzstan - 15,000 u .
Sub-total Central Asia  and
Transcaucasia
15,000 u .
East and South-East Asia
-Japan 5.910 lt. -
5.130 kgMyanmar - 1,027.690 kg
Sub-total East and South-East Asia 5.130 kg
5.910 lt.
1,027.690 kg
Total Asia 5.130 kg
5.910 lt.
1,027.690 kg
15,000 u .
AMERICAS
South America
-Peru 36.920 kg -
Sub-total South America 36.920 kg
Total Americas 36.920 kg
EUROPE
Eastern Europe
-Belarus 82.200 kg No report
-Croatia - 2.000 lt.
No reportEstonia 20.700 lt. -
43.000 kgLatvia - -
- 89.000 lt. 0.130 lt.
22,000 u . - -
53.220 lt.Lithuania 96.090 lt. 86.000 lt.
No reportRepublic of Moldova 27.100 kg -
No reportUkraine - 171.200 kg
Sub-total Eastern Europe 43.000 kg
53.220 lt.
22,000 u .
109.300 kg
205.790 lt.
171.200 kg
88.130 lt.
Western Europe
0.060 kgDenmark 0.010 kg 0.030 kg
0.030 kgNorway - -
1 u . - -
0.050 kgSpain - -
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Sub-total Western Europe 0.140 kg
1 u .
0.010 kg 0.030 kg
Total Europe 43.140 kg
53.220 lt.
22,001 u .
109.310 kg
205.790 lt.
171.230 kg
88.130 lt.
OCEANIA
0.080 kgAustralia 0.080 kg 1.630 kg
2.000 lt. - -
Total Oceania 0.080 kg
2.000 lt.
0.080 kg 1.630 kg
TOTAL  OPIUM (LIQUID) 48.350 kg
56.240 lt.
22,001 u .
146.310 kg
211.720 lt.
1,200.550 kg
88.140 lt.
15,000 u .
Opium (raw and prepared)
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AFRICA
North Africa
0.010 kgAlgeria No report No report
16.960 kgEgypt 16.270 kg 31.160 kg
13.000 kgTunisia No report No report
Sub-total North Africa 29.960 kg 16.270 kg 31.160 kg
West and Central Africa
No reportGabon 0.000 kg No report
Sub-total West and Central Africa 0.000 kg
East Africa
0.130 kgUnited Republic of Tanzania No report -
Sub-total East Africa 0.130 kg
Southern Africa
0.200 kgZambia 2.340 kg 0.100 kg ICPO
Sub-total Southern Africa 0.200 kg 2.340 kg 0.100 kg
Total Africa 30.290 kg 18.620 kg 31.260 kg
ASIA
Central Asia  and Transcaucasia
9.130 kgArmenia 1.910 kg 2.050 kg
254.900 kgAzerbaijan  Govt 39.040 kg 83.330 kg ICPO
No reportGeorgia 17.590 kg No report
245.000 kgKazakhstan 500.000 kg 1,000.000 kg Govt  Govt
726.890 kgKyrgyzstan 1,489.680 kg 1,639.480 kg
No reportTajikistan 3,405.000 kg No report
834.790 kgUzbekistan 1,865.000 kg 2,364.170 kg Govt
Sub-total Central Asia  and
Transcaucasia 2,070.710 kg 7,318.220 kg 5,089.030 kg
Near and Middle East /South-West Asia
-Bahrain - 0.010 kg
126,554.000 kgIran ( Islamic Republic of) 149,577.000 kg 162,413.950 kg
-Iraq 1.000 kg 4.820 kg
-Israel  + 0.000 kg 5.100 kg
0.020 kgJordan 43.350 kg 22.670 kg
30.380 kgKuwait 40.800 kg 11.710 kg ICPO
7.000 kgLebanon 3.000 kg 7.630 kg
0.880 kgOman 12.000 kg 0.060 kg INCB
109,420.400 kgPakistan 7,422.770 kg 2,737.000 kg ICPO
2.270 kgQatar 0.340 kg 0.960 kg ICPO
155.770 kgSaudi Arabia 23.040 kg 16.130 kg ICPO
-Syrian Arab Republic - 6.000 kg
61.610 kgUnited Arab Emirates 16.270 kg 3.820 kg
Sub-total Near and Middle East
/South-West Asia 236,232.320 kg 157,139.580 kg 165,229.850 kg
South Asia
No reportBangladesh 0.070 kg No report
    . (+ )  Small quantity
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1,339.000 kgIndia 2,875.000 kg 3,221.000 kg Govt
0.210 kgNepal 0.440 kg No report
0.080 kgSri Lanka 0.150 kg 1,571 u .
Sub-total South Asia 1,339.290 kg 2,875.660 kg 3,221.000 kg
1,571 u .
East and South-East Asia
19.000 kgCambodia  Govt No report 15.010 kg ICPO
1,110.000 kgChina 1,745.000 kg 1,900.000 kg ICPO
8.000 kg  Govt 12.800 kg 3.400 kgChina (Hong Kong SAR)
0.030 kgIndonesia 0.030 kg -
32.820 kgJapan 31.110 kg 39.060 kg
695.500 kgLao People's Dem. Rep.  Govt 199.000 kg 200.100 kg Govt  Govt
155.090 kgMalaysia 2.640 kg 150.310 kg Govt
1,060.720 kgMyanmar 1,300.000 kg 8,078.350 kg
7.140 kgRepublic of Korea 0.570 kg 6.810 kg
80.490 kgSingapore 28.460 kg 1.550 kg
927.460 kgThailand 381.320 kg 1,550.060 kg ICPO
No reportViet Nam 839.850 kg No report
Sub-total East and South-East Asia 4,096.250 kg 4,540.780 kg 11,944.640 kg
Total Asia 243,738.570 kg 171,874.240 kg 185,484.510 kg
1,571 u .
AMERICAS
North America
1.430 kgCanada 1.150 kg 11.930 kg
222.910 kgMexico 196.420 kg 342.080 kg
42.080 kgUnited States 61.930 kg 39.010 kg
Sub-total North America 266.420 kg 259.500 kg 393.020 kg
Central America
5.730 kgPanama - -
Sub-total Central America 5.730 kg
South America
144.160 kgColombia 102.770 kg 121.550 kg
23.810 kgPeru - -
Sub-total South America 167.970 kg 102.770 kg 121.550 kg
Total Americas 440.120 kg 362.270 kg 514.570 kg
EUROPE
Eastern Europe
88.540 kgBelarus - 1.120 kg INCB
0.370 kgBulgaria 0.080 kg 8.240 kg
0.010 kgCroatia - 0.000 kg +
-Czech Republic 1.000 kg -
No reportEstonia 0.000 kg -
0.080 kgHungary - No report
-Latvia 0.000 kg 0.230 kg
3.110 kgLithuania 0.280 kg 0.240 kg
    . (+ )  Small quantity
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1.380 kgRepublic of Moldova - 20.000 kg
1.000 kgRomania 1.440 kg 2.490 kg ICPO
1,156.900 kgRussian Federation 1,400.500 kg 222.710 kg
9.960 kgThe former Yug.Rep of Macedonia 2.000 kg No report
23.000 kgUkraine 194.530 kg -
Sub-total Eastern Europe 1,284.360 kg 1,599.830 kg 255.030 kg
Western Europe
1.770 kgAustria 17.670 kg 9.040 kg
0.020 kgBelgium - -
0.030 kgCyprus 0.650 kg 1.910 kg
-Denmark 0.050 kg 0.110 kg
0.080 kgFinland 0.250 kg -
1.010 kgFrance 4.330 kg 2.700 kg
14.530 kgGermany 45.390 kg 41.660 kg
0.410 kgGreece 0.240 kg 2.560 kg
0.100 kgItaly 0.620 kg 9.820 kg
- - 54 u .
6.000 kgNetherlands No report -
0.020 kgNorway 1.290 kg 0.020 kg
-Portugal - 0.010 kg
0.010 kgSpain 2.860 kg 26.290 kg
7.730 kgSweden 30.680 kg 7.710 kg
- - 139 u .
0.130 kgSwitzerland 0.170 kg 0.040 kg
121.550 kgTurkey 233.000 kg 38.680 kg
5.500 kgUnited Kingdom 11.400 kg 17.780 kg
Sub-total Western Europe 158.880 kg 348.580 kg 158.320 kg
193 u .
Total Europe 1,443.240 kg 1,948.420 kg 413.350 kg
193 u .
OCEANIA
0.120 kgAustralia 8.070 kg 2.100 kg
687 u . - -
0.190 kgNew Zealand No report 0.020 kg INCB
Total Oceania 0.310 kg
687 u .
8.070 kg 2.110 kg
TOTAL  OPIUM (RAW AND
PREPARED)
245,652.530 kg
687 u .
174,211.610 kg 186,445.790 kg
1,764 u .
Opium (plant,capsule)
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AFRICA
North Africa
17,621,797 u .Egypt 3,639,320,927 u . -
13.000 kgTunisia No report No report
Sub-total North Africa 13.000 kg
17,621,797 u . 3,639,320,927 u .
West and Central Africa
No reportSao Tome and Principe No report 0.300 kg
Sub-total West and Central Africa 0.300 kg
Total Africa 13.000 kg
17,621,797 u . 3,639,320,927 u .
0.300 kg
ASIA
Central Asia  and Transcaucasia
7.740 kgArmenia 76.830 kg 4.460 kg
95,000.000 kgAzerbaijan  Govt No report 38,750.000 kg ICPO
No reportGeorgia 19.170 kg No report
-Kazakhstan 335.720 kg No report
1.370 kgKyrgyzstan - -
936.380 kgUzbekistan 863.770 kg 118.290 kg
Sub-total Central Asia  and
Transcaucasia 95,945.490 kg 1,295.480 kg 38,872.750 kg
Near and Middle East /South-West Asia
23.510 kgKuwait No report No report
-Saudi Arabia 0.040 kg No report
-United Arab Emirates - 129 u .
Sub-total Near and Middle East
/South-West Asia 23.510 kg 0.040 kg
129 u .
South Asia
10.000 kgIndia No report -
-Nepal - 0.690 kg ICPO
Sub-total South Asia 10.000 kg 0.690 kg
East and South-East Asia
21,313.000 kgChina - No report
-Indonesia - 1,620 u .
8,240 u .Japan - 6,803 u .
-Malaysia No report 321 u .
235,896 u .Republic of Korea 72,645 u . 24,301 u .
115.880 kgThailand  Govt No report 202.080 kg ICPO
1,418.000 kgViet Nam No report 919.000 kg ICPO
Sub-total East and South-East Asia 22,846.880 kg
244,136 u . 72,645 u .
1,121.080 kg
33,045 u .
Total Asia 118,825.880 kg
244,136 u .
1,295.520 kg
72,645 u .
39,994.520 kg
33,174 u .
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AMERICAS
North America
0.480 kgCanada 4.760 kg 18 u .
-United States - 50.690 kg
- - 0.110 lt.
Sub-total North America 0.480 kg 4.760 kg 50.690 kg
0.110 lt.
18 u .
Central America
No reportGuatemala - 2.600 kg Govt
No report - 69,119 u .  Govt
Sub-total Central America 2.600 kg
69,119 u .
South America
-Argentina 301 u . 2.470 kg Govt
76,117,500 u .Colombia 75,000 u . 104,818,500 u .
0.440 kgPeru 534.250 kg 1,754 u .
Sub-total South America 0.440 kg
76,117,500 u .
534.250 kg
75,301 u .
2.470 kg
104,820,254 u .
Total Americas 0.920 kg
76,117,500 u .
539.010 kg
75,301 u .
55.760 kg
0.110 lt.
104,889,391 u .
EUROPE
Eastern Europe
1,470.000 kgBelarus 1,792.000 kg 327.740 kg INCB
18.560 kgBulgaria 48.500 kg -
0.010 kgCroatia - 769 u .
1,500 u . - -
No reportEstonia 135.430 kg 165.800 kg
216.000 kgLatvia 0.180 kg 218.000 kg
432,000 u . - -
976.000 kgLithuania 1,652.000 kg 1,291.000 kg
1,100.000 kgPoland 1,000.000 kg 8,500.000 kg
4,397.590 kgRepublic of Moldova - 597.000 kg
22,864.600 kgRussian Federation 19,469.800 kg 853.020 kg
199.200 kgUkraine - 34,003.260 kg
36,797 u . - -
Sub-total Eastern Europe 31,241.950 kg
470,297 u .
24,097.910 kg 45,955.830 kg
769 u .
Western Europe
8.560 kgAustria 1,103.860 kg 1.190 kg
106 u .Greece 130 u . 640 u .
5,034 u .Italy - 1,448 u .
252.790 kgNorway - 0.120 kg
-Portugal 150 u . -
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75,867.000 kgSpain 11,186.000 kg 862.110 kg
0.780 kgSweden - - *
1,508 u .Turkey - 389,372 u .
Sub-total Western Europe 76,129.130 kg
6,648 u .
12,289.860 kg
280 u .
863.420 kg
391,460 u .
Total Europe 107,371.090 kg
476,945 u .
36,387.770 kg
280 u .
46,819.250 kg
392,229 u .
OCEANIA
0.040 kgAustralia 0.000 kg 0.100 kg
105 u . - -
2,715 u .New Zealand  Govt No report No report
Total Oceania 0.040 kg
2,820 u .
0.000 kg 0.100 kg
TOTAL  OPIUM (PLANT,CAPSULE) 226,210.930 kg
94,463,198 u .
38,222.290 kg
3,639,469,153 u .
86,869.910 kg
0.110 lt.
105,314,794 u .
. (*)  Includes other opium
Opium (poppy seed)
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AFRICA
North Africa
2,655.580 kgEgypt - -
Sub-total North Africa 2,655.580 kg
Total Africa 2,655.580 kg
ASIA
Central Asia  and Transcaucasia
No reportArmenia - 2.330 kg
-Kyrgyzstan 32,392 u . -
0.200 kgUzbekistan - -
Sub-total Central Asia  and
Transcaucasia 0.200 kg
32,392 u .
2.330 kg
Near and Middle East /South-West Asia
0.000 kgBahrain 0.020 kg -
Sub-total Near and Middle East
/South-West Asia 0.000 kg 0.020 kg
South Asia
17.900 kgSri Lanka 58.250 kg -
Sub-total South Asia 17.900 kg 58.250 kg
East and South-East Asia
-China 29,754.000 kg No report
-Japan 12,425 u . -
-Republic of Korea - 0.040 kg
Sub-total East and South-East Asia 29,754.000 kg
12,425 u .
0.040 kg
Total Asia 18.100 kg 29,812.270 kg
44,817 u .
2.370 kg
AMERICAS
North America
0.000 kgCanada 0.050 kg 0.010 kg
2,134.420 kgMexico 1,155.150 kg 587.030 kg
Sub-total North America 2,134.430 kg 1,155.200 kg 587.040 kg
Central America
No reportGuatemala - 0.010 kg Govt
Sub-total Central America 0.010 kg
South America
208.910 kgColombia - 411.200 kg
0.150 kgPeru - -
Sub-total South America 209.060 kg 411.200 kg
Total Americas 2,343.490 kg 1,155.200 kg 998.260 kg
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EUROPE
Eastern Europe
-Croatia 14.000 kg -
No reportRepublic of Moldova 2,264.000 kg -
Sub-total Eastern Europe 2,278.000 kg
Western Europe
-Finland - 6.520 kg
-Italy 15,919 u . -
-Norway 41.100 kg -
-Portugal 0.040 kg -
Sub-total Western Europe 41.140 kg
15,919 u .
6.520 kg
Total Europe 2,319.140 kg
15,919 u .
6.520 kg
OCEANIA
-Australia - 1.410 kg
Total Oceania 1.410 kg
TOTAL  OPIUM (POPPY SEED) 5,017.170 kg 33,286.600 kg
60,736 u .
1,008.550 kg
Synthetic narcotics
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AFRICA
North Africa
13,656 u .Tunisia No report No report
13,656 u .Sub-total North Africa
West and Central Africa
216,434 u .Côte d'Ivoire - -
No reportGambia No report 1,750 u .  ICPO
No reportMali No report 1.100 kg ICPO
No report No report 3,336 u .  ICPO
No reportNiger No report 752,718 u .  ICPO
56 u .Nigeria No report 760.750 kg ICPO
1,264 u .Senegal No report No report
Sub-total West and Central Africa
217,754 u .
761.850 kg
757,804 u .
East Africa
-Mauritius - 784 u .  ICPO
Sub-total East Africa 784 u .
Southern Africa
No reportZambia No report 0.880 kg ICPO
No report No report 383 u .  ICPO
Sub-total Southern Africa 0.880 kg
383 u .
Total Africa
231,410 u .
762.730 kg
758,971 u .
ASIA
Central Asia  and Transcaucasia
No reportArmenia 1.020 kg -
No report 1,550 u . -
No reportGeorgia 0.000 kg No report
0.320 kgKyrgyzstan 13.990 kg 0.020 kg
-Uzbekistan - 287 u .
Sub-total Central Asia  and
Transcaucasia 0.320 kg 15.010 kg
1,550 u .
0.020 kg
287 u .
Near and Middle East /South-West Asia
129,832 u .Kuwait No report No report
-Qatar - 2,503 u .  ICPO
No reportYemen No report 60 u .  ICPO
129,832 u .
Sub-total Near and Middle East
/South-West Asia
2,563 u .
South Asia
No reportBangladesh 16,075 u . No report
-Nepal - 6,439 u .  ICPO
Sub-total South Asia 16,075 u . 6,439 u .
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East and South-East Asia
145 u .Brunei Darussalam - -
240,212 u .China 79,373 u . No report
212.000 kg - -China (Hong Kong SAR)
-Indonesia 138 u . 863 u .
3.010 kgJapan 0.030 kg 0.010 kg
7,411 u . 15,098 u . 8,240 u .
No report No report 8,968 u .  ICPOMacao
59,541 u .Malaysia No report -
-Philippines - 93 u .  ICPO
-Republic of Korea 200 u . -
233 u .Singapore 69,631 u . 7,670 u .
No reportThailand No report 86 u .  ICPO
Sub-total East and South-East Asia 215.010 kg
307,542 u .
0.030 kg
164,440 u .
0.010 kg
25,920 u .
Total Asia 215.330 kg
437,374 u .
15.040 kg
182,065 u .
0.030 kg
35,209 u .
AMERICAS
North America
0.170 kgCanada 0.400 kg 154.120 kg
0.030 lt. 1.960 lt. 0.290 lt.
- 827 u . 2,645 u .
0.030 kgUnited States 767.100 kg -
1,652 u . 6,646 u . -
Sub-total North America 0.200 kg
0.030 lt.
1,652 u .
767.500 kg
1.960 lt.
7,473 u .
154.120 kg
0.290 lt.
2,645 u .
South America
0.360 kgArgentina No report -
8,406 u . No report -
Sub-total South America 0.360 kg
8,406 u .
Total Americas 0.560 kg
0.030 lt.
10,058 u .
767.500 kg
1.960 lt.
7,473 u .
154.120 kg
0.290 lt.
2,645 u .
EUROPE
Eastern Europe
0.340 kgBulgaria - -
3,685 u .Croatia 4,438 u . 3,554 u .
6.400 kgHungary - No report
-Latvia 0.020 kg -
-Lithuania 0.020 kg 0.000 lt.  *
- 0.020 lt. -
- 92 u . 252 u .  *
-Russian Federation - 287 u .
. (*)  Includes other
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No reportSlovenia 186 u . 81 u .
No reportUkraine 9.780 kg -
Sub-total Eastern Europe 6.740 kg
3,685 u .
9.820 kg
0.020 lt.
4,716 u .
0.000 lt.
4,174 u .
Western Europe
31 u .Andorra No report No report
0.110 kgAustria - -
549 u .Belgium - 1,100 u .
2,273 u .Denmark - -
1,164 u .France 630 u . 854 u .
0.560 kgGermany - 0.180 kg
- 4,443 u . 0.990 lt.
1,932 u . - 3,482 u .
0.010 kgGreece - -
19 u . - -
No reportIreland - 34.000 lt.
No report - 408 u .
3.120 kgItaly 1.900 kg 0.080 kg
156 u . - 5,080 u .
5 u .Luxembourg - -
0.120 lt.Malta - 0.010 kg
- 94 u . -
1.000 kgNetherlands No report -
2,946 u . No report -
5,877 u .Norway 14,431 u . 16,076 u .
0.200 kgPortugal - 0.000 kg
- - 7 u .
2,857 u .Switzerland - 5.230 kg
135,629 u .Turkey 259,097 u . -
-United Kingdom 87.530 kg -
- 175 u . -
Sub-total Western Europe 4.990 kg
0.120 lt.
153,438 u .
89.430 kg
278,870 u .
5.490 kg
34.990 lt.
27,007 u .
Total Europe 11.730 kg
0.120 lt.
157,123 u .
99.250 kg
0.020 lt.
283,586 u .
5.490 kg
35.000 lt.
31,181 u .
OCEANIA
2.170 kgAustralia 2.560 kg 2.260 kg
0.140 lt. 0.250 lt. -
2 u . 3 u . -
2,148 u .New Zealand No report No report
Total Oceania 2.170 kg
0.140 lt.
2,150 u .
2.560 kg
0.250 lt.
3 u .
2.260 kg
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TOTAL  SYNTHETIC NARCOTICS 229.800 kg
0.290 lt.
838,115 u .
884.350 kg
2.230 lt.
473,127 u .
924.640 kg
35.280 lt.
828,006 u .
Depressants (Excluding Methaqualone)
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AFRICA
North Africa
10.280 kgEgypt - -
178,815 u . - -
523,317 u .Morocco  Govt 28,988 u . 36,236 u . Govt  Govt
No reportSudan 14,345 u . No report
13,664 u .Tunisia 4,330 u . No report
Sub-total North Africa 10.280 kg
715,796 u . 47,663 u . 36,236 u .
West and Central Africa
No reportBenin No report 24 u .  Govt
255 u .Cameroon 222 u . No report
22,696 u .Côte d'Ivoire 8,290 u . 71.500 kg
- - 44,699 u .
No reportGabon 100 u . No report
1,171 u .Gambia 18,650 u . No report
0.140 kgGhana - -
16,000 u . - -
3.500 kgMali No report No report
6,138 u . No report No report
No reportNiger 591,703 u . No report
91.000 kgNigeria 1,183.250 kg 1,426.490 kg
No reportTogo 9.280 kg No report
Sub-total West and Central Africa 94.640 kg
46,260 u .
1,192.530 kg
618,965 u .
1,497.990 kg
44,723 u .
East Africa
4,064 u .Mauritius 1,886 u . No report
4,064 u .Sub-total East Africa 1,886 u .
Southern Africa
0.480 kgZambia 0.830 kg No report
20,715 u . No report No report
Sub-total Southern Africa 0.480 kg
20,715 u .
0.830 kg
Total Africa 105.390 kg
786,835 u .
1,193.350 kg
668,514 u .
1,497.990 kg
80,959 u .
ASIA
Central Asia  and Transcaucasia
No reportGeorgia 0.220 lt. No report
No report 4,956 u . No report
2,400 u .Kyrgyzstan - -
88 u .Uzbekistan 40 u . 970 u .
2,488 u .
0.220 lt.
4,996 u . 970 u .
Sub-total Central Asia  and
Transcaucasia
Near and Middle East /South-West Asia
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24.120 kgJordan - 2,794 u .
-Lebanon 14,510 u . 490 u .
-Qatar 12 u . No report
30,946 u .Saudi Arabia 23,594 u . No report
16 u .Syrian Arab Republic 17,921 u . -
Sub-total Near and Middle East
/South-West Asia 24.120 kg
30,962 u . 56,037 u . 3,284 u .
East and South-East Asia
18,186 u .Brunei Darussalam - 3,227 u .
231,419 u .China - No report
318,142 u .  Govt - 512,832 u .China (Hong Kong SAR)
48,294 u .Indonesia 0.100 kg -
- 48,294 u . -
0.470 kgJapan 109,778 u . 56,895 u .
79,468 u . - -
23,287 u . 5,942 u . No reportMacao
1,131 u .Philippines - No report
-Republic of Korea 130,000 u . 681,233 u .
48,117 u .Singapore 273 u . 582 u .
Sub-total East and South-East Asia 0.470 kg
768,044 u .
0.100 kg
294,287 u . 1,254,769 u .
Total Asia 24.590 kg
801,494 u .
0.100 kg
0.220 lt.
355,320 u . 1,259,023 u .
AMERICAS
North America
0.470 kgCanada 0.270 kg 0.880 kg
- 25,183 u . 0.120 lt.
42,386 u . - 122,359 u .
-Mexico 1,108,863 u . 117,104 u .
0.070 kgUnited States 0.330 kg 0.030 kg
- 442,712 u . 0.870 lt.
300,331 u . - 709,685 u .
Sub-total North America 0.550 kg
342,717 u .
0.590 kg
1,576,758 u .
0.910 kg
0.990 lt.
949,148 u .
Central America
106 u .Honduras No report 1 u .
106 u .Sub-total Central America 1 u .
South America
-Argentina No report 5,759 u .
-Chile 48,392 u . -
-Uruguay 2 u . No report
Sub-total South America 48,394 u . 5,759 u .
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Total Americas 0.550 kg
342,823 u .
0.590 kg
1,625,152 u .
0.910 kg
0.990 lt.
954,908 u .
EUROPE
Eastern Europe
-Bulgaria - 0.630 kg
-Croatia - 4,915 u .
No reportEstonia 0.020 lt. 9.140 kg
No report - 908 u .
No report 120 u . -
0.100 kgLatvia 0.980 kg 20,830 u .
100 u . 1,731 u . -
16.800 kgRussian Federation 91.000 kg 975 u .
No reportSlovakia No report 10,642 u .
No reportSlovenia 1,138 u . -
No reportUkraine 36.870 kg -
Sub-total Eastern Europe 16.900 kg
100 u .
128.840 kg
0.020 lt.
2,989 u .
9.770 kg
38,270 u .
Western Europe
201 u .Andorra No report No report
1,284 u .Belgium - -
123 u .Cyprus - -
8,053 u .Denmark - -
16,841 u .Finland 74,997 u . 48,395 u .
0.100 kgGermany 4,195 u . 6,035 u .
2,345 u . - -
No report 569 u . 1,058 u .Gibraltar
3.940 kgGreece 6.100 kg 10.400 kg
9,359 u . 41,520 u . 26,403 u .
No reportIreland - 0.250 kg
No report - 4,935 u .
0.230 kgItaly 2,599 u . 14,437 u .
4,081 u . - -
395 u .Malta 14 u . 212 u .
34,079 u .Norway 53,908 u . 130,000 u .
736 u .Portugal 1,544 u . 1,945 u .
127,128 u .Spain 63,543 u . 59,352 u .
6.600 kgUnited Kingdom 7.700 kg -
Sub-total Western Europe 10.870 kg
204,625 u .
13.800 kg
242,889 u .
10.650 kg
292,772 u .
Total Europe 27.770 kg
204,725 u .
142.640 kg
0.020 lt.
245,878 u .
20.410 kg
331,042 u .
OCEANIA
258 u .Australia 1.820 kg 0.380 kg
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- 336 u . -
402 u .New Zealand No report No report
Total Oceania
660 u .
1.820 kg
336 u .
0.380 kg
TOTAL  DEPRESSANTS (EXCLUDING
METHAQUALONE)
158.290 kg
2,136,537 u .
1,338.510 kg
0.230 lt.
2,895,200 u .
1,519.690 kg
0.990 lt.
2,625,932 u .
Hallucinogens (Excluding LSD but including Ecstasy)
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AFRICA
North Africa
-Egypt 19.450 lt. 46.570 lt.
28,267 u .Morocco - -
28,267 u .
19.450 lt. 46.570 lt.Sub-total North Africa
East Africa
2 u .Mauritius - No report
2 u .Sub-total East Africa
Southern Africa
2,135 u .South Africa - 118,784 u .
2,135 u .Sub-total Southern Africa 118,784 u .
30,404 u .
19.450 lt. 46.570 lt.
118,784 u .
Total              Africa
ASIA
Near and Middle East /South-West Asia
-Jordan - 10,178 u .
Sub-total Near and Middle East
/South-West Asia
10,178 u .
East and South-East Asia
20 u .  Govt - 49,613 u .China (Hong Kong SAR)
0.330 kgIndonesia 0.440 kg 5.200 kg
303 u . 300,052 u . 89,413 u .
0.010 kgJapan 298 u . 56 u .
No report 1,452 u . No reportMacao
-Malaysia No report 1,397,979 u .
Sub-total East and South-East Asia 0.350 kg
323 u .
0.440 kg
301,802 u .
5.200 kg
1,537,061 u .
Total Asia 0.350 kg
323 u .
0.440 kg
301,802 u .
5.200 kg
1,547,239 u .
AMERICAS
North America
159.830 kgCanada 50.260 kg 47.700 kg
- 719 u . 9,288 u .
-Mexico - 611.040 kg
43.280 kgUnited States 8,383.410 kg 44.590 kg
- 53,598 u . 59.970 lt.
236 u . - 151,934 u .
Sub-total North America 203.100 kg
236 u .
8,433.670 kg
54,317 u .
703.330 kg
59.970 lt.
161,222 u .
South America
18 u .Uruguay - No report
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18 u .Sub-total South America
Total Americas 203.100 kg
254 u .
8,433.670 kg
54,317 u .
703.330 kg
59.970 lt.
161,222 u .
EUROPE
Eastern Europe
-Belarus 0.310 kg No report
-Croatia - 0.000 kg
-Czech Republic - 0.000 kg
- - 4 u .
No reportEstonia 2,058 u . -
0.260 kgLatvia - 0.010 kg
2,080 u . - 23 u .
-Lithuania 56 u . 0.000 kg
- - 1,641 u .
1.000 kgRussian Federation 0.800 kg -
7,354 u .Slovenia - 7,440 u .
Sub-total Eastern Europe 1.260 kg
9,434 u .
1.110 kg
2,114 u .
0.010 kg
9,108 u .
Western Europe
201 u .Andorra No report No report
31,338 u .Austria 25,118 u . 23,522 u .
12.770 kgBelgium - 132.000 kg
320,441 u . - 125,718 u .
-Cyprus - 3 u .
2,115 u .Denmark 15,262 u . 0.100 kg
- - 5,802 u .
-Finland - 0.200 kg
- - 3,147 u .
5.520 kgFrance 1.520 kg 1.610 kg
380,858 u .Germany 692,397 u . 694,281 u .
No report 300 u . -Gibraltar
1,554 u .Greece - 0.010 kg
- - 136 u .
1,820 u .Iceland No report No report
3.700 kgIreland - 9 u .
123,699 u . - -
0.140 kgItaly 22,958 u . 0.030 kg
160,185 u . - 161,044 u .
18 u .Liechtenstein - 565 u .
784 u .Luxembourg 545 u . 367 u .
519 u .Malta - 247 u .
15 u .Monaco - -
391.000 kgNetherlands No report 1,054,918 u .
40,418 u . No report -
10,103 u .Norway 12,852 u . 13,182 u .
77 u .Portugal - -
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739,511 u .Spain 340,444 u . 184,950 u .
0.070 kgSweden 0.120 kg 0.140 kg
- - 1,540 u .
46,467 u .Switzerland 81,917 u . 86,676 u .
554,000 u .United Kingdom 0.100 kg 394.130 kg
- 5,797,729 u . -
Sub-total Western Europe 413.200 kg
2,414,123 u .
1.740 kg
6,989,522 u .
528.220 kg
2,356,107 u .
Total Europe 414.460 kg
2,423,557 u .
2.850 kg
6,991,636 u .
528.230 kg
2,365,215 u .
OCEANIA
6.450 kgAustralia 2.110 kg 1.390 kg
476 u . 56,128 u . -
3.400 kgNew Zealand No report No report
269 u . No report No report
Total Oceania 9.850 kg
745 u .
2.110 kg
56,128 u .
1.390 kg
TOTAL  HALLUCINOGENS
(EXCLUDING LSD BUT INCLUDING
ECSTASY)
627.760 kg
2,455,283 u .
8,439.070 kg
19.450 lt.
7,403,883 u .
1,238.150 kg
106.530 lt.
4,192,460 u .
LSD
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AFRICA
North Africa
406 u .Egypt 669 u . 15 u .
406 u .Sub-total North Africa 669 u . 15 u .
Southern Africa
3,107 u .South Africa 11,804 u . 2,730 u .
No reportZambia No report 0.080 kg ICPO
2 u .Zimbabwe No report No report
Sub-total Southern Africa
3,109 u . 11,804 u .
0.080 kg
2,730 u .
Total Africa
3,515 u . 12,473 u .
0.080 kg
2,745 u .
ASIA
Near and Middle East /South-West Asia
-Israel - 0.040 lt.
- 16,660 u . -
5,796 u . - 7,342 u .
No reportKuwait No report No report
-Saudi Arabia 3,882,730 u . No report
5,796 u . 3,899,390 u .
0.040 lt.
20,587 u .
Sub-total Near and Middle East
/South-West Asia
South Asia
113 u .India 1,285 u . - Govt
18 u .Nepal - No report
131 u .Sub-total South Asia 1,285 u .
East and South-East Asia
No report 46 u . 52 u .China (Hong Kong SAR)
3,328 u .Indonesia 3,328 u . -
2,261,423 u .Japan 3,668,201 u . 3,471 u .
2,264,751 u .Sub-total East and South-East Asia 3,671,575 u . 3,523 u .
2,270,678 u . 7,572,250 u .
0.040 lt.
24,110 u .
Total              Asia
AMERICAS
North America
73,523 u .Canada 0.260 kg 22,519 u .
- 17,613 u . -
0.010 kgUnited States 0.100 kg 1.490 kg
- 74,396 u . 0.450 lt.
- - 79,073 u .
Sub-total North America 0.010 kg
73,523 u .
0.360 kg
92,009 u .
1.490 kg
0.450 lt.
101,592 u .
Caribbean
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No report - 18 u .Bermuda
Sub-total Caribbean 18 u .
South America
49,105 u .Argentina 1,291 u . 563 u . Govt
0.000 kgBrazil - 3 u .
34 u .Chile 1,205 u . 1,764 u .
28 u .Uruguay 12 u . No report
Sub-total South America 0.000 kg
49,167 u . 2,508 u . 2,330 u .
Total Americas 0.010 kg
122,690 u .
0.360 kg
94,517 u .
1.490 kg
0.450 lt.
103,940 u .
EUROPE
Eastern Europe
387 u .Croatia 172 u . 114 u .
500 u .Czech Republic - -
No reportEstonia 4 u . -
266 u .Hungary 1,079 u . 1,450 u .  Govt
-Latvia 16 u . 205 u .
-Lithuania - 2 u .
-Poland - 542 u .
13 u .Romania - No report
No reportSlovakia No report 2 u .
No reportSlovenia 947 u . 156 u .
No reportUkraine - 14 u .
1,166 u .Sub-total Eastern Europe 2,218 u . 2,485 u .
Western Europe
148 u .Andorra No report No report
2,602 u .Austria 4,166 u . 5,243 u .
5,458 u .Belgium 13,704 u . 621 u .
-Cyprus 1 u . -
1,282 u .Denmark 262 u . 381 u .
500 u .Finland 41 u . 323 u .
70,217 u .France 74,780 u . 5,983 u .
71,069 u .Germany 67,082 u . 78,430 u .
No report 3 u . - *Gibraltar
426 u .Greece 1,106 u . 166 u .
11 u .Iceland No report No report
819 u .Ireland 5,901 u . 1,851 u .
35,499 u .Italy 14,191 u . 8,140 u .
100 u .Luxembourg 122 u . 4 u .
9 u .Malta 45 u . 19 u .
305 u .Netherlands No report 137,218 u .
1,321 u .Norway 551 u . 6,888 u .
11 u .Portugal 705 u . 84 u .
15,437 u .Spain 13,373 u . 25,368 u .
. (*)  Includes other psy. substances
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373 u .Sweden 2,459 u . 1,541 u .
5,098 u .Switzerland 9,010 u . 9,424 u .
381,800 u .United Kingdom 216,697 u . 1,860 u .
592,485 u .Sub-total Western Europe 424,199 u . 283,544 u .
593,651 u .Total Europe 426,417 u . 286,029 u .
OCEANIA
0.040 kgAustralia 0.650 kg -
1,364 u . 6,180 u . -
18,426 u .New Zealand Govt No report No report
Total Oceania 0.040 kg
19,790 u .
0.650 kg
6,180 u .
TOTAL  LSD 0.050 kg
3,010,324 u .
1.010 kg
8,111,837 u .
1.570 kg
0.490 lt.
416,824 u .
. (*)  Includes other psy. substances
Methaqualone
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AFRICA
East Africa
537,000 u .Kenya - 5,000 u . +
No reportUganda 78.350 kg No report
14 u .United Republic of Tanzania No report 57 u .
Sub-total East Africa
537,014 u .
78.350 kg
5,057 u .
Southern Africa
970 u .Botswana No report No report
1,986 u .Malawi 1,000 u . 185.650 kg
- - 200,307 u .
3,719 u .Namibia 4,846 u . No report
30.010 kgSouth Africa 34.200 kg 50.560 kg
886,846 u . 432,807 u . 1,629,531 u .
26,830 u .Swaziland 7,408 u . 15,245 u .  ICPO
19,550.490 kgZambia 2.780 kg 0.000 kg ICPO
No report No report 611 u .  ICPO
459 u .Zimbabwe No report No report
Sub-total Southern Africa 19,580.500 kg
920,810 u .
36.980 kg
446,061 u .
236.220 kg
1,845,694 u .
Total Africa 19,580.500 kg
1,457,824 u .
115.340 kg
446,061 u .
236.220 kg
1,850,751 u .
ASIA
Near and Middle East /South-West Asia
-United Arab Emirates - 6,000.820 kg
Sub-total Near and Middle East
/South-West Asia 6,000.820 kg
South Asia
20,485.000 kgIndia 2,212.000 kg 1,740.000 kg Govt
Sub-total South Asia 20,485.000 kg 2,212.000 kg 1,740.000 kg
East and South-East Asia
No report 25 u . 4 u .China (Hong Kong SAR)
48,294 u .Indonesia 53,290 u . -
1,002 u .Myanmar - -
49,296 u .Sub-total East and South-East Asia 53,315 u . 4 u .
Total Asia 20,485.000 kg
49,296 u .
2,212.000 kg
53,315 u .
7,740.820 kg
4 u .
AMERICAS
North America
4 u .Canada 0.000 kg -
- 78 u . -
12,972 u .United States 80,585 u . 1,330 u .
Sub-total North America
12,976 u .
0.000 kg
80,663 u . 1,330 u .
    . (+ )  Small quantity
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Total Americas
12,976 u .
0.000 kg
80,663 u . 1,330 u .
EUROPE
Western Europe
123 u .Cyprus - -
-Greece - 41 u .
123 u .Sub-total Western Europe 41 u .
123 u .Total Europe 41 u .
TOTAL  METHAQUALONE 40,065.500 kg
1,520,219 u .
2,327.340 kg
580,039 u .
7,977.030 kg
1,852,126 u .
Stimulants
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AFRICA
North Africa
No reportAlgeria 43,211 u . No report
4,088,525 u .Egypt 415,237 u . 94,881 u .
-Tunisia 3 u . No report
4,088,525 u .Sub-total North Africa 458,451 u . 94,881 u .
West and Central Africa
No reportBurkina Faso No report 40,750 u .  ICPO
8,463 u .Côte d'Ivoire 1,809 u . -
25.000 kgGabon No report No report
1,207 u .Mali No report No report
No reportNiger 220,368 u . 186,574 u .  ICPO
45.000 kgNigeria 10.650 kg 309.530 kg
No reportSenegal 17 u . No report
Sub-total West and Central Africa 70.000 kg
9,670 u .
10.650 kg
222,194 u .
309.530 kg
227,324 u .
Southern Africa
14 u .South Africa 3,266 u . 0.280 kg
282.290 kgZambia 0.090 kg 0.050 kg ICPO
Sub-total Southern Africa 282.290 kg
14 u .
0.090 kg
3,266 u .
0.330 kg
Total Africa 352.290 kg
4,098,209 u .
10.740 kg
683,911 u .
309.860 kg
322,205 u .
ASIA
Central Asia  and Transcaucasia
No reportArmenia - 0.040 lt.  ICPO
No reportGeorgia 0.050 kg No report
No report 4.370 lt. No report
No report 224,461 u . No report
-Kyrgyzstan - 0.020 kg
-Uzbekistan 0.360 kg 0.430 kg ICPO
Sub-total Central Asia  and
Transcaucasia 0.410 kg
4.370 lt.
224,461 u .
0.450 kg
0.040 lt.
Near and Middle East /South-West Asia
7,583 u .Israel 50,784 u . 30,807 u .
-Jordan 2,586,467 u . 0.290 kg ICPO
- - 2,794,059 u .  ICPO
No reportKuwait 3.410 kg No report
30,700 u .Lebanon - -
4 u .Qatar 27 u . 1,026 u .  ICPO
6,571,645 u .Saudi Arabia 4,016,752 u . 10,852,279 u .  ICPO
65,000 u .Syrian Arab Republic 1,484,690 u . 2,463,977 u .
-United Arab Emirates 8,563 u . -
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No reportYemen No report 3,704 u .  ICPO
Sub-total Near and Middle East
/South-West Asia
6,674,932 u .
3.410 kg
8,147,283 u .
0.290 kg
16,145,852 u .
East and South-East Asia
-Brunei Darussalam 0.100 kg 0.120 kg
- 6,479 u . -
5.000 kgCambodia  Govt No report 13,928 u .  ICPO
1,303.000 kgChina 1,599.000 kg 1,330.000 kg ICPO
15.400 kg  Govt 46.800 kg 73.600 kgChina (Hong Kong SAR)
No report 14,295 u . 3,461 u .
-Indonesia 0.330 kg 5.620 kg
- 303 u . -
89.190 kgJapan 652.190 kg 173.530 kg
- - 2.200 lt.
135 u . - 1,415 u .
No reportLao People's Dem. Rep. 9.700 kg 774,714 u . Govt  Govt
0.130 kg 0.250 kg No reportMacao
-Malaysia No report 2.000 kg
-Myanmar 5,906,555 u . 5,028,600 u .
207.590 kgPhilippines 1,394.460 kg 694.480 kg ICPO
- - 2.000 lt.  ICPO
12.980 kgRepublic of Korea 33.250 kg 24.870 kg
0.010 kgSingapore 252 u . 0.090 kg
- - 8,141 u .
561.000 kgThailand  Govt 442.000 kg 2,167.000 kg Govt  Govt
234.000 kgViet Nam No report No report
Sub-total East and South-East Asia 2,428.300 kg
135 u .
4,178.080 kg
5,927,884 u .
4,471.310 kg
4.200 lt.
5,830,259 u .
Total Asia 2,428.300 kg
6,675,067 u .
4,181.910 kg
4.370 lt.
14,299,628 u .
4,472.050 kg
4.240 lt.
21,976,111 u .
AMERICAS
North America
-Canada 0.560 kg 2.260 kg
- 1,572 u . 0.230 lt.
-Mexico - 38.090 kg
997.900 kgUnited States 1,469.160 kg 1,428.800 kg
- 25,890 u . 84.940 lt.
- - 3,747,486 u .
Sub-total North America 997.900 kg 1,469.730 kg
27,462 u .
1,469.150 kg
85.170 lt.
3,747,486 u .
Caribbean
No reportBahamas No report 0.200 kg ICPO
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No report 0.260 kg -Cayman Islands
Sub-total Caribbean 0.260 kg 0.200 kg
South America
13,744 u .Argentina 480 u . 504 u . Govt
-Brazil 0.030 kg -
27,044 u .Chile 17,463 u . 55,686 u .
-Uruguay 37 u . No report
Sub-total South America
40,788 u .
0.030 kg
17,980 u . 56,190 u .
Total Americas 997.900 kg
40,788 u .
1,470.010 kg
45,442 u .
1,469.350 kg
85.170 lt.
3,803,676 u .
EUROPE
Eastern Europe
0.410 kgBelarus - No report
-Bulgaria - 134.290 kg
1,739 u .Croatia 2,075 u . 1.260 kg
- - 1,596 u .
0.170 kgCzech Republic 21.760 kg 0.620 kg
- - 56 u .
No reportEstonia 0.020 kg 0.730 kg
No report No report 0.080 lt.
3,797 u .Hungary 2.470 kg 12.330 kg Govt
- 5,818 u . No report
1.000 kgLatvia 1.340 kg 0.370 kg
500 u . - -
0.340 lt.Lithuania 0.050 kg 0.210 kg
- 1.040 lt. 1.350 lt.
- - 5,641 u .
18.870 kgPoland 15.250 kg 27.150 kg
0.010 kgRepublic of Moldova - 20.610 kg
No report - 1,034 u .
14 u .Romania 11,420 u . 3,289 u .  ICPO
4.700 kgRussian Federation 21.800 kg -
0.000 kgSlovakia No report 0.090 kg
No reportSlovenia 18,748 u . 1.410 kg
-The former Yug.Rep of Macedonia 42 u . No report
No reportUkraine 7.100 kg 39.500 kg
Sub-total Eastern Europe 25.150 kg
0.340 lt.
6,050 u .
69.800 kg
1.040 lt.
38,103 u .
238.550 kg
1.430 lt.
11,616 u .
Western Europe
4 u .Andorra No report No report
1,562 u .Austria 3,767 u . 7,895 u .
77.030 kgBelgium 24.000 kg 77.000 kg
504 u . 184,413 u . 511 u .
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0.050 kgCyprus 0.000 kg 0.050 kg ICPO
120 u . 18 u . -
40.000 kgDenmark 26.700 kg 119.400 kg
20.120 kgFinland 22.410 kg 22.190 kg
3,752 u . 1,011 u . 1,101 u .
103.660 kgFrance 127.970 kg 194.050 kg
273,779 u . 349,210 u . 198,941 u .
137.850 kgGermany 159.770 kg 233.630 kg
No report - 0.030 kgGibraltar
0.110 kgGreece 0.010 kg 0.030 kg
1,725 u . 2,104 u . 958 u .
5.150 kgIceland No report No report
1.500 kgIreland 19,244 u . 102.590 kg
No report - 22,191 u .
1.100 kgItaly 154,503 u . 0.380 kg
9,071 u . - 10,950 u .
0.020 kgLiechtenstein 122 u . -
91 u .Luxembourg - 0.010 kg ICPO
-Malta 686 u . 0.060 kg
- - 100 u .
0.020 kgMonaco 1 u . -
15 u . - -
46.000 kgNetherlands No report -
850 u . No report -
52.770 kgNorway 30.290 kg 93.240 kg
695 u .Portugal 4,093 u . 0.020 kg
- - 549 u .
35.040 kgSpain 53.410 kg 119.580 kg
277.380 kgSweden 163.780 kg 187.370 kg
- - 16,057 u .
2.150 kgSwitzerland 4.520 kg 7.980 kg
-Turkey - 460,020 u .
813.000 kgUnited Kingdom 2,623.240 kg 2,718.000 kg
- 1,956 u . -
Sub-total Western Europe 1,612.930 kg
292,168 u .
3,236.090 kg
721,128 u .
3,875.620 kg
719,273 u .
Total Europe 1,638.080 kg
0.340 lt.
298,218 u .
3,305.890 kg
1.040 lt.
759,231 u .
4,114.170 kg
1.430 lt.
730,889 u .
OCEANIA
618.480 kgAustralia 339.960 kg 202.810 kg
0.070 lt. 0.100 lt. -
546 u . 13,742 u . -
0.250 kgNew Zealand  Govt No report No report
Total Oceania 618.730 kg
0.070 lt.
546 u .
339.960 kg
0.100 lt.
13,742 u .
202.810 kg
 1995Region /country or territory  1996  1997
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TOTAL  STIMULANTS 6,035.310 kg
0.410 lt.
11,112,828 u .
9,308.510 kg
5.510 lt.
15,801,954 u .
10,568.240 kg
90.840 lt.
26,832,881 u .
Khat
 1995Region /country or territory  1996  1997
Other drugs
- 247-
AFRICA
North Africa
28.000 kgEgypt 4.200 kg 1.770 kg
Sub-total North Africa 28.000 kg 4.200 kg 1.770 kg
East Africa
367.800 kgUnited Republic of Tanzania No report 592.130 kg
Sub-total East Africa 367.800 kg 592.130 kg
Southern Africa
39,888.790 kgZambia No report 40.120 kg ICPO
Sub-total Southern Africa 39,888.790 kg 40.120 kg
Total Africa 40,284.590 kg 4.200 kg 634.020 kg
ASIA
Near and Middle East /South-West Asia
0.090 kgBahrain 0.160 kg -
-Jordan - 1.000 kg
- - 245 u .
No reportKuwait 0.020 kg No report
1.160 kgQatar - No report
80,693.060 kgSaudi Arabia No report No report
-Syrian Arab Republic 1.890 kg -
1.820 kgUnited Arab Emirates 1.500 kg 0.890 kg
Sub-total Near and Middle East
/South-West Asia 80,696.120 kg 3.560 kg 1.890 kg
245 u .
Total Asia 80,696.120 kg 3.560 kg 1.890 kg
245 u .
AMERICAS
North America
-Canada - 2,492.910 kg
-United States - 27.940 kg
Sub-total North America 2,520.850 kg
Total Americas 2,520.850 kg
EUROPE
Eastern Europe
-Czech Republic 3.100 kg -
Sub-total Eastern Europe 3.100 kg
Western Europe
2,270.500 kgDenmark 4,534.630 kg 4,050.800 kg
68.110 kgFinland 264.460 kg 249.010 kg
209.330 kgFrance 36.860 kg 779.030 kg
213.890 kgItaly 61.210 kg 180.400 kg
1,930 u . - -
1,333.630 kgNorway 1,544.300 kg 1,725.450 kg
 1995Region /country or territory  1996  1997
- 248-
1,955.000 kgSweden 1,955.330 kg 2,691.000 kg
432.420 kgSwitzerland - -
Sub-total Western Europe 6,482.890 kg
1,930 u .
8,396.790 kg 9,675.680 kg
Total Europe 6,482.890 kg
1,930 u .
8,399.890 kg 9,675.680 kg
TOTAL  KHAT 127,463.600 kg
1,930 u .
8,407.660 kg 12,832.440 kg
245 u .
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19
97
Y
ea
r
 unit ** 
 Cannabis (liquid) 
 Cannabis herb 
 Cannabis plant 
 Cannabis resin 
 Cannabis seed 
 Coca leaf 
 Coca bush 
 Cocaine (base and 
salts) 
 Heroin 
 Morphine 
 Other opiates 
 Opium (liquid) 
 Opium (raw and 
prepared) 
 Opium 
(plant,capsule) 
 Synthetic narcotics 
 Depressants 
(excluding 
methaqualone) 
 Hallucinogens 
(Excl. LSD but incl. 
Ecstasy) 
 LSD 
 Methaqualone 
 Stimulants 
 Khat 
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Statistics on laboratories detected and type of drug seized:
breakdown by drug, region and country or territory,  1993 - 1997
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
Amphetamine group
AFRICA
North Africa
1993 Amfetamine (Maxiton Forte)    1 lab (163.470 lt)Egypt
1994 Amfetamine    1 lab (64.900 lt)
1995 Amfetamine (Maxiton Forte)    1 lab
1997 Maxiton Forte    1 lab
    4 labs (228.380 lt)Subtotal North Africa
    4 labs (228.380 lt)Total Africa
AMERICAS
North America
1993 Amfetamine   12 labsUnited States
1994 Amfetamine    5 labs
1995 Amfetamine    2 labs
1996 Amfetamine    5 labs
1997 Amfetamine    2 labs
   26 labsSubtotal North America
   26 labsTotal Americas
EUROPE
Eastern Europe
1997 Amfetamine   10 labs (114.740 kg)Bulgaria
1997 Amfetamine    2 labsEstonia
1993 Amfetamine    1 labHungary
1996 Amfetamine    1 labLatvia
1997 Amfetamine    1 lab(4,398 units)Lithuania
1993 Amfetamine    1 lab (2.000 kg)Poland
1994 Amfetamine    2 labs (8.000 kg)
1997 Amfetamine   10 labs (11.000 kg)
   28 labs (135.740 kg)(4,398 units)Subtotal Eastern Europe
Western Europe
1993 Amfetamine    1 labBelgium
1994 Amfetamine    1 lab
1997 Amfetamine    1 lab
1994 Amfetamine    2 labsFinland
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-251-
1995 Amfetamine    1 lab
1996 Amfetamine    7 labs (0.200 kg)(200 units)Germany
1997 Amfetamine    9 labs (0.000 kg)
1995 Amfetamine    1 lab (934.000 kg)Italy
1993 Amfetamine    4 labsNetherlands
1993 Amfetamine hydrochloride    1 lab (0.500 kg)Spain
1996 Amfetamine    1 lab (2.000 kg)Sweden
1997 Amfetamine    2 labs (10.000 kg)
1993 Amfetamine   12 labsUnited Kingdom
1994 Amfetamine   12 labs
1995 Amfetamine   11 labs (5.000 kg)
1996 Amfetamine   20 labs (1.100 kg)
1997 Amfetamine    4 labs
   90 labs (952.800 kg)(200 units)Subtotal Western Europe
  118 labs (1,088.540 kg)(4,598 units)Total Europe
OCEANIA
Oceania
1993 Amfetamine    1 labAustralia
1994 Amfetamine    1 lab
    2 labsSubtotal Oceania
    2 labsTotal Oceania
  150 labs (1,088.540 kg) (228.380 lt)(4,598 units)Total : Amphetamine group
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-252-
Cannabis group
AMERICAS
North America
1993 Cannabis liquid    4 labsCanada
1994 Cannabis liquid    8 labs
1995 Cannabis  liquid    9 labs
1996 Liquid Hashish   17 labs
1997 Liquid Hashish    8 labs
   46 labsSubtotal North America
South America
1993 Cannabis liquid    1 labColombia
1994 Cannabis liquid    1 lab
    2 labsSubtotal South America
   48 labsTotal Americas
ASIA
Near and Middle East /South-West Asia
1996 Cannabis resin and cannabis liquid    2 labsLebanon
1997 Cannabis resin and oil    2 labs (58.000 kg)
    4 labs (58.000 kg)Subtotal Near and Middle East /South-West Asia
South Asia
1994 Cannabis liquid    1 labNepal
1995 Cannabis resin / liquid    1 lab
1996 Cannabis resin    1 lab
    3 labsSubtotal South Asia
    7 labs (58.000 kg)Total Asia
EUROPE
Eastern Europe
1993 Cannabis resin    1 labUkraine
1997 Hashish    1 lab
1997 Marijuana    1 lab
    3 labsSubtotal Eastern Europe
Western Europe
1994 Cannabis liquid    1 lab (0.000 kg)Germany
1997 Cannabis liquid    2 labs
1996 Herbal cannabis    1 lab (66.000 kg)Italy
    4 labs (66.000 kg)Subtotal Western Europe
    7 labs (66.000 kg)Total Europe
OCEANIA
Oceania
1993 Cannabis liquid   30 labsNew Zealand
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-253-
   30 labsSubtotal Oceania
   30 labsTotal Oceania
   92 labs (124.000 kg)Total : Cannabis group
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-254-
Coca group
AFRICA
West and Central Africa
1994 Cocaine (crack)    4 labsGhana
1996 Cocaine (crack)   30 labs
1997 Cocaine (crack)   30 labs(144 units)
   64 labs(144 units)Subtotal West and Central Africa
   64 labs(144 units)Total Africa
AMERICAS
Central America
1993 Cocaine (crack)    1 lab(3,367 units)Costa Rica
1994 Cocaine (crack)    1 lab (4.220 kg)
1995 Cocaine (crack)    1 lab
1996 Cocaine (crack)    1 lab
    4 labs (4.220 kg)(3,367 units)Subtotal Central America
North America
1993 Cocaine hydrochloride    1 labUnited States
    1 labSubtotal North America
South America
1997 Cocaine base 2238 labs (13.690 kg)Bolivia
1995 Cocaine    2 labs (70.500 kg)Brazil
1996 Cocaine salt    1 labChile
1997 Cocaine HCL    1 lab (4.250 kg)
1993 Coca paste  300 labs (19,800.000 kg)Colombia
1993 Cocaine base    1 lab
1994 Cocaine  420 labs (68.790 kg)
1996 Cocaine  470 labs (14,652.000 kg)
1997 Cocaine  208 labs (41.160 kg)
1994 Cocaine HCL   21 labsPeru
1995 Cocaine hydrochloride    1 lab (7,658.640 kg)
 3663 labs (42,309.020 kg)Subtotal South America
 3668 labs (42,313.240 kg)(3,367 units)Total Americas
EUROPE
Western Europe
1993 Cocaine (crack)    1 labGermany
1994 Cocaine (crack)    4 labs (0.030 kg)
1995 Cocaine (crack)    5 labs (0.060 kg)
1996 Cocaine (crack)    4 labs(598 units)
1997 Cocaine (crack)    1 lab
1994 Cocaine    4 labs (122.000 kg)Italy
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
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1995 Cocaine    1 lab (190.000 kg)
1997 Cocaine    1 lab (50.000 kg)
1993 Cocaine    1 lab (17.390 kg)Spain
1994 Cocaine    1 lab (1,270.000 kg)
1995 Cocaine    9 labs (311.540 kg)
1996 Cocaine    1 lab (17.870 kg)
1997 Cocaine    5 labs (14.990 kg)
   38 labs (1,993.880 kg)(598 units)Subtotal Western Europe
   38 labs (1,993.880 kg)(598 units)Total Europe
 3770 labs (44,307.120 kg)(4,109 units)Total : Coca group
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-256-
Combined amphetamine, methamphetamine and ecstasy
EUROPE
Western Europe
1993 Amfetamine/metamfetamine   15 labs (0.420 kg) (0.150 lt)Germany
1994 Amfetamine/metamfetamine   17 labs (0.050 kg)
1995 Amfetamine / Metamfetamine    8 labs (0.250 kg)
1994 Amfetamine/phencyclidin    1 labNorway
1994 Amfetamine/MDMA    1 lab (0.020 kg)(363 units)Spain
1995 MDMA / amfetamines    3 labs (0.010 kg)(303 units)
1993 Metamfetamine/amfetamine    1 labUnited Kingdom
   46 labs (0.750 kg) (0.150 lt)(666 units)Subtotal Western Europe
   46 labs (0.750 kg) (0.150 lt)(666 units)Total Europe
   46 labs (0.750 kg) (0.150 lt)(666 units)Total : Combined amphetamine, methamphetamine
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-257-
Combined opiates, coca and cannabis
ASIA
Near and Middle East /South-West Asia
1994 Heroin/cocaine base/cannabis
liquid/cannabis resin
   1 labLebanon
    1 labSubtotal Near and Middle East /South-West Asia
    1 labTotal Asia
EUROPE
Eastern Europe
1993 Poppy preparations/cannabis
preparations/ephedrine preparations (not
controlled)
   1 labRussian Federation
    1 labSubtotal Eastern Europe
    1 labTotal Europe
    2 labsTotal : Combined opiates, coca and cannabis
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-258-
Depressants
AFRICA
East Africa
1997 Nitrazepam    1 lab (1.000 kg)Mauritius
    1 lab (1.000 kg)Subtotal East Africa
Southern Africa
1996 Methaqualone    2 labs (33.000 kg)South Africa
1997 Methaqualone    1 lab (0.640 kg)(62 units)
    3 labs (33.640 kg)(62 units)Subtotal Southern Africa
    4 labs (34.640 kg)(62 units)Total Africa
ASIA
East and South-East Asia
1993 Flunitrazepam (Rohypnol)/nitrazepam
(Mogadon/nipam)
   1 lab (14.500 kg)Indonesia
1994 Methaqualone    1 lab (7,000.000 kg)Philippines
    2 labs (7,014.500 kg)Subtotal East and South-East Asia
South Asia
1994 Methaqualone    8 labs (7,111.960 kg)India
1995 Methaqualone    4 labs (7,336.000 kg)
   12 labs (14,447.960 kg)Subtotal South Asia
   14 labs (21,462.460 kg)Total Asia
EUROPE
Eastern Europe
1993 Glutethimide    1 labHungary
    1 labSubtotal Eastern Europe
Western Europe
1994 Valium/rohypnol/lexotan/depronal    1 labLuxembourg
    1 labSubtotal Western Europe
    2 labsTotal Europe
   20 labs (21,497.100 kg)(62 units)Total : Depressants
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-259-
Ecstasy group
AFRICA
Southern Africa
1996 MDMA    1 labSouth Africa
1997 MDMA    1 lab
    2 labsSubtotal Southern Africa
    2 labsTotal Africa
AMERICAS
North America
1993 Tenamfetamine (MDA)    1 labCanada
1994 Methylenedioxyamfetamine (MDA)    2 labs
1996 MDA    3 labs
1997 MDA    1 lab
1997 MDMA (Ecstacy)    2 labs
1993 3,4-methylenedioxymetamfetamine
(MDMA)
   3 labsUnited States
1993 Tenamfetamine (MDA)    2 labs
1994 3,4 Methylenedioxymetamfetamine
(MDMA)
   3 labs
1994 Tenamfetamine (MDA)    1 lab
1995 MDMA    2 labs
1996 3,4-Methlylenediioxymetamfetamine
(MDMA)
   3 labs
1997 3,4-methylenedioxymetamfetamine
(MDMA)
   7 labs
   30 labsSubtotal North America
   30 labsTotal Americas
ASIA
Near and Middle East /South-West Asia
1996 MDMA    1 lab (0.790 kg)(497 units)Israel
    1 lab (0.790 kg)(497 units)Subtotal Near and Middle East /South-West Asia
    1 lab (0.790 kg)(497 units)Total Asia
EUROPE
Eastern Europe
1997 Ecstasy    1 lab(10,026 units)Ukraine
1997 MDMA    1 lab (3.500 kg)
    2 labs (3.500 kg)(10,026 units)Subtotal Eastern Europe
Western Europe
1996 Ecstasy    1 labBelgium
1997 Ecstacy    2 labs
1996 Ecstasy    1 lab(300 units)France
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
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1993 Tenamfetamine (MDA)    2 labsGermany
1994 MDMA/tenamfetamine (MDA)    5 labs
1994 N-Methyl-1-1(1,3
Benzodioxol-5-YL)-2-Butanamin
(MBDB)
   1 lab
1996 Amfetamine-derivative (Ecstasy)    7 labs (4.400 kg)(615 units)
1997 Amfetamine-derivative (Ecstasy)    3 labs (0.040 kg)
1993 3,4-methylenedioxymetamfetamine
(MDMA)
   3 labsNetherlands
1993 N-ethyltenamfetamine (MDEA)    3 labs
1993 Tenamfetamine (MDA)    1 lab
1994 Methylendioxymetamfetamine    1 labNorway
1993 3,4-methylenedioxymetamfetamine
(MDMA)
   1 lab (0.750 kg)Spain
1996 Deritive of amfetamine (Speed and
MDMA)
   1 lab (7.730 kg)(17,407 units)
1997 MDMA    1 lab(1,010 units)
1993 3,4-methylenedioxymetamfetamine
(MDMA)
   2 labsUnited Kingdom
1993 Tenamfetamine (MDA)    1 lab
1994 MDMA    1 lab
1995 MDMA    1 lab(90,000 units)
1996 Ecstacy   50 labs
1997 Ecstasy (MDMA, 2C_B, DOB)    3 labs
   91 labs (12.920 kg)(109,332 units)Subtotal Western Europe
   93 labs (16.420 kg)(119,358 units)Total Europe
  126 labs (17.210 kg)(119,855 units)Total : Ecstasy group
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-261-
Hallucinogens
AMERICAS
North America
1993 Phencyclidine (PCP)    1 lab (1.300 kg)Canada
1993 Psilocybine    3 labs(389 units)
1994 Phencyclidine    1 lab
1994 Psilocybine    1 lab (5.300 kg)
1995 Phencyclidine    1 lab
1996 LSD    1 lab
1997 LSD    3 labs
1997 PCP    3 labs
1993 2,5-Dimethoxyamfetamine
(DMA)/brolamfetamine (DOB)
   1 labUnited States
1993 Phencyclidine (PCP)/phencyclidine
analogues (PCC/PHP)
   7 labs
1994 2,5-Dimethoxy-4-ethylamfetamine
(DOET)
   1 lab
1994 Phencyclidine (PCP)    9 labs
1995 PCP    6 labs
1996 PCP   10 labs
   48 labs (6.600 kg)(389 units)Subtotal North America
   48 labs (6.600 kg)(389 units)Total Americas
EUROPE
Eastern Europe
1996 LSD    1 lab(713 units)Slovenia
    1 lab(713 units)Subtotal Eastern Europe
Western Europe
1993 3,4,5-Trimethoxyamfetamine (TMA)    1 labGermany
1993 Mescaline/2,5-Dimethoxyamfetamine
(DMA)
   1 lab
1993 Paramethoxyamfetamine/mescaline    1 lab
1994 Brolamfetamine (DOB)    1 lab(20 units)
1994 Mescaline    1 lab (0.010 kg)
1995 Mescaline / MDMA    1 lab (0.020 kg)
1997 Mescaline    1 lab (0.000 kg)
1993 LSD    1 labNetherlands
    8 labs (0.030 kg)(20 units)Subtotal Western Europe
    9 labs (0.030 kg)(733 units)Total Europe
   57 labs (6.630 kg)(1,122 units)Total : Hallucinogens
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-262-
Methamphetamine group
AFRICA
North Africa
1996 Metamfetamine (Maxiton Forte)    1 labEgypt
    1 labSubtotal North Africa
    1 labTotal Africa
AMERICAS
North America
1993 Metamfetamine    3 labs (0.680 kg)Canada
1994 Metamfetamine    6 labs (0.060 kg)
1995 Metamfetamine    4 labs
1996 Metamfetamine    6 labs
1997 Metamfetamine    4 labs
1995 Metamfetamine    8 labsMexico
1997 Metamfetamine    7 labs
1993 Metamfetamine  218 labsUnited States
1994 Metamfetamine  253 labs
1995 Metamfetamine  327 labs
1996 Metamfetamine  879 labs
1997 Metamfetamine 1352 labs
 3067 labs (0.740 kg)Subtotal North America
 3067 labs (0.740 kg)Total Americas
ASIA
East and South-East Asia
1995 Metamfetamine   26 labs (1,303.000 kg)China
1996 Metamfetamine   30 labs (1,599.000 kg)
1994 Metamfetamine    1 lab (22.000 kg)China (Hong Kong SAR)
1996 Metamfetamine hydrochloride    1 lab (603.320 kg)Philippines
1993 Metamfetamine    4 labs (2.950 kg)Republic of Korea
1996 Metamfetamine    4 labs (4.680 kg)
1997 Stimulants (metamfetamine)    2 labs (1.830 kg)
1997 Metamfetamine   16 labs(17,500,000 units)Thailand
   84 labs (3,536.770 kg)(17,500,000 units)Subtotal East and South-East Asia
Near and Middle East /South-West Asia
1996 Metamfetamine    1 labIsrael
    1 labSubtotal Near and Middle East /South-West Asia
   85 labs (3,536.770 kg)(17,500,000 units)Total Asia
EUROPE
Eastern Europe
1993 Metamfetamine (pervitin)   50 labs (0.110 kg)Czech Republic
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
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1994 Metamfetamine   40 labs (0.800 kg)
1995 Metamfetamine (pervitin)   18 labs (0.100 kg)
1996 Metamfetamine (pervitin)   16 labs (0.760 kg)
1997 Metamfetamine (pervitin)   14 labs (0.700 kg)
1997 Metamfetamine    1 lab (0.040 kg)Slovakia
  139 labs (2.510 kg)Subtotal Eastern Europe
Western Europe
1997 Metamfetamine    1 lab (0.000 lt)Germany
    1 lab (0.000 lt)Subtotal Western Europe
  140 labs (2.510 kg) (0.000 lt)Total Europe
 3293 labs (3,540.020 kg) (0.000 lt)(17,500,000 units)Total : Methamphetamine group
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-264-
Opioids
AFRICA
West and Central Africa
1997 Heroin   16 labs(300 units)Ghana
   16 labs(300 units)Subtotal West and Central Africa
   16 labs(300 units)Total Africa
AMERICAS
North America
1993 Opiates    3 labs (29.300 kg)Mexico
1993 Fentanyl    2 labsUnited States
1994 Methadone    2 labs
    7 labs (29.300 kg)Subtotal North America
South America
1993 Heroin   10 labs (20.000 kg)Colombia
1993 Morphine    1 lab
1994 Heroin    1 lab (95.400 kg)
1994 Morphine   70 labs (85.750 kg)
1996 Heroine   81 labs (8.500 kg)
1997 Heroin    7 labs (297.170 kg)
  170 labs (506.820 kg)Subtotal South America
  177 labs (536.120 kg)Total Americas
ASIA
Central Asia  and Transcaucasia
1994 Promedol    1 lab (9.000 kg)Armenia
1996 Promedol    1 lab (1.020 kg)
    2 labs (10.020 kg)Subtotal Central Asia  and Transcaucasia
East and South-East Asia
1994 Heroin   20 labs (100.000 kg)China (Hong Kong SAR)
1995 Heroin No 2 and 3    3 labs (35.860 kg)Malaysia
1997 Heroin No.3    7 labs (55.000 kg)
1994 Heroin    2 labs (74.700 kg)Myanmar
1996 Heroin, liquid heroin   13 labs (151.610 kg) (264.950 lt)
1997 Heroin,opium,opium liquid,opium inferior   32 labs (1,479.860 kg)
1993 Opium raw    1 lab (15.000 kg)Republic of Korea
1997 Heroin    3 labsThailand
   81 labs (1,912.030 kg) (264.950 lt)Subtotal East and South-East Asia
South Asia
1993 Heroin    6 labs (3.520 kg)India
1994 Heroin    3 labs (27.060 kg)
1995 Heroin    8 labs (6.000 kg)
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
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1997 Heroin    9 labs (13.000 kg)
1997 Morphine   11 labs (83.000 kg)
   37 labs (132.580 kg)Subtotal South Asia
  120 labs (2,054.630 kg) (264.950 lt)Total Asia
EUROPE
Eastern Europe
1996 Opium liquid    1 labBelarus
1993 Codeine    1 labHungary
1993 Dihydrocodeine    1 lab
1993 Morphine    1 lab
1997 Methadone    1 lab (0.050 kg)Latvia
1994 Opium liquid   98 labs (25,000.000 lt)Lithuania
1995 Liquid opium   55 labs (50.000 lt)
1996 Opium liquid   14 labs (20.000 lt)
1997 Liquid Opium   16 labs (23.000 lt)
1993 Decoction of poppy straw  600 labs (175.000 kg)Poland
1994 Poppy straw extract  405 labs (223.000 lt)
1995 Polish heroin  380 labs (75.600 lt)
1997 Polish Heroin  707 labs (1,004.000 lt)
1997 Opium Liquid    9 labsRepublic of Moldova
1993 Opium    1 labUkraine
1997 Opium Extract    1 lab (171.000 kg)
 2291 labs (346.050 kg) (26,395.600 lt)Subtotal Eastern Europe
Western Europe
1993 Methadone hydrochloride    1 lab (0.010 kg)Germany
1993 Heroin    1 lab (3.130 kg)Spain
1993 Heroin    1 lab (64.140 kg)Turkey
1994 Heroin    6 labs (179.000 kg)
1995 Heroin    6 labs (145.000 kg)
1996 Heroin    1 lab (1,350.000 kg)
1996 Morphine Base    1 lab (750.000 kg)
1996 Opium    1 lab (63.370 kg)
1997 Heroin, opium gum, morphine base   14 labs (563.750 kg)
   32 labs (3,118.390 kg)Subtotal Western Europe
 2323 labs (3,464.440 kg) (26,395.600 lt)Total Europe
OCEANIA
Oceania
1993 Heroin    1 labAustralia
1994 Heroin    1 lab
1993 Heroin/morphine   10 labs (1.320 lt)New Zealand
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
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   12 labs (1.320 lt)Subtotal Oceania
   12 labs (1.320 lt)Total Oceania
 2648 labs (6,055.180 kg) (26,661.870 lt)(300 units)Total : Opioids
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-267-
Other
AMERICAS
South America
1995 PBC   19 labsPeru
1997 PBC,PBC-L,C.C   18 labs
   37 labsSubtotal South America
   37 labsTotal Americas
ASIA
East and South-East Asia
1996 Hydrochloric acid pehtidine    1 labRepublic of Korea
    1 labSubtotal East and South-East Asia
    1 labTotal Asia
EUROPE
Eastern Europe
1995 Psychotropic substances   24 labs (20.000 kg)Poland
1997 Psychotropic substances   14 labs (12.000 kg)
   38 labs (32.000 kg)Subtotal Eastern Europe
Western Europe
1997 Psychotropic substances and narcotics    1 labBelgium
1995 DOB    1 lab(246 units)Germany
1996 Ecmosil    2 labsSwitzerland
1996 Carobonade    1 lab (0.270 kg)Turkey
    5 labs (0.270 kg)(246 units)Subtotal Western Europe
   43 labs (32.270 kg)(246 units)Total Europe
   81 labs (32.270 kg)(246 units)Total : Other
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-268-
Other synthetic stimulants
AMERICAS
North America
1993 4-Methylaminorex    1 labUnited States
1993 Methcathinone (not controlled)   22 labs
1994 Methcathinone   20 labs
1995 Aminorex    2 labs
1995 Methcathinone   19 labs
1996 Methcathinone   10 labs
1997 Methcathinone    7 labs
   81 labsSubtotal North America
   81 labsTotal Americas
ASIA
Central Asia  and Transcaucasia
1995 Ephedrone    2 labs (0.330 kg)Kyrgyzstan
    2 labs (0.330 kg)Subtotal Central Asia  and Transcaucasia
    2 labs (0.330 kg)Total Asia
EUROPE
Eastern Europe
1994 Methcathinone    3 labs (500.000 lt)Lithuania
1995 Ephedron    3 labs (0.300 lt)
1996 Ephedron    4 labs (0.400 lt)
1997 Ephedron   13 labsRepublic of Moldova
   23 labs (500.700 lt)Subtotal Eastern Europe
   23 labs (500.700 lt)Total Europe
  106 labs (0.330 kg) (500.700 lt)Total : Other synthetic stimulants
Region
   Country or territory
Year Name of drug
seized 
Number of 
laboratories
 detected and quantity 
of drug seized  
-269-
Precursors
AMERICAS
North America
1993 Phenyl-2-propanone (P2P)    1 labUnited States
1994 1-Phenyl-2-propanone (P2P)   10 labs
1995 P2P    4 labs
1996 P2P   30 labs
1996 Phenyl-2-propanone    3 labs
1997 P2P (Phenyl-2-Propanone    2 labs
   50 labsSubtotal North America
   50 labsTotal Americas
ASIA
Central Asia  and Transcaucasia
1996 Ephedrine    4 labs(400 units)Kyrgyzstan
    4 labs(400 units)Subtotal Central Asia  and Transcaucasia
    4 labs(400 units)Total Asia
EUROPE
Western Europe
1996 Benzilmethylketoneketone    1 labMalta
1996 Acetic Anhydride    1 lab (2.680 kg)Turkey
    2 labs (2.680 kg)Subtotal Western Europe
    2 labs (2.680 kg)Total Europe
   56 labs (2.680 kg)(400 units)Total : Precursors
 10447 labs (76,671.830 kg) (27,391.10 lt)(17,631,358 units)GRAND TOTAL :
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D.  RESPONSES BY GOVERNMENTS TO THE 
ANNUAL REPORTS QUESTIONNAIRE (ARQ), 
PART III (ILLICIT TRAFFIC)
(As at February 1999)
REGION Conventions* and parties thereto ARQ (part III) received for
Country or territory 1961 1961 1971 1988 1993 1994 1995 1996 1997**
as amended by
1972 Protocol
AFRICA
   East Africa
Burundi x x x
Eritrea x
Ethiopia x x x x x x x
Kenya x x x x x x
Madagascar x x x
Mauritius** x x x x x x
Rwanda x x
Seychelles x x x x
Uganda x x x x
United Republic of Tanzania x x x x x
Subtotal 8 7 7 3 6 4 3 3
   North Africa
Algeria x x x
Egypt x x x x x x x x
Morocco x x x x x x x x
Sudan x x x
Tunisia x x x x x
Subtotal 2 3 5 5 2 3 3 2 2
   Southern Africa
Democratic Republic of the Congo x x x
Lesotho x x x x
Malawi x x x x x x
Mozambique x x x
Namibia x x x x x
South Africa x x x x x x x x
Zambia x x x
Zimbabwe x x x
Subtotal 8 8 6 1 4 3 3 2
   West and Central Africa
Benin x x x x
Burkina Faso x x x x
Côte d'Ivoire x x x x x x x x
Cameroon x x x
Chad x x x x
Congo x x x x x
Equatorial Guinea x x
Ghana x x x x x x x x
Guinea-Bissau x x x
Mauritania x x x
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REGION Conventions* and parties thereto ARQ (part III) received for
Country or territory 1961 1961 1971 1988 1993 1994 1995 1996 1997**
as amended by
1972 Protocol
Nigeria x x x x x x
Sao Tome and Principe x x x x
Sierra Leone x x x x
Saint Helena x
Togo x x x x
Subtotal 1 11 12 12 6 6 3 5 7
TOTAL AFRICA 3 30 32 30 12 19 13 13 14
AMERICA
   Central America
Belize x x
Costa Rica x x x x x x x
El Salvador x x x
Guatemala x x x x x
Honduras x x x x
Nicaragua x x x x x
Panama x x x x x x x
Subtotal 1 5 5 7 1 3 3 4 4
   North America
Canada x x x x x x x x
Mexico x x x x x x x x
United States x x x x x x x x
Subtotal 3 3 3 3 3 3 3 3
   South America
Argentina x x x x x x x
Bolivia x x x x
Brazil x x x x x x
Chile x x x x x x x
Colombia x x x x x x x x
Ecuador x x x x x x x x
Falkland Islands x x
Guyana x x x x
Paraguay x x x x x x
Peru x x x x x x x
Suriname x x x x x x
Uruguay x x x x x x
Venezuela x x x x x x x
Subtotal 11 12 12 6 6 11 10 10
Caribbean
Anguilla x x x
Antigua Barbuda x x x x
Bahamas x x x x x
Barbados x x x
Bermuda x x x
British Virgin Islands x x
Cayman Islands x x x
Cuba x x x x x
Dominica x x x x
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REGION Conventions* and parties thereto ARQ (part III) received for
Country or territory 1961 1961 1971 1988 1993 1994 1995 1996 1997**
as amended by
1972 Protocol
Dominican Rep. x x x x x x x
Grenada x x x x x x x
Montserrat x x
Saint Lucia x x x x x x x
Saint Vincent and the Grenadines x
Trinidad and Tobago x x x x x
Turks and Caicos Islands  x x x
Subtotal 9 8 16 5 6 3 10 7
TOTAL AMERICA 1 28 28 38 15 18 20 27 24
ASIA
   Central Asia and Transcaucasia
Armenia x x x x x x
Kazakhstan x x x x x
Kyrgyzstan x x x x x x
Tajikistan x x
Uzbekistan x x x x x x x x
Subtotal 4 4 5 1 3 3 4 3
   East and South-East Asia
Brunei Darussalam x x x x x x x x
China** x x x x x
Hong Kong SAR of China x x x x
Indonesia x x x x x x x x
Japan x x x x x x x x
Lao People's Dem. Rep. x x x x
Macao x
Malaysia x x x x x
Myanmar x x x x x x x x
Philippines x x x x x x x
Republic of Korea x x x x x x
Singapore x x x x x x x x
Thailand** x x
Subtotal 2 9 11 9 8 9 9 9 8
   Near and Middle East/ 
   South-West Asia
Bahrain x x x x x x x x
Iran (Islamic Republic of) x x x x x x x
Iraq x x x x x x x x
Israel x x x x x x x
Jordan x x x x x x x x
Kuwait x x x x
Lebanon x x x x x x x x
Oman x x x x x x
Pakistan x x x
Qatar x x x x x x x
Saudi Arabia x x x x x x
Syrian Arab Republic x x x x x x
United Arab Emirates x x x x x x x x
Subtotal 2 11 12 11 11 11 11 9 8
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REGION Conventions* and parties thereto ARQ (part III) received for
Country or territory 1961 1961 1971 1988 1993 1994 1995 1996 1997**
as amended by
1972 Protocol
   South Asia
Bangladesh x x x x x x
Bhutan x
India x x x x x x x
Maldives x x x
Nepal x x x x x x
Sri Lanka x x x x x x x x
Subtotal 4 3 5 5 5 4 3 2
TOTAL ASIA 4 28 30 30 25 28 27 25 21
EUROPE
   Eastern Europe
Belarus x x x x x x
Bulgaria x x x x x x x
Croatia x x x x x x x
Czech Republic x x x x x x x x
Estonia x x x
Hungary x x x x
Latvia x x x x x x
Lithuania x x x x x x x
Poland x x x x x x x x
Republic of Moldova x x x x x
Romania x x x x x x x
Russian Federation x x x x x x x
Slovakia x x x x x x
Slovenia x x x x x x x
The former Yug. Rep.of Macedonia x x x x
Ukraine x x x x x x
Yugoslavia x x x x x
Subtotal 2 15 17 16 8 10 10 13 12
   Western Europe
Austria x x x x x x x x
Belgium x x x x x x x x
Cyprus x x x x x x x x
Denmark x x x x x x x
Finland x x x x x x x x
France x x x x x x
Germany x x x x x x x x
Gibraltar x x
Greece x x x x x x x x
Iceland x x x x x
Ireland x x x x x
Italy x x x x x x x
Liechtenstein x x x x x x
Luxembourg x x x x x x x x
Malta x x x x x x x x
Monaco x x x x x x x x
Netherlands x x x x x
Norway x x x x x x x x
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REGION Conventions* and parties thereto ARQ (part III) received for
Country or territory 1961 1961 1971 1988 1993 1994 1995 1996 1997**
as amended by
1972 Protocol
Portugal x x x x x x x x
San Marino x x
Spain x x x x x x x x
Sweden x x x x x x x x
Switzerland x x x x x x x
Turkey x x x x x x x x
United Kingdom x x x x x x x x
Subtotal 2 21 22 21 20 20 21 22 23
TOTAL EUROPE 4 36 39 37 28 30 31 35 35
OCEANIA
Australia x x x x x x x x
Christmas Island x
Cocos (Keeling) Islands x
Cook Islands x
Fiji x x x x x
Kiribati x
Micronesia (Fed. States of) x x x x
Nauru x
New Zealand x x x x
Norfolk Island x
Papua New Guinea x x x x x
Tongo x x x
Vanuatu x x
TOTAL OCEANIA 6 6 4 3 8 5 3 2
GRAND TOTAL 12 128 135 139 83 103 96 103 96
* including the Single Convention on Narcotic Drugs of 1961; the 1972 Protocol amending the 1961 Single Convention; 
   the Convention on Psychotropic Substances of 1971; and the United Nations Convention against Illicit Traffic in
   Narcotic Drugs and Psychotropic Substances of 1988. 
   (Note that the lists of States with parties to the Conventions are not complete, covering only those that have submitted
   ARQs within the last five years).
  ** ARQs (part III) for 1997 were received from China, Mauritius and Thailand subsequent to the finalization
       of this document and data could, therefore, not be included.
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ANNEX II. Demand Statistics
1. Responses by Governments to the Annual Reports Questionnaire,
part II (drug abuse) 
Region, country or territory  Annual Reports Questionnaire - Part II - Drug Abuse
 1992  1993  1994  1995  1996  1997 
Africa
East Africa
Eritrea - - 1 - - -
Ethiopia         1         1          -         1          -         1 
Kenya          -          -         1         1         1         1 
Mauritius         1         1         1         1         1          - 
United Republic of Tanzania          -          -          -         1          -         1 
Number of ARQs submitted from East Africa         2         2         3         4         2         3 
North Africa
Morocco         1         1         1         1         1         1 
Number of ARQs submitted from North Africa         1         1         1         1         1         1 
Southern Africa
Dem. Republic of the Congo          -          -         1          -          -         1 
Lesotho          -          -         1          -          -          - 
Malawi          -          -          -          -          -         1 
Namibia         1          -         1         1         1         1 
South Africa         1         1         1         1         1         1 
Number of ARQs submitted from Southern Africa        2        1        4        2        2        4 
West and Central Africa
Burkina Faso          -         1          -          -          -          - 
Côte d'Ivoire         1         1         1         1         1         1 
Chad         1          -          -         1         1          - 
Congo         1         1         1         1          -         1 
Equatorial Guinea         1         1         1          -          -          - 
Ghana         1         1          -         1         1         1 
Nigeria         1         1         1         1         1         1 
Sao Tome and  Principe          -          -          -          -          -         1 
Sierra Leone          -          -          -          -         1         1 
Togo         1          -          -          -         1          - 
Number of ARQs submitted from West and Central Africa        7        6        4        5        6        6 
     Africa Total      12      10      12      12      11      14 
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Region, country or territory  Annual Reports Questionnaire - Part II - Drug Abuse
 1992  1993  1994  1995  1996  1997 
Americas
Central America
Belize          -          -         1          -          -          - 
Costa Rica         1         1         1         1         1         1 
Guatemala          -          -          -          -         1         1 
Honduras          -          -          -         1          -         1 
Nicaragua          -          -          -         1          -         1 
Panama         1         1         1         1         1         1 
Number of ARQs submitted from Central America        2        2        3        4        3        5 
North America
Canada         1         1         1         1         1         1 
Mexico         1         1         1         1         1         1 
United States         1         1         1         1         1         1 
Number of ARQs submitted from North America        3        3        3        3        3        3 
South America
Argentina         1         1         1         1         1         1 
Bolivia         1          -         1         1         1         1 
Brazil          -         1          -         1         1         1 
Chile          -          -         1         1         1         1 
Colombia         1         1         1         1         1         1 
Ecuador         1         1         1         1         1         1 
Falkland Islands          -         1          -         1          -          - 
Guyana          -          -          -          -         1          - 
Paraguay          -          -          -         1         1          - 
Peru         1         1         1          -         1          - 
Suriname          -          -          -         1         1         1 
Uruguay          -         1          -         1         1          - 
Venezuela         1         1         1         1         1          -
Number of ARQs submitted from South America        6        8        7      11      12        7 
Caribbean
Bahamas         1         1          -          -          -          - 
Cuba          -         1          -          -         1          - 
Dominica          -          -          -          -         1          - 
Dominican Rep.          -          -         1         1         1         1 
Grenada          -         1         1         1         1         1 
St. Lucia         1         1         1          -          -          - 
Number of ARQs submitted from the Caribbean        2        4        3        2        4        2 
    Americas Total      13      17      16      20      22      17 
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Region, country or territory  Annual Reports Questionnaire - Part II - Drug Abuse
 1992  1993  1994  1995  1996  1997 
Asia
Central Asia  and Transcaucasia
Armenia          -          -         1         1         1         1 
Kazakhstan         1          -          -         1         1          - 
Kyrgyzstan          -          -          -         1         1         1 
Tajikistan          -          -          -          -         1          - 
Uzbekistan          -         1         1         1         1         1 
Number of ARQs submitted from Central Asia and Transcaucasia        1        1        2        4        5        3 
East and South-East Asia
Brunei Darussalam         1         1         1         1         1         1 
Cambodia          -          -          -         1          -          - 
China          -          -          -         1         1          - 
Hong Kong  SAR of China          -          -         1          -         1         1 
Indonesia         1         1         1         1         1         1 
Japan         1         1         1         1         1         1 
Lao People's Dem. Rep.         1         1         1          -          -          - 
Macao          -          -         1          -         1          - 
Malaysia          -          -         1         1          -         1 
Myanmar          -         1         1         1         1         1 
Philippines         1         1         1         1         1         1 
Republic of Korea         1         1          -         1         1         1 
Singapore          -         1         1         1         1         1 
Viet Nam          -          -          -         1          -          -
Number of ARQs submitted from East and South-East Asia        6        8      10      11      10        9 
Near and Middle East /South-West Asia
Bahrain         1          -         1         1          -          -
Iraq         1         1         1         1         1         1 
Islamic Republic of Iran         1         1         1         1          -         1 
Israel         1         1         1         1         1          - 
Jordan          -         1         1         1         1         1 
Kuwait          -         1         1          -          -          - 
Lebanon          -          -          -         1         1          - 
Oman         1         1         1          -          -          - 
Qatar          -         1         1         1         1         1 
Saudi Arabia          -         1          -          -          -          - 
Syrian Arab Republic         1          -         1          -         1         1 
United Arab Emirates         1         1         1         1         1         1 
Number of ARQs submitted from Near and Middle
East/South-West Asia
       7        9      10        8        7        6 
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Region, country or territory  Annual Reports Questionnaire - Part II - Drug Abuse
 1992  1993  1994  1995  1996  1997 
South Asia
Bangladesh          -         1         1          -         1          - 
India         1         1         1         1          -         1 
Maldives          -         1         1         1          -          - 
Nepal          -         1         1         1         1          - 
Sri Lanka         1         1         1         1         1         1 
Number of ARQs submitted from South Asia        2        5        5        4        3        2 
Asia total      16      23      27      27      25      20 
Europe
Eastern Europe
Belarus         1         1         1         1         1         1 
Bulgaria         1         1         1         1         1         1 
Croatia         1          -          -          -          -         1 
Czech Republic         1         1         1         1         1         1 
Estonia          -          -          -          -          -         1 
Hungary         1          -         1          -         1         1 
Latvia         1         1         1         1         1         1 
Lithuania          -          -         1         1         1         1 
Poland         1         1         1         1         1          - 
Republic of Moldova          -         1         1         1         1         1 
Romania         1         1          -          -          -          - 
Russian Federation         1          -         1         1         1         1 
Slovakia          -          -         1          -          -         1 
Slovenia          -         1          -          -          -          - 
The former Yug. Rep. Of Macedonia          -          -          -         1          -          -
Ukraine         1         1          -          -         1         1 
Yugoslavia         1         1         1         1          -          -
Number of ARQs submitted from Eastern Europe      11      10      11      10      10      12 
Western Europe
Austria         1         1          -         1         1          - 
Belgium         1         1         1         1         1         1 
Cyprus         1          -         1         1         1          - 
Denmark         1         1         1         1          -          - 
Finland         1         1         1         1         1         1 
France         1         1         1         1         1         1 
Germany         1         1         1         1         1         1 
Greece         1         1         1         1         1         1 
Iceland          -          -         1         1          -         1 
Ireland          -          -         1         1         1         1 
Italy         1         1         1         1         1          - 
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 1992  1993  1994  1995  1996  1997 
Liechtenstein          -          -         1         1         1         1 
Luxembourg         1         1         1         1         1         1 
Malta         1         1         1         1         1         1 
Monaco         1         1         1         1         1         1 
Netherlands          -         1         1         1         1         1 
Norway         1         1         1         1         1         1 
Portugal         1         1         1         1         1         1 
San Marino         1         1         1          -          -         1 
Spain         1         1         1         1         1         1 
Sweden         1         1         1         1         1         1 
Switzerland          -         1         1         1         1         1 
Turkey         1         1         1         1         1         1 
United Kingdom         1         1         1         1         1         1 
Number of ARQs submitted from Western Europe      19      20      23      23      21      20 
Europe Total      30      30      34      33      31      32 
Oceania
Australia         1         1         1         1         1         1 
Fed. States of Micronesia          -          -         1         1          -          - 
Fiji          -          -         1          -         1          - 
Kiribati          -          -          -         1          -          -
Nauru          -          -          -          -          -         1 
New Zealand         1         1          -         1          -          - 
Papua New Guinea         1         1         1         1          -          - 
Vanuatu          -          -         1         1          -         1 
Cook Islands          -          -          -          -         1          - 
Number of ARQs submitted from Oceania        3        3        5        6        3        3 
Oceania Total        3        3        5        6        3        3 
World Total       74       83       94       98       92       86
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2. Drug abuse among prison populations, 1992-1997 
Region, Country or territory 1992 1993  1994 1995 1996 1997
 % of prison 
population 
abusing drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
AFRICA
Congo 5.8 2.4
Kenya 10.0 30.0
Mauritius 25.4 7.5
Namibia 90.0 3.0 90.0 3.0
Nigeria 5.0 5.0
Sierra Leone 30.0 2.0
South Africa 70.0 3.0 70.0 3.0
AMERICAS
North America
Canada 70.0 2.0 70.0 1.5 10.0
Mexico 30.0 30.0
United States 70.0 10.0 70.0 10.0 70.0 15.0
Central America
Costa Rica 34.6 57.8 40.0 10.0 40.0 15.0 50.0
Panama 80.0 10.0 80.0 10.0
Caribbean
Bahamas 70.0 14.3 70.0 14.3
Grenada 30.0 2.0 30.0 2.0 30.0 2.0 15.0 0.0
Saint Lucia 40.0 60.0 1.7 40.0 2.0
South America
Argentina 50.0 20.0 60.0 20.0 45.0
Bolivia 35.0 50.0 58.7 35.0
Colombia 13.0 13.0 39.0 6.0 32.6 32.6
Ecuador 27.0 39.4 75.0 25.0 70.0 14.3
Suriname 20.0 10.0 20.0 10.0 25.0 10.0
Uruguay 4.8 11.3
Venezuela 2.7
ASIA
Central Asia
Kyrgyzstan 4.8 4.2
Tajikistan 30.0 25.0
Uzbekistan 5.0
Near and Middle East
Israel 60.0 30.0 70.0 2.5 70.0 70.0 0.3
Lebanon 30.0 10.0 5.0 10.0
Oman 10.0 0.0
Qatar 43.0 0.0 42.0 0.0 7.9 0.0
Syrian Arab Republic 7.3 2.0 7.3
South Asia
India 14.0 1.0
Nepal 10.8 6.0
Sri Lanka 55.0 2.0 45.0 45.0 35.0 1.0 33.0 1.0 41.0
East and South-East Asia
Brunei Darussalam 19.2 1.8 10.9 7.8 12.0 2.7 30.9 1.0
China (Hong Kong SAR) 35.0 11.0
Indonesia 3.1 72.0
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Region, Country or territory 1992 1993  1994 1995 1996 1997
 % of prison 
population 
abusing drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
 % of prison 
population 
abusing 
drugs 
 % of females 
among 
prison 
population 
abusing 
drugs 
Japan 7.8 25.8 7.8 26.8 7.5 30.3 7.7
Macao 11.2 92.0
Malaysia 55.9 1.4 41.5 1.0
Myanmar 12.5 1.0 12.5 1.0
Singapore 53.7 4.2 46.2 7.7 38.6 7.5
EUROPE
Eastern Europe
Belarus 1.0 10.0
Bulgaria 7.5 0.0 12.0 5.0 12.0 5.0
Croatia 7.0 5.0 20.0 1.0
Czech Republic 7.5 46.7 6.5 1.6 5.5 15.0 5.0
Hungary 5.0
Lithuania 29.8 10.0 4.0 3.8 10.0
Poland 0.5 10.0 1.0 10.0 6.0 2.0 6.0 5.0
Slovakia 8.0
Slovenia 6.0 90.0
Ukraine 7.3
Western Europe
Belgium 29.6 0.0 32.5 31.8 0.0 40.0 50.0
Denmark 31.0 5.0 31.0 6.3 33.0
Finland 6.0 6.0 12.0 4.0 30.0 4.0 30.0 4.0
France 15.0 4.5 15.0 4.5 5.0 15.0 5.0 20.0 6.0
Germany 10.0 10.0
Iceland 13.0 11.0
Italy 33.5 7.0 28.8
Liechtenstein 90.0 2.0 7.5 10.0
Luxembourg 10.0 10.0 25.0 10.0 35.0 10.0 60.0 10.0 36.0 10.0
Malta 65.0 10.0 75.0 10.0
Monaco 15.0 10.0 15.0 10.0
Netherlands 45.0
Norway 40.0 10.0 40.0 10.0 50.0 10.0 50.0 50.0
Portugal 48.0 6.9 65.0 70.0 10.0
Spain 37.8 9.1 30.2 9.0 40.0 9.5 40.0 9.6 40.0 9.6
Sweden 40.0 40.0 40.0 20.0 40.0 30.0 40.0 30.0 40.0 30.0
Switzerland 23.0 10.0
United Kingdom 11.5 9.0 11.2 24.0 3.0 22.0 5.0
OCEANIA
Australia 26.0
Fiji 9.9 6.0
Papua New Guinea 2.0 1.0 17.0
Vanuatu 15.0 15.0
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                            Mode of Transmission (%)
Adults and 
children, 
cumulative
Hetero sexual Homo sexual IDU Blood
Mother-to-
child
Period of 
reporting
AFRICA sexual
Algeria 326 63 9 5 18 5 1985-1997
Angola 1,296 59 1 9 24 8 1985-1997
Benin 2,275 92 0 0 2 6 1985-1997
Botswana 5,337 94 0 0 0 6 1988-1995
Burkina Faso 10,108 …  …  …  …  …  …
Burundi 9,119 …  …  …  …  …  …
Cameroon 9,626 …  …  …  …  …  …
Central African Republic 7,016 …  …  …  …  …  …
Chad 7,354 98 0 0 0 2 1986-1997
Comoros 18 …  …  …  …  …  …
Congo 10,223 …  …  …  …  …  …
Côte d'Ivoire 37,963 …  …  …  …  …  …
Dem. Republic of the  Congo 38,426 92 0 0 3 4 1986-1995
Djibouti 1,672 98 0 0 0 2 1995-1997
Egypt 153 67 14 6 14 0 1995-1997
Equatorial Guinea 231 98 0 0 0 2 1988-1996
Eritrea 3,464 …  …  …  …  …  …
Ethiopia 21,569 97 0 0 2 2 1986-1996
Gabon 1,376 96 0 0 0 4 1987-1996
Gambia 504 94 0 0 0 6 1989-1996
Ghana 18,730 …  …  …  …  …  …
Guinea 3,352 98 0 0 0 2 1987-1996
Guinea-Bissau 823 100 0 0 0 0 1989-1993
Kenya 74,754 …  …  …  …  …  …
Lesotho 2,436 90 0 0 6 4 1986-1993
Liberia 176 …  …  …  …  …  …
Libyan Arab Jamahiriya 17 …  …  …  …  …  …
Madagascar 32 …  …  …  …  …  …
Malawi 50,970 89 0 0 2 9 1995-1996
Mali 4,028 …  …  …  …  …  …
Mauritania 161 93 2 1 1 2 1988-1995
Mauritius 43 84 0 16 0 0 1987-1997
Morocco 390 72 16 9 3 1 1995-1997
Mozambique 6,126 84 0 0 10 6 1986-1997
Namibia 6,784 …  …  …  …  …  …
Niger 3,002 99 0 0 0 1 1987-1995
Nigeria 17,066 95 0 0 4 1 1986-1995
Réunion 166 17 35 35 8 4 1987-1990
Rwanda 12,056 …  …  …  …  …  …
Senegal 1,982 97 1 0 1 0 1986-1994
Sierra Leone 205 97 1 0 0 3 1987-1996
Somalia 13 …  …  …  …  …  …
South Africa 12,825 79 7 0 1 13 1982-1997
Sudan 1,649 98 0 0 0 1 1995-1997
Swaziland 2,449 86 0 0 0 14 1991-1995
Togo 7,993 91 0 0 2 7 1987-1997
Tunisia 338 45 7 28 11 8 1995-1997
Uganda 51,779 …  …  …  …  …  …
United Republic of Tanzania 88,667 96 0 0 0 3 1983-1995
Zambia 44,942 94 0 1 5 0 1984-1990
Zimbabwe 65,939 86 0 0 0 14 1987-1997
AMERICAS
North America
Canada 15,101 13 71 13 2 1 1993-1996
Mexico 32,339 34 55 1 8 2 1993-1996
United States of America 612,078 13 52 33 2 0 1993-1995
Central America
Belize 198 65 30 1 0 4 1993-1996
Costa Rica 1,173 22 73 2 1 2 1993-1996
El Salvador 2,019 84 9 2 0 5 1993-1996
Region, Country or territory
3. Cumulative AIDS cases by mode of transmission, 1980-1997
Source: UNAIDS/WHO Global HIV/AIDS and STD Surveillance
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                            Mode of Transmission (%)
Adults and 
children, 
cumulative
Hetero sexual Homo sexual IDU Blood
Mother-to-
child
Period of 
reporting
Region, Country or territory
Guatemala 2,011 77 16 1 2 3 1993-1996
Guyana 842 86 7 1 3 3 1993-1996
Honduras 6,406 80 11 0 0 8 1993-1996
Nicaragua 157 49 41 7 2 2 1993-1996
Panama 1,430 57 36 1 0 5 1993-1996
South America
Argentina 10,669 21 31 42 1 4 1993-1996
Bolivia 157 60 29 4 0 7 1993-1996
Brazil 110,845 34 34 25 4 4 1993-1996
Chile 1,967 25 67 6 1 2 1993-1996
Colombia 7,953 16 83 0 1 1 1993-1996
Ecuador 625 42 56 0 0 1 1993-1996
Paraguay 283 50 28 12 4 6 1993-1996
Peru 5,958 47 48 0 2 3 1993-1996
Suriname 211 86 5 0 0 9 1993-1996
Uruguay 924 24 38 30 2 7 1993-1996
Venezuela 6,916 36 54 4 3 3 1993-1996
Caribbean
Bahamas 2,567 92 2 0 0 6 1993-1996
Barbados 762 79 16 0 0 6 1993-1996
Cuba 599 45 54 0 1 1 1993-1996
Dominican Republic 3,940 81 6 4 6 3 1993-1996
Haiti 4,967 …  …  …  …  …  …
Jamaica 2,184 84 8 0 0 8 1993-1996
Trinidad and Tobago 2,613 83 13 0 0 4 1993-1996
ASIA
Central Asia and Transcaucasia
Armenia 8 …  …  …  …  …  …
Azerbaijan 9 …  …  …  …  …  …
Kazakhstan 14 0 0 0 0 0 ...
Kyrgyzstan 0 …  …  …  …  …  …
Tajikistan 0 …  …  …  …  …  …
Turkmenistan 1 …  …  …  …  …  …
Uzbekistan 4 …  …  …  …  …  …
East and South-East Asia
Brunei Darussalam 10 …  …  …  …  …  …
Cambodia 617 80 1 0 0 19 1993-1997
China 155 17 5 59 20 0 1985-1997
Hong Kong SAR  of China 274 57 35 2 6 1 1985-1997
Dem. Peo. Rep. of Korea 0 …  …  …  …  …  …
Indonesia 153 72 24 3 0 1 1987-1997
Japan 1,447 39 27 1 33 1 1985-1997
Lao People's Dem. Rep 69 78 0 0 18 4 1991-1997
Malaysia 1,110 16 3 68 12 2 1987-1997
Mongolia 0 …  …  …  …  …  …
Myanmar 1,822 …  …  …  …  …  …
Philippines 310 56 39 1 3 2 1984-1997
Republic of Korea 83 84 12 0 4 0 1987-1997
Singapore 314 46 31 2 20 0 1986-1997
Thailand 59,782 …  …  …  …  …  …
Viet Nam 1,020 18 0 81 1 0 1993-1997
Near and Middle East/South-West Asia
Afghanistan …  …  …  …  …  …  …
Bahrain 37 …  …  …  …  …  …
Iran (Islamic Republic of) 154 48 0 10 43 0 1995-1996
Iraq 104 …  …  …  …  …  …
Israel 466 31 36 17 13 2 1980-1997
Jordan 51 …  …  …  …  …  …
Kuwait 24 …  …  …  …  …  …
Lebanon 97 …  …  …  …  …  …
Oman 135 …  …  …  …  …  …
Pakistan 147 92 0 0 0 8 1995-1997
Qatar 85 …  …  …  …  …  …
Saudi Arabia 334 69 2 2 21 5 1995-1997
Syrian Arab Republic 49 …  …  …  …  …  …
United Arab Emirates 8 …  …  …  …  …  …
Yemen 82 91 2 0 7 0 1995-1996
South Asia
Source: UNAIDS/WHO Global HIV/AIDS and STD Surveillance
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                            Mode of Transmission (%)
Adults and 
children, 
cumulative
Hetero sexual Homo sexual IDU Blood
Mother-to-
child
Period of 
reporting
Region, Country or territory
Bangladesh 10 52 45 2 0 1 ...
Bhutan 0 …  …  …  …  …  …
India 4,980 …  …  …  …  …  …
Maldives 5 …  …  …  …  …  …
Nepal 183 …  …  …  …  …  …
Sri Lanka 77 …  …  …  …  …  …
EUROPE
Eastern Europe
Albania 10 …  …  …  …  …  …
Belarus 17 …  …  …  …  …  …
Bosnia and Herzegovina 6 …  …  …  …  …  …
Bulgaria 53 77 19 0 4 0 1987-1997
Croatia 119 36 50 8 6 1 1986-1997
Czech Republic 111 16 68 2 13 0 1986-1997
Estonia 17 …  …  …  …  …  …
Georgia 22 …  …  …  …  …  …
Hungary 277 10 77 0 12 0 1986-1997
Latvia 20 …  …  …  …  …  …
Lithuania 12 …  …  …  …  …  …
Poland 594 14 33 51 2 1 1986-1997
Republic of Moldova 17 …  …  …  …  …  …
Romania 5,147 20 2 0 63 16 1985-1997
Russian Federation 268 32 64 1 2 2 1986-1997
Slovakia 18 …  …  …  …  …  …
Slovenia 62 23 59 7 7 4 1986-1997
Ukraine 357 24 6 64 1 5 1988-1997
Yugoslavia 683 17 15 53 14 1 1985-1997
Western Europe
Austria 1,767 15 46 30 7 2 1983-1997
Belgium 2,412 44 40 7 5 4 1980-1997
Cyprus 54 …  …  …  …  …  …
Denmark 2,102 17 70 9 3 1 1981-1997
Finland 268 23 69 4 4 1 1982-1997
France 47,407 19 48 26 5 1 1980-1997
Germany 17,048 8 70 16 5 1 1981-1997
Greece 1,740 18 65 5 12 1 1982-1997
Iceland 43 7 83 5 5 0 1985-1997
Ireland 609 13 35 44 5 3 1983-1997
Italy 40,950 14 15 68 2 2 1982-1997
Luxembourg 122 19 56 17 7 1 1984-1997
Malta 43 12 51 2 32 2 1986-1997
Netherlands 4,630 13 72 12 3 1 1982-1997
Norway 599 20 58 17 4 1 1983-1997
Portugal 4,701 27 24 44 4 1 1983-1997
Spain 48,989 11 17 68 2 2 1981-1997
Sweden 1,557 21 60 12 6 1 1982-1997
Switzerland 6,099 17 39 41 2 1 1980-1997
The Former Yug. Republic of 
Macedonia 23 …  …  …  …  …  …
Turkey 254 51 19 17 12 2 1985-1997
United Kingdom 15,081 15 70 8 5 2 1981-1997
OCEANIA
Australia 7,386 5 89 3 4 0 1982-1997
Fiji 8 …  …  …  …  …  …
New Zealand 621 8 87 2 3 0 1984-1997
Papua New Guinea 306 87 4 0 0 10 1984-1997
Total: 54 26 11 6 3
Source: UNAIDS/WHO Global HIV/AIDS and STD Surveillance
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7. Drug abuse trends 
Number of countries reporting increase, stable development or decrease in drug abuse
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997*
Cannabis
Increase 26 29 22 23 21 19 22 28 36 37 38 44
Stable 18 18 19 18 17 14 17 17 20 21 17 14
Decrease 10 7 5 7 13 9 7 9 5 6 7 9
Net increase 16 22 17 16 8 10 15 19 31 31 31 35
Heroin
Increase 11 12 12 18 18 14 22 22 24 26 28 26
Stable 11 10 6 10 6 6 13 15 14 15 10 6
Decrease 9 6 10 9 10 3 4 10 8 7 7 13
Net increase 2 6 2 9 8 11 18 12 16 19 21 13
Opium
Increase 3 3 2 1 1 4 10 6 5 5 4 11
Stable 1 2 0 3 1 4 5 7 6 8 9 5
Decrease 6 3 5 4 2 6 5 5 4 8 10 7
Net increase -3 0 -3 -3 -1 -2 5 1 1 -3 -6 4
Cocaine
Increase 13 16 16 21 16 19 18 15 16 11 20 16
Stable 4 3 2 3 3 9 3 7 10 8 6 10
Decrease 2 0 2 4 1 0 4 6 3 6 2 6
Net increase 11 16 14 17 15 19 14 9 13 5 18 10
Amphetamine-type stimulants
Increase 12 12 8 9 8 9 13 13 19 27 31 31
Stable 5 5 4 5 6 6 13 13 12 11 13 12
Decrease 3 2 2 1 4 9 7 9 6 4 5 12
Net increase 9 10 6 8 4 0 6 4 13 23 26 19
Hallucinogens
Increase 0 0 1 1 1 3 11 12 10 14 15 7
Stable 2 3 3 2 0 5 9 9 11 10 13 11
Decrease 0 1 1 0 0 4 5 4 6 2 3 5
Net increase 0 -1 0 1 1 -1 6 8 4 12 12 2
Benzodiazepines
Increase 6 8 7 10 3 8 10 12 14 19 17 11
Stable 2 6 11 7 8 5 8 13 7 6 7 9
Decrease 2 2 0 2 3 2 4 4 5 3 8 8
Net increase 4 6 7 8 0 6 6 8 9 16 9 3
Inhalants
Increase 3 4 4 8 6 7 6 8 12 20 15 11
Stable 5 8 5 4 4 4 10 12 8 6 10 13
Decrease 3 3 2 1 0 5 8 7 6 7 3 10
Net increase 0 1 2 7 6 2 -2 1 6 13 12 1
* Preliminary 
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